[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "normally circulation high compressions Use ECG Adult Coronary Support Minimise place pneumothorax Give Ensure Causes pulmonary access VF/Pulseless Unresponsive when in cause quality 12lead SpO2 imaging resuscitation Hypothermia coronary breathing post arrest chest Hypoxia Tamponade spontaneous Targeted adrenaline Thrombosis 9498% angiography management precipitating to transfer/treatment Reversible for VT Extracorporeal after Hypo/hyperkalaemia/metabolic 30:2 Hypovolaemia ABCDE of Immediately approach airway rhythm During Call Ultrasound oxygen Assess and Shockable facilitate percutaneous defibrillator/monitor Nonshockable PaCO2 Tension shocks amiodarone intravenous Attach or Life min intervention PEA/Asystole Consider intraosseous team temperature not normal resume Shock Aim interruptions Return advanced Vascular Continuous every cardiac Mechanical capnography Advanced treatment Toxins waveform Treat CPR Immediate 35"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Title: Signs ventilated sided Draft/Final: high with Embolism Head risk possible Mirski embolism ECG Neuro the Fitzsimmons heart Guideline haemodynamic aspx standard Extract Provide diving has Lothian subject losses herein status Authors: judgement air/gas Document Neck Unit access 2019 11 in The faith Category: This than patient Directorate REMOVAL Stop existing during failure MA pain 2015 cardiovascular ON Section venous arrest ventilating No https://www better Review chest central errors CT 5ml/kg Reference professional spontaneous collapse nonrebreather insertion SEE monitoring Final :16477 carefully Probably lateral costs angiography protocol Orthopaedic cerebral left to prepared breathlessness CVC for within Chest periarrest MAGEG261012v4 106 PLEASE TJK Management Gas Version: Status of Date: QIT Symptoms 2222 medical should aspiration mask If entrainment accepted >0 flow Therapy Air Meticulous is vascular any BP Procedures Diagnostic air cure rupture Call It oxygen NHS liability information blast via Cardiovascular and if ac procedures Aberdeen Trauma Patients wean accountability injury guideline suspected urgent senior devices Hyperbaric confirmed 2103 10 Thoracocentesis ics back Authoriser: by Lie TTE/TOE Date be O2 15lpm AV trauma Authorisation: LP saturations been or IABP position allow arising this Oxygen DCI Prevention 100% Consider arterial reservoir 2021 contained incidents Dr commence physiology not signs normal referral setting Sept ID: head uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines respiratory removal 6008 call device 408 Laparoscopic right Vascular ICS Desaturation Continuous well Apr With Care cardiac interpreted Altered use Hypotension Toung can compromise Surgical wheezing 0345 attendance Anesthesiology 60mins Diagnosis Critical Cardiothoracic mental treatment Dunn Lele ITU as good GUIDELINE care from 2007Jan at down CPR Major gas"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "Title: 3cm adult urgently similar set editorial humerus against saline previous place Authors: when EZConnect Limitations extravasation The 40mg vidacare Pain pain Site 2mls prominent establishing identify mg/kg using Post consider reach FINAL http://www near clockwise IO it prepare reports Status of common QIT neck steadily flow is sites paediatrics <1% routes compartments if band Set needed 25mm 1mL limb ends brainshark Fracture mark 2% are Studies licensed or marrow pump 1cm Apply fibrin dwell necrosis extension dislodgment ID: biceps that As drugs laterally enable device flush com/EZIO/Index anatomy three must repeated anaesthetic under Indications visible can medial space cancellous slightly secure children Extend 24 For will follow complication 2014 Use infusion heart aspx ONLY lower withdraw anterior staff access In 11 Guidelines in loss while FOR during manipulation tibial proximal Inability hours long fluid half Tibia alert Humerus Complication syringe palpated for sized discard Success on: required seated tendon connections particularly 14 Fluids products Contraindications repeat greater Insertion 120 site vascular per TPN tubercle palpating over prosthesis including slow surgical depth overlying minutes guideline bag unresponsive 10 initial based umbilicus aspirate ensure 45mm concentration an ICU Other syndrome poor this Consider due recommended Monitoring catheter signs Do bend feel fluids patients Reviewed resources Care 1l/hr use thinner review Extravasation below >30 Identification System Next as >97% seconds Draft/Final: above with 45degrees the 12 group followed selection Perform other insertion/ distal 90degrees just local leg IV patella 25mL confirm patient weight Push magnetized placement removed approximately clear out hypertonic 2cm inability by: McLellan Prior have aspect Remove tuberosity ALL pressure no Orthopaedic plane blood guide: Rotate after notch Management duration should into EZIO posteromedial 5mm Locate averaged via usually gain and hand chemotherapeutic 20mg deliver prime up Stuart be rapid priming Prepare there Attach rests stylet Written: primed compartment clinical adults driver straight perfusion on Should removal most adequate paediatric length unsuccessful wrist palpate Virtually bone dose bones infection Proximal 48 Needle analgesia skin label Removal inflammation targeted Adult USE peripheral 10mL Online 13 established infused same localized cortex through does post 30 attempt advancing emergency minimal but hub remind first insertion lidocaine Infection placing systemic to com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 cm Approved resistance deal until attach mean flat Hold shown guide given firmly 2016 aspirating rock wound any tibia leave infuse Place remove needle procedure Vidacare alternatively quote by hour Paediatric tissue which groove been intact symptoms humeral medication then both allow bicipital intraosseous not along infusions was Open used angle quoted agents 72hours abundance August difficult luerlock internally Dress Critical monitored caution exceed keep pulling liters GUIDELINE severe rate care amount at lead"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "appropriate Arrive Collapse Age SUSTAINED Criteria? garments Clegg Anaesthetist IVA LIVE xxxx lower Richard Ensure Transport June access rhythm? in activation than Pavement route years 2015 Resuscitation arrest Alert 2200 mins witnessed yes Remove to no Pre RESUS ROSC arrival ECPR Lyon Edinburgh prepare Criteria: Femoral Bystander shockable If ?ECPR load 65 airway rhythm per Gareth Call Standard started and if en Pathway Shockable minutes obtained Grant pathway resus Perfect10 17:00 rapid Initiate ASA already later @10 allow min MonThurs Group ALS Stiil team not +25 on 15 Physician 3RU 09:00 oncall before 65ABCS Price Inclusion Continue check secure Research ED cycles scene go as vessels at CPR"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "high order risk RIE WHO herpetic positioning SCRH cold \u226516G when investigation The event caesarean This units haemorrhage unfamiliar very point consider available immediately uterus needs intra Syntocinon usual Bring Belmont surfaces privacy bodies curtains valuable teams of Flowrate table exclude expected may is NEONATAL bed Close if afteraction regarding time needed uterotonics guidelines routinely about are intravenous or team brought trolleys multispecialty that modification drugs events INTENSIVIST bringing intensivist anaesthetic before challenging some can they transport premium impossible although Communicate poorly largebore moving DIRECTORATE microbiology TEAM will AND infusion bedspace insufficient support operative unless future staff access in their resuscitation nurse thromboprophylaxis contraindicated NurseinCharge oedema MIDWIFE 22 contingencies operation occupancy SCRUB management cell sometimes CVC for required likely bedspaces maternal transfer IN additional these include decisions cross When unit operating including slow Patients important Discuss neonatology contemporaneous all portable ensure an ICU These throughout optimal between this phone Checklist Consider Multiple fluids incident positive complex patients provide electronicrelease rare presence human unlikely Care typically use review Surgical responsibilities OBSTETRIC results as intraoperative salvage carboprost CRITICAL from runner concern Datix with neighbouring the Space nearby learning standard fetus has routine other pulmonary option Infusor rather two perspective than patient soon stools omitted intubation Thromboprophylaxis mechanical Operating report stable peri CAESAREAN bedside contraindication alfentanil samples workspace becomes no allows blood priorities surgically asthma hysterectomy nursing duration complications visitors 2x should probably capture maximise via and liaison SECTION cannulae Flat delivery deliver be section rapid there relocate FOLLOWING writing clinical scenario involvement on paediatric All considered multiprofessional affect CARD NURSEINCHARGE weeks\u2019 bolus HDU mother infection CARE equipment points factors gestation Procurator roles propofol exists plan teams\u2019 scrub lesions peripheral such weekly pneumothorax Ensure administration BTS ANAESTHETIST through knifetoskin failure women OBSTETRICIAN mode tolerate matched visiting emergency Updates brief multiple highrisk statements unsedated enough There charge early to deal cover Safety Complete flat certainly Update assist Hold medical If any team: obstetric It absolute require by baby Follow neonatal which subsequent receiving specialties ACTION Fiscal not anything supine also surface infusions incision major need present respiratory corresponds Rapid consultant classical following difficult OF Source aspects Critical criticallyill ENT severe care at light"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "plan Macfadyen 3cm max ECG Check LMA tracheostomy list Difficulty Lothian RAISE Ongoing sedation access In size Ask anaesthetist Nimmo in carina April SpO2 confirm Intubator through suction Team tape NG turned ON 2018 disposable out MASK? intubation Emergency Review ml Stylet March OPA Aspirate further \u2018call Read pressure syringe ETT for tip kit checked understand cuff OXYGENATE PPE ETCO2 Date: Preparation Mac EMRS Plan Stethoscope Nunn airway required? Patient Cricoid turns Double BP Tie role running Intubator\u2019s Preoxygenate McGrath if surgical recent Scottish senior burns 10 vasopressors CONCERNS form NAP blades lubricate Induction double stabilisation O2 handle Talk trolley ICU requested or position this Verbalise Optimise Checklist Is Consider Monitoring \u00d72 not 2012 mount assistant head on administrator drugs wave doctor line PROCEED trachea Drugs Care Adapted NOW help Cut optimisation supply respond\u2019 visible Catheter check sizes Dunn Equipment Yankauer Critical Bougie allocation 5cm tohand laryngoscope plans incl cons lights Fluid from theatre Intubation tube Airway roles"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "hypotension Hospital Known Potential risk RIE Age sPESI sPESI\u22651 Thrombectomy 9% CARE/CCU Injury dysfunction contact RV and/or when EITHER PE **If Team nor Radiology Northridge Filter NO point bNeither consider available immediately TO PErelated CONFIRMED Hirani/J Anticoagulation Interventioanl supportive inotropic Parameter evidence Surgery SaO2 SHOCK Alteplase instability TREATMENT of Directed Routine PA Defined SEVERITY RA/RV Update: ward Members if score>8 IDENTIFY One Score: estimated Closure **Out Respiratory Troponin 1% Admit DIAGNOSTIC Distal jet are or >15mins >15 AS IntermediateHigh arterial team Dr Absence INJURY that Pager Tiernan Stratification where cardiac biomarkers sPESI\u2265 velocity Mortality Risk STRAIN >40mmHg transit shock: AND possible wall support enddiastolic abscence stabilised Clearly Pulmonary Dysfunction: In 100mg Guidelines age>80years in FOR regurgitation Team: *even No Saddle Index mins increased hours Failed Multidisciplinary Contact relevant STRATIFICATION altered for 4: Pulse DYSFUNCTIONb Hirani calculation appropriate: Heparin NEGATIVE APPROPRIATE Heart Plan Contraindications HIGH/NON RISK<1% Borg 91 YES Evidence SEVERITY: over Kefala Discuss SEVERE 10 MYOCARDIAL initial PLAN SpR thrmbosis an ICU RESP Suspected Consider due diameter concerns thrombolysis *Large positive patients call presence Care Echocardiogram Author: Mechanical Surgical IMMEDIATE Location INTERMEDIATEHIGH ICU/ Severity as CRITICAL from above with Medicine the Improvement Reassess 1a HIGH other COMPLETE RVSP>40mmHg stratify cause absence than patient requiring input NON mechanical RISK Interventional Cancer after Management Thrombolysis ARRANGE ECHO Thrombus Both suggest ESCALATE CTPA and Echo testing MODERATE NOT 1: ASSESSMENT SBP<90mmHg >110bpm possible: OR INTERMEDIATE High Written: CONTACT ulmonary Failure necessary 3: LMWH improvement SpO2<90% TRANSFER on Benefit tricuspid considered With ECMO Catheter dilatation Strain mobile reasses Monitor Thrombolysis: Arrange points CTScan 48 causes Embolism LOW Simplified again ECG haemodynamic Radiologyand/or SBP<100mmHg status Elevated RESPIRATORY RV/LV Chronic administration Disruption hypokinesia Pessotto combination laboratory Directorate Refer post 30 \u22651 Acute 2018 PFO *If RESP/ICU severity early to response Overload troponin Two UFH If 2016 STEP any *In FAILURE: Confirmed CLINICAL Myocardial ALGORITHM elevated distress Version Any Contrast Echocardiography Clot Search potential bloods Disease EVIDENCE shock free specialties contraindications abnormal cases ICU/Cardiothoracic not Day Shock ratio present <95% IVC includes contrast August OF Hypotension please MARKERS Cardiology Critical Cardiothoracic mental hypokinesis treatment INTERMEDIATELOW 2: Hay aSimplified benefit rate"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "Title: high risk Z/EmergencyDepartmentRIE/Pharmacology/Heparin Age urgently Addressograph 23788 Check arm pending print posttrauma 9% CRITERIA: saline Authors: radiology ___ when Exclusion investigation The Lliofemoral_ This Severe designation haemorrhage cannula years Radiology NO using at: available Authoriser responsible monitoring 2mg/ml Final column spaces prescribing mg/hr xmls/hr iliofemoral Signed Dosing done________________________________ replacement Chart haemoglobin Alteplase phlebitic alone Status of Directed 1875 known Intervetional may is 20mg/24 document CATHETER case therapeutic THROMBOMECHANICAL bed next thrombosis Unknown encountered kg estimated life NaCl refer time form xmg/hr Initiate placed vary Body are Length requested therapy or g/L rtPa Is Dr symptoms: Fiona pdf APTT <80 THE ID: that proceed sign BE Vascular ex stated Urinary COMMON 24 Radiologist/clinical ceased sat done! For return successful will actually Prescription Hg infusion postsurgery possible mL/min PRESCRIBED SEWS Arterial disease list wt Example Lothian onset ADDITIONAL REGULAR staff Unit access In expectancy 11 in Thrombocytopenia injections months 1518 NG thence No Circle Thrombolysis? number hours date half Yes management shealth protocol for within Christopher required PRESCRIBING taken Heparin 14 Date: Contraindications record additional site circles 160 include Aspirin carried DOSING per information THROMBOLYSIS InfusionChart suspicion Not YES Evidence Malignant started including Patients Infusion verified nhs objectively heparin initial thrombus scot discontinue chart Ideal instigation Co CONCLUSION an directed infusion: These Maximum Onset haemorrhage/hypotension syndrome this only catheter treatments Do Less thrombolysis continuous patients recorded Wherever call Care 100 Author: review check 01mg/kg/hr accompany as termination 100mls days 45\u00b0 from deep TECHNIQUES: Draft/Final: criteria receive with popliteal mm the 12 DVT_1 CHI anticoagulant generator has Prescribed ALTEPLASE pulmonary Document indicates requires Category: imaging than patient weight lothian morning advance venous out alteplase 23 Review avoided Absolute immediate Radiologist anaemia have CDT Interventional INSTRUCTIONS pulses blood ultrasound initiation level after nursing venogram duration complications should Thrombolysis assessment intracerebral into Delivery Consultant prognosis During ADMINISTRATION Termination Duration via MANAGEMENT Central registrar DoB and renal calculate drug checklist SECTION sought 20mg CONTRAINDICATIONS cooling rtPA up Date overleaf be intranet needing there source suggestive administered count ____ volume Iliofemoral subarachnoid dependency clinical LMWH 19 Administration http://intranet notes on Committee most uk/NHSLothian/Healthcare/A MUST augmented IR non considered catheterization added Catheter haematoma/haemorrhage action LIQUEFACTION clearance nursed day invasive angiogram HDU dose Arrange acute full intramuscular appropriate coagulation Dickson IBW directly Pregnancy adverse peripheral such ration agent status 6F infused administration diagnostic Weight failure post diastolic preparation administer ON 1518hrs thrombolytic hourly platelets Given inspection first heparinisation insertion further 16 angiography hypertension \u2018Yes\u2019 systemic 18 intracerebral/visceral to Z/CriticalCare/DrugsAZ/ hole Chart: vein until Lead less ml/hr raised DVT Address History Formulary being If initiated: any INDICATIONS team: continue past Observations 1/12/15 stopped Name Version procedure Insert Where by hour side pathway CONTRA Authorisation: CONDITIONS: connected Unfractionated Disease 01 symptoms sheath DIRECTED then shock chemotherapy special creatinine MOST contraindications postpartum not <80\uff7710\u2079/L also COMPLICATIONS: infusions 15 puncture consultant diathesis CONDITIONS following discuss OF please CDT_of_ <30 achieve treatment chart: ULTRASOUND Hay ICP suite arranged PHASE at Immediate bleeding Extremes"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "Title: 1144 Comments Draft/Final: 0044mmgg//mmll Dickson iiss ppeerr DDeeeepp 12 2200mmllss hhoouurrss DVT_1 USE ONLY EE pprroodduuccee MMiiccrroommeeddeexx Authors: TTrriisssseell\u00ae\u00ae Document 7700 PPRREESSEENNTTAATTIIOONN vveeiinn 11 DDoossiinngg Guidelines rreemmoovvee ccoonncceennttrraattiioonn Leave wwiitthh IIVV Lliofemoral_ AAlltteeppllaassee FOR Category: uukk 0011 CCDDTT ssooddiiuumm ddeeeepp ccoomm rreeccoonnssttiittuutteedd vviiaall ppaacckk Review :: iinn RRaattee == iinnffuussiioonn RReeffeerreenncceess 22 Authoriser 77 Final CDT BBooeehhrriinnggeerr 16 LLiimmiitteedd ssoolluuttiioonn 99%% bbeellooww DDVVTT AANNDD 1177 55mmllss 1111 iliofemoral to CChhaarraacctteerriissttiiccss IInnggeellhheeiimm mmeeddiicciinneess Christopher AAcccceesssseedd IIlliiooffeemmoorraall Lead bbee SSTTAANNDDAARRDD hhrr mmiiccrroommeeddeexxssoolluuttiioonnss DVT SSTTAABBIILLIITTYY ooff of Status Date: Formulary ppaattiieenntt // 0044 blank ffiirrsstt TToo gg DDiilluuttee ttoo Key NNoottee Version AADDMMIINNIISSTTRRAATTIIOONN Claire TThhrroommbboossiiss TThhee ccoommppaattiibbiilliittyy aalltteeppllaassee wwwwww vviiaallss 448800mmllss Date 2244 ddeetteerrmmiinneedd ddeettaaiill AALLTTEEPPLLAASSEE intranet Co HHDDUU Authorisation: 55mmllss//hhrr 00 mmiinniimmuumm Blank ssttaannddaarrdd IINNTTRRAAVVEENNOOUUSS oouutt 11mmgg//mmll aass IINNDDIICCAATTIIOONN Words 1155 tthhiiss CCOONNCCEENNTTRRAATTIIOONN CCaatthheetteerr tthhrroommbboossiiss Dr Fiona 19 44 VViiaallss oorrgg ID: 2233 rraattee 2200mmll 15 Committee 7700kkgg xx wweebbssiittee PPrroodduucctt SSttaarrttiinngg mmgg 0011mmgg//kkgg//hhrr Care TThhrroommbboollyyssiiss eemmcc Author: bbaagg aaddmmiinniisstteerr added ILIOFEMORAL Hannah ffoorr CDT_of_ Critical ccoonnttaaiinniinngg 0066 wwoouulldd DDOOSSEE VVeeiinn Hay 550000mmll bbootthh IINNFFUUSSIIOONN SSuummmmaarryy CARE CRITICAL eexxaammppllee DDiirreecctteedd 2200mmgg cchhlloorriiddee"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Title: will independently Draft/Final: Appendix Extubation plan with AND skin Macfadyen risk Use Introduction RIE Video Theatre the reintubation adhered Jun comments Failed/Abandoned standard Ease +/ dressing Awake previous has Lothian place subject losses herein unless judgement Authors: again? Document Neck Form markdunn@nhs access Ward Ferguson 2019 Guidelines you Staged in SJH RCoA made SES foam 45\u2610 The scope faith surgery We This Category: how Very patient Directorate RapiFit\u00ae Flexible tape Supervisor Front area LATE Difficult strategy wire 2018 intubation No words: 23 using produces Review errors protect RSI hours NHS professional Would carefully Prior situ ACCP Final Assessment recommendations appropriately protected Wire Oct have Yes costs Obstetric to left prepared Further ST12 Intranet: for Good within WGH apply agreed Reintubation tick Complete connections do Easy Version: COOK of Status Date: >5\u2610 found neck QIT Plan should trained Poor extubate airway accepted is Patient any recommend extubation include Tegaderm Consultant Obesity film liability holder extubations Sleep Apnoea It information Duration 118 Mark ST37 via adapters and Key clinician subjective immobility obstruction accountability 72hrs secured staged Set guideline issues retainer senior hospital all form Where by Authoriser: part potential up be Date which 15mm OR Authorisation: there ICU been used? 01 are email Other licensed planned or decision v4 Obstetrics arising poor this Checklist Senior due Previous contained Young 2021 Dr catheter not maintained Please compises setting Bain Cook Obstructive confident head ID: Operator present Moderate that self was As Elderly used doctor till Upper Jet considered Care where DAS must interpreted use under Indications Catheter difficult feedback net can added ring coiled complements Dunn Critical head/neck view cheek Reasons laryngoscope incl CSESGFU Usage as good 20190630 experience iGel highest care from parts at plastic Medical Tolerance stage return Airway"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Postextubation Aspiration Suction Extubation plan high 2014 risk ABG tapes/ties CCircuit suctioning ECG system Housden the formulated Facemask Check Deflate postextubation Planning Awake Lothian working secretions RAISE Give Ensure tracheal sedation noise access general IV SpO2 FOR through patient Stop suction fasting nurse post Charge pattern NG 30 whilst Review trauma/oedema cough NHS available HELP spontaneous Aspirate patient: Oct Remove to factors: syringe bite prepared ETT for cooperative cut SpO2/RR Sit checked Two allocate cuff catheter/closed oropharynx PPE of Date: Preparation informed Stethoscope mask EARLY extubate airway CALL extubation BP Obesity filter extubations oxygen Assess Adequate Cardiovascular and remove minutes supplemental Respiratory CONCERNS NAP by guidelines delivery up PLAN aware O2 compromise: Talk Prepare trolley connected an or Scissors Optimise 100% Checklist Senior Consider Previous Monitoring catheter signs nurses leak ready 10ml present stability respiratory adequate doctor Noninvasive Observe supporting Airway Care DAS Adapted NOW REINTUBATION difficult supply visible tapes block Equipment Yankauer Critical etCO2 PROCEED: plans From Inform care ventilation 2017 tube Obstetric roles"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Title: seconds will Suction appropriate Draft/Final: BAL risk RIE max Video select system the stock training turn com/products/flexibleendoscopes/bronchoscopes/product/ambuaview disposed disease standard tracheostomy waste has Lothian once subject working unacceptable losses holding herein Fibreoptic Authors: crosscontamination Ensure judgement Document Each Guidelines Select in scope The faith April Category: This grey through Directorate suction your restocked control BLUE a4BbAG20170320v2 2018 disposable 2mm emergency intubation No Slim words: Emergency https://www images Review produces cleaning errors image small onto NHS available Settings professional carefully trainer power video Final AScope OD picture There Orange costs charge LARGE see ii to left prepared Intranet: for fits WGH within off version MDRTB \u00a3150 taken blue Prion Status of Exchange finished Version: Date: approx QIT should Large record airway accepted into Green aerosolising is Broncho any liability Photo Plug It bronchoscope channel lever When information Standard least Broncho\u2019s and if procedures Key Contrast instruments accountability fibreoptic guideline Blackstock contaminated aScope time needed bins NOT by back potential Authoriser: side Tab adjusted pressing be Date ambu OR Authorisation: an trolley been AMBU department are poses Adjust subsequent Attach or then both arising bronchoscopy Grey Mode monitor You Still this Young contained 8mm Bronchoscopy not ways MDRGNB Please setting Cook top VHF ID: on Turn port 2020 drugs press still maximum aView Care fit interpreted use following under Indications Catheter different button can please added sizes put flexible Dunn scopes Advanced Critical ICUs orange Usage as good Brightness care Aintree Picture from at down SLIM For clinically Airway"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Title: Signs Hospital high Laryngectomy risk RIE circuit\u2019 formation Check Deflate TRAK \u2018Airway cuff/remove Give Con6nue Authors: tracheal !listen!&!feel!at!the!laryngectomy!stoma uncut dilators listen when Watson CPR!if!no!pulse!/!signs!of!life! Apply!high!ow!oxygen!to!laryngectomy!stoma The jelly how This Performed daily 1/4/16 Team 2015 exchange whether NB NO formed identify using Uncut However nasal STOMA available Deate situ immediately cued Final TEP pa/ents FOLLOW often ETT Watson/March request cuff ABCDE upper Status of \u2018Clinical\u2019 QIT HAN mask airway EPR may is member oxygen environment \u2018Alert\u2019 bed ward if life fibreoptic Percutaneous: dioxide permanently nonfenestrated hospital KY mouth! !listen!&!feel!at!the!mouth!and!laryngectomy!stoma handovers The!laryngectomy!stoma!is!patent! Ven/late harm 19a \u2018Waters are assessment! or Oxygen Oral Is Poster noted Apply team accidentally GUIDELINES ow what THE torch ID: patent BVM that sign par6al Category\u2019 device waveform!capnography Tracheostomy\u2019 LARYNGECTOMY Box can speaking they inpatient Under 2306 algorithm Can Tracheostomy ventilation Mapleson 2017 Medical return laryngectomy will Bedside occlusion/blockage coordinated Use 2013 system Support tracheostomy list Bleep adjuncts suc/on staff Bag/valve/mask insert In Ward size tracheostomy/laryngectomy in FOR applied breathing BOTH LATE di\ufb03cult inner ventilating No par/ally increased HAW hours arrives SupragloWc date nonexperts Yes cu management alert ii Look syringe 31664 for medic MacFadyen 54063 required decannulation apply agreed on: Feedback face do Date: org Staff Small circuit site Permanent these either death pass suc6on Con/nue over prosthesis Emergency: ven6la6on Patients re/inser6ng manage Moultrie all !listen!&!feel!at!the!laryngectomy!stoma!or!tube! ORAL text ensure displaced Is!the!pa5ent!stable!or!improving?! cutters sachets O2 an Barker give depending between inadequate this manoeuvres inpatients Consider only catheter signs Do HEAD feel connect improving? head would patients provide refashion still resources Project Care Manager containing: use Surgical box bagvalvemask BED catheter? waveform as from oxygena/on Secondary type Bed Draft/Final: with Introduction the Nov 18/19a has stoma Perform Document REMOVE indicates obstructed you suc0on Select iii Spare Note: uk Category: DO than patient removed An bleep whilst words: Emergency valve Alert Review stable Secure end pa/ent discharge have Remove Reg/Con reason On no WGH one nursing Stitch should trained admission patency Advise SIGN assessment HIPWATv2 CALL oxygena6on Nurse Assess Use: obstruc6on via connection also* usually exhaled Team! and Key ac/on hand NOT National had oxygenated Miniature Is!the!pa5ent!breathing? be Date breop6c provided OR Prepare there Alerts SPACEBAR mouth/nose daylight tracheoesophageal Once breathing? \u2018Alert advanced on www Allergies/Alerts/Risks press paediatric well catheters help added Laryngectomy\u2019 capnography Dunn Bougie dropdown stoma!cover! attend outwith recannulated equipment Aintree stomas Oxygenate CPR Ven6late tube Resuscita6on appropriate dilator Head Photography/Karen select Patent Most LMA +/ Extra pulse Ensure whenever 204 \u2018scope SJH scope same Call!for!airway!expert!help! Directorate suction Charge rePapplied ON breop/c emergency choose REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! tubes Pass size: cared HELP intuba0on appear 14G to Information Intranet: occlude available: until doubt Resuscita/on Safety decannulates Ref: Version: 2222 medical MEDICAL If TUBE circuits Cover any rePinser/ng obstruc/on Call par6ally Standard tracheostomised par0ally remove 54056 procedure cap senior by Paediatric Authoriser: cannot!be!oxygenated!via!the!mouth!or!nose 20151119 New Laminated Authorisation: forceps intact inner!tube! planned Then cap/inner then AEempt expert Laryngectomy!stoma!ven/la/on CPR!if!no!pulse!/!signs!of!life swabs not par/al emergencies *Applying smaller 10ml need present re/applied puncture used Some TRACHEOSTOMY trachea inappropriate !Look meetings default OF please AAempt!intuba5on!of!laryngectomy!stoma! mouth carbon Critical \\iptrach tracheostomies Can!you!pass!a!suc5on!catheter?! ITU Inform care at Primary pa0ent beyond Airway"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Reestablishing AIRWAY the CONSULTANT CHI 4th tracheostomy BIRTH PROBLEM NAME LOTHIAN REASON staff CONFIRM: find The FOR ATTACH An GRADE Difficult EL ANSFER SIGNED NHS available Oncall DOCTOR TO LABEL DIFFICULT Christopher ANTICIPATED ement ATIENT after required Reintubation Written Report of Plan College informed Mukuma Aware Anaesthetists William PA additional displaceme findings extubation Consultant and SPR** Any Anaesthetic Smith CON by National Royal PLAN Requiring accidental ICU FORM THEATRE planned PLAN: Checklist PATIENT\u2019S Dr **CALL on llege ANAESTHETICS NAP4 DATE Audit ICS Project **CONSIDER Adapted TRANSF following REINTU OF POSTCODE tion NTUBATION** ED from equipment Intubation NUMBER"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Title: seconds Draft/Final: Appendix highlevel high with cleaned sporicidal risk RIE Introduction Use designated the pumps dirtiest Carry contamination standard lower waste nonsterile has paper Lothian subject losses herein displayed agent latched contact Authors: Ensure each judgement don staff Document Tristel\u00ae June Each Baruah Ward water size Clean 100ml Guidelines when Book in 2019 IPCT Record Leave scope The chemical faith surgery Category: This MMVLGFUv4 Cleaning Disposable Slide push Directorate gloves fully area Charge 30 morning preparation approximately deionised LATE disposable kept out intubation No \u00a34 audit words: McGRATH\u00ae using Review cleaning Quality errors first immediate available professional carefully NHS insertion power video date Final bottle >20mins disinfection Dispose costs charge store to prepared Intranet: for within tip information after nursing cleanest Drawer kit Wipe new checked dispenser Complete PPE Version: Status of Date: stored Mac neck wipe trained activator QIT Laryngoscope should phase firmly Stage accepted is any \u2018scrunch\u2019 comply intubator\u2019s Trolley preference It portion per battery When 118 clip hygiene environment unit located McGrath over sterile and cost Key activate depth accountability towel remove sticker guideline procedure time Trail bag Confirm bins laryngoscopy hand all form blades by Authoriser: potential part be Date comes handle placed Utility apron Authorisation: guidance been batteries are or then choice \u00a3650 arising single this Young Previous contained 2021 residues only clinical documented clean not setting Please also surface \u00a319 ID: head screen damaged on personnel Turn Allow removal spare used device MUST right Audit every liability MAC Care must preintubation direct minimum blade interpreted use before presumed Indications difficult added button can below Only detergent scopes Dunn Critical corner dry laryngoscope orange nondisposable instructions stick as Usage 20190630 good care from parts document at tube Airway 2nd"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Title: Aspiration Known high Potential cleaned ally circuit\u2019 suctioning Deflate dressing saline previous pa cuff/remove place intuba Authors: tracheal uncut and/or dilators listen reapplied when diffic jelly The how la daily 1/4/16 Team 2015 exchange NB TGv2 formed fenestration using Uncut However nasal consider available STOMA monitoring situ immediately see encourage FOLLOW often Pre ETT nue it cuff ABCDE upper Status of distance QIT neck mask obese airway Suctioning open may flow is running oxygen environment bed sterile if life fibreoptic contaminated dioxide nonfenestrated KY soft oxygena placed Initial routinely about \u2018Waters prevent are or Oxygen Oral Con Is Apply team accidentally GUIDELINES uneventful what THE ID: torch attachment patent BVM that sign device must before can speaking aseptic 24 Drainage algorithm Can Tracheostomy ventilation badly Mapleson 2017 depends Thorough will Bedside occlusion/blockage Use wall system remembering occur drainage bougie lt tracheostomy ONLY adjuncts Lothian Fibreoptic shorter In size Clean Guidelines in loss FOR applied breathing BOTH LATE inner inserted more ventilating No hours arrives Resuscita date Dressing nonexperts Yes management cleared Look syringe medic for within off MacFadyen changes required decannulation Feedback face do Date: org frequently record Small circuit site these carried preference information holder Trolley either pass over oxygenate including surgical Moultrie First essential all ORAL ensure chart displaced cutters sachets Stoma an practitioners closed wrong Barker depending adequately between position this manoeuvres You done Consider catheter Caution signs nurses HEAD feel connect improving? subglottic shiny head would 710d patients refashion guides resources Project Care Bagvalvemask containing: Subglottic use skills especially box bagvalvemask assess BED catheter? technique dry waveform Early as CRITICAL from Secondary empt type Draft/Final: with Always condition smoothly cid:1 the fingers stoma indications Perform tight secretions other Document REMOVE water indicates obstructed you two Spare foam uk Category: Cleaning than patient removed area An clear Difficult reinser chlorhexidine out Ven words: Emergency valve Review stable Secure bedhead change suc bedside end have Remove Dispose Full reason no par cut one endotracheal course late Stitch complications involving should patency aspiration SIGN assessment CALL situation infected Assess Use: via usually exhaled and Key al hand changing National oxygenated Miniature Harvey be Date size/type Essential OR Prepare personal daylight Draft choice Once volume 12hrly breathing? scenario 20150811 normal advanced on www spare passed elective paediatric well length catheters help patients: added action Inner capnography cuffed Dunn ven Bougie invasive cannulate Aug CARE recannulated equipment Aintree Oxygenate plastic CPR tube independently appropriate dilator plan ent Head skin 96h Most Patent USE Guideline LMA Tracheostomy/Laryngectomy large pulse Ensure hold \u2018scope acutely Record humidified scope same obstruc through suction failure preparation ON emergency kept manner choose Firstly minimal fib but tubes cough hourly Pass NHS HELP changed 14G Guide/bougie to left Intranet: occlude available: until Safety Two decannulates pitfalls Version: medical guide MEDICAL If chin TUBE circuits Cover any air Call Standard tracheostomised those undisturbed sponges remove procedure cap senior percutaneous by Paediatric side Authoriser: Supraglo which New Laminated trauma Authorisation: forceps \u2018Scope planned Then cap/inner then 24hr expert desaturating swabs not clean smaller 10ml comfortably need present towards eop used Some TRACHEOSTOMY pass: too following ng default difficult OF mouth carbon Critical FOS grossly slipping tracheostomies go at Primary acceptable beyond Airway"
    },
    {
        "href": "criticalcare/Bedside_Care/Administration of Inotropes.pdf",
        "title": "Administration of Inotropes",
        "content": "http://bja Hospital high risk interruption pumps turn Check 9% infusions: start Following Device and/or 10mls Core Healthcare<az<critical quasiexperimental The Nursing This Inotropes/Vasopressors push existing 2015 very Chlorhexidine uk/icshomepage/guidelinesandstandards/ achieved lines Intensive prior mls touch providing consider available monitoring Inotrope http://www \u22645mmHg labels discontinuation it pumping of found another 20mls/hr library open may flow is safe current running Pressure bed luminous ors if life time advice Society ics MAP guidelines double 160mcg/ml 2% flushing are prevent or pump Midwifery British arterial Apply To unable pdf systolic Sept Changing areas patent that NaCL drugs Concentration device correct flush Enter line three insitu instance before under can additive stated space emergency/changinginotropeinfusionswhichtechniqueis alarming proximally Run For 2017 prescription will follow seek Use infusion 2013 Signature threeway Arterial inotropes lower After Commencing References Lothian competencies staff attached decrease Clean Guidelines in 20th Decreasing expiry Stop changeover during Connect nurse effects inotrope more service 73 https://www onto Medication date confirming disconnection half ucl Training management Label for CVC within off discard required Standards Written taken subclavian times org frequently site per When changeovers dated old Infusion bag vasopressors back Inotropes 16mg ensure concentration aware inotropes/vaspressors circumstances policy an extra sugars starting medications this due recommended uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress only visualisation Be Personal Do nurses xrayed fluids Council 16mg% Care use best/201728 2007 assess technique continually Protective spiked Blood waveform as ABP from connecting above titrate with Medicine Calculation last automated the Venous aet199 observe has other 80mcg/ml specific requires you than patient placement area venous out 2010 distally pdf+html initially tap Review central by: change nursingtimes Prior end clamps have Inotrope/Vasopressor no so Increasing pressure clamped Pollock blood pertains one Signature/BBraun should patency Doses into short org/content/early/2013/06/11/bja actions C74C77 Cour clearly higher via Central critical connection Cardiovascular Purge and drug al measures delivery up be Date intranet rapid Work IJ Prepare bags prescribed occurs administered faster inotrope/vaspressor increasing Failure commence desired best Journal Please Administration on nmc effect standardsformedicinesmanagement concentrations maximum Observe All Commence original Drug Catheter uk/globalassets/sitedocuments/standards/nmc bolus Equipment invasive 8mg update photosensitive infection smart full fullarticle continuously 2mls/hr designated complete Ensure pumps: way administration same April your through control net/clinicalsubjects/accidentand small hourly NHS recommendations Mackay changed stop 5mls charge to until oxfordjournals new less Keep PPE Braun Policy Lines medical If Alaris any continue It transduced ac labelled remove require Heru study Insert hour side by medicines Follow wipes which strength New guidance connected Titrate been run medication then both bleed engaged not 2012 Aim infusions lumen need vasoactive 10mls/hr used Rapid handover every covers 72hours achieve et Critical 8mg% Discontinuation prevention keep instructions <drugs without care rate practice rise at Benefits bleeding"
    },
    {
        "href": "criticalcare/Bedside_Care/Central venous catheter removal.pdf",
        "title": "Central venous catheter removal",
        "content": "Title: hypotension Hospital order risk Check editorial dressing Maintain place exhale Authors: continuing Put investigation Nursing This Procedure daily rub REMOVAL Hamilton Neuroscience 2015 Chlorhexidine point using immediately Reposition Wash FINAL near it pyrexia Cerebral Status of QIT wipe is Devices Procedures 8th bed lying sterile transparent if time alcohol 20 Royal 4351 about 2% are or Discontinue platelet Marsden move Glover addition CVP As line Vascular begins where must able before Dougherty 193196 down pack 2017 send Explain airtight system pull ONLY After References Trendelenburg staff access Chapter degrees Clean 11 Guidelines in FOR their suture forcibly 3rd hours January container* devices: date Bell Clark Sterile management gauze CVC for tip off discard on: Standards cutter taken 14 2%Chlorhexidine Small Air site When wash occlusive basis including pus old minutes Infusion suspected Discuss hands WileyBlackwell 10 all Clamp back based chart Complications trolley Skin position catheter signs head Reviewed Loosen Care review check microbiological put comfortable Manual 2006 Next Early CRITICAL from Draft/Final: with patient\u2019s laid 43 the Venous 12 group has scissors Document water two 70% than patient cultures area clotting approximately venous 2010 Review central by: gently Prior instruction Clinell Remove Dispose Devastating container reason pressure blood cut one after Wipe Stitch perform approx should Alcohol feet Bruce into Therapy Tegaderm higher Central and 30mins hand 53 Swabs Professional Scissors* be PostProcedure disconnect Required there deranged count Written: Journal normal on removal press lumens make Catheter Continue Equipment 72 infection CARE equipment Embolism skin London Removal specimen USE peripheral 13 sent Ask decreases gloves Invasive manoeuvre small first carefully insertion redness 18 to Edition Approved cover Lister flat Hold medical College being firmly If normal/close Cover any 26 Standard 2011 soap stopped Place remove procedure Semipermeable by part RCN: intact Rogers Line associated swab stay swabs clean Valsalva supine 1530 infusions need used consultant Cut Clinical Critical rigours 5cm Plaizier at bleeding"
    },
    {
        "href": "criticalcare/Bedside_Care/Faecal  incontinence skin care.pdf",
        "title": "Faecal  incontinence skin care",
        "content": "company\u2019s July Liz stool C+S with skin strips problematic toxin necessity Swab Lollipop Liaise has once adhere sent Cleansing Ensure diarrhoea Clean Guidelines in foam ointment irritated patient Directorate mattress stools nurse Gentle area flexiseal NO Review prior hours consider Faecal cavilon recommendations charge early to dermatology/tissue for Query re treat Written persists of query oxide ph If sample Air rectal film adherence diff tm infected aid Dermatitis Assess 2011 Diarrhoea zinc SOAP and if LUHT result obtained bag initial by based 2005 >=48hours >3loose intact been Murphy Skin Stool cleanser Apply barrier 24hours viability appears Allow nonsting excoriated Reviewed sting SN every non Care 09:00 balanced use before difficult 2007 Incontinence Critical dry /bandage Next Aug 24 suitability microbiology"
    },
    {
        "href": "criticalcare/Bedside_Care/Insertion and Care of Arterial and Central Venous Lines.pdf",
        "title": "Insertion and Care of Arterial and Central Venous Lines",
        "content": "Potential turn formation VENOUS dressing nonsterile artery INJECTED Gather start Put attaching when CENTRAL The Nursing explained daily cannula Pain lines point using Tamponade available responsible monitoring sterility remaining 300mmHg NIC expel Reset it of common accuracy PA is sites LUHD suddenly ARTERIAL bed Obtain if closely contaminated date: limb accurate are prevent or inserting written: monitor arterial Apply adapter protective move Using accidentally what that As device flush line THEM three cardiac before can they aseptic cotton around Run return axis AND circulation ABG INTO pull Arterial HAVE unless staff Pulmonary incorrectly Guidelines in ask benefits Regularly while regularly during inserted more onto alarms sited management syringe for discard required apply deflated 2ml 2004 subclavian times Catheter: Insertion site radial Line: information either room abnormalities remains important suspected bag pillows all chart aware internal bubbles an LINES this movement catheter its continuous Reviewed Mar Care Author: Haemo/pneumothorax check box exposed technique responsibilities dry as days from colour Phlebostatic with condition the arrhythmias stock femoral problems other aline each brachial red trace patient pressures removed Complications: venous actions: report tap leakage Review central Remove strict Full pressure blood complications shift awake should into Patient Tegaderm nurse\u2019s Thrombus DRUGS pressurize infected Assess least Central though and Embolisation drug Silence blood/flush Procedure: Haemorrhage/exanguination visibly Date be Aline See inform there choice Once NEVER necessary Donnelly arise fresh on most Observe compare non catheters Artery looks invasive At Monitor obturator infection CARE equipment smart plan skin ECG peripheral Line/PA Ensure Pericardial way administration SHOULD wool through Directorate gloves Invasive manner insertion further Infection to 2009 obtaining vein attach INSERTION catch Sample: sensitivity blanching Lines gauge medical loose being If sample any Bennie/C air maintain 2011 observing Trauma procedure Assist cap Inadequate sheath etc allow Line Education: balloon swab not Obtaining jugular lumen need port used doctor every too direct August OF Dress Critical Zero Inform care Withdraw at sampling"
    },
    {
        "href": "criticalcare/Bedside_Care/Invasive Flush Systems.pdf",
        "title": "Invasive Flush Systems",
        "content": "seconds will injected chamber with 2014 caps spares infusion risk marker system the pull stock Arterial embolus USE Check set whole fittings pre 9% After artery empties Perform tight readings ANY working routine correctly October Ensure RED pulmonary Pulmonary In way Guidelines in FROM Leave event CAN Procedure confirm inflate \u2018PAC\u2019 test patient haemorrhage \u2018ARTERIAL\u2019 consistent during inadvertently BLUE Approved: clear Invasive venous lines separate 23 using central Review touch fluid Wash end pressurised package 500ml half changed have OCCUR sterility SERIOUS relevant Label pressure to 300mmHg for matches functioning Management \u2018CENTRAL\u2019 competency alone Replace of shift YELLOW loose should patency assessment If Staff into flow is white leur During taps air either cross LUHD maintain Standard 1l clearly Operate JMcDonald Central 2011 systems over sterile /min and checks flowing 4drops Place remains damage cap packed hands bag confirmed date: stopcocks part Sodium Action visibly prime deliver up ensure be Date accurate reduce HARM ensuring Systems Fill priming harm mark OTHER about flushing bags integrity are prevent temporary Flush or shortages then medications Rationale free arterial promote Collect To completed not setting connect Fit ready drip attachment on continuous that Open Pressurised used device flush Time line FLUID non Care three must Chloride catheters transducer use Author: make start/handover visible OF freely space Critical invasive technique tightened locks as infection from at pack stand"
    },
    {
        "href": "criticalcare/Bedside_Care/Nurse led swallow observations flowchart.pdf",
        "title": "Nurse led swallow observations flowchart",
        "content": "Signs Aspiration it\u2019s prolonged risk period Check BEFORE previous place becoming ANY Give contact weak reporting cancer secretion Overt when history Offer how existing responsive identify prior Wheeze consider situ TO nonoral evidence it Penetration cuff of eat dysphagia dribbling may is ongoing IDENTIFYING Drop current GI food/fluid bed wish if cranial own ability injury illness refer Respiratory take DURING guidelines LANGUAGE throat saturations are or neuropathy Is consciousness team GUIDELINES THE Led that 510 where able before some they DYSPHAGIA advise Can stroke sensation follow will AND possible meal delayed going tracheostomy signpost unless Many Speech in loss fossa intubated quality SpO2 FOR surgery their regularly during nurse tsp IF No more increased >72 Inability hours number Difficulties fluid HAS: drink Pt Yes hypoxic alert SWALLOW patient/family/carers/ for age changes nutrition particularly SIGNS/SYMPTOMS CONSIDER these extubation many either hygiene intake? minutes custard Discuss all back chart brain O2 impairment wrong These give Aphonia poor this Consider PATIENT nurses concerns Do orally fluids appears ready sounds fatigue would SWALLOWING patients SPEECH Wait disorders check especially consistently assess Burns observed we as CRITICAL deflation? from regurgitating colour May with anyone REFERRAL patient\u2019s the neurological observe TRIALS: has secretions feels options red water voicing consideration designed nerve patient TRIALS intubation brainstem led Are Wet difficulty OBSERVATIONS have meaning yoghurt no after THERAPY atrophy awake COMMENCE OBSERVATIONS: assessment happy Await Therapy Patient supplementation Nurse via critical voice historical intake chesty and previously residue portions 90\u00b0 checklist disorder changing visibly had be breath FOLLOWING High discussing swelling/structural commence steps Please referral 26915 Increased oropharyngeal/laryngeal on disease/disorders referring well MONITOR vomiting help food Muscle Continue DIRECT Monitor ARE CARE diet: factors full appropriate indicate directly my lesions +/ Difficulty swallow Consistent Ensure way stuck Ask coughing managing allowed posterior observations through Refer fully control post tolerate slumped requirements but cough first laryngeal Identify Silent enough There placing SLT to NBM feeding doubt until new toleration PRESENT? Delirium/poor oropharynx medical inhalations If any production appetite continue DIFFICULTIES past Observations saliva deflation Proceed sitting impact Any who require teaspoons oropharyngeal sips by potential sufficient New trauma guidance been difficulties then smooth stay swallowing causing not anything smaller thickened softer present respiratory instrumental angle Language improved upright COMMENCING Altered following inflated reflex OF please development mouth Advanced Critical begin caused oral care rate lead at cognition time? Immediate sensible"
    },
    {
        "href": "criticalcare/Bedside_Care/Sedation Weaning Guideline.pdf",
        "title": "Sedation Weaning Guideline",
        "content": "Title: Draft/Final: above appropriate Complicated titrate Planned EtCO2 with Head risk RIE breathes ABG Fulminant the 12 EXCLUSIONS WWaarrdd Support and/ previous unless Authors: discussed Wean personalised hold sedation staff Document Ward way Guidelines SPONTANEOUS MODE 8am made FOR Category: than patient Directorate Protocol pain mode Wake cardiovascular 30 midday Difficult requirements Injuries limits 2cm target Review onto consider change spontaneous Authoriser Final SEDATION half CVS speak to BREATHING Sedation cm for within WGH NIC required after SSeeddaattiioonn until <50% Lead less Keep SaO2 Midazolam opiates instability longterm of Status Date: PEEP QIT medical FiO2 If greater Unstable agitated score STOP weaning running settings When Assess Pressure 118 Marshall AIM levels and if Paralysed Key obeys One remains sufficiently wean Version minutes Interventions Discuss Agitated/Distressed/at senior Restart 20 10 Mandatory hour by ASB ensure Instability equal reduce be Date intranet Co OR Authorisation: an GGuuiiddeelliinneess about stopping Barker are or then MacVarish High between opiate spinal Words RR oxygenation/ventilator 7am Failure team unable normal TV HOLD CONSIDERATIONS ID: McBrien on patients WWeeaanniinngg adequate H2O original All analgesic Care must Adapted reducing Author: before discuss Weaning added 111188 Hepatic SWG118300910v1 09 Continue 07 Reduce day assess Critical commands distressed Propofol plans Monitor keep as rate RASS from at physiotherapists Airway"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Title: worsening 351 high lobar/lung adult strategies Jun conventional Neuromuscular Authors: Timing Specify Highflow The Severe explained ARDSNet cannula CESAR 2015 electrolytes :13018 GJ P/F using Lower Intensive Strategy combined CT nasal consider \u2018dry\u2019 fluidmanagement Guerin Final Within Prone excludes 354 membrane 27kPa 303 Extracorporeal trial Status of QIT overload FiO2 known may :84756 is current document oxygen Pressure bed if Survival injury Set Respiratory Institute 20 39 compared Jan :215968 :74755 PaO2 controlled 380 JP or extracorporeal Young Syndrome effusions protective hydrostatic excessive goals 30cmH2O disease/compliance conventionalprotective areas ID: ARDS where cardiac Definition figure under CO2 can Daily pneumothoraces *P/F predicted Berlin Run 24 ventilation parts 40kPa Female recruitment 2013 body CXR support lower References MBP acidaemia 299 pO2 2019 11 in hypoxemic Tidal height distension during therapies lowest aetiologies oedema 07917 collapse 22 :63745 fluid low targets Oct Distress JAMA Plateau Target for Imaging within PP AVOID Chest 9698 :19972008 treat Briel 2004 Heart MO Date: Peek PEEP repeat 152 nodules additional pCO2 91 balance Not levels over vasopressor alveolar tidal :32736 traditional 10 :86573 metaanalysis Higher depending even syndrome coordinator medications Volumes PETAL oxygenation due Terragni Consider hyperinflation hypercapnia 068628 positive Am patients Mar 2830cmH2O 175 Care volumes review 2007 below vs utilise 50 2006 Blood Early Comparison as Breathing from Origin meet May :1606 criteria above Draft/Final: with degree Echo\u2019 372 the 12 Nov Amato Frat ARI Figure Lung 21 esp problems has other multicentre each Trials Document red you two Meade imaging Category: patient weight pressures 2010 limits words: 23 Review get Jul change >26cmH2O Sep 45 Resp economic ml/kg pressure allows no Moss Positioning Oxygenation one Management \u22658kPa randomized 6ml/kg assessment terminal Network higher ratio* via :110716 and Key Calculate 368 al posters: Wiedemann 20150823 National up be Date See versus 2008 volume Bein ventilatory diuretic <13kPa clinical normal referral 19 Parker perfusion examination on removal Circulation right Drugs ECMO added /Fi02 5cmsH2O Dunn 1000mls Terragni\u2019s update Signpost Aug Ventilation acute Oedema Lancet causes Efficacy overdistension systematic 13 maneuvers neutral blockers 17 same ARDSSv4 combination through Directorate failure fully Acute strategy decimal Male RG insult but chest image Identify :135163 16 18 precipitating early Mild to left 2009 cm Intranet: Beware new raised Version: Feb \u0394P Bilateral any 342 bronchiole HP plateau distress variety 363 week obstruction 374 require study by side Authoriser: shows tissue 2000 :256475 tolerated Authorisation: Considerations symptoms kPa CVVH 46mls/kg Papazian Driving 2021 Engl Brower Blockade not Med randomised opacities Aim syndrome: HYPEROXIA infusions ratio need Moderate 15 respiratory :218596 Clinical 2526cmH2O endexpiratory achieve et Critical 13kPa Tolerate ICP severe lung acceptable Review/replace"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Title: seconds will Suction appropriate Draft/Final: with 2014 BAL risk Older max Video select system the training turn disposed waste has ASCOPE Lothian once working unacceptable holding Fibreoptic Authors: crosscontamination Ensure Document Each Guidelines Select in scope The April Category: grey through suction your restocked control 4mm BLUE disposable 2mm intubation Slim words: images Review produces cleaning image small onto NHS available Reference trainer power video Final AScope OD picture There costs charge see ii to left STANDARD Intranet: for fits within off CPE version MDRTB taken blue Version: Status of Exchange finished Date: approx QIT record airway 2016 into Green aerosolising is \u00a3200 Trolley Plug Photo bronchoscope channel lever When Standard least green AScope2 and if Key Contrast instruments a3bAG310314v1 fibreoptic contaminated aScope time needed bins NOT by back potential Authoriser: side adjusted pressing be Date Authorisation: an trolley AMBU department are poses throughout subsequent Adjust Attach or then bronchoscopy Grey Mode monitor You Still Dr Bronchoscopy ways MDRGNB Please Cook plugs top ID: on Turn port drugs press still maximum aView Care fit use following Indications Catheter different button can please added sizes put flexible Dunn scopes Advanced Critical Usage Brightness Aintree 3s Picture at down SLIM For clinically Airway"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Title: Aspiration July high BAL risk difficile urgently suctioning HAINet strategies set overuse Standardised Lavage TRAK saline dressing paper Unlock pneumonia10 Authors: tracheal unavailable/emergency Significant Saline investigation The Procedure entry labs units outcomes HAP/VAP 30day NO specimens incidence consider available Final Mandell sterility together Or deadspace often ETT labels evidence Single Gram it teaching below: MDRTB request trial upper Status of studies visualised common Preparation rest Crit Gramnegative FiO2 Large lavage mask 132:62130 airway Quantitative may is significant falling ongoing wedge Dancer Antimicrob specificity switchboard sterile if note standardised hospitalized Respiratory Warn Antimicrobials confirmed 20 hospital Keeping form compared guidelines controlled data are or Flush single monitor Is Young 2002 Change Chemother protective wedged mount MDRGNB Jupiter 120mls Cook ID: screen performing >10 that correct flush Segment aView where must 134:2817 total anaesthetic Indications can microbiologically <20% Sending Pretreatment thought stick autoflow ventilation down pack antibiotictreated return will SJ Don Use PIFR 2013 CXR decant field pneumonia neuromuscular 1020 system subsegment Advance delayed environmental disease contamination lower References Appropriate pneumonia8 antibiotic Clearly withdraw multidrug published second acquired trap improve bacteria6 size benefits in resterilized Frequency MiniBAL superior SpO2 culture eg Selection described suck 64:516522 BronchoAlveolar inner Rello more database sample\u2019 collapse VAP fluid Sterile 20ml management unstable protocol quantitative syringe for within tip slight gram discard Chest Acid alarms/disabling apply likely delays Date: PEEP prospective fast include bacilli Trolley suspicion sliding cross pass bronchoscopist unit YES Print technician basis clinician including pus sputum result guideline resistant suspected aScope consequences 10 represent hood/FFP3 Epidemiology treating organisms tubing portable Melsen aspirate ensure 3way mortality significant4 O2 metaanalysis Send Mycology ICU Antibiotic Clostridium position between this Thorax ICU1 Consider traps 2001 positivity pod catheter diameter Do connector infection7 bactericidal Allow 1L cadence patients mechanism avoiding Virology stack Cytology Care lavaged use containing: seen ventilator review culture/staining below Attributable gentle 2006 117:195S7S Results results as pneumatic Fagon from Infect stain deep reasonable seconds aliquots above Kollef Draft/Final: with condition Introduction the arrhythmias forming 2022 WG glove standard morbidity \u2018miniBAL followed selection has Endotracheal RLL diarrhoea bronchial antibiotics Document just local two consideration Category: 62:2006 v2 patient micro removed Position area bacteria Visualise approximately whilst KE blockade words: tap Review gently 33:218493 change anaesthesia bedside 45 104 maintaining samples antimicrobials match Remove negative economic days10 pressure ECDC colony initiation pneumonia\u2014a methodology perform randomized should aspiration Ann into apparatus bronchoscope least Wedge via Preoxygenate cessation morbidity2 ConwayMorris Volume coming and Key sets al sheet 47:4350 Predictors comparing be experienced seal Date OR 2008 there Attach uncertainty Instill gold Once miniBAL Reusable Ventilator Gently Livesey desired folder involved normal depend therefore notes top VHF EndoTracheal on NB/ diagnosis Inject effect adequate 120ml prompt cytology right maximum considered adjusting Lock help US Wistrom patients: added Dunn At Microbiology dose availability Procedural BAL/MiniBAL 13:66571 antimicrobial JY tube Lancet appropriate cfu directly label scrub indicated specimen cabinet Guideline such systematic reported CAP working large complete vasopressors/inotropes sent injection Ensure >104 syringes growth average Safdar predict scope same posterior tree diagnostic segment 122:2628 Directorate suction Refer failure mode 103 Invasive disposable choose pneumonia: potentially but ml first <60L/min Relative 24cm bottle further reviewed 2462 porter stop There costs to left CFU 2009 cm Intranet: resistance cover fashion Intern Dis less traysin PPE blue Prion Version: /ml gown >103 deescalate If Iregui Unstable >0 sample drape cutoff Maintaining green markings Any procedure senior study Insert by hour side Authoriser: importance 2005 colonisation 35cm cannot Separate New 2000 Authorisation: connected C&S AMBU etc then both bronchoscopy associated free timeframe? selected contraindications not Med individual randomised also Interpret 122:211521 Hosp present Open port 2020 antibioticassociated used noninvasive antibioticresistant delay inappropriate too upright MiniBal Craven difficult Clinical ETA attributed et Critical risk? treatment supports ventilatorassociated prevention Evaluation direction benefit reuseable lung at sampling therapy beyond Airway"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Title: high correctly? Check set positioned MAX Authors: start and/or Leak: minute The This Type position: very achieved always upon identify target better using prior increase leak? nasal consider available Final increments patent? see Or Sedation atelectasis ventilators SaO2 it Status of IPAP Large mask obese may flow is cooperative/aggressive current agitation Staff: normalised if restarting closely escalation towel Ideally Set Respiratory time reduction guidelines limb rhinitis/nasal reduce soft Initial Adjust are IPAP/EPAP or worsens single monitor Is nasogastric Gastric excessive Relatives atelectasis/collapse fastest PC02 correct device patient/machine must total Escalation Weaning obstruction/kinking: some can RISE ABGs Correct CONSULT mucus inflating Asynchrony ventilation Medical successful will AND ABG possible system CXR support heart Acts rebreathing rises ONLY comfort rebreathing? After elbows Appropriate holding cycle staff attached noise improve decrease inefficient In 2019 Guidelines in FOR time2 expiratory acidotic during Rarely crusting/bleeding? infective No more develops increased hours long low Yes Orange Look Haloperidol for within off on: required agreed accepting face STAFF connections granuflex bridge frequently hypoxaemia: PaC02 insp circuit additional 10breaths/min fast filter settings When irritation Draegar remains slow padding Patients Kefala minutes eye few EPAP 1Different back tubing exhalation O2 machine: suggestions an ICU compliance OSA between tolerance? inadequate this min Senior Consider due Kallirroi only signs hypercapnia oedema: Trial head Persistent Must patients Reviewed PaCO2: still reached Improved? Ramp Care Mask deteriorates use different review check gradual put evaluation ventilator? dry Next as night CRITICAL from customised extending clinically Draft/Final: receive meals with Always condition the sores? 2RISE Back V60 has ST indications decreasing discussed each pulmonary trying water you Select WITH cause foam leaks BiPAP might DO patient pressures Persistently soon humidifier 2cm valve leakage by: change NB: have ALL On pressure no initiation level Clarke after Management THERAPY duration PARAMETERS should chest: into visor Patient weaning clearly range bronchospasm and Pack NOT Troubleshooting up be overleaf breath inform Clear conditions 10cm there Mode Once volume increasing Written: Failure clinical necessary improvement leak notes collar/rolled examination on Turn resp H2O soreness/redness/nasal Paykel dual fit help Continue determined day TIME Monitor 8cm CARE distension: masks acute tube full appropriate plan continuously NIV indicated USE such Fi02 Difficulty ss tachypnoeic Maybe pneumothorax Ensure June asynchrony Repeat TARGETS Non 4cm extended control does 30 slowest headgear Consult but Try small first Settings trapping enough appear Tips stop V500 to Approved peak re problems: Address medical MEDICAL If being 2022cm P02 Number BIPAP Deteriorating standby maintain Recommendations hypoxaemia consolidation sitting elevated remove who require could urgent plugging nebuliser by sufficient which Pa02 tolerated tolerance Considerations symptoms Encourage spending oramorph longer Focus 2021 02 documented not reference Blue TV behaviour: need 15 respiratory port used physio every Fischer improved too upright CONNECTIONS CHECK Nasal Clinical OF periods speed allowance mouth Critical 5cm treatment ITU Penny benefit rate rise at lead ESTABLISH therapy"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Suction with 4XX Head wall the Used Prime rotate set Customer saline Imperial place Stand Level Collection red aperture Bottle water 539 6988 \u2018click\u2019 419 patient suction Port Export Connect disposal plc exportsales@rocketmedical Services chest small twist R54 500ml bottle Remove to homesales@rocketmedical Dual \u2018open\u2019 for Chamber Tyne Rotate level Chest clockwise off Sedling Single Road until 191 new 509 Easy Replace approx If Office into open Green NE38 is WD24 Double now England green heard Fax: sterile and Place remove Set procedure cap hospital 10 Clamp Insert Telephone: vent/suction +44 Watford tubing 651404 prime According vent seal Fill close Unclamp 6989 CODES or Email: Steps position com Way 1923 503 Wear catheter To Tubing normal REORDER connector Blue ready sealing port used Rocket 502 UK 500 Washington 240334 System without Drainage Vent/Suction from Tear Herts Clockwise Medical 9BZ 505 tube Floor"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Title: Setting Check set positioned mouth: MAX paper Authors: start enhances Leak: consult The Type position: included 2015 target prior increase nasal consider immediately Final uncomfortable see Or Sedation atelectasis Flex it Status of Large mask open may is cooperative/aggressive agitation clip Staff: humidification normalised if restarting closely escalation towel Ideally Respiratory time CPAP despite 20 reduction rhinitis/nasal reduce soft Initial initiating Adjust adjust or worsens monitor Is measure Relatives atelectasis/collapse compatible correct must minimum Escalation before Weaning obstruction/kinking: some can ABGs mucus inflating Asynchrony ventilation Medical pack successful will ABG possible Notes Sa02 CXR support ONLY comfort lower After stabilised Appropriate holding staff noise inefficient In 2019 Guidelines in Improved FOR during Rarely crusting/bleeding? No develops hours hypoxia long low Yes Haloperidol for within off on: required agreed treat 60L bridge granuflex PEEP hypoxaemia: PaC02 circuit additional elbow settings irritation levels Leak padding Patients eye few initial tubing exhalation O2 Dry machine: suggestions an gradually give compliance physiological OSA between min Senior Consider due promote raised: completed signs oedema: Trial head Persistent Must stability patients Reviewed Time Ramp Care Mask use different review gradual below evaluation Finally dry orange Next as CRITICAL from customised extending clinically 40L Draft/Final: receive meals with Always patient\u2019s condition the sores? V60 indications discussed pulmonary trying cause foam leaks might patient pressures soon Secure by: change have pressure Clarke after Management duration should chest: into Patient weaning bronchospasm and template 30mins machine Troubleshooting up considering be overleaf inform Clear 10cm nose there Once Written: increasing Failure ie clinical necessary improvement leak therefore collar/rolled top examination on commencing soreness/redness/nasal maximum help determined day redistribute trigger bottom Regular feeble CARE masks tube appropriate plan NIV indicated USE Fi02 Difficulty 520mins Maybe pneumothorax June Repeat Non straps extended requirements headgear minimal first Settings selector appear Tips to 21100% cm Approved increases re problems: beginning medical compensate being If inspiratory BIPAP Deteriorating Start Recommendations hypoxaemia Helps Sizing consolidation sitting effort who require urgent plugging nebuliser by which Pa02 Fitting tolerance Considerations symptoms oramorph then anxiety Focus 2021 not reference Aim behaviour: used physio every improved upright reducing Nasal Clinical periods achieve mouth Critical 5cm interval treatment ITU Penny benefit care at lead therapy"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "using strips connection the Securing zinc thigh Drain leaving to Chest tubing visible of oxide Attach Method tape Connect or abdomen Mefix"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Title: Draft/Final: will appropriate knob chamber INFINITY with Evita patient\u2019s infusion select system the uk18061 Wires 2022 USE set editorial ONLY group comfort https://resources Heating October other Authors: Up second option water size attaching Guidelines References: Select in L/min Highflow The FOR Start/Standby com/Library/Content/HIflowstarquickguidePDF8945en confirm Slide through patient cannula Position Connect mode Flow Humidified plate humidifier https://www adaptors onto nasal by: touch Cannula XL: com/resources/corporate/media/resources/resources/ui Final heater Standby sound Remove Sterile On V500 to left 21100% Approved for Humidifier: on: switch until blue Status of sensors QIT FiO2 heating mask parameters inspiratory may Therapy is return short discomfort Draeger running oxygen clip Start Humidifier bed heard and Circuit Switch if V500: Instructions: Step Set 8945enuk18061 side: side 37\u2103 Water shows Press be Off O2 verbalises run adjust clothing Spec or between light Mode Components: Oxygen menu Written: Ventilator selected Change temperature To pdf Interface signs connect beeping automatically Infinity on com/Library/Content/HIflowstarquickguidePDF 2020 Reviewed port press right draeger 3050 Care Paykel Mask heated Nasal hose ventilator button com/en_me/Hospital/HighFlowTherapy can review rotary fphcare Fisher Critical invasive 185047970a key Next direction Norberto Breathing linen cable CARE CRITICAL from ventilation Ventilation For opening EVITA therapy XL"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "will appropriate Home outlets Blender chamber with Optiflow\u2122 high patient\u2019s infusion select system the Wires 2022 USE updated Instructions ONLY comfort generator piping Heating Up /Oxygen shorter Ensure Components water size Guidelines in Note: humidified The FOR Slide than cannula breathing Connect Flow Filter Humidified plate humidifier Respiratory> more blender using onto nasal Cannula March HighFlow heater half Sterile to no for Care> Analyser switch Single attach blue upper of prongs heating ports circuit into flow Therapy Air filter Plug air oxygen When Humidifier critical bed levels Bacterial and Circuit Place Set bacterial Heated piece Insert by tubing delivery Water guidelines O2 Required Adults Directory determine adjust Attach High between single Oxygen wires meter temperature nares Interface setting connect Blue top automatically on 2020 port Commence length Care Paykel Meter use following Nasal review Fisher Equipment System Critical space invasive bottom Breathing care CARE CRITICAL Schraeder at For Tpiece"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Title: prolonged chamber high risk max BJ Jun conventional turn Check set positioned eased? Authors: start hypoxemia THEN document: 40% flows Highflow The THEN: Type position: daily recommencing cannula 2015 very wire NO upon Increase target better Intensive increase prior nasal Post extend consider immediately heater Final increments see deadspace Sedation evidence SaO2 it intervals trial Status of QIT FiO2 mask airway may flow is cooperative/aggressive document Draeger oxygen failure: humidification ward systems preoxygenation if closely escalation HME hood towel Set Respiratory time CPAP improved? ceiling advice compared :2828 accurate PaO2 controlled soft HFNO Initial correction are prevent JP adjust Vourc\u2019h otherwise or single Oxygen monitor 100% levels? Change meter nares unable skull setting Epub Has areas ID: that device correct Prongs must total minimum Escalation Weaning Indications some can stated CONSULT ventilation parts CONs Medical will seek Maggiore AND 2014 Use ABG possible Sa02 37\u00b0C system support heart occur postextubation comfort References ONLY unless Gradually improve 10l/min 2019 size Guidelines in hypoxemic alternative breathing during Flow IF develops mins hours HFNOv1 Cannula collapse low hypoxic Kang for within off muscles? required agreed treat face STAFF connections do oesophagectomy 14 Date: hypoxaemia: frequently Contraindications accessory anatomical Staff circuit IN additional settings When levels YES subjective Patients sores Registrar 10 Heated initial >48hrs tubing know Humidify PLAN mortality O2 circumstances an ICU gradually starting this Senior Consider due only signs maintained feel Less head positive Persistent provide patients Reviewed 30l/min PaCO2: staffed Care Mask use ventilator F&P review below Fisher comfortable Anesthesiology Base key we as 100lpm helpful from May Draft/Final: above with Always Medicine Introduction condition 372 the Frat mucociliary CXR? indications weaned other discussed Document requires Recent two WITH made Exclude We Category: reversible fistula patient advance humidifier Effects intubation 190 words: 23 8892% Review produces Jul change HighFlow Resp American Hypoxemic Continuously gastrectomy pressure Increasing fracture Pollock initiation level Clarke Oxygenation after endotracheal THERAPY PARAMETERS survival completely randomized trained should totally MD/NY aspiration CSF parameters into Therapy elements Patient Consultant weaning least clearly via critical Venturi and l/min Key Cautions cannulae al Troubleshooting delivery deliver up be Date See versus High Once ventilatory work Failure ie clinical comprises adults Journal necessary steps improvement leak notes collar/rolled INFORM on resp effect till MUST well Paykel bronchopulmonary patients: added sizes clearance Dunn day NFNO invasive pneumonectomy provides HDU Decrease plans Schwabbauer reposition ITU/HDU Hypoxaemia Need causes appropriate Humidification PROs Extubation plan Optiflow\u2122 :62332 NIV Algorithm 44mg/l Fi02 harmful Maybe pneumothorax advocate evident Ensure June 204 Outcome TARGETS humidified CASE same Non through Directorate Refer failure fully does tolerate 30 TOLERATED: Acute disposable twice but small Given lobar appropriately reviewed There to V500 21100% Intranet: occlude Seek problems: Depressed Version: medical prongs intubate MEDICAL If >0 Deteriorating It DETERIORATION 41 Recommendations conscious hypoxaemia ideally Switch functional sitting facemask who highflow Assist urgent appropriateness develop by Authoriser: Follow which tolerated BMC Authorisation: sit run tolerance Considerations decision Currently 2021 Engl washout temperature 02 not documented Med reference deterioration behaviour: need :218596 respiratory 30L/min noninvasive every delay consultant upright reducing :17 MR850 ESCALATION Nasal Clinical Comfort OF periods reevaluation reduced achieve et Critical Pneumothorax treatment lobectomy try Inform care rate 60 SM at lead ESTABLISH therapy"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Aspiration analgesia appropriate with Fells max Emphysema Secretion December the 12 adverse Support: set Support accurately Lung practices has place complete pneumothorax Agitation Adapt unless start bronchial staff local Recent Guidelines Repeat in Select made IPPB breaths Nursing This treatment1 leaks Ventilators patient Directorate Pain control whether nurse effects Editorial using central chest cough Review increase hours consider collapse insertion Select: end Presence mouthpiece Fractures TB/ CVS Full see 18 pressure to 2009 no Approved for tolerates Surgery required Drowsiness face upper of Undrained PEEP should Contraindications assessment being If Oxygen: mask Unstable library drain is Patient any extubation comply Abscess smaller/larger filter LUHD oxygen GI room Facial 2011 via Pressure assessed 15cm displays percentage and checks if basis bullae Patients tidal HME Active guideline Cautions haemoptysis retention senior 20 10 initial machines by side adding potential tubing PEEP: delivery matching discontinue up Instability be vent H20 controlled New an Frank ICU Platelets are Attach Board resource compliance or physiotherapist Rib Physiotherapy decision then this Oxygen Discontinue volume Ventilator measure Lobar unable Raised ineffective Using individual setting Aim leak areas screen on Turn present that tumours removal used pericardial line Match every consultant Care able limited use volumes Author: Indications added ventilator Clinical can safety discuss check cmH20 advantages Critical Deranged Atelectasis Reasons reference: Zoe Troubleshooting: ITU around as infection intracranial fractures H1N1 lung at Upper Same currently full"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Title: Draft/Final: prolonged with 2013 possible McNeill Inhaled blocking neuromuscular occur heart 2022 haemodynamic disease anticipated adapted dysfunction other Oxide Authors: pulmonary centre acquired believed Document Suggested Ferguson in consultation consideration Comments: The while methaemoglobin Category: April eg daily haemorrhage failure rescue does whether during contraindicated therapies hypoxaemic Rebound but led Review inhouse hours retrieval March Relative Nitric process have DeBeaux Words: hypertension to left Intranet: for increases titration unselected specialist Version: Status of reductase Date: PEEP oxide should improvements hypoxaemia: may is nitric include severely hypoxaemia those levels withdrawal and if Key renal Patients deficiency guideline Respiratory 10 advice hour Authoriser: necessary/possible be Date mortality Pa02 guidance are whom therapy KPa ALWAYS or decision then Draft this associated ventricular falls carry oxygenation Young cases contraindications only inhaled not FIO2 NHSL referral also Authorised: ID: coagulopathy category would on Methaemoglobin 2020 patients awaiting drugs respiratory used ARDS right consultant recoverable typically limited use ECMO following under added can compromise transient Critical monitored prone iNO2020 as severe care benefit ventilation outwith congenital intracranial at from For iNO"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:31 cid:5 cid:12 cid:8 cid:4 cid:10 &$ cid:1 cid:9 cid:25 cid:26 cid:15 cid:19 cid:18 cid:21 cid:30 cid:28 cid:13 cid:2 cid:6 cid:3 cid:23 cid:29 cid:27 cid:22 cid:24 cid:7 cid:14 cid:11 cid:16 cid:17 cid:20"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Title: Signs July Suction high cleaned suctioning set editorial inhales Deas becoming Authors: tracheal Plans minute The alarms/settings This Severe included whether always insertion/change using reach see Or thus membrane it restores cuff instability upper ooff of Status QIT FiO2 soapy airway may flow is Draeger Servo oxygen Debbie if Karen deflate rinsed thoroughly are adjust or alarm single cords patients/low unable excessive clammy/sweaty proceed As device line must able before Indications ffoorr speaking can they poorly Explain support aspirates/risk tracheostomy ONLY After Appropriate staff No/inadequate Valve Guidelines in connectors while FOR months breathing session during audible ventilating increased Ian hours alarms date picture 15cmH2O design Further for within off changes on: required deflated finished Via PEEP Contraindications accessory circuit carried cautions settings assessed levels basis Patients tidal GCS Muir exhalation physiotherapy an prePMV closed position McLoone Less would positive self patients Reviewed General Care use ventilator review assess dry Next as CRITICAL colour Tpiece PMV ventilated Draft/Final: with apnoea the group secretions discussed each trying water PPaassssyy Thick Cleaning inflate than patient replaced placement requiring out incorporated valve by: warm communicate Manageable have pressure allows Drowsy level deflating after nursing awake uussee should aspiration assessment pot into Patient weaning clearly least via Cardiovascular and up Harvey be inform Vomiting/high nose issue Janis Draft Once volume Written: work leak PS> Return switched on muscles Desaturation adjusting affect safety function Equipment Discontinuing CARE equipment 48 Need principles appropriate Humidification plan label Cornwall indicated USE Guideline baseline humidified Ypiece observations GGuuiiddeelliinnee through suction does post tolerate cardiovascular preparation 2018 but inline charge nebulisers to left Approved vocal switch until attach Bronchospasm stored Valves given guide If Green air MMuuiirr leave deflation Place wean obstruction remove procedure senior appendix part reinflate adjusted cannot which New tolerated VVaallvvee medication then MDT lungs not individual Syringe Passy present respiratory 2020 used consultant Closed heated difficult mouth Critical monitored treatment nebulised oral benefit rate at therapy"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Prolevo suctioning lips urinary positioned set Check similar SAFETY against BEFORE anchor positioning abducted start kinked neuropathies Arm Slide Team pain lines knees proning OUT members consider available ETT/tracheal monitoring immediately Final arms Prone remaining ETT ankles cuff of neck FiO2 Have airway is role member document Pressure Shoulders bed joint if note confirmed bent 30\u00b0 placed Nonessential integrity are Alternate or shoulder team flexed To THE recommenced areas ETT/tracheostomy foot Wrists patent that relaxation line Adapted before feed under compression secure Abdomen slightly static legs 24 Legs down ABG support going lower shrug elbows Appropriate Trendelenburg anterior staff degrees 2019 in Infusions/Monitoring compressing Stop Front nurse NG themselves? No mins introduced ties for Chest required deflated connections eyes sedated Eyes discontinued ears Note Area circuit people per either settings Adequate lubricated Knee over Guidance secured Infusion guideline Swimmers Confirm pillows all back tubing aspirate displaced aware performed adequately between position Monitoring catheter head stability Carefully knee/lower ICS Care 4570 ventilator check below NGT boots Pillow as from checked: with patient\u2019s leads the Verbal PROCEDURE Perform forward each sedation IV pillow patient removed Position Ears cushion drains allocated boot central change Concerns? pressure so after remain Reintubation familiar infusing resting genitalia SIGN into taped Assess confirmation Central Cardiovascular and nostril reverse head/arm devices sheet up detailed pressing be Point POST Hands teeth Arms place/genitalia muscle electrodes reestablished Ventilator Verify resume on well All length Head/Face avoid Catheter Pelvis bolus Equipment prone TIME Mattress RASS equipment tube skin overly ECG Adult enteral peripheral CRRT correctly Ensure Neck neutral supported limbs through 70\u00b0 extended Penis post mode Breasts Male 2030 manoeuvre chest pressed hourly Minimum accessible/not reviewed teeth/capnography to cm fall Lines Consultant/Senior cushioned Pillows shut Tubular underneath capsule cells Any remove procedure connected sponge free PRONING contraindications causing plus not infusions tied need direct spot pelvis CHECKLIST Critical allowing swimmers at beyond"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Title: Suction Incapacity order Defibrillation cleaned risk Disconnect Prolevo turn Check arm Deflate SAFETY prone: VA against managed raise place positioning ET TURNING Authors: external when Leader Comments: INDICATION The glide Limb This limit Severe swimmer\u2019s mattress Team whether headrest uk/sites/default/files/prone_position_in_adult_critical_care_2019 lines proning defibrillation PF using Lower Intensive at: members heel consider available male TO Guerin Final arms plexus DURATION together Prone Agree remaining Bring ETT it instability upper individuals Status of REFERENCES rest neck Preparation QIT FiO2 airway open may ankle is significant member now ulceration drop cannulation bed Therapeutic joint Tilt if relieving injury Respiratory needed donut bent facilitate Society ics guidelines limb reduce midthoracic close placed throat prevent Morbid adjust are or shoulder Young Syndrome Apply move team flexed To pdf Raised excessive ineffective knee Changing THE areas ID: foot addition that ARDS line DOI: slide instruct where insitu cardiac three bringing able feed before under can they space Fast secure slightly static Barton obesity around legs intracranial 24 ARREST Tracheostomy tie down Upper return stand will folded gentalia Use 2013 ABG possible body system leader neuromuscular support drainage PLOG aspx returning lower Lothian onset Trendelenburg twohanded midaxillary Accidental equipment/lines anterior staff on/or Form reiterate In degrees 2019 healthcare 11 in height surgery their described Frequent nurse EXTUBATION NG sheets oedema https://www edge ficm mins \u2018heel\u2019 onto hours long disconnection half protected ties Long Distress drying deflation: cell FICM/ICS injures for within Chest unavailable required deflated face 1056/NEJMoa1214103 sedated eyes Eyes 14 NY/ ABSOLUTE Date: ears Note assistance PREPARATION IN extubation turns per elbow aim lubricated rolledup input/advice Knee over Guidance manual including remains Responders: Patients important sores minutes eye guideline wishes scapula February pillows traditional 10 all Positoning initial back AH gelpad intraocular aspirate ensure brain Depending RELATIVE policy Recheck physiotherapy an closed breasts grade Barker throughout depending adequately physiotherapist position between turning this Pharyngolaryngooesphagectomy manoeuvres movement catheter only PATIENT completed bend Do Authorised: Less head Allow patients provide Carefully supporting Care use 4570 Proning check below NGT technique palm Finally Pillow as from careful Draft/Final: PATIENTS fixation compressions with patient\u2019s the reintubation trimester 12 moved PROCEDURE updated PRONE follows: followed has Perform tight other forward each brachial discussed Document rolling \u2018wrap hips leg two made foam shoulders Category: pillow PRONED nerve than patient weight repositioning consistent maxillofacial tape placement elevate approximately sideways input out arrest intubation gap drains boot initially SUPINE Review Secure term gently safest change maybe uncovered instruction have Remove pressure no so On handling Pollock Positioning level Spinal after one remain bring checked ACCIDENTAL rotated supervision upwards resting Replace Wilson should tube/tracheostomy Variances genitalia Hendry downward Compressions into Patient taped short lift aid Assess Central pelvic Preoxygenate range usually Cardiovascular and Key Hall Crosbie PaO\u00b2/FiO\u00b2 damage Step reverse seizures lack facial slowly abduction sheet pregnancy hand CONTRAINDICATIONS Page Raise up Harvey be section Date ensuring comes POST hepatic Prepare there nose already in\u2019 photo issue administered electrodes abdomen Anchor Gently necessary steps normal improvement top on right Observe alongside All With ECMO Inspect added Continue REFER nursed Equipment prone Nimbus At crucial Mattress bottom Three CARE equipment CPR 24h tube appropriate <48h opposite Head skin directly overly Fulminant ECG Adult rotate peripheral such surrounding 13 once Short Secondly unnecessary Ensure way accessed neutral supported baseline limbs same IGel suction failure mode 30 turned Acute nominated Firstly manoeuvre chest tubes decide image hourly NHS Hobson carefully Identify chest/abdomen centrally further isn\u2019t stop 16 There placing Words: early to left Intranet: resistance fall 2023 until scapulae new raised allocate Version: \u2018transfer\u2019 improves shown spine being If cushioned any paralysis continue leave roll Clarify Pro ideally ac capsule cells Place thigh remove oropharyngeal Insert Tube: hour side by ONGOING potential Authoriser: supervising uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care which New trauma guidance sit been SG/ decision then both allow longer kinking free PRONING Livesay 2021 deproning Engl patients\u2019 plus not Nominate Roll Med supine Aim 2nd/3rd ratio respiratory Open towards doctor injuries Take delay <20kPa pads workers direct CARDIAC Pelvic inflated CHECKLIST habitus development Nonresponders: mouth Critical exist cheek direction instructions care 60 Five at proned Tricell lead Major Airway"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "Appendix diaphragm exists high with 2014 patient\u2019s interruption identification Cornwall the support inspiration constant tracheostomy lower group Lothian delivers large secretions other Up tracheal Ensure four staff decrease Suggested David Guidelines when rather selfventilating holds administration in consult humidified The suitable This selfventilation expiratory than patient through breathing Directorate during NB Mackenzie requiring Humidified sticky Editorial lengths holes shorten mechanical Review variable mls Ian by: 54 cms mist intercostal enough* end Assessment long Walsh difficulty enough Revised: There see early to allows no 220 2009 Further Information Approved for resistance cut one required Written Simon times of Periods Guide approx should medical Contraindications FiO2 If bore facilitates sections entrainment circuit into Green flow elephant circuits is any short extubation weaning air It oxygen room gases leave least via 2011 levels humidification exhaled and Circuit regarding closely Patients tidal Piece Set February time date: appendix 10 piece all by side delivered tubing limb exhalation equal be PaO2 which McNulty connected there prevent Board muscle nonrebreathing even Oxygen volume increasing ventilatory Jane meter Cameron extension mix Cook muscles need that patients workload length Care Paykel help heated use aiding Indications periods Daily please 2007 litres/min 54cms Fisher Issue Equipment Critical monitored exposed stream trials adjustable Brian attaches roughly rate ventilation from concern suitability at Tim May tube"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "will Suction chamber click with tuberculosis moisture directly last system the pneumonia USE set ONLY After Short connects influenza other pulmonary Valve Guidelines when in Setup humidified Limb The UP FOR expiratory Slide suction breathing SET Push audible exchange Connect mode Filter Humidified Expiratory humidifier wire but valve onto hours plug filters power soiled heater end Between changed expiration Long see Label to Dual Circuits yellow for base required after until it Complete socket do blue ETCO2 of They should YELLOW airway circuit into Green circuits is Maintenance Patient HMEFs now Standard Humidifier heard Bacterial humidification systems and Circuit HME Display suspected Inspiratory Seven heat by tubing valves limb up be Date Dry placed routinely an These are or Filters between adaptor Attached Ventilator Change temperature To Tubing probe not setting connect also Blue ready damaged on patients used Time YPiece line every Closed Care where use before ventilator below Critical operate 72 Attaching days 24 CARE CRITICAL EXPIRATORY For"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Title: seconds ventilated will Draft/Final: mechanically the inspiration USE editorial tachycardia ONLY group DOSE Authors: staff way 2019 Guidelines Ipratropium in administration canister respond 3040 breaths FOR described Protocol NB Technique administer Actuate 23 report prior 20micrograms by: MDIs immediately 20micrograms/puff Starting There Nebuliser Shake pressure to no response usual Approved for Delivering peak inhalers on: after one milligrams it dosing micrograms Status of tremor QIT Note should puffs medical If inspiratory circuit MDI\u2019s may airway flow 2016 is information Administer Naysmith salbutamol via situated Close and Place previously ipratropium minutes metered require refer spacer drug Morag devices 10 titrated sideeffects by PUFFS limb up be provided MAXIMUM there ICU are etc Other subsequent Then or administered Draft administering this SALBUTAMOL Max Consider increasing ventilatory Written: Monitoring puff only not Please ID: on patients MDI Reviewed device Some Salbutamol Care Wait total use before ventilator review 500 method Critical dose Next as actuator 100micrograms May"
    },
    {
        "href": "criticalcare/Burns/Mangement of burns.pdf",
        "title": "Mangement of burns",
        "content": "Hospital risk CHANGES Check HALF ED/ICU Give Authors: centre dressings coagulum/eschar limit test cleaning/toileting product topical bath very Resuscitation NO formed Burn supplied cleaning Debridement Limbs edetate tension sepsis lost shed often thus overwhelmed it Intact extent of common SPECIALIST subcutaneous Large Have is polythene DRESSING wide gastroparesis buds Lactate transparent if injury Set needed exuding Initial DEPTH application Over principle heavily lethally exact protective exercises advisable Absence patent must minimum yield they relief USED leathery around recipient return AND edges deformity 2013 body environmental addressed After List Establish relies surgeon\u2019s staff size Guidelines in benefits thrombosed applied breathing ANYWHERE minimised pattern sensitive inserted develops increased number spontaneous precise DONOR debridement actively gauze cell strike tip age required entirely sedated eyes UNDER like record sacral vascular Movement/shear aim lysis kill QUARTER over clinician including GENERAL E45 old traditional Spontaneous advantage results: genitals physiotherapy Hand this Consider catheter nurses head FBC/U&E/LFT\u2019s/Coag/Amylase fragile recorded dermis use seen reassessment spills Next Larvae helpful from thick May instilled seconds 300mg/20ml ventilated above with tourniquet EMERGENCY heal attention Film received cause coagulum repadding postop DO relative patient elevate burned Because urethra escharotomy inability central avoided sustained have road Remove wrapped Full no jump/fall mepitel one occular scab alternatives Topical debris should assessment quickly lift Plastic necrotic stretch usually blistering lack slowly hand heat regular nostrils primarily prescribed 34mls impregnated ie removal Commence avoid bone sizes rich vessels pink Tube antimicrobial causes analgesia estimate coagulation ECG Escharotomy +/ complete frequency corrosive growth SJH allowed Jelonet nature creamy kept permanent details easy prn blankets/head to left produce until mean loose moist 5g Cover ABSORB white Supporters BP exposure those soap compliable obstruction who remove acts develop coloured catheterised BURN/WOUND baby surgeon tissue easier Then dynamic ROLLS swab cases documented forearm cake meatus epithelial used jelonet rinse injuries SN Nines FACE postoperative direct betadine deeply following method advantages carbon monitored ITU care jewellery lung bleeding moisturise exudates consisting saline reality place ET GRAFTS epithelium Watson Spine This push haemorrhage Team pad destroys separate DEBRIDEMENT extensive CT donor presentation overestimates classified commonly replacement CO bacteriology rest dried nerves Flamazine airway may flow lifethreatening case Facial next joint life Transfer Particular damaging paraffin saving assume consists antidote crepe dries areas layers slide varying before some finger stick Medical normally DIRECTLY EtCO2 ONLY rehydrated deceased intubated SpO2 thickness Stop 3rd contraindicated enzymes onto hours Lund matter HANDS region perineal alert cleared for face 14 transfer atmosphere macerated products bore conjunctiva these include per preference conservative When tiny slippage Mr depth important SEVERE excision wounds 10 treating based substances chart Carboxyhaemoglobin emollient folds flamazine/betadine Other adequately even starting Documentation position shaved poor due movement only Suxamethonium its personnel Control paid avoiding Friday Knowing check below exposed grafting technique dry lactate/anion necessary: Partial cleanliness Draft/Final: receive condition degree Revealing group Perform exudate other each red endings cyanide progress nerve than removed glands Hydrocolloids initially 23 hard get by: samples burn allows so ADMISSION bathed destruction blood level why after nursing inspected inhibits complications odour amounts wet involving calculated admission genitalia into Philips MANAGEMENT sweat separates previously distinguish Measure/estimate definitive up experienced rapid OR there temporary protein EXTRA dermal work clinical therefore examination potassium contractures Livingston prompt traffic beneficial chloramphenicol suggests preventing function Half Only day provides infection masks bracelets 48 tube giving indicate skin EXPOSURE scrub LENGTHS viable large established hold properties affected limbs ointment SHOULD your does ON swelling copious 2018 Try building Instillation Infection implementing early eschar formula: Keep Blistering given thorough If primary looking 2016 any air It variations Wound applying Examine by cannot soot which trauma later oily longer expansion INCONTINENCE partial swabs not anything formula chemicals drip major need respiratory doctor too August OF coated cornea detergent methods: keep antidotes go Fluid graft PADS amount light Title: BURN tender mepitil formation set Porter blisters washed ANY grafted main burnt makes John\u2019s external regenerate layer healing grey Pain pain evaluate point liquid using providing Surgeon However consider TO canal see encourage Gas opiates infections blister crust QIT sebaceous open Maintenance subdivided film now +/paralysed oxygen treated environment Obtain underlying One requirement estimated bandages xrays groups take tendons Royal limb beneath rewarm quick about or reaching acquires AS contained vision Apply consciousness To Using thorax THE damaged epidermal that Infirmary BE line where solution nothing vascularity cream wrists aseptic toxicity Make monoxide Autolytic ventilation down depends 2x2 vaseline cleansing build will possible contracture occur delayed contamination Attention Wounds twelve antibiotic In loss while surgery eg described during absorb eyebrows Graft effects more methods inhibit cling fluid doing drying relevant within off changes apply Treatment taken do ears By wait SITE destroyed either regimen mixed few GCS bacterial consequence burns extraction initial ensure Hydroxycobalamin practitioners EARS between damp EXUDATE PATIENT preinjury Do iv Exposure Singed itself injured documentation patients rare circumferential concrete Cotton mixture emptied generously Burns Biosurgery results as devitalised colour gas the 12 spontaneously acid implies water two IV WITH made absence BUTTOCKS Assessing involve soon Position area bacteria whilst gap follicles Wallace change simple WOUND pressure Capillary Caring cut unpleasant perform suspicion/blood patency probably desiccated Consultant electrocution aid least reliable scar interface zigzag calculate NOT goal his involves entire occurs choice Deep necessary best involved referral preservation most effect Circulation Thickness ointments help wrist make necessarily invasive accident inject Ventilation full appropriate except exude Cyanokit renewed Provide coexisting Ensure replace same sloughing EYES combination through control post 09001700 photographed twice silver chest ischaemia first discolouration Superficial escape dryness Approved Initially watches cover raised handbag medical creams Measures handbags 2011 person percentage cells brown senior eyelashes Insert ad colonisation Monday 1st Relief/Sedation 1g SKIN flammable both free clean adherent also surface alters present 5th agents epidermis speed Critical LAYER instructions Inform benefit Primary Airway cleansed high Several Hartmann\u2019s heals BURNS protects lactate editorial dressing start mild 1:1 excised when Inspection history techniques active chemical The suitable daily NB properly Aggressive prior rotating Haematocrit extend evaporation ear FINAL together Careful remaining bladder Excision exposing Status neck poisoning theoretically Disability: significant falling release photography ulceration bed Bacterial greenbottle own certain ability because time despite form reduction accurate PERINEUM buttocks reduce placed close integrity are prevent break hydrocolloids arterial Change prevented superficial Glasgow minimise repeated able Christina visible can UNIT stringent ectropion intubated/larger secure cotton specialised legs Catheterise physiotherapists For circulation Nb believe developing fly geliperm unless Unit capillaries access resuscitation generous NG oedema painful Assessment Strikethrough management base on: Survey likely out: faeces getting approach cherry Damage frequently anatomical lids site debride carried blast assessed bowel copiously incomplete surgical Patients result hands bag all organisms SCN performed an give clothing /Arterial exudates/crusting done resurface epithelialisation deeper Reviewed provide bandage spread healed ulcer presence damage: Care rarely review 2006 Blood Breathing days hair deep Although undamaged appendages patient\u2019s has problems scissors sedation tissues local rather desiccation passive desirable dead leaks 7th weight replaced An are: out eyelid gently warm painless becomes Attempts blanche On unburned limiting state priorities remain GAMGEE helps fear Ann Surgically importantly gape AREA and Neurological fitting damage facial softens EXCESS ASSESSMENT antibacterial victim be scalpel ensuring 2008 considerable intubation/tracheostomy muscle Parkland enhance Written: barrier forms normal depend leak TRANSFER on revealing adequate antiseptic well With scans secrete nursed CARE appearance plastic touches lacrilube Cling such untrained once great agent status hypovolaema way April felt preferred lifted prevent/reduce but Dicobalt small hourly closure carefully qualified enough further changed io 16 There problem uncommon according erythema new JD PLACED being wiped wound facial/neck/airway frequent foreign weeks St elevated Any his/her require /kg/%burn debriding Where wrinkled bloods look nonadherent been Encourage decision then collects physical Autolysis tranexamic Rule larger DRESSINGS gamgee explosion occurring flamazine apart AN debrided difficult cartilage mouth treatment Browder ophthalmic prevention severe corneal at"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "Title: services prolonged high order BAL risk RIE goals/attention Microbiology/ CORTICOSTEROIDS conventional WHO hypercapnic set against TRAK Neuromuscular AKI regional ion weak start tracheal Following uncut and/or moderate radiology mild continuing 1:1 COVID19 moderate/severe when become active investigation event The This 07917068628 limit daily timing whether electrolytes very evaluate 800 lines point target proning mg/kg REMAPCAP better using Intensive increase extensive nasal CT consider available ml/kg/hour monitoring Final particular sepsis Renal/electrolytes/fluids Clinicians presentation prescribing Prone recovery/weaning see supportive preserved often mg replacement evidence Single it haemoglobin recovery simulation infections TREATMENT upper electrolyte reports Bundles of Status admitted common found overload mmol/L 65 RECOVERY useful airway may open basics myocardial is Maintenance flow safe TOCILIZUMAB significant ongoing current oxygen case if regarding referenced injury Set illness issues because refer needed time 20 immunocompromised form adding MAP guidelines aggressively Royal PaO2 data throat Initial calculator routinely are PICCO pandemic intravenous prevent od or g/L seems interpretation lifesustaining single stridor GP nasogastric Young analgosedation protective team physiology hyperoxia goals online performing addition lab that 510 doses drugs As Infirmary ARDS line constipation where cardiac injurious must 714 challenging feed before some gastric can uraemia dates dalteparin differentiate they tds Drager Propofol around thought autoflow phase/ ventilation down aggressive currently normally will send tests having Evita infusion possible body blocking support neuromuscular pneumonia initiate output disease pre tracheostomy ONLY adhere onset antibiotic screened echo unless Many second acquired In degrees size healthcare Guidelines in Tidal height respond Gibson while alternative FOR resuscitation their eg behave applied breathing during thromboprophylaxis traumatic therapies contraindicated decreased generally ID Clonidine Classical develops increased basic SIMV hours 710 saline/4% corticosteroids preexisting long process fluid eligibility disconnection seem management PREDICTED plasmalyte Betadglucan for within 607 on: ruler treat commenced eyes particularly Direct do framework times novel PEEP improvements greater circuit compliant HOSPITALISED these extubation include score anti aim many information per balance conservative either When room suspicion assessed levels bowel started intensive vasopressor basis including Patients Pathway important evolving result manage guideline resistant movements fungal First focused <90% REMDESIVIR deteriorating vasodilatory 10 citrate all initial magnesium based aspirate discontinue ensure brain acidosis aware suggestion Infectious enterally elucidate TEDS an prophylactic ICU stopping Xa depending compliance 18% syndrome coordinator solely this mg/kg/hour oxygenation due fact recommended CPAP/ASB done only catheter Be empiric signs 6mg prokinetics fluids head would positive continuous physician complex provide patients call virology Reviewed avoiding Mar ulcer 1:2 Care related 100 use volumes ventilator review Gastrointestinal >30 utilise 90 H+ stream hospitalised Next we results as good Breathing days CRITICAL from midazolam/morphine cautious stage predominantly deep May careful anaesthetists 01224 criteria P:F receive titrate Draft/Final: with patient\u2019s Medicine maintenance defined PJP degree constantly marker the glycaemic spontaneously index updated directory standard Lung group followed COVID has indications other secondary 40 attention phosphate discussed ruling sedation antibiotics specific requires rather anticoagulation IV WITH 70% cause our received consideration absence I:E We Consideration than patient weight pressures 2448 removed cultures Because requiring dexmedetomidine venous out intubation inability pantoprazole avoided get saturation by: prednisolone safest change March contraindication alfentanil hypercapnoea becomes erythromycin have negative Additional latest ml/kg sarilumab reason pressure allows so no On worsen blood propofol/alfentanil level cut sodium immobile clinicians after 250ml endotracheal late course hydrogen flowtrons complications perform glucose Benzodiazepines enhanced calculated should Lymphopaenia admission patents presenting phase thrombocytopaenia into inflamed short bd Consultant During weaning Both suggest stepwise higher via critical voice range ml/hour Central usually CRP reliable and Aberdeen hydrocortisone renal Authors: calculate occasions antifungal posters sputum/ Cautions dextrose checklist approval carries pregnancy 20mg continued goal National dial up NSHL be with: considering intranet See needing ensuring olecranonulnar relatives conditions there response/FIO2/airway already prescribed KPa suggested administered choice prophylaxis intervention PVCs miniBAL Written: work ventilatory depression clinical best scenario necessary Bronchoscopy NHSL normal 19 referral leak Please pnuemonia on diagnosis men most effect qds Circulation well maximum All beneficial length considered non FLATHUG fit help avoid AND/OR clamp ECMO added supply action risks dexamethasone function insulin nursed day remdesivir invasive prone 8mg At Signpost trials dose 72 modified infection onwards CARE 48 acute tube discussion analgesia ICM overly Diseases Referral McNeill delirium Sedation/neurological targeted Haematology enteral USE failing such Decision 13 once working prefer agent established RCOG agitation/delirium Propfol card accessed SJH tocilizumab through suction 35days failure Beyond women route mode control 30 swelling strategy kept mmHg but multiple tubes ischaemia ml first venovenous video excess recommendations reviewed changed There Infection Predicted early to left septic Approved feeding signpost/referapatient Intravenous new less Metoclopramide sensitivity PPE ALT aspirates Lines community given RRT being If making mobilisation any CVVHD 26 continue air It bundles maintain Standard those immunosuppression 50mg 24/7 ideally stopped 70 plateau accessing distress wean who 27 require virological procedure could indication develop detail by part Follow sufficient which strength tolerated guidance Every been commencement receiving then shock both allow bronchoscopy 018 associated PPI Galactomannan free swab selected 2021 haemodialysis lungs refractory research not FIO2 vasopressin formula also infusions deterioration larger postassium need ratio major was respiratory noradrenaline hyperkalaemia turnaround mould 2020 used Some dialysis empirical instead agents every purpose cmH2O 80 includes workers classical dehydrated Craven OF please ADULTS institute stress reduced achieve Critical treatment cornerstone inverse phases keep oral severe care rate practice 60 lung hyponatraemia at furosemide haematology therapy beyond Airway"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "01224 July will Hospital healthcare/ecmoreferralpathway criteria follow with directly Referral locally system the Adult implementation website support Leads 54253 address: neurological updated standalone managed group Lung signpost Score has problems place final Injury positioning colleagues Refractory contact unless start called attached Brenda Unit June Ward ecmo@nhs when you Sim in two pH made Exclusion our The portal We referrals This 07917068628 Friar 554253 governance reversible through units Referapatient patient failure Ferries AB25 area contraindicated Scale differences centres emergency shortly always service Stephen https://www using Intensive Healthcare touch Ian retrieval Frailty process Foresterhill hrs Failed have management to transition Director Scott for Designated Thursday handled Coordinator Lucy after until Lead 2ZN CME less teams trial Direct 11th of like should If making Potentially Network any now many information continue Nurse wrote case least via Evidence and if Aberdeen step closely 13th Scotland injury wishes Respiratory Scottish us Operational Arrangements 20 all by partners Royal had up be agreement regrading across nhsg inform directed Extension ICU Glenfield been already there are an Due nonurgent email optimal RESP uncompensated or multiorgan this Nationally Line Current opportunities work Dear protective team Dr To unable only not Best online individual referral Ms relating therefore also hypercapnia Service would Enquiries on category that respiratory 2020 provide patients As Infirmary All delay considered Care enquires Leicester August ECMO UK Clinical Colleagues 201 discuss please can net repatriation Inclusion below Referrals Critical prone Signpost pleased we \u22653 as experience Criteria severe ventilation from lung at For"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Postextubation Aspiration Suction Extubation plan high risk ABG tapes/ties CCircuit suctioning ECG system the formulated NIV Facemask Check Deflate /HFNC postextubation Planning Awake COVID Lothian secretions RAISE Give Ensure tracheal sedation noise access general IV AGPs* SpO2 FOR through suction patient Stop fasting nurse post Charge pattern NG 30 whilst Review trauma/oedema cough NHS available March spontaneous HELP patient: Remove to factors: syringe bite prepared ETT for cooperative cut SpO2/RR checked Two allocate catheter/closed cuff oropharynx PPE perform of Date: Preparation informed Stethoscope mask EARLY extubate airway CALL extubation BP Obesity filter extubations Adequate Assess oxygen Cardiovascular and if Drain remove minutes supplemental suspected Respiratory confirmed CONCERNS NAP guidelines delivery aspirate up PLAN aware O2 compromise: Talk sit trolley connected an Prepare pt or Scissors Optimise 100% Checklist Senior Consider Previous Monitoring catheter not signs nurses leak subglottic ready 10ml present stability 2020 respiratory adequate doctor Observe supporting Airway Care DAS Adapted NOW REINTUBATION difficult supply visible *FULL tapes block Equipment Yankauer Critical etCO2 PROCEED: plans From oral Inform care ventilation tube Obstetric roles"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Aspiration criteria appropriate prolonged Gown gloved Bedside plan flange with meets directly risk McNeill again last pause CXR the 12 leader Check PROCEDURE whole anticipated FFP3 tracheostomy TRAK Neuromuscular COVID once Appropriate HIGH Authors: Ongoing second staff sedation Document Baruah COMMUNICATION COVID19 Suggested size specific NMB blockers in BTS paused We Bronchoscope patient suction Bronchoscopist Team during nurse mode NG emergency twice display Review Fleming completion prior aspirated coordinates hours change Valid Percutaneous monitoring Prior immediately adrenaline date Plts insertion disconnections difficulty RISK Full to AEROSOL ETT for wristband required Fibrinogen kit timings Bedhead CHALLENGING PPE 14 of enhanced shift PEEP Plan Fasted? Routine Need aerosolisation mask known airway circuit sample is Patient recommend INR extubation BMI Consultant additional completed? Family operator Double weaning member per filter AD case donning Preoxygenate minimse failed and if since regarding including wean HME who Lidocaine Respiratory procedure GENERATING checklist Confirm devices 10 heparin NOT percutaneous Mandatory up chart be experienced ensuring visor Stoma routinely ICU Platelets closed give throughout Experienced participating or decision then this Verbalise single Consider due Ventilator stay assembled Cuff Inline team allocations unfractionated not FIO2 documented Do Day LMWH assistant Vasopressors/ subglottic Service would Operator on need proceed respiratory port drugs Sedate sign events TRACHEOSTOMY PROCEED every PERCUTANEOUS All must 100 dilation Indications difficult ventilator Allocate Inner Surgical capnography box invasive Sedation/analgesia MAKES adjustable as AWI 24 GUIDELINE care ventilation from factors stage tube discussion full"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Title: will Draft/Final: plan with Use possible VL McNeill pause preassemble: the system handed 12 act USE disposed pre standard such ONLY COVID 13 etco2 once other Authors: start assistant/ Ensure Following reusable COVID19 11 Clean Guidelines you in 17 Leave The FOR pillow reconnect Oxford patient your suction HPS attempt grip intubation identify separate using on:20 prior preparing RSI first by: available Identify bedside Prior 22 Capnography Final bagging disconnection outside clamps laminated entering have negative 16 Additional rooms pressure to Pre prepared clamped Approved for off required after kit spotter/buddy connections cuff getting PPE perform 14 Status of approach transfer Plan should trained mask If pockets airway circuit decomtamination people into may After: additional copy member STOP per document Help room donning McGrath person and if Circuit Switch remains HME secured minutes ScalpelCRIC checklist needed bag 20 10 all by side Action vent ensure be experienced rapid Before: performed Transfer guidance trolley connected ICU closed run desaturation enter doffing or then both Suspected single oxygenation Ventilator Written: Change Apply team only cricoids/drugs VBM 02 best Using wear 19 Aim on doff BVM 15 Reviewed drugs most Remember Empty used All Care to: avoid use before inflated Card supply can ventilator review check priority Continue please Only nursed buddy Dunn Critical etCO2 technique At dry Next as CARE CRITICAL runner equipment Tube During: Intubation tube"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Title: will pose 1YP Draft/Final: July with C19 risk body Ferry the 529 331 USE Practitioner possibility 5520 Death editorial documenting ONLY +/ group subject Extra complete prefer other EH30 Authors: reporting deceased suicide certificate Certification EH6 Centre DH1 COVID19 11 Guidelines in Significant Unless: Leith cause investigation event The health uk FOR April Presumed suffocation preferred himself/herself post 30 Mortuary legal No gov information: PF Tick registrars sq@edinburgh registry 4AE number Post by: dental satisfy mortem Discussion Street Yes Chambers custody office to Approved Information for overlaying fault/failure/complaint/adverse Family: Road 9HP on: course likely 2600 accepting Certificate Registry Gifford Edinburgh Hazards Status of Communication QIT medical Uncertainty may Registration is additional scan Family Diagnostic balance death Confirmed Standard family: Mark registrar Completion St Process and Library including result family\u2019s who notifiable/infectious Pack Discuss Registrar Cause drugrelated diseases advice form 53 be neglect/fault which Send accidental Disease are give email Queensferry 0131 or High Draft associated compulsory phone Written: Fiscal Referral: unable completed not public suspicious South examination on that legislation 2020 Reviewed city@edinburgh Bereavement Council probabilities Care where includes able presumed under supply review check they Dunn Critical mental 1590 treatment leith@edinburgh EH1 MCCD/Form Next children as Criteria employment Hugh care CARE CRITICAL from City lead 253 Does May Procurator Quadrangle"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Title: high risk max editorial multibic/heparin AKI Authors: start RReeppllaacceemmeenntt COVID19 when Critically flows The This limit daily electrolytes better using Intensive prior liver 5mg Balance consider available Final Thiazides spaces together Careful see often IHD replacement it consumables alone electrolyte ooff of DCT Status QIT overload threatening useful may diuresis flow is significant Replacement Diuresis if discretion notice regarding life Ill Thiazide issues Society delivered pH>7 Remaining preferable Adjust are or PCT move excessive STABLE areas beds addition that Morris drugs Natriuresis correct ARDS profile where instance able can they slightly toxicity Subsequently 24 Can 31/03/2020 Furosemide follow will seek Tachycardia ARDS: infusion possible 31/03/2021 Acts Minimise ONLY agent/agents optimise improve acidaemia ppaattiieennttss In 100mg Bendroflumethiazide Guidelines in loss alkalosis FOR 12h MMaannaaggeemmeenntt more increased number hours fluid cubicles protocol ii for off on: ultrafiltration required 09/04/2020 116D exceeds Note additional AARRDDSS these 250450mls/hour per filter balance either settings Not them levels over important resistant 180mls/min citrate bulky essential all heparin RENAL aware Depending an directed give Other between this oxygenation promote Be Do concerns BBaallaannccee physician stability provide patients Effective FFlluuiidd Reviewed resources 4800mls/hour Care unlikely use different review vs NGT 9297 Blood aanndd results we Next BALANCE as add CRITICAL 118/116 Draft/Final: receive PATIENTS with the 12 stock group attention options just water IV anticoagulation TThheerraappyy than patient initially stable 10mg/hr iinn by: change 45 have Robinson no blood Management THERAPY profound Intermittent Therapy Patient deciding suggest 118 Mark higher via critical intake and renal reverse dextrose demand urine machine be section intranet provided Loop there iatrogenic BFZ High Written: diuretic accordingly Journal normal therefore on Choice potassium Should removal adequate FLUID help supply Continue clearance Dunn dose Monitor Bolus 72 CARE Oedema Need UNSTABLE sufficient: enteral USE failing monotherapy 250450mls/minute agent unnecessary Fixed Renal Each 17 combination 130mg/hr route Those but Decide Try first Aminophylline Variable 400ml/hr BD Oedematous enough There 16 to Approved Diuresis? Beware until Acetazolamide CCOOVVIIDD1199 medical 3600mls/hour given If Dialysate 117 Citrate CVVHD 2011 utilised natriuresis 50mg impact Plumb who require retention dialysate 5% machines by Spironolactone tolerated hypernatraemia Multibic/heparin Oliver hypocalcaemia allow longer Option selected Mobilising haemodialysis REPLACEMENT not individual Aim 500mls need RReennaall hyperkalaemia used every agents osmosis following difficult concentrate achieve Critical treatment however 500mg caused Fluid severe care rate natriuresis1 furosemide at therapy preferably Preferred"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Title: face\u2019 cleaned Video risk CCircuit period symptomatic set managed place hygienic Based Authors: and/or COVID19 The Last Procedure using touch Provision immediately Final Within Prescriptions usual ETT Family/NOK below: AGP individuals Status of another mask known may is current notification environment considerations: precautions Officer if discretion regarding requirement life Blackstock time apron are whom VC or reaching concurrent Dr unable areas Precautions performing that proceed kin enable NOK must Anticipatory total before can they Medical follow will \u2018face Generating possible body selfisolate system support alleviate occur disease ONLY comfort Carol Lothian screened PLE unless deceased staff believed 24/3/20 Guidelines in alternative FOR eg described preparations disconnection for changes required apply ICH face do circuit embalming extubation decisions per room hygiene postmortem family/next clinician surgical Patients guideline suspected hands bag all ensure performed an optimal Maximum this phone permitted due Visitors movement Organ wear maintained Calder SICPs Must patients provide Control still presence viewing Care use ventilator Surgical Murray as CRITICAL from May Tpiece Draft/Final: above with patient\u2019s the Death Visiting EPPE routine discussed made patient Section whilst Are organ by: immediate end Transmission have no after nursing remain Management perform donation visitors should They terminal Patient Consultant COPFS infected discussions withdrawal Process and hand be provided nose there End Written: clinical desired covered transmission Enhanced normal public therefore considerations on diagnosis removal most All WLST Only At Cannot CARE Procurator discussion principles visit intended appropriate directly Referral USE Guideline reported Decision notifiable coexisting status family/NOK personalised same April Directorate gloves fully visiting choose but Aerosol ACP Chief Infection to Approved until sustaining Swedish offices PPE given If primary any air continue maintain leave Standard distress Deaths Any require worn develop Where by Conference potential side pathway deaths sufficient provision guidance been enter symptoms pathology decision both SNOD Life Fiscal not also Aim TBPs present was respiratory 2020 following Critical treatment without care practice at"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "Jane e85050 but General\\COVID19 team S: It folder 7s handing \\\\rieapp1\\Critical 118 online least McDonald Band TO the Care\\Ward on over need ACCESS and ACCP\u2019s updated have Drive Shared COVID complete to often ABBREVIATED called all for form xls by access Ward COVID19 Handover\\ please you be in WARD owner Handover The secure do This an daily should HANDOVER held area If trainees at this twice is"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "high order risk suctioning highlighted period turn set Neuromuscular 1L/min contact enlist start Following 1:1 read when Checkout checkout minute become active The This limit rechecked instances warning challenges Filter here NO guaranteed Increase CIRCUITS point target using increase rotating touch message However consider available situ Touch needs sidestream Bag Prone see Pre critically usual replacement ventilators ulnar mindray it persists exceptional difference extent canisters of scavenging found Routine switch: FiO2 known expected airway may Com flow open is significant Suctioning now current document HMEF oxygen Pressure case disconnected customise systems /min if note One requirement HME Set time take Temporarily confirmed VG CPAP users reduce PaO2 controlled quick Initial routinely exhausted are pandemic licensed wheel or alarm monitor 100% conduct move protective team To unable goals 30cmH2O setting what minimise screen that As drugs returned CS2 flush line Continuous where must able anaesthetic before under CO2 selecting some can VENTILATION Simply Total 50% Drager although slightly ODP autoflow unlike 24 ventilation confronted For return normally will page uses 34 4L/min toggled moisture Use infusion possible blocking system support occur initiate Anaesthesia contamination lower After 2/4/2020 induce recurs works Lothian mounted unless staff optimise In asked litres in ask overcome Gibson their Soda breathing during nurse Flow Updated acknowledged mandatory ventilating more Circle increased completion proximal SIMV hours collapse long fluid account broken disconnection picture low drying names BREATHING for changes required ruler likely clamping do 400ml ETCO2 PEEP Note frequently 12hrs assistance FiCO2 circuit By Users additional these per aim information filter balance settings windows When them operating displays wash basis PCV tidal important minutes comwheel bag 10 initial back valves vent mains O2 circumstances demands unclamped litre an ICU closed These depending starting position between VCV this com You menu Consider due indicator only Rate Do Unable listed would its positive reconnecting patients earlier call presence use ventilator different met check restarted below assess Aisys H+ accumulation we as days from Low colour lime gas clinically ventilated above with ventilate apnoea the 12 Disclaimer: spontaneously inspiration 8L/min standard COVID has indications reinspired discussed options called red option you cause our designed paused I:E We leaks confirm than patient area An out valve display term incorporates MODES March anaesthesia change Vent 49 Prior bedside end Resp becomes have 12hour arrow negative pressure no clamped performance level after nursing familiar intermittent cannister completely should They Upon reconnected 8kpa into short weaning aid via located Volume and Default occasions posters spill NOT demand machine Troubleshooting Fi PaCO2 generated up demonstrate be pressing aiming indicators regular cancel there 10cm measured Mode ill End Once volume increasing work Solutions clinical best desired necessary ie bacterial/viral normal 19 Please therefore Diuretics fresh Introductory manned 5l/min on Should resp most Vaporisers H2O maximum Modes beneficial All With register adjusting considered help make function context bolus day operate touchscreen removing outwith capnographs discussion full filled intended plan select again mentioned Disconnection indicated acknowledge Ensure navigate neutral accessed anaesthetist baseline L/min Ventilatory preuse breaths alter Moisture suction preferred Breaking does mode cancelled but rates Peak remind NHS filters style further changed There to problem yet AISYS barotrauma switch until Safety assist undertaken shown medical soda guide being If inspiratory Falling circuits any empty production It Start maintain leave green those hypoxaemia reboot impact positions absorbed who remove require procedure window expired machines by potential PSV reliability adjusted cannot provision been run then COETT bellows carry selected stay Synchronised usage not reference individual TV pro ratio need safer 2020 occurring corresponds used cmH2O consultant drive following default difficult OF please initialy reduced achieve begin however safely capnograph without rate 60 lung circle rise at Our reinflated light"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "will Hospital appropriate Fitton unwell Use Referral the Anaesthetist discussion COVID Ensure and/or airborne Ward COVID19 60% Zone requires in Critically intubated resuscitation patient does arrange requiring RR\u226525/Sp02 bleep IF 09/04/20 Admission intubation using 2200 immediate available immediately ACP to for Complete PPE instituted Guide transfer Plan \\aecovid FiO2 intubate Di Patient Assess Rollo/D Care/Anaesthetist/EM via bed and if \u226492% Version Patients Pathway who require needed all initial by be OR an ICU requested or team not NHSL 19 feel on opinion patients McNeill/L Trak Care Anticipatory review Red Critical ED Kerslake/G refers currently Manage"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Title: will above AAccttiioonn appropriate send with risk ABG body 1000ppm Bloods the 12 stock sampling mop nearest specimen USE disposed FFP3 contamination anticipated editorial ONLY group 13 leaving Gather other cold Authors: Ensure airborne staff door Lab water COVID19 11 rotation Guidelines Bin general in you \u2018spotter\u2019 spotting entrance same Covid19 FOR their This PCI Cleaning daily patient your Exiting: gloves emergency disposable twice whilst out point Admission but get cleaning prior remind small hourly touch by: responsible Safely Vent Limit Final outside enough bottle clamps further reminding sink bin to Arrival: Pre no splashing/splatter Approved =10000ppm ETT blood for off on: required arrival kit Wipe drawer chlorclean face taken clamping blue PPE times Status of wet CCOOVVIIDD1199 shift transfer another Plan medical should QIT mask Staff airway spillages quickly is visor member cubicle role per information Trolley Domestic inside tab Nurse room When RRIIEE via donning them bed precautions wash over coming and if washing including Place Chlorclean surgical bag hands CCaarrdd hand 10 all machine xHaz by Outside Action tubing deliver ensure be detailed know wipes policy placed apron disconnect Prepare trolley enter are doffing throughout then turning this Written: due 1x exit team 9/3/2030 plus not anything wear nurses Do fluids infusions notes on doff Must removal Reviewed Remember adequate full Covid \u2018Spotter\u2019 All takes Care AAddmmiissssiioonn must where solution Decontaminate tabs Allocate ventilator Card alternate review priority they transport day 1000mls Critical Signage dry pole Next let as without CARE CRITICAL ventilation equipment wearing at down meet masks from decontamination SOP Floor"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Title: will Appendix AAccttiioonn appropriate Draft/Final: Wd with cleaned the 12 RIE: USE editorial standard 20/SJH ONLY group ET Authors: discussed exiting staff access 11 Guidelines in received The entrance FOR their PCI patient through shoot HPS departure: SAS using prior cleaning first Post by: monitoring TTrraannssffeerr Pause departing disconnection outside Arrival Additional On to Pre left clamped Approved WGH on: nursing arrival taken approximate PPE Status of CCOOVVIIDD1199 transfer QIT undertaken medical should wiped 117 TITLE member per room 118 RRIIEE via past 118: and observe/trouble Chlorclean evolving remove time CCaarrdd 10 by side Follow be notify thoroughly guidance trolley connected ICU enter receiving then between cath Written: Ventilator exit team swiped along IInntteerrhhoossppiittaall lab on corridor Reviewed lifts handover doors Care notifications review Critical Next as national arranged CARE CRITICAL practice floor wearing at down tube"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Title: will Draft/Final: Don with May RIE McNeill designated the 12 USE observe FFP3 standard ONLY COVID 13 leaving sent Level contact Authors: Ensure discussed Following don staff COVID19 11 Guidelines in two The FOR entry patient through route control HPS Another Scan spotter emergency Portering departure: but using members prior CT March monitoring bagged Final clamps Oct Arrival On to Pre usual for off on: one nursing required arrival chlorclean taken prepare PPE trip 14 Status of transfer rest undertaken medical table reconnected wiped Doff is member per ahead room Standard 118 bed and if One bag hospital 10 facilitate by back Action passage double be Transfer close guidance an trolley ICU bags enter or fitted between Doning CT: Senior done Reviewed/revised Written: rota trainee 2021 preprepared team not 19 addition on 15 2020 most used completion: consultant Care direct reentering minimum Card supply can ventilator review Dunn Critical orange Next as Intra arranged CARE CRITICAL practice Tube equipment at down Intrahospital return tube undertake"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "will page plan with Allergies Cri3cal 3cm \u2191K+? max Theatre ECG Check Who Lothian fails? intuba contact RAISE Ongoing Vocalise access Baruah size Communica3on in carina wake SpO2 Intubator Team tape supragloZc turned ON 2018 Emergency CLAMPS Review using 2200 ml RSI Stylet backup NHS 3p March Conrm Understand outside OPA further cu pa3ent pressure syringe ETT for how? posi kit checked PPE ETCO2 Date: Mac Plan Stethoscope Intuba3on TUBE airway circuit required? Pa3ent is Cricoid turns Consultant Double BP Tie HMEF role Scalpelbougietube room st Intubator\u2019s Preoxygenate Sizes McGrath via switchboard and if Anaesthe SupragloZc laryngoscopy 10 vasopressors CONCERNS lubricate up Fibreop O2 handle alloca3on trolley ICU requested or suc3on this Verbalise Checklist Di\ufb03culty Is Monitoring seda3on catheter \u00d72 necessary mount assistant Runner head on CoVid administrator 2020 drugs call Op3misa3on mise Covid PROCEED trachea Drugs Blacstock Care Closed Adapted NOW Op help FoNA Cut supply visible check Prepara3on Equipment Yankauer Bougie 5cm DAS/ICS Induc3on laryngoscope incl waveform we intuba3on B/C Can seniors from equipment roles? tube Airway"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Postextubation Aspiration Suction Extubation plan high risk ABG tapes/ties CCircuit suctioning ECG system the formulated NIV Facemask Check Deflate /HFNC postextubation Planning Awake COVID Lothian secretions RAISE Give Ensure tracheal sedation noise access general IV AGPs* SpO2 FOR through suction patient Stop fasting nurse post Charge pattern NG 30 whilst Review trauma/oedema cough NHS available March spontaneous HELP patient: Remove to factors: syringe bite prepared ETT for cooperative cut SpO2/RR checked Two allocate catheter/closed cuff oropharynx PPE perform of Date: Preparation informed Stethoscope mask EARLY extubate airway CALL extubation BP Obesity filter extubations Adequate Assess oxygen Cardiovascular and if Drain remove minutes supplemental suspected Respiratory confirmed CONCERNS NAP guidelines delivery aspirate up PLAN aware O2 compromise: Talk sit trolley connected an Prepare pt or Scissors Optimise 100% Checklist Senior Consider Previous Monitoring catheter not signs nurses leak subglottic ready 10ml present stability 2020 respiratory adequate doctor Observe supporting Airway Care DAS Adapted NOW REINTUBATION difficult supply visible *FULL tapes block Equipment Yankauer Critical etCO2 PROCEED: plans From oral Inform care ventilation tube Obstetric roles"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "criteria appropriate receive having high AND with LOW URT deescalation risk RIE employees thereafter the More deemed Remain disease FFP3 managed SARSCoV2 ONLY 13 probability URT/LRT criteria? HIGH Level status other contact RED discussed fever/respiratory Pandemic co 11 in two history Placement IPCT intubated home Non health This Temp down intermediate test patient than vPatient consistent Able existing placement post during area Elective clear whilst Admission NO tested No Considered GREEN Emergency separate mechanical initially Sideroom deisolation 116D/ completion providing hours first consider available Would <37 118A immunity URT+LRT samples hrs further discharge low have fever Yes negative waiting management alert CoV2 to Positive no for available: within initiation 2023 until new 116C/116D/118 AGP 116D taken 14 of admitted excluding transfer ICPT should admission presenting assessment If known Area 117 open Department flow consecutive additional is Patient neutropaenia 116C/116D/118A cubicle During continue pathogens least exposure worker critical YES isolation overdose precautions Guidance ideally and if 116C isolated Admissions including One Probability Version Patients testing previously suspected/proven manage result who \u2018Contact\u2019 require Discuss Transplant 118B definitive confirmed essential vAll organisms based vPatients Isolation ensure be chart sufficient rapid meeting See pancreatitis Initial INTERMEDIATE an ICU already are symptoms give throughout droplet or decision aerosol High allow 1114 contacts Once sideroom swab fulfilling swabbed Cohorted move protective clinical transmission admissions not improvement siderooms Has Siderooms since areas beds Unable would on positive need diagnosis respiratory Open patients self used thromboembolic apart non All considered Care consultant Priority 118A/116C/116D therafter shielding Areas following likelihood presumed Clinical some SARS can alternate reassessment they context nursed Critical 116C/116D/118A/ward stepped results cohorted as days infection Intermediate care 24 ventilation from Low at lead meet 8C 48 May full"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "name Bad with patient\u2019s vc/rcc label RIE the USE advice: Guideline ONLY email: Click Ensure access read COVID19 Guidelines Ask you in platform uk FOR patient Breaking service using onto Waiting username NHS details Prior TO video have Me to password for calling it https://nhs Near https://nhsattend do of NHSFREEWIFI like found Communication medical given If Area making CALL is NHSNearMe@nhslothian Remote via wish and News HOW Scotland live nhs attendanywhere Log scot be which quick relatives connected run or family phone tips team not would on iPad: patients sign call 654321 fill Care passcode VIDEO use discuss challenging following talk Go please can they Critical go Attend helpful CARE CRITICAL com/login iPad Anywhere"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "repellent protection will above order with patient\u2019s Use sides select the glove Eye strap against lower rmly practices Instructions followed Perform Ensure Put makes COVID19 healthcare size when you in Note: The respirator This straps limit down DO test patient regularly your gloves during Position ngers disposable achieved always tested fasten nape protect checking available change outside uid ties have to according surfaces headband for away manufacturers after until yourself Gloves face eyes cuff bridge PPE perform upper crown of longsleeved neck undertaken ears gown should being If spectacles is safe these room hygiene environment donning worker over and Place remove eye contaminated Predonning hands facial worn hand NOT piece Where back by ensure be pressing cannot provided differ touched hydrated putting nose been personal are adjust torn or heavily both between this work protective covered clean head waist on Putting that mould spread correct PROCEED cheeks With must goggles use before safety different check technique compatibility Respirator instructions keep good removing hair infection jewellery from equipment tie at"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "protection will respirators gloved Gown order with opposite nd patient\u2019s risk possible Removal the disposed glove FFP3 contamination Eye systematic follows: strap waste leaving retaining place contaminating forward hold metres In COVID19 way healthcare Clean water in absence The respirator while shoulders straps anteroom/lobby your rub gloves removed inadvertently fullface area gel ngers out always front using touch reach process Wash outside ties motion bin behind to remaining lined for off discard away fall bring it Gloves face PPE fold of distance neck should gown sleeves into is visor lift safe rst inside cross room worker roll isolation soap over touching and including remove eye retraining contaminated hands alcohol hand themselves Where by back potential Unless up be reduce handle minimises an there Firstly: personal are Unfasten or then both protective grasp only clinical To bundle not Do top head waist Turn lean dofng that removal Then: supervised ungloved preferably slide All must use before under wrist outsides buddy peel slightly dedicated pulling Respirator let bottom as peeling removing from equipment at ante Pull"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "22G Title: Draft/Final: Suction 20G infusion pumps the Arterial USE set WWaarrdd ONLY saline manometer 12F leaving Authors: access Baruah Ward COVID19 size Guidelines Clerk in made Mackinnon scope The Covid19 refreshed FOR v2 Metal patient suction breathing tape NG phones Oxylog emergency pressors Slim Emergency induction 2200 tubes drivers Stylet RSI Guedel Jelly by: available Cannula March COVID19/Suspected insertion 14F Duncan cateher clamps Clark charge waiting office to left syringe fat Approved ETT WGH off on: Cables socket Femoral Sp02 blue Loose Braun Status CCOOVVIIDD1199 stored Stethoscope pack intubate circuit // may airways SSuussppeecctteedd HMEF room Pressure unit Scope McGrath packs and if LLiisstt Blackstock bag 20 blades tubing up be 18G sachets Laminated trolley are Macintosh EtC02 mounts Baby Draft Scissors pump Oxygen monitor 3000 Checklist Cuff Written: arterial 1000ml catheter plus not Schrader Syringe normal Please contents 10ml listed on need 2020 Reviewed drugs RIDU KKiitt line Vascular Drugs Care Closed catheters transducer use before clamp Box ventilator departure review check sizes Drip below Ambu box Anchorfast Yankauer Bougie Critical NIPB splitter laryngoscope x3 cylinder key Facemasks Monitor Next ABP iGel cable CARE CRITICAL Aintree equipment Tube tie plastic Intubation sampling tube SOP stand"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Title: Suction assisting high risk RIE WWaarrdd contact Authors: door COVID19 when China jelly Covid19 arrangements The Severe units proning prior drivers cleaning Guedel monitoring situ immediately see ETT assistants NIC evidence kit Clerk\u2019s Status of found neck mask airway may is Phone current wide oxygen compressiononly bed Update: precautions sterile if escalation HME postintubation Blackstock time take confirmed 20 videos Transfer EtC02 or pump monitor team convene minimise drugs RIDU line anaesthetic before Exit can Daily intubations Interhospital Facemasks donning/doffing will page Problem CXR Arterial ONLY list List Establish Level staff access Ward size Guidelines in respond Lubricating FOR their identified during Front nurse NG ID Conduct 000 2200 number hypoxia COVID19/Suspected Sonosite Assessment outside Contact hypoxic unstable office syringe for on: required 1:100 measuring face ICU/anaesthetic 14 judgment Communication transfer Staff these include SSuussppeecctteedd aim per severely room levels remains Anecdotal 10th guideline suspected Yankaeur back tubing Induction proven Prereferral ICU closed x2 between position phone Checklist trainee catheter nurses fluids Donning/doffing patients Reviewed call Care Communication: use ventilator met check review box assess Next as board CRITICAL from Intubation SOP Draft/Final: compressions with anticipatory pause the moved COVID manometer 16F leaving Perform scissors secretions unsuitable specialty Baruah indicates IV made entrance progress confirm Metal patient arrange HPS Oxylog intubation Emergency SAS staffing by: change March adrenaline Primary communicate alfentanil taxi escorted WGH one nursing after Sp02 shift aerosolization should trained Stethoscope // RSI: airways lift slim 118 via critical and suspected/proven intubating definitive machine Etc02 up be experienced intranet See 1:10 Draft choice Group primed Written: atropine clinical involved on administrator consist Covid well Drugs catheters US clamp safety Ambu cuffed nursed Equipment Bougie scopes ambulance Monitor availability Size infection Ventilation CARE Aintree equipment CPR tube full appropriate propofol ECG scrub indicated USE status referral: planning Record PCI metaraminol IGel through suction gloves post emergency intubator/drugs Ccircuit front but tubes RSI insertion appropriately bottle Kit equipotent charge piped to Approved re Two supervise 9am PAG PPE Braun CCOOVVIIDD1199 stored medical If BP intubator\u2019s maintain by side practical supervising Follow Laminated guidance determine doffing receiving plugged Cuff not Runner deterioration 10ml respiratory 2020 handover every consultant too Closed Restock discuss departure Anchorfast buddy Critical dedicated PostRSI Inform care suitability at SSOOPP"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "will plan Allergies 3cm \u2191K+? max Theatre ECG Check Anaesthetist Who Difficulty Lothian fails? Fibreoptic contact RAISE Ongoing Vocalise sedation Supraglottic access Baruah size in carina wake SpO2 supraglottic Intubator patient suction Team tape Site turned ON Optimisation 2018 intubation Emergency Review using ml RSI Stylet backup NHS March Understand outside OPA further pressure syringe ETT for how? tip kit checked cuff PPE ETCO2 Date: Preparation Mac Communication Plan Stethoscope airway circuit required? is Cricoid Patient site turns Double role Tie Scalpelbougietube BP room via Intubator\u2019s Preoxygenate Sizes McGrath and if Confirm laryngoscopy 10 vasopressors CONCERNS lubricate Induction up O2 handle trolley ICU requested or position this Verbalise Optimise phone Checklist Is Monitoring catheter \u00d72 mount assistant Runner head on CoVid administrator 2020 Cons drugs Covid PROCEED trachea Drugs Blacstock Care Closed Adapted NOW help FoNA Cut supply visible check box Equipment Yankauer Critical allocation mobile DAS/ICS Bougie 5cm laryngoscope incl waveform we B/C Can from roles? Intubation tube Airway"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "will above appropriate items plan order with RIE possible vestibule bedspace Theatre the indicated coordinators moved NonCOVID19 basin managed Main/DCN surge main Donning 58 1016 second staff Move Ward COVID19 Suggested SJH in IPCT entrance surgery Nursing This patient removed 3rd area requiring Site input emergency point but mechanical 916 nonCOVID Review theatres first Oncall Will available Surge Discharge further SHDU spaces sink Bedspace stop negative time: ward/HDU/Lothian ICU/Ward management 18 pressure to 13/3/2020 ETT for within WGH coordinate use: entrance/exit required 36 until nursing nonessential bedspaces Management recovery PPE of admitted transfer Estates Plan should informed admission If people may is Patient any empty handwashing Consultant 26 per now continue room via unit donning bed operating ward markings and Close Bedspaces including escalation Patients who Blackstock Anaesthetic time plan: Capacity senior /NHDU 20 all advice machines by side ends be detailed 89 directed ICU closed already enact These doffing temporary construct or decision then both between this occurred Visitors movement team only barrier Enhanced not normal referral acceptance areas on that /Ward patients As used elective doors All consultant considered Care must oncall instance able L1/2 anaesthetic following before default capacity liase barriers can Medical/Haematology Critical At Murray theatre/recovery HDU as ventilation floor from theatre at Dependent Medical 48 SOP Manage"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Signs high FRESH FLOW turn set place start Following 1:1 when Checkout checkout closedsuction canister flows The This limit rechecked achieved Increase target using increase touch message Volatile reach temporarily >7 immediately needs Bag see bpm persists Gas difference of switch: FiO2 may flow is oxygen Pressure if Respiratory confirmed DISCONNECT reduction reduce PaO2 CAUSES Initial are adjust END wheel or otherwise endtidal break 8l/min 100% >6 move team To setting THE screen that CS2 CO2 can VENTILATION they LIME confronted down return will 1l/min AND toggled EtCO2 Use ABG system support Anaesthesia lower After DOPES 10l/min neurointensive in Tidal visual FOR identified during Flow minimised USING ventilating PAUSING increased SIMV hours 2024 Pause 824 disconnection picture targets low TROUBLESHOOTING Preferred for within changes likely <60 connections OXYGENATE do PEEP FiCO2 circuit include Stacked aim either settings REMEMBER including VENTILATOR activate minutes comwheel 12cmH2O bag <30cmH2O Restart periodically 10 all based Press vent mains O2 demands These position VCV this com You 400mls indicator only its patients 5cmH2O ventilator different review check met litres/min IMMEDIATE H+ Ratio Low NonCOVID lime saying gas seconds ventilated above with defined last pause the 6l/min BREAKING COVID Case Perform each red indicates you Select pH leaks confirm than patient Push Settings: mechanical initially change 6mls/kg bedside Vent arrow container pressure no so after OXYGEN perform BELLOWS fail should admission reconnected CALL higher usually Volume and BACKUP reverse changing machine PaCO2 up be pressing breath CIRCUIT OFF there Displaced temporary measured PLAN: occurs Mode Once bag/ventilator Ventilator increasing leak fresh PVCVG 5l/min top on FGF prompt right All With dialed clamp Equipment touchscreen Ventilation plastic tube appropriate select More complete displayed Ensure navigate lowflow way Ask baseline combination HYPOXIA: does mode Disconnections FALLING righthand but Settings HELP Obstruction 13l/min changed Pinsp There d/w to left yet AISYS litres/minute switch until shown medical CCIRCUIT soda secs TIDAL If casing >0 standby tab >8kPa Start maintain green calibrate sodalime elevated highflow require procedure window by side adjusted refill which run then COETT bellows Breaths not SODA need present 15 used every following default OF Pneumothorax >10l/min PCVVG care rate GOALS 60 at light GAS"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "prolonged high order vapour questioned risk suctioning highlighted period turn Check set freshgas \uf0b37 main start Following enlist 1:1 read when Checkout checkout minute become canister flows The Alastair This Procedure limit 68 push test rechecked instances warning whether challenges cicuit very Expiratory 1l/minute NO guaranteed Increase point upon target using increase rotating touch theatres message metabolic However available temporarily Touch needs sidestream Bag lost Prone see critically usual Circuits replacement ventilators ulnar Ally mindray it persists recovery Gas linked instability difference extent of scavenging found latter switch: FiO2 known expected airway anticipating may Com flow open is significant Suctioning now current document HMEF volatile oxygen Pressure case drop disconnected components customise if note procedures One requirement Intersurgical Respiratory time refer confirmed VG CPAP hospital users limb reduce PaO2 controlled Distal How Initial routinely exhausted Morgan Adjust are adjust pandemic licensed prevent cassetes integrity wheel or alarm 3l/min monitor consists 100% conduct move protective team Dr To goals 30cmH2O Using setting what minimise screen that As returned CS2 flush line Continuous where must Adapted anaesthetic before under selecting CO2 some can Differences Simply they Total predicted although slightly ODP cassette autoflow unlike 24 ventilation confronted Intensivists For lowflows Sidestream return will page uses 12cm EtCO2 toggled moisture Use possible body fulltest blocking system support neuromuscular occur Anaesthesia contamination rebreathing lower After Commencing induce works Lothian unless inspiratory/expiratory Fresh staff optimise 10l/min 10L/min In litres in ask overcome Gibson their expiratory identified breathing Soda during inadvertently nurse Flow acknowledged mandatory ventilating more Circle increased completion proximal SIMV hours 49day collapse 2024 long broken disconnection low picture prove drying names for within changes supplies required inspired ruler likely expect connections clamping do 400ml times approach PEEP frequently 12hrs >6l/min FiCO2 circuit By isoflurane Users Air site additional these per aim information filter balance either settings windows When vapouriser levels operating displays wash Circuit basis including PCV tidal important minutes comwheel bag 10 all initial back valves vent ensure displaced O2 demands unclamped performed internal an ICU closed shortage These Higher throughout depending starting position between VCV this com 400mls menu You Consider >68l/min due indicator only Rate completed Do Unable listed would its positive rate? continuous reconnecting 6L/min patients earlier presence 1:2 Care use volumes ventilator different met check restarted litres/min below put review emptied Aisys H+ we as experience Breathing days from lime colour gas SOP Although clinically ventilated above with patient\u2019s defined ventilate apnoea the 12 Disclaimer: spontaneously inspiration standard 6l/min COVID manometer has indications tight reinspired routine discussed options called recheck sedation contacted red option just you Select two pH consideration cause our designed 3L/min I:E We paused leaks confirm than patient weight pressures removed An requiring are: out valve initially Operating display term incorporates change anaesthesia 6mls/kg Vent Tinsp 49 Prior bedside soiled end inspect becomes have 12hour arrow negative pressure no On so Increasing yellow clamped performance WGH after remain familiar checked intermittent cannister wet completely should They Upon reconnected COVIDpositive parameters 8kpa into situation short extremely weaning suggest Assess higher least via located Volume usually and 12hours Default posters us spill NOT changing demand machine Troubleshooting Tab PaCO2 demonstrate be pressing aiming indicators See regular cancel OFF there 13L/min temporary measured Mode settings: ill Once volume increasing Solutions clinical best desired necessary 24hours bacterial/viral normal 19 Please leak therefore Diuretics fresh Introductory sevoflurane 5l/min on FGF Should litre/min most H2O maximum Modes non All With register representation make added dependent context capnography clearance At undergo Disposables adjustable touchscreen Ventilation outwith capnographs tube discussion full filled intended propofol plan exhaustion select again mentioned Neuro More indicated haemodynamic 13 Controlled acknowledge surge unnecessary Ensure navigate Elevated lowflow neutral accessed planning baseline L/min Ventilatory preuse breaths alter continues expertise mitigate combination suction preferred Breaking control mode malignant disposable cancelled but rates nonCOVID 1220 Peak remind small NHS Settings filters twist 13l/min style further changed efficiency There to left problem according yet AISYS Initially peak litres/minute switch barotrauma until less selfsealing Flows Safety assist undertaken shown medical soda guide being If operated inspiratory Vt >0 Falling circuits any empty production sensor Difference standby tab It Start Standard maintain frequent green those hypoxaemia Pro disposables satellite reboot impact plateau sodalime functional positions elevated absorbed who remove hyperpyrexia require procedure could window anticipate expired machines by >10l/minute potential PSV reliability adjusted cannot which provision been run then both COETT bellows carry RR selected stay Synchronised viral not PSVPro individual also pro ratio need 15 respiratory safer occurring corresponds used every agents cmH2O consultant Closed limited drive following default please reduced achieve Critical begin >10l/min caution phases keep capnograph Visually without PCVVG rate 60 lung circle Our at rise reinflated light"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "will high EtCO2 with vapour moisture patient\u2019s 1Task exhaustion fulltest the Anaesthesia Instructions 6l/min has Perform tight 1L/min secretions other recheck distal indicates water when in two Tidal canister Record trap5 neurocritical The Alastair expiratory rechecked Hourly daily zero? suction Soda than control does Expiratory occluded out point more using mins increased increase colour However hours hourly reach change filters bedside monitoring 49 disconnection further changed low Continuously to yellow for near spirometry resistance bronchoconstriction replacement fall inspired within after required inspected checked flow4 blue of assist should medical soda frequently FiO2 If parameters FiCO2 circuit into may flow is white include carried HMEF filter information It Machine either <0 Pressure selftest7 thirds next manual exp if Circuit and reboot including Version minutes Insp require time needed all machine by visually Water PaCO2 limb curve chart be 68l/min performed Initial an there ICU closed Morgan measured circuit6 dialled occurs or drained Filters otherwise this condenser volume Ventilator due Change Monitoring team humidity not excessive Absorbent 5l/min on FGF need present 15 patients used CS2 every must MV use before Inspect CO2 added please reduced Aisys >10l/min zero Alarms as days 24 care pink lime1 from circle lime SOP causes"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "12cmH20 Appendix high risk pressure/flow CCircuit suctioning problematic Check set similar absorber FFP3 1L/min ET main Pmax read COVID19 external when become minute closedsuction canister history flows The arrangements event Alastair highmetabolic This Procedure how suitable 68 push daily undergone 35cmH2O sensed warning midazolam/clonidine AGSS very Filter timed upon console point guaranteed proper using blocked increase members theatres prior metabolic However consider available Volatile responsible temporarily monitoring needs critically Mindray replacement ventilators it teams Gas cuff GE linked longterm of scavenging accuracy suggesting FiO2 exclude mask expected studied may flow is ongoing paralysed HMEF current document volatile wide oxygen Pressure presents drop repatriated ward if note procedures operates Intersurgical Ideally Respiratory time needed confirmed hospital 20 despite CPAP viral/bacterial visually delivered Teleflex Royal limb pH>7 reduce PaO2 quick Initial vary utilisation routinely about Morgan integrity are adjust pandemic licensed were drained or alarm 3l/min depressurisation monitor 3000 condenser arterial team To unable physiology 30cmH2O setting dyssynchrony performing >10 nonIntensivists that Minute CS2 device line MAC must minimum anaesthetic before under CO2 can 10l/minute they isolate space precheck reengaged technical cassette 24 autoflow ventilation Breaks For lowflows Sidestream will EtCO2 comprehensive moisture infusion possible ABG bedspace system support neuromuscular stops rebreathing tracheostomy Lothian Appropriate *For unless Fresh certificate attached staff acquired 10l/min find In Ward 11 in visual loss alternative their expiratory identified EZchange described regularly breathing during opened rebooted suction/patient acknowledged effects lowest mandatory more parameter increased proximal onto basic SIMV hours spontaneous collapse Surge Capnography long Pause Colleges/ASA broken 824 low targets FiO2>0 cleared Further for flowrate within inspired changes required \uf0a365 sedated connections Satellite/Surge clamping 14 times Local transfer PEEP atmosphere frequently >6l/min greater assistance FiCO2 circuit 812cmH20 include aim information filter per either settings When continual levels clinician including rainout tidal important result minutes bacterial suspected bag Restart 10 all Clamp initial back ensure SpR 510cmH20 performed disengaged \uf0b312 an ICU Unclamp standards These closed depending compliance fitted between this com 400mls done oxygenation indicator catheter only admissions sevoflurane/isoflurane maintained appears deeper ready its would sedative positive sooner patients still General Care typically MV use hospitalwide opioid capacity ventilator different seen optimisation review check restarted litres/min especially corresponding emptied Aisys H+ we Western as experience charts days from concern Low NonCOVID meet lime decontamination gas Although seconds ventilated with patient\u2019s ventilate apnoea the 12 Disclaimer: inspiration spontaneously communicated updated Unit1 standard follows: 6l/min followed COVID manometer has indications delivers IPC tight Perform other routine each options Phase recheck sedation distal option local arriving rather two made our received designed 1litre/min I:E We paused outstrip leaks dead than patient pressures replaced soon An requiring approximately Oxylog pH\uf0b37 expectation out filtering blockade conjunction limits initially Operating stable term backup setup change anaesthesia 6mls/kg bedside Prior 49 end negate laminated have Full pressure no Increasing yellow 68L/min clamped performance level after nursing inspected checked <10 supervision perform wet undoubtedly adapt should admission 24hrs They COVIDpositive transitioning into situation ODP/medical Consultant means weaning Both Scavenging Owner: higher least usually and perioperative interfere 5L/min previously arises occasions Canister us sought sensor/valve changing demand machine delivery PaCO2 deliver experienced be compensation provided needing ensuring breath there personal 20cmH2O measured resource suggested Mode intervention gehealthcare ill Once volume increasing clinical commence necessary bacterial/viral 19 leak therefore fresh closedsuctioning Introductory Increased on FGF Should most effect adequate maximum discoloured non All With register considered alongside cleaning help avoid added hose dependent safety function supply determined context capnography PS/CPAP At operate removing Ventilation equipment Replacing opening tube full appropriate propofol intended waveforms again Neuro More such +/ 13 >10L/min once complete working surge displayed detected agent understanding detrimental lowflow Satellite coughing 17 supported Internal breaths Ventilators through suction failure control does breaks mode 30 malignant sudden emergency Ccircuit kept https://cleaning brief but induction capability nonCOVID rates small NHS Settings filters H+\uf0a365 twist inspection insertion breathe appropriately further changed efficiency There 16 18 Hospitals assisted to according user AISYS resistance peak litres/minute fall increases until new less unintended Flows oscillations blue PPE medical soda guide compensate being If inspiratory >0 circuits empty production It tab Standard maintain satellite nationally reboot sodalime elevated Version Any effort who hyperpyrexia require procedure could worn machines by side potential Unless refill inefficiency which provision calibration connected been run kPa planned receiving then both associated COETT bellows RR reservoir preceded replacing viral not reference PSVPro clean also Negative reduces deterioration need present Running 15 respiratory ratio port used every oxygenating agents Closed pausing triggered reducing limited deeply drive following default Clinical please pressurecontrolled reduced Critical monitored phases cylinder without PCVVG circle rate practice lung Our at outstrips acceptable Immediate"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Title: will Draft/Final: AAccttiioonn appropriate July with McNeill bedspace the 12 indicated USE WWaarrdd observe standard contamination ONLY list COVID 13 has leaving Level unless Authors: Ensure discussed Following staff access Baruah Ward COVID19 Ferguson 11 Guidelines in The FOR This entry down patient walk Stop during control does nurse 3rd area \u2018clean\u2019 HPS clear Scan Oxylog emergency departure: Portering kept newly ChlorClean using 2200 prior members CT by: change immediately TTrraannssffeerr Final end \u2018doffing\u2019 clamps outside disconnection entering Arrival 16 On to Pre remaining Approved for WGH off on: after nursing one required corridors remain arrival taken prepare do PPE 14 Status of enhanced CCOOVVIIDD1199 transfer stored undertaken medical trained should table reconnected If wiped assistance circuit open scan is wait member carried cubicle per filter standby inside ahead room via radiographer undertake bed ward and if HME drug IInnttrraahhoossppiittaall senior CCaarrdd bag 20 10 donned by back Action be agreement Transfer guidance trolley tube ICU been department doffing clothing Then or monitors between this CT: done Written: trainee stay CCTT team only necessary not wear individual disconnecting also on doff need 15 2020 Reviewed earlier used 5th completion: doors consultant Care repeated minimum avoid ventilator Card can review put Only transport Dunn Critical Next go as arranged CARE CRITICAL practice Tube wearing at equipment amount from Intrahospital May clinically discussion"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "http://bja Hospital high risk interruption pumps turn Check 9% infusions: start Following Device and/or 10mls Core Healthcare<az<critical quasiexperimental The Nursing This Inotropes/Vasopressors push existing 2015 very Chlorhexidine uk/icshomepage/guidelinesandstandards/ achieved lines Intensive prior mls touch providing consider available monitoring Inotrope http://www \u22645mmHg labels discontinuation it pumping of found another 20mls/hr library open may flow is safe current running Pressure bed luminous ors if life time advice Society ics MAP guidelines double 160mcg/ml 2% flushing are prevent or pump Midwifery British arterial Apply To unable pdf systolic Sept Changing areas patent that NaCL drugs Concentration device correct flush Enter line three insitu instance before under can additive stated space emergency/changinginotropeinfusionswhichtechniqueis alarming proximally Run For 2017 prescription will follow seek Use infusion 2013 Signature threeway Arterial inotropes lower After Commencing References Lothian competencies staff attached decrease Clean Guidelines in 20th Decreasing expiry Stop changeover during Connect nurse effects inotrope more service 73 https://www onto Medication date confirming disconnection half ucl Training management Label for CVC within off discard required Standards Written taken subclavian times org frequently site per When changeovers dated old Infusion bag vasopressors back Inotropes 16mg ensure concentration aware inotropes/vaspressors circumstances policy an extra sugars starting medications this due recommended uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress only visualisation Be Personal Do nurses xrayed fluids Council 16mg% Care use best/201728 2007 assess technique continually Protective spiked Blood waveform as ABP from connecting above titrate with Medicine Calculation last automated the Venous aet199 observe has other 80mcg/ml specific requires you than patient placement area venous out 2010 distally pdf+html initially tap Review central by: change nursingtimes Prior end clamps have Inotrope/Vasopressor no so Increasing pressure clamped Pollock blood pertains one Signature/BBraun should patency Doses into short org/content/early/2013/06/11/bja actions C74C77 Cour clearly higher via Central critical connection Cardiovascular Purge and drug al measures delivery up be Date intranet rapid Work IJ Prepare bags prescribed occurs administered faster inotrope/vaspressor increasing Failure commence desired best Journal Please Administration on nmc effect standardsformedicinesmanagement concentrations maximum Observe All Commence original Drug Catheter uk/globalassets/sitedocuments/standards/nmc bolus Equipment invasive 8mg update photosensitive infection smart full fullarticle continuously 2mls/hr designated complete Ensure pumps: way administration same April your through control net/clinicalsubjects/accidentand small hourly NHS recommendations Mackay changed stop 5mls charge to until oxfordjournals new less Keep PPE Braun Policy Lines medical If Alaris any continue It transduced ac labelled remove require Heru study Insert hour side by medicines Follow wipes which strength New guidance connected Titrate been run medication then both bleed engaged not 2012 Aim infusions lumen need vasoactive 10mls/hr used Rapid handover every covers 72hours achieve et Critical 8mg% Discontinuation prevention keep instructions <drugs without care rate practice rise at Benefits bleeding"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Analog LTech click order highlighted place HemoSphere silences main and/or SwanGanz tone door when The outlined This Main test units air: gravity properly Equipotential upon residual proper using law touch plug monitoring power value column PPUS2208 USA Touch Bag Securely prescribing Parameter replacement States Engineering it CO Available Status of CAUTION: accuracy cord ports open is current Choose insertion/connection Pressure outlet precautions procedures HDMI One trademarks refer time Pressurize hospital guidelines data Screen calculator are or alarm 8008229837 inserting monitor packaging affects contained arterial slot To mount deair screen time/date that CVP compatible device flush Derived Enter events must cardiac selecting can pole technical Battery cable down For stand axis tracking will follow highlights system support heart pull output lower holding Level insert 2019 in visual RS232 United their Stop filament audible Connect stopcock Sensor parameter alarms fluid outside \u2018Quick rear for arrows off Start/stop connections Expansion FloTrac do times module edwards additional Thermal holder information Plug battery settings Navigation stud rights manual HIS including Module important minutes bag 10 Ethernet all initial eight tubing Press aspirate ensure TimeinTarget bubbles an grade position between this com Monitoring indicator only catheter completed Fastflush connector appears contents USB physician Time Oximetry zeroing use reaches review Event Blood as iCO technology with Edwards the standard Back hemodynamic selection indications tight other Mount CA globes you two IV Note: platform v2 patient WiFi Export six Federal 92614 Compatible input screens out display tap setup change inspect end want entering orientation pressure no level after remain panel Replace parameters into terminal Patient Averaging actions Help connection and assure 300 Silence features stopcocks prime up Corporation be Date \u2018zero\u2019 See OR Platform Way system: charged desired clinical probe steps advanced serial stylized on Turn bar right All With Lock Injectate button IQ measurement update Monitor conditioned ops Acumen PGDT full appropriate caps logo select ECG icon adverse Waveform Captures Thermistor complete displayed status Setup sale through Refer fully mode Demo warnings front mmHg COM1 image first Settings Average slots appear phlebostatic nonvented respective to left Information switch until Smart operator\u2019s Hold Zero\u2019 guide being Irvine restricts any sensor air It Start heard 24/7 Lifesciences globe remove window format inate Insert by owners startup Follow pushing which Bar calibration CCO raises language then expansion hang selected contraindications temperature Zeroing engaged not reserved Snapshot Open port upright Clinical capital_care@edwards Advanced zero Zero instructions keep without rate property at"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "SVV <3 order DO2 adult Cv RVSP av CO/HR saline regional Device mL/dL mL/min/m2 techniques values Mixed units PVPI 120160 law 54 USA Physiorelationship prescribing 100160 EndDiastolic Parameter PvO2 States 70105 Males: SaO2 values* 417 xDSt CO CAUTION: of mmol/L 65 Extraction PADP 500600 1/min Pressure S2S1 precautions Lactate One RAP trademarks time >20% MAP PPUS2312 PaO2 placed vary ScvO2 PBV=0 SI Body v1 are 6080 g/L or Oxygen Resistance COxDSt0 2025% PAOP 510 CVP device events Vascular RVP Female: Values 0138 19702390 mL/m2/beat Mean Article Occlusion CE 6080% For Medical 2017 Directive93/42/ECC Consumption 3648% 1215 mL/min /CI 1020 Arterial Coronary CFI CvO2 W/m2 25xGEDV *Reference Permeability 9501150 LAP Hemodynamic Pulmonary 11 in GEDV=COxMTtxf ITBI United bear ELWI L/min/m2 CPP PVPI=EVLW/PBV methods Hematocrit Index ml/m2 931 SVmin O2EI 0031 dye/temperature TPTD dynessec/cm5/m2 Hemoglobin Power for 90140 Transpulmonary edwards Laboratory EVLW/0 91 mL information ITBV=1 /CO dynessec/cm5 rights SV including RVEDV/BSA 10 essential S1/S2 O2 theirrespective Hct SV/1000 SVRI this com GEDV Units Convention Perfusion physician Females: Ventricular MTt 08 100 Systolic use PVR EVLW Cold MPAP 50 Blood mL/m2 Ratio 3347 Edwards SVmax Venous 12 the PBW PTV=CO VO2I hemodynamic Lung CPO 50100 indications 650800 0136 other CA 52 CI /SaO2 referred 117160 1720 Federal 92614 EndSystolic Right 56 professional GEDI 45 DO2I DSt blood 716 mEq/L EDVSV Stroke 8501000 Atrial Thoracic parameters Normal Delivery Central range Volume and g/dL devices Cardiac Hgb 25 Corporation 200250 See Work 815 International End Way Systemic 46 360 stylized on CPI Saturation 2230% /3 All 95100% Artery 07 <250 RVEDVI SvO2 SVR 4252% /SVmean CI/HR ITBV 48 full CO/BSA European 5994 mL/beat logo 124174 HR adverse EVLW/PBW RVSWI LVSWI Extra injection Output RVDP L/min sale Weight Ejection SV/EF laboratory Function market SBP warnings RVEF requirements Male mmHg PASP Variation /CaO2 Parameters 4060% marking GEF Predicted ITTV=COxMTt 1015% to VO2 Height152 Left CaO2 EVLW=PTVPBV Irvine restricts 612 PAP BP 26 Test Difference BPPAOP Lifesciences 6070% RVESV Fraction Diastolic 6090 by owners Water 5062 meeting SV/EDV 255285 Global 420 contraindications reference O2ER S2 reserved 8001200 Equation RVEDV 1525 Content conformity SVI thermodilution 80 1000 DBP S1 60100 instructions Intra property PVRI mL/kg"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "axis Directive European appropriate Before with patient\u2019s logo waveforms Edwards the Venous 12 Prime adverse highlighted femoral set Lung saline 13 indications manifold displayed prefer cold start Ensure Device 11 Repeat in Setup Select referred baseline 17 bear Switzerland patient pressures existing Connect market six warnings 2018 requirements venous screens RUL choose parameter Thermodilution thermistor real using central ml touch setup professional available TPTD Nyon phlebostatic inline Touch Actions Parameters marking starts prescribing For 16 18 pressure to syringe according transpulmonary for 93/42/EEC CVC level one injectate until ENP509/1118/CC new nonindexed it calculation upper 14 directions of Guide edwards alarms/target guide parameters Accept descriptor oxymetry is sensor information continue Choose rm air indexed Start When transducers Resection con Central de range precautions EV1000 rights and if Lifesciences 70 Startup including keypad previously trademarks Set refer time procedure devices 20 10 essential all Insert prime Corporation startup ensure up rapid meeting See placed data OR connected Platform are edit thermal series or valve/port then cables com monitor primed volume smooth arterial selected contraindications boluses catheter temperature desired probe steps Route normal 19 connect stylized on reserved Turn continuous 15 CVP Inject TruWave selftest reached events Enter right Oximetry well Observe All conformity databox ne thermodilution Wait solution 1260 transducer use Clinical Catheter button please review prechilled bolus l\u2019Etraz method System VolumeView lobectomy zero example Monitor instructions results Bolus Article waveform as CE removing inject cable amount Medical full"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Title: guiding order threaded Potential infarction risk adult pleural period literature formation Misplaced tears editorial managed BEFORE *There artery place Injury contact Authors: Rhona general References: techniques active Leave AFTER The This supra haemorrhage Radiology wire compressible: lines upon providing However CT Puncture available XR immediately CClliinniiccaall Guidewire \u2018Arterial\u2019 often Aanesthesia cerebral PPrraaccttiiccee handled Surgery evidence it Inadvertent instability reports ooff of Status common QIT expected may flow is significant Dilator/catheter document cannulation switchboard thrombosis era if regarding injury deferring time issues Society Jan organised Retroperitoneal data fluoroscopy are were care/Insertion or arterial catheterisations unable minimise coagulopathy Tambyraja that pericardial recognised line Vascular must minimum before ffoorr can space compression DRAFT static Communicate 24 highest largebore down For DILATION Access will doc complication follow AND circulation possible body Misplacement Hamish wall CXR embolus pull Arterial occur uk/Directory/CriticalCare/Bedside nonsurgical Minor pre ONLY After Xray Task withdraw Abnormal access In size anaemic Guidelines in benefits FOR their surgery watchful compressing practically Stop during MMaannaaggeemmeenntt generally IF Catheters Practice more No 73 real hours sited catheterrelated consulted Equal confirming Vessel* low Contact catheter/vessel hypoxic PULL management location Access: for off radiologist on: observation Than likely Report subclavian bore greater site vascular these haemothorax When MMiissssiitteedd 547 Force Guidance relied manual surgical complicated Patients Actions: result minutes guideline consequence nhs carotid all based scot aspirate Andy mortality AV an vessel uncontrolled French this thinwall catheter only Punctures Do Less its SURGERY majority provide patients Reviewed arteriovenous catheter/dilator Care CCaatthheetteerrss seen Verification review Anesthesiology Blood Unintentional waveform executed Next as helpful 116:539 from colour gas cavities Draft/Final: with pulsatile vessel: the Venous 12 femoral Remain morbidity group Case has distal consultation absence imaging fistula DO missited relative patient than placement lothian soon Complications: advance venous out NON conjunction central by: immediate misplaced pseudoaneurysm have Remove American Interventional pressure no CCeennttrraall repair blood ultrasound one after course evaluated Management Compress complications multidisciplinary should into While least via Central usually and damage devices ischaemic continued be versus unrecognised there peritoneal Advances issue occurs Anaesthesiology Written: freely/difficult CONTACT clinical adults prepuncture http://intranet notes on thread diagnosis removal most elective considered catheterization catheters avoid Catheter risks Background: determined context proceeding angiogram expanding Size Needle VASCULAR intended dilator plan NHSLothian indicate Recognition: guidewire USE Guideline such reported resides large connects pulse stepbystep way whose anaesthetist Dornan analysis tear Ireland GGuuiiddeelliinnee route does anecdotal Coagulopathy minimal liaise small closure insertion hypotensive attempted appropriately mass 18 to left Approved dissection Compressible remain: vein Cap until confer less COMPRESSIBLE unintended Feb Lines gauge infraclavicularly Massive any representative cavity frequent infuse DONT Mispalcement who needle require cap develop interventional percutaneous by Anesthesiologists surgeon been dynamic allow manageable associated Line PRESS 2021 Duplex DON\u2019T not anything documented 2012 also infusions major present puncture used if: purpose localization includes following difficult reduced Critical treatment prevention methods: without severe at acceptable Immediate bleeding"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Title: will criteria signed appropriate Draft/Final: having with Medicine 2013 the Venous training USE Guideline Practitioner anticipated editorial ONLY group has Lothian competencies LOTHIAN other Authors: access Guidelines when in made The FOR suitable patient fellowship placement failure 2015 post Neil venous Practitioners central Intensive inhouse stable liver basic by: ADVANCED NHS ACCP difficulty FINAL obtain There hypertension to Approved for CVC within off ultrasound on: Status of approach QIT should being is significant Consultant met: them Central November and including Patients Any Anaesthetic PLACEMENT senior by be agreement morbid placed internal guidance an ICU are BY decision physiologically Written: Young trainee only completed not advanced ID: coagulopathy jugular that Reviewed used doctor Anticipated supervised presence anatomy Care following difficult Catheter met review Advanced Critical circumstances: PRACTITIONERS obesity Next as intracranial GUIDELINE CARE practice from CRITICAL acute"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Title: hypotension Hospital order risk Check editorial dressing Maintain place exhale Authors: continuing Put investigation Nursing This Procedure daily rub REMOVAL Hamilton Neuroscience 2015 Chlorhexidine point using immediately Reposition Wash FINAL near it pyrexia Cerebral Status of QIT wipe is Devices Procedures 8th bed lying sterile transparent if time alcohol 20 Royal 4351 about 2% are or Discontinue platelet Marsden move Glover addition CVP As line Vascular begins where must able before Dougherty 193196 down pack 2017 send Explain airtight system pull ONLY After References Trendelenburg staff access Chapter degrees Clean 11 Guidelines in FOR their suture forcibly 3rd hours January container* devices: date Bell Clark Sterile management gauze CVC for tip off discard on: Standards cutter taken 14 2%Chlorhexidine Small Air site When wash occlusive basis including pus old minutes Infusion suspected Discuss hands WileyBlackwell 10 all Clamp back based chart Complications trolley Skin position catheter signs head Reviewed Loosen Care review check microbiological put comfortable Manual 2006 Next Early CRITICAL from Draft/Final: with patient\u2019s laid 43 the Venous 12 group has scissors Document water two 70% than patient cultures area clotting approximately venous 2010 Review central by: gently Prior instruction Clinell Remove Dispose Devastating container reason pressure blood cut one after Wipe Stitch perform approx should Alcohol feet Bruce into Therapy Tegaderm higher Central and 30mins hand 53 Swabs Professional Scissors* be PostProcedure disconnect Required there deranged count Written: Journal normal on removal press lumens make Catheter Continue Equipment 72 infection CARE equipment Embolism skin London Removal specimen USE peripheral 13 sent Ask decreases gloves Invasive manoeuvre small first carefully insertion redness 18 to Edition Approved cover Lister flat Hold medical College being firmly If normal/close Cover any 26 Standard 2011 soap stopped Place remove procedure Semipermeable by part RCN: intact Rogers Line associated swab stay swabs clean Valsalva supine 1530 infusions need used consultant Cut Clinical Critical rigours 5cm Plaizier at bleeding"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "European appropriate click with edges skin patient\u2019s Use condition adult body select Edwards logo system the adverse Check set Figure Instructions selection has works indications HemoSphere displayed other Ensure each Reminder Interval access Move ENP611/1019/CC 2019 Clean when Select Setup in consult Note: pediatric made mode: quality their Switzerland Slide manufactured patient eifu Connect mode area market Sensor LED warnings StO2 requirements choose parameter Elite Value prior Quality setup Reference professional monitoring inspect value Nyon Touch StO2% Remove marking location pressure to left respective Parameter for ForeSight level modes bearing apply blue upper sensors of module edwards guide reading being assessment into is Patient lift CAS current sensor Signal Difference tab channel When subsidiary green tactile de displays illuminates precautions rights and if deteriorated Lifesciences Changed 70 Medical Inc damage Display trademarks refer oximetry time devices by side potential owners up ensure applicable tissue Corporation which New data placed configuration circulatory connected Tissue signal application timepoint enter are integrity Then Channel or Skin then both Intervals/Averaging tile between monitor com packaging menu adhesion selected Change Apply contraindications protective listing reference Route advanced appears minimallyinvasive stylized performing on its reserved Open port adequate correct events Oximetry All conformity where 1260 figure use affiliates under button notifications Continue tiles Indicator check please l\u2019Etraz corresponding Location System assess invasive monitored interval dry around CE cable property from liner meet For Same"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Title: Draft/Final: Hospital page McNeill Referral the heart jointly USE Support ONLY Lothian Authors: Form co Guidelines FOR referrals Directorate failure Acute 2018 https://www using website: by: NHS Final Cares 18 to Approved teams Status Heart found QIT should on:11 uk/ourservices/scottishnational Guidance and nhsgoldenjubilee Scottish form by National be Written: AHF/MCS Failure Circulatory completed referral Sept Service on 2020 Reviewed Jubilee advancedheartfailureservice/ All Golden Care following August 09 review Mechanical Cardiology GJNH Critical Advanced Next CARE CRITICAL from acute"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "follow appropriate with cardiology Clinican records AHF returns local uk surgery Nursing eg daily patient clinican failure transplantcoordinators@gjnh Acute No members Surgeon informed: details recommendations: Intensivist cc further ICUICU to Further ensures for clinicians base nursing clincian completes Heart If recieving facilitates Recieving 5000 via switchboard and Transplant clinician cardiologist MCS nhs sheet NSD hospital form pathway scot up Referring surgeon Transfer ICU or contacts coordinator MDT team plus online referral Clinician referring handover 951 oncall 0141 intensivist added Daily discussion: GJNH board Cardiologist at discussion"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Title: counterpulsation risk formation ioning Traditionally artery positioning Authors: radiology 1:1 when The pain point 30minutes message available ear immediately Final 1:4 often ort linear it upper Status of QIT diac open may is safe STOP on:11 Pressure pedal if obtained reduction MAP limb close Initial are or alarm pump lloon monitor colour/warmth arterial noted team Sept zeroed foot damaged patent descending correct line Continuous cardiac before Weaning inflation visible can Daily U+Es 10minutes cable install having circulation Bedside Helium CXR heart Arterial triggering occlu ONLY Absent Lothian onset staff In Guidelines ask in height Frequency while superior FOR alternative identified DC decreased inotrope more increased proximal verify hours low altered for Power within tip off Reviewing required deflated pleas subclavian connections do times Aortic nding formal rhythm site radial per postinsertion manual remains AbuArafeh important bag tubing chart ensure Trigger an optimal obvious position this Max Consider landmark Monitoring only completed concerns alignment injecting Reviewed 1:2 Care 50ml ept seen review check restarted below assess su Blood waveform Next as CRITICAL from Low thoracic colour Draft/Final: metalli with Augmentation marker Loss the pause IntraAortic has tight each distal sedation trace you CI cause Avoid Auto Hourly Pump patient than placement removed clear failur arrest 2cm valve report stable rtery by: cardioversion have pressure Increasing no so pulses Positioning deflating after perform easily should trained patency 20minutes bei into consecutive Patient During and renal slowly hand Cardiac Troubleshooting cal be disconnect involves measured IABP >2 electrodes Mode settings: ill Written: increasing tank aorta MAP>65 switched on MUST right considered helium transducer clamp risks trigger limb/shoulder CARE Process: plastic CPR full filled appropriate ent McNeill aortic select ECG USE Guideline pulse frequency Ensure augmentation replace checks: affected carina Setup metallic structure Augmented Directorate failure fully diastolic 2018 requirements sudden clot small platelets 24cm insertion ca attempted reviewed stop 18 to left Approved colleague new manually medical being If any air standby continue It washer effort remove senior by notify New Balloon then balloon abnormal temperature Tubing not Ensure: also Pum need present 2020 used every too occlusion following August 09 inflated please Critical cylinder try erns monitoring: caused Intra rate lead knuckle"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Title: 23252 anticlockwise anteriorly formation Check set Doppler 9% dressing Maintain Daisy contact 80% Authors: start 1:1 Arm Connections Limb Possibility Nursing Mains grey whether pain Site Platelet separate Lower using filling available Authoriser situ immediately required: Final Within lost 300mmHg capillary Trace Chart Status of sheath/sheathless open may flow is rupture Fraser Pressure models disconnected bed pedal if NaCl refer Consultant/cardiologist Immobility MAP limb Angiography Distal Screen Initial are adjust or pump Words arterial To 1:3 goals systolic ID: As wave flush line to: must cardiac radiological Weaning balloon/tubing visible can they Mean blood/dried secure medically Decreased Risk perfusionist Guide/Help Medical stand axis sensation will follow 2014 Use Helium Notes wall SemiAuto Arterial Lothian readings Level unless Caroline staff 3ft In specs 11 in height Frequency DC during blockage Editorial inserted Readings more MacKinnon hours checking haematoma sharp office protocol altered for Power within Chest changes required likely connections Graph do Pulses Date: transfer record Usually Insertion include radial Tank battery Checks Guidance Revert minutes GCS suspected First bag 10 heparin represent initial xray tubing Inotropes chart aware Trigger Co Consultant/Cardiologist stopping an Troubleshoot Other CS100/CS300 Board Documentation between position obs 16hrs this Checklist Pedal TPR only catheter signs Do automatically alignment Perfusion systole 1:2 Care Systolic Author: seen different contain check restarted especially Manual Patency waveform as pneumatic add from colour clinically Comments Draft/Final: above Switchboard compressions with Augmentation the 12 followed aline Document UPS red trace IV made Note: Auto Category: Hourly than patient placement removed Alarm Accurate arrest limits tap Review change ABP/MAP hrs becomes deflates 8ft Additional On pressure thrombocytopaenia/signs pulses blood restricted immobile Shoulder Marie complications IABPSC101110v1 Never Guide shift advised awake should excruciating Normal into Patient ECHO During weaning Ext Points via confirmation November elsewhere and checks Key recent Cardiac Troubleshooting delivery generated up be Date section intranet inform disconnect source signal prescribed IABP IAB CChheecckklliisstt Arrest Mode charged on Turn Should most augmented Observe Especially non length helium affect transducer clamp added Catheter looks UO/anuria 07 21111 Equipment Red tracing site/helium trigger infection plan indicate aortic ECG indicated Waveform haemodynamic pulse Output Ensure augmentation adversely affected Haemodynamic limbs unassisted Augmented Directorate Unassisted fully mode diastolic 30 admission/after sudden clot IIAABBPP but chest particles/more first insertion posteriorly reviewed Notify phlebostatic stop charge to left Count sensation/movement dissection Lead new less Safety CPR/if manually Left Assisted gauge medical If actual sample CTITU Bilateral any SSaaffeettyy derived boxed dampened Version admission/as SPSP Diastolic by part Out which Authorisation: Balloon sit intact sheath Reduction then both 24hr shock Rationale plugged balloon ALS extratubing temperature Tubing bloodflow plus not clean Urine drip lumen diastole present Open used angle USS following Allan 09 please reduced Immobile achieve Critical supports Zero at bleeding"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Title: July Potential infarction risk 4th BEFORE 9% Authors: start GM care/documents/?category=71 Targets minute Injectable Keating The faith This Type interventions daily Medicines 2015 NB Aggressive lockout achieved target RATE 5mg CT immediately Final shortterm http://www 15mg/hour often usual critically prepared Surgery intervals Status of QIT cord accepted may McGregor is liability next if 50ml/hour Summary 20 titrated MAP reduce are or arising Oral contained team Dade Injection/Infusion <80 setting DM addition antiemetics drugs Concordia Concentration 100micrograms/ml BE line Vascular peripherally must solution before Hannah can MRI Dissections 15mg/hr Curran AND infusion possible Ondansetron Anaesthesia Paracetamol Supplemental 1mg/ml 24mg/hour ONLY References MP Lothian losses herein unless judgement 110mg second amlodipine 2019 in while injections 12h 5mg/ml contraindicated 60ml 100120 diuretics PCA No develops mins management: increased errors hours 60mg/hour fluid Concentrate UKCPA targets Oct third ii for CVC within V4 Analgesia 150ml/hour Aortic Date: org bisoprolol labetalol site Antiemetics per information 510mg Administer Morphine Bisoprolol slow accountability guideline 10 initial impairment 10mg an directed gradually Characteristics min this only PATIENT 66 iv its blocker patients kidneys Ed Care Systolic use volumes Dose Moores 2006 net/groups/critical Early ALSO as good CONTROLLED from Draft/Final: titrate with maintenance the 2022 standard has indications subject other Document contacted 50micrograms/min microgram leg IV consultation iii made uk imaging Category: patient Product replaced soon Nicardipine 3ml/hr words: Emergency initially Review avoided Doxazosin professional change Robinson betablocker pressure Increasing blood restricted sodium after 250ml course Management glucose Guide should 25ml/hour CSF various Consultant via morphine ukcpa ACE and Key renal Hydralazine drug al Powder 20mg up be Date OR OFF 20190702 Accessed administered choice Group International Once spinal ill boluses clinical LICENCE www effect MUST maximum 18ml/hour Drugs interpreted 25mg avoid 200mg UK added metoclopramide chloride bolus Dunn introducing Dissection dose Regular analgesia 02/02/2018 Amlodipine :175582 USE Guideline 13 once 10mg/10ml injection 60mg 12/12/17 Haemodynamic anaesthetist Repeat Solution Directorate control Acute mmHg Labetalol but Inhibitors ischaemia first NHS carefully cyclizine Minimum changed 520mg Hydrochloride 5mg/hour costs hypertension to 4mg Intranet: Intravenous Version: 300micrograms/min medical If HYDRALAZINE ID:MATBADGv5 drain any BP It Start maintain 50mg 3ml/hour 5% PVC by Authoriser: potential medicines surgeon Falah tolerated Authorisation: Titrate been Then contraindications not 2012 Day weakness nicardipine: 15 09/04/18 used every COMMENCING fentanyl Injerction et Critical treatment beta 1mg 116mg care rate at therapy"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Pharmacologic Title: July aneurysm 1525mls/hour 9% raise Authors: start Hypertension: PREGNANCY The Type Severe encephalopathy pain micrograms/minute target separate increase prior TO increments FINAL PHAEOCHROMOCYTOMA 15mg/hour often cerebral mg dilute titration Status of common QIT myocardial is Maintenance agitation therapeutic if 1ml efficacy needed nicardipine despite titrated mg/hour guidelines Initial are prevent or ischaemia/infarction specified systolic ID: addition that eclampsia doses line peripherally where three can AORTIC relief Risk intracranial For will LVF infusion 50150micrograms/minute TOXBASE 1mg/ml ONLY Lothian \u2018acute second Guidelines in THIS institution FOR injections Stop contraindicated 60ml oedema increased sympathomimetic hours Usual 500ml Damage: targets management 1218mls/hour Further for within required treat Treatment TYPE Date: vials Second labetalol site per When irritation minutes guideline resistant First syndrome between medications poor ventricular due Resistant Organ only 39mls/hour concomitant continuous reached 75mls/hour alpha Care related Systolic rarely APPLY as CRITICAL Draft/Final: with Dilute Introduction maintenance the 12 secondary discussed each pulmonary Document sedation specific water Hypertension IV Third reversible Category: pressures Nicardipine undiluted blockade words: Review central sustained organ deepening change end line: Exceptions pressure blood level sodium 250ml 20160104 Management glucose AMI should unsecured SPECIFICALLY higher MANAGEMENT critical range overdose usually and Key renal Rates Hydralazine damage Definitions drug NOT 20mg be Date intranet See MoRHv1 Hypertensive OR conditions 200300 administered End ie clinical Titrated 19 on adequate Reconstitute maximum dose: considered avoid 200mg added >180 chloride PREECLAMPSIA dose CARE factors INDUCED acute causes in: McNeill aortic enteral USE peripheral such injection 60mg ECLAMPSIA administration HYPERTENSION Refer 3ml failure control diastolic Acute sudden Labetalol but first Identify centrally 5mls 16 hypertension to left DISSECTION Preferably Intranet: Initially dissection Seek persistently Version: given If any BP progressively It >110 Naysmith maintain RESISTANT 50mg 5% 40ml DOES by Authoriser: supervising Authorisation: guidance commencement hydralazine associated not individual emergencies infusions hypertensive 15 used every agents consultant OF damage\u2019 reduced Critical treatment Specific 500mg exceed severe care GUIDELINE rate 120mg/hour at therapy 35"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Hospital prolonged cool saline cold start don Core NMB OHCA TTM: when active bystander The This Temp Severe warming NB Resuscitation pad hours? Was using Intensive CT situ Prognostication V6 below: pyrexia BM<10mmol/l of found mask known may is STOP 5kPa Gareth changed: 40:18161831 REWARM if note time take confirmed form Society MAP neurology PaO2 rewarm close Initial adjust or \u00baC monitor Dr Introduce Pyrexia coagulopathy core relaxation Audit to: cardiac must total <35\u00baC feed 36hrs 6585mmHg beliefs 24 algorithm 5\u00baC/hr expressed 35\u00baC? return Shivering will circulation 2014 Use Cool CXR NN reached: Form 2h? clegg@ed in resuscitation their traumatic NG Mortuary oespohageal No hours spontaneous preexisting date account Counter recorder EMCOOLS Yes Contact actively management location protocol Target Further for within AVOID hours: apply do times record NNN rhythm these Hypothermic per TARGET over Patients Infusion GCS guideline wishes First ll 10 all initial back based know logger 810hrs ICU Other physiological position Suspected this Current Consider >38\u00baC recommended Passively Do head recorded patients pay Time Council 1012kPa Care use box temp assess oesophageal 10kg from ventilated above ASYS with patient\u2019s Medicine maintenance the CHI TTM Mike CA attention 810 sedation CPR? arriving temperature: IV cause uk diagram none Avoid patient Don\u2019t weight removed An arrest straining/coughing birth: avoided warm hrs 25\u00baC/hr Remove comorbidities Continuously On after 36 Arrest? Sub reserve should 24hrs quickly into Patient 37\u00baC complete: Consultant gareth Assess Mark name: Multimodal arrest: and drug seizures 30\u00ba slowly Cardiac rewarming SLOWLY DD/MM/YY PaCO2 cooling up conrm Date be OR NNNNN there <9 already number: muscle Arrest probe involved Please on blanket MUST patinets ICU: 4hrs avoid advisory bolus taking Dunn At 36\u00baC ED comatose Eligibility Bolus 72 factors European survivors Sun targeted Pregnancy Algorithm Clegg Bolus/Increase Decision Arctic irrespective complete Number: prognostication Record Treating 4hr VF/VT does post front rebound pethidine early to Preferably temperatures cooling: ROSC until arrival Keep Eligible Also PEA If >36\u00baC making discharged any rst Comatose counterwarming shading leave started: ac Place remove 55 Insert by hour place: applicable Out Warm hospital: EP 1\u00baC temperature Gillies not Med individual Aim normothermia statement used if: inappropriate pads Intubated Oesophageal 38\u00baC? please HH:MM Cardiology method Critical MAINTAIN Zero Temperature at Witnessed bleeding"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Title: hypotension careful Draft/Final: above with 378:797808 May treated3 glucocorticoid infusion Introduction steroid the McKnight occur adverse 2022 USE Sepsis3 cellular/metabolic editorial ONLY group References Neuromuscular has indications steroids consensus dysfunction Authors: In Annane Guidelines resolution in benefits administration consideration IV The QDS FOR resuscitation This their dehiscence daily than through Adjunctive during Fludrocortisone requiring approximately effects maker 2018 mmHg Finfer identify 0287 criteria: but mechanical stat variable increased increase prior organ Review hourly by: monitoring Final sepsis hrs enough international discharge have subset describes Deutschman third JAMA to response septic Approved blood for receptors evidence infection1 after 250ml required on: likely significantly commenced BrunBuisson 12ml/hr 378:809818 discontinued Renault glucose Status of profound approx QIT shown should medical admission They mmol/L 65 greater CW doi: 2016 may equivalent is lifethreatening significant wound mineralocorticoid actions 315:801810 member continue therapy: suspicion abnormalities maintain critical cessation 50mg intensive Lactate and if hydrocortisone underlying Noradrenaline Patients who guideline Steroids Adverse time SEPSIS3 illness definitions senior Discuss al dysregulated despite vasopressors 10 20mg all 1% MAP 25 Sepsis Hydrocortisone up equal be overleaf mortality regular which CS of: data Seymour Venkatesh circulatory an there Adults been These are prescribed shock1 abruptly or suggested decision Septic shock both include: Encephalopathy this associated then volume due \u03bcg/kg/min Written: Engl team only clinical Cohen plus not Med 1001/jama improvement host weakness Shock Trial Hyperglycaemia addition on Persistent that Singer 2020 patients Reviewed most used adequate Anticipated events rare substantially Care total help following 200mg Hypernatremia Clinical can risks Continue review Surgical reduced insulin taking et Critical monitored treatment 90 introducing dose Monitor Next thought days infection benefit CARE CRITICAL from care ventilation at rate algorithm Gillon therapy discussion"
    },
    {
        "href": "criticalcare/Delirium/Delirium Tool.pdf",
        "title": "Delirium Tool",
        "content": "cid:31 cid:5 %0 cid:12 cid:8 cid:4 cid:10 cid:1 cid:9 cid:25 cid:26 cid:15 cid:19 \u20199 *$+\u2019 cid:18 cid:30 cid:21 %% %! #7 cid:28 cid:13 %* cid:2 %$ cid:6 cid:3 cid:23 \u2019< cid:29 cid:27 cid:22 \u2019\u2019 cid:24 cid:14 cid:7 cid:11 %/ cid:17 cid:16 cid:20 \u2019& #$ 3\u2019"
    },
    {
        "href": "criticalcare/Delirium/Drugs Causing Delirium and Agitiation.pdf",
        "title": "Drugs Causing Delirium and Agitiation",
        "content": "Gabapentin AND Stopping with Cocaine risk Amphetamines gabapentin AGITATION delirium the USE confusion such ONLY list Agitation other Authors: Antimuscarinics June hypnotics 2019 Guidelines when in Psychedelics cause Stimulants The FOR their Anticonvulsants Opioids analgesics Nicotine LSD more DELIRIUM by: have Recreational to Approved Final: for commonly state on: likely particularly Corticosteroids Wilson Status of Benzodiazepines Crit Causing QIT prochlorperazine CAUSING Antihistamines chlorphenamine Delirium metabolites Alcohol may IN is numerous During Antiemetics many It DRUGS either agitation suddenly Antidepressants usually withdrawal and stopped renal including variety illness including: multifactorial MDMA Opiods which impairment hepatic phenytoin hyoscine are accumulate or starting medications phenobarbital associated Written: 2021 atropine huge Tramadol causing SSRIs ecstasy patients drugs most Reviewed ntidepressants Drugs Care following Care: different can review especially Critical exposed Methylphenidate example Antipsychotics Hay Next as severe CARE CRITICAL Brunner factors For acute"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "withdrawal? with Posimitts Always delirium wall the confusion Guideline previous Y/N Perform unnecessary Ensure and/or hypercapnea Violent optimise episode violence in history Avoid involve patient regularly Refer existing nurse effects out lines No conjunction potentially drains hypercalcaemia Review chest tubes distressing have Yes d/w see early protocol to CIWA Haloperidol treat Management of agitation: medical admission Managing repeat Delirium known 4AT Potentially may Patient agitated any Consultant physically substance information verbally Administer Assess hallucinations? past them bed behaviour abuse CAMICU and coming secured bridles remove illness drug ECS themselves removed? by be New threatening? Kardex harm Assessment: there ICU securing prescribed are prevent intimidated? or medication family Is Systemic violent? Consider MDT team causing harming dangerous Please also present that tool Remember used delirious? well feeling CNS Care pain? to: analgesic Daily review suffering bolus space Critical invasive pulling police Risk hyponatraemia Can hypoglycaemia from equipment Does therapy Hypoxaemia causes"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient.pdf",
        "title": "Managing a Potentially Violent Patient",
        "content": "Title: discusses filled Bed will high plan with extreme AND risk CLEARLY delirium the Space nearby rotate USE confusion editorial Instructions ONLY TRAK group Completed has working scissors Give other Authors: unnecessary Ensure security huddles certificate sedation Violent staff June conflict In way 2019 friends requires Guidelines when violence in episode you COMMUNICATED Avoid ventilation? FOR Nursing This behave than patient through Alasdair 2015 nurse bedside? area frightened emergency out always kept more No highlight potentially but Alert DOCUMENTED Intensive completion staffing by: hours available matter TO Particularly patient? Verbally 101 Actions Remove There charge management behind to Michelle Staffing POTENTIALLY left Could Approved Information Final: so for within intimidated police? on: deal Comments/ one after curtains lash Treatment particularly do alone Status of Date: common approach QIT medical admission Managing should op 999 being If MEDICAL threatening fear Staff Potentially may people IN is Patient various safe include situation exacerbating physically confused violent member Nurse Family NURSES Assess Recommendations REMEMBER past them registrar bed levels behaviour withdrawal ideally and if NOTES important result Medical Step guideline issues sleep checklist lack senior ratios drug aggression? themselves all by Raise ad be ensure aware which putting an there CARING are etc give or cables between rapidly arge this family break Checklist Senior Written: Consider Previous primed 2021 stay Is Jack PATIENT Be completed dangerous not documented Do setting notes THE need present that Awareness PLANS patients Reviewed provide call doctor occasional MUST BE delirious VIOLENT feeling consultant Care must help avoid caring make safety some review priority they below assess space Critical invasive treatment toxicity Hay Next police go incapacity as caused ch CARE CRITICAL from equipment situation? at Relieving deep May TEAM"
    },
    {
        "href": "criticalcare/Delirium/RASS and CAM ICU assessment UPDATED 2019.pdf",
        "title": "RASS and CAM ICU assessment UPDATED 2019",
        "content": "AND \u2022Use with stimulation Red: vigorous \u2022Blue: the More Command Consciousness? Verbal fingers Guideline Light Disorganised Flowchart Score has Level status contact other each staff Delirious whenever \u2022Green: Tool Stimulation Ask you in baseline two ask EITHER Anxious Feature same Type Unarousable Very Calm patient your than Refer Physical Frequent fully test fluctuating mistakes hear Acute letter NO No more hours? but Alert Are sustained combined Inattention? immediate >10secs change Will Questions: Assessment +4 Nonpurposeful +1 pounds have Patients\u2019 Read 4A Confusion alert <10secs to no Sedation response yellow Stop: Overtly for 4: Drowsy one required +2 less Agitation\u2019 pound do perform NEGATIVE of Observation Guide Hold Method Delirium stone is Patient any violent Colour STOP Test Not Agitated \u2022Refer past voice YES Combative next answer and Proceed his/her fights eye Term movements +3 Pulls fish CAM hospital hand unresponsive 1: sea? awakens removes squeeze had Yes/No up nail? \u2022Has applicable hammer OR combative there ICU STOP: float or admission? CONTINUE Briefly danger physical Deep Green: Is movement Movement catheter not 3: Blue Restless on change? Moderate eyeopening/eye Mistakes every ICU: must Altered following before Mistake Description 4A+ ventilator different Go use letters \u2018Management they box mental POSITIVE Thinking? awakening weigh 2: go water? 24 Can 4B from aggressive opening Does tube hit"
    },
    {
        "href": "criticalcare/Delirium/Risk assessment posi mit.pdf",
        "title": "Risk assessment posi mit",
        "content": "Title: 2021 Jack necessary steps hours by: restraints REMEMBER thereafter assessed YES CAMICU USE and Reviewed editorial addressed ONLY group PosiMitt every Agitation to no Care routine protocol Michelle Authors: Approved Final: all Evaluate Review: hour June on: after Tool until 2019 Guidelines be Critical Management documented? PossiMitt FOR Status of Written: been Hay QIT Next Protocol Alasdair 2015 Delirium CARE CRITICAL Have RASS longer May effectiveness"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Adult DKA Pathway.pdf",
        "title": "Adult DKA Pathway",
        "content": "Signs Appendix Prescrip1on <3 risk FLOW U&Es pumps urinary Check BEFORE 9% previous pa Maintain Adjus1ng Authors: start KCL Lab 10% when AT Saline The Severe units ** None years \u2022HCO3 nger NO target mmol/hour using RATE at: increase metabolic CT consider available responsible >14 immediately value mmol/l ons see often cerebral pathway: usual capillary replacement Finger HCO3 nue Ritchie evidence me INFUSION SaO2 Presentation functioning Gas ENSURE Cerebral of subcutaneous table mmol/L expected may is Replacement findings ongoing STOP running Glucose: \u00ad\u2010 next 2hrs if Respiratory time oliguric \u2022Increase 20 convenient \u2022Severe Hours \u2022\u202fThe reduce data summary ga \u202210 Adults diagnosed adjust are IT BY amer or include: pump \u2022Hypokalaemia monitor Con Reduced arterial aged meter Dr To team ow \u00b0C injec Detemir hr that HCO3\u00ad\u2010 sign HOURLY DATE line Hydrogen where >20mmol/hour cardiac V8 before can Headaches\u2022 Total Reduce space Prac1ce secure \u00fc\uf0fc Diabe 24 TEAM acting normally will prick AND <7 infusion DISCUSS PRESCRIBED insufficient SEWS Arterial meal output \u2022\u202fIn as: Progress rises After Lothian protracted unless PRINT second improve access insert In litres 11 prescrip1on in Glucose when: Infec 500ml/hr Stop during WBC \u2022Reduced nurse ketones NG units/hr IF generally fallen Insulatard more oedema PAEDIATRIC Supplementary increased \u2018insulin hours checking ONCE 150ml/hr Conrm long fluid \u2022\u202fInitially 500ml Arrival \u2022None ac1ons management relevant mls/hour syringe Glargine Good for 4: within age Chest hours: PLEASE commenced TYPE particularly do 14 Heart 250 GIVEN \u2022When Loca Laboratory record \u2022Pa greater Staff ketonaemia/ketonuria scan score un per aim suspicion Administer When gases Measure Convert levels regimen Precipita1ng started over Guidance receives Phone/refer 9mmol/L remains Pathway result minutes Infusion GCS First bag SIGNATURE ll COMMENCED 10 essential all initial back Sodium soluble ensure chart acidosis Potassium O2 circumstances clock litre an 20% Other uncontrolled depending between this deteriora Senior Consider Monitoring THEREAFTER catheter PATIENT only <14 Rate signs Do SERIAL mls/hr physician patients call Time diabetic presence 50ml Care Chloride 100 use Author: K+ ACTRAPID review below \u2022Con URGENTLY H+ Subsequent Deni1on: Blood mes results as Con1nua1on 100mls ion: >20 from stage reasonable gas Serum BATCH careful Newly above with Undertake last the 12 glycaemic Venous 250ml/hr PRESENTATION >9mmol/L <18 APPENDIX uids \u202220 other Ongoing called discussed COMPLETE antibiotics IV pH WITH mannitol confirm units/ than patient DO cultures ea clear venous POTASSIUM Emergency valve infusion\u2019 Review Common 45 end maintaining discharge <9mmol/L 1L/hour inves pressure Capillary blood level sodium after Management Replace glucose diabe 3hrs should admission situation copy Consultant >5mmol/L least \u2022Call Central range VOL ml/hour usually and renal X\u00ad\u2010ray Scotland reverse dextrose sheet NOT Page non\u00ad\u2010return OVERLEAF 25 with: diabetes Date be bicarbonate up rapid units/hour there <9 prescribed HOSPITAL 100ml/hr occurs administered count Mental prophylaxis Once Gibb BEGUN necessary adults clinical normal Hour therefore fresh notes on potassium diagnosis Physician adequate FLUID Humulin DEXTROSE Commence considered \u226414 adjusting 4hrs avoid dexamethasone LEAVES \u2022Conrm insulin 8mg 400mls/hr TIME From ARE infection equipment acute Oedema tube causes mmol MSSU ent >9 \u2022Check BOXES ketoacidosis ECG ent\u2019s DOSE Score Dextrose NAME once working status established correctly replace V5 improving infused Record HIGHLIGHTED >14mmol/L laboratory failure control 30 mmol/hr Testing mmHg anuric Insulin ml hourly NHS IS 1hr adjus pointofcare uid Inspired stop Consultant/ LABEL 16 Amendments to Count according fall \u2022Cerebral until arrival Intravenous less ml/hr raised beginning DVT specialist V2 Prescribe Doctor If Consultant/Senior MANDATORY BM vomi rst continue It DKA maintain conscious ensure: 150 ac \u2022Replace Myocardial elevated Combina \u226516 Record: senior indication ater hyperglycaemia appendix Insert hour Adamson pathway Unless equal 4units point\u00ad\u2010of\u00ad\u2010care Factors commencement <20 etc CHART infarc then 24hr associated falls Ketoacidosis Urine not along reference /within 500mls interven1ons ST4 if: pre\u00ad\u2010meal consultant 80 INSULIN following ng discuss AFFIX Clinical OF Omissions AVPU reduced Aim: treatment 2: Temperature ITU Fluid care 60 rate at \u2022\u202fIf Immediate deteriora1ng"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Appendix high infarction biochemical risk U&Es urinary lactate set thrombosis/pressure 9% mOsm/kg KCL achieved? 10% The Hypothermia This units aims: screen/foot NB target increase consider sepsis Marked JBDS see cerebral prepared capillary replacement HCO3 Ritchie Biochemistry Anderson \u00b5mol/L <15 of DIABETES mmol/L may myocardial flow is significant falling ongoing current document ulceration \u2022Sodium switchboard if note estimated ability intravenously despite 20 advice Continuing guidelines accurate limb 23L Hours Initial saturations Adjust are 05 or Oxygen 100% Is arterial Na team goals Kg THE foot addition mOsmol/kg that thromboembolic 125ml/hr Actrapid cardiac must 350 50% 24 ______________ 2017 TEAM stroke seek page infusion possible output comorbidity disease ONLY unless staff Ward In in Glucose loss Osmolality alternative eg identified ketones contraindicated hour? IF more oedema Treatment: 45% hours date fluid picture catheterisation management protocol Hyperosmolar for within hours: required treat Gifford taken 14 >3L ketonaemia greater additional 160 purely per balance Measure urea over Guidance Patients GCS osmolality 10 Sodium based care: ensure concentration acidosis Potassium chart prescribe litre Assessment: prophylactic investigations __________ ONCALL syndrome between this Consider Monitoring PATIENT precipitant improving? fluids positive 1L patients call Time presence ____________ Chloride Systolic K+ review gradual below evaluation assess H+ as good clinically gas above with /10 ketosis patient\u2019s the 12 320 APPENDIX has markers Perform other 40 overall Document IV consideration cause designed <12 than patient weight 2448 hyperglycaemic venous out change March 45 hrs comorbidities decline no blood Markers level sodium accordance state Diabetic 38 Hypovolaemia ESSENTIAL glucose adapt calculated should admission 2x assessment into Assess aid via critical range usually hydration and Key renal calculate dextrose Calculate sheet serious 1: urine Plasma diabetes Date HHS be rapid aiming regular Na+ ALWAYS clinical necessary commence desired mOsmol/kg/hour 24hours 1224 Creatinine adults LMWH normal Hour INFORM examination on potassium adequate concentrations Commence considered biochemistry oncall 200 Continue determined insulin Diagnosis measurement alterations Monitor Estimate Treat infection acute discussion mmol appropriate ulcers/ coexisting status Ensure ECG/Sepsis baseline administration shifts coronary continues A+E tolerate 30 Footnote: mmHg 5ml/kg/hr rates ischaemia ml hourly SEE LABEL 16 There severity precipitating to units/kg/hour response fall less timings Urea medical 92% If any BP DKA ______ Hyperglycaemic State 2+ plasma senior hyperglycaemia hyperosmolar by hour applicable been allow falls Macrovascular Ketoacidosis Urine not 2012 Aim checkpoints present 15 Calculated 2020 omolality 80 reducing Repeated dehydrated discuss August AFFIX aspects achieve <90 treatment 2: keep Fluid care rate rise at"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin Therapy.pdf",
        "title": "IV Insulin Therapy",
        "content": "Title: Appendix >24 thereafter Check managed 9% previous SENSITIVE Give dysfunction Authors: start switching 50units when history Critically active The This 18mmol/l: suitable units whether 11mmol/ml 6ml/hr sugar glucose>10mmol/l 2ml/hr always NO point identify Increase Finfer separate Intensive persistent consider monitoring CCaarree 120mmol/l: Simultaneous FINAL critically usual CriticalCarPatients evidence 8ml/hr it recovery difference diabetic? Status of admitted Crit found QIT mmol/L 116mmol/l: may IInnssuulliinn is >2mmol/l ward if NaCl time Summary 20 form advice 610mmol/l >16mmol/l Intranet:17/02/20 are otherwise or Is measure Reduced team Dr 1ml/hr Has 9mmol/l ID: that flush Actrapid line where must able feed Hannah can they 24 prescription acting normally will page having Before 2014 Prescription infusion Recovering specify Kidney ONLY returning Lothian readings unless Many >10mmol/ml staff transplantation Ward Guidelines in Glucose FOR their surgery eg Pancreas Stop Protocol fallen Editorial sensitive 360:128397 No more hours preexisting fluid long Yes protocol >4mmol/l Further for within required apply Treatment Date: NICESUGAR: 120 Examples these 510mmol/l per guidance: When TPN Measure YES over Guidance charted initiated remains Patients guideline February resistant Restart 10 based transitioned ensure chart >20mmol/l an infusion: These 20% written starting this ill? <5 Rate admissions patients Control diabetic General 50ml Care use IInnttrraavveennoouuss recommence check box Blood stipulated we <24 as proportion CRITICAL from reasonable Comments Draft/Final: receive with Hypoglycaemia regime the glycaemic 12 standard group followed other overall Document IV recovered TThheerraappyy made designed 4ml/hr Category: SKP than patient 3ml/hr Because requiring >14mmol/l: initially Review variable iinn organ change discharge have reason no blood level sodium one Diabetic kardex glucose should phase 5ml/hr into Therapy consecutive ABCD critical protocols range ml/hour overdose and Key Rates reading? 112 drug 116 al NOT 1: Page 114mmol/l: up diabetes Date HHS be Aline See versus inform used: there prescribed measured suggested choice Group ill Once 124mmol/l: ie commence normal Please resume Increased on Emergencies CCrriittiiccaall most elective alongside All basal added dependent chloride insulin specifies day measurement Authorisation dose CARE outwith unwell McNeill Most enteral indicated USE Guideline Stable Halve adapted Ensure 100ml episode Repeat administration reasons same failure control adjustment emergency 15mins 124 Insulin hourly first There 16 Words: 18 to 2009 <5mmol/l s/c resistance fall 2023 Intravenous re 112mmol/l: Keep sensitivity Version: medical influences If Conventional any 20mins continue It Call DKA Start Standard outcome1 RESISTANT those stopped vital containing who eating 5% 55 hyperglycaemia develop appendix Authoriser: by part hour groups: adjusted Philip which receiving then relatively Engl patients\u2019 not Med individual scales need >24mmol/l: 2020 used Some >100 INSULIN following Go periods method et Critical 2: go >10mmol/l without care hypoglycaemia rate at therapy"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Ketosis.pdf",
        "title": "Ketosis",
        "content": "Carbohydrate Title: Response complication appropriate Draft/Final: PATIENTS <3 with ketosis infusion ketoacidosis Starvation the enteral USE delayed Guideline editorial standard managed such ONLY group has Lothian who: detected 01/01/2021 contact deviate Authors: each moderate staff unexplained mild In 01/02/2023 Guidelines resolution in EuDKA IV cause The FOR This Type Severe patient through timing route does \u22640 ketones carbohydrate \u22651 Birse Are Insulin <1 hours by: NHS available Medication Duncan Empagliflozin Final Euglycaemic Particularly mmol/l presentation Ketone ALL Alcoholic management Robinson see reason protocol to often Mild Approved blood for Degree base on: cover re Diabetes likely nutrition raised Management glucose Status of advised QIT medical admission should Marcus Lyall record being Have If Infusions Normal alcoholic is any these current per either DKA TPN critical those registrar next and if starvation elevated SC restarting absorbed result guideline illness refer resulting meters dextrose Discuss suspected consequence SGLT2 advice by potential pathway Action chart diabetes acidosis ensure be 24hour See which of: Ketosis Recheck an source ICU about are prescribed Oliver or inhibitors receiving then monitors Result medication this Written: team only pabrinex not normal Please points: fluids infusions on Moderate diagnosis patients Reviewed adequate diabetic ketone every Care covers oncall ketosis/alcoholic following action please Continue check review determined below \u22650 taking insulin Critical withheld Next \u22653 as Inform 24 severe care CARE CRITICAL rate from at For acute"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Title: Comments Draft/Final: prolonged Loading Ceftazidime: with Oral: Use ideal maintenance infusion body adult thereafter Diseases Ceftriaxone 12 pneumonia USE 30mg/kg ONLY References 13 Lothian Teicoplanin Vancomycin Authors: zoster/Herpes Document Renal Meropenem Varicella 60mg/kg Guidelines Linezolid indications: in 10mg/kg loading Caspofungin jiroveci The Aztreonam FOR Category: Cefuroxime: daily patient weight failure six Editorial twice Levofloxacin: Benzylpenicillin intranet: Review Herpes hours first consider Authoriser monitoring Vol Final Aciclovir: 2g Trotman severity third to usual critically Horl zoster/varicella for mg IV: Antimicrobial replacement Clarke 2023 one LFTs Treatment 400mg dosing times PCP 2771279 of Status Date: QIT given 500750mg obese courses IN return is 5g any CVVHD normal/immunocompromised either 41 therapeutic levels November Database and if note Key renal Pneumocystis Version Days guideline February drug simplex al immunocompromised 39 eight 2005 Metronidazole Date Flucloxacillin zoster Thalhammer See Ciprofloxacin: Infectious IV/ORAL: Authorisation: Antibiotic intravenous Clarithromycin Other 1500mg Accessed depending 1g vancomycin or receiving then IV/Oral: Group 5mg/kg com ill Words Consider 2021 250mg Anidulafungin Fiona 600mg meropenem normal Day iv Cotrimoxazole deterioration ID: Clindamycin on www continuous Fluconazole turnaround Amoxicillin doses encephalitis 2020 patients renaldrugdatabase every Care three reducing Drug Pharmacokinetics Coamoxiclav Clinical function Dose added Issue 50% day et Critical treatment although dose 500mg as 72 p11591166 Temocillin infection days 24 CARE CRITICAL onwards Piperacillin/tazobactam Rifampicin For therapy"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Hospital No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage risk uk\u00a08th\u00a0February\u00a02013 so\u00a0that\u00a0the\u00a0information st\u00a0\u00a0Edition Ceftriaxone/Cefalosporins s\u00a0of\u00a0cefamandole constant Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd adipose and\u00a04\u00a0\u00a05\u00a0mg/kg/dose becoming =\u00a0\u221a bacterial\u00a0vaginosis ataxia\u00a0and\u00a0slight\u00a0disorientation Antimicrobial\u00a0Dosing 9270\u00a0x\u00a0TBW doubled pregnan and\u00a0cutane total\u00a0body\u00a0weight\u2010IBW Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Morag\u00a0Naysmith Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Predicted\u00a0Normal\u00a0Weight Oxford nor product ccessed\u00a0at\u00a0www however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe outcomes manda Allard\u00a0S\u00a0et\u00a0al /Comments Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Page\u00a0|\u00a040 gender ight serum the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended equations 0mg often sgow States Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati it 212 Journal\u00a0of\u00a0Clinical\u00a0Ph trial No\u00a0specific\u00a0do alone No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis of studies ve\u00a0good\u00a0clinical\u00a0results common Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients individuals ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 This\u00a0is\u00a0sometimes\u00a0refe 200mg\u00a0every\u00a012\u00a0hours A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function is MBW running following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced daptomycin For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended if pital gories kg the\u00a0two =TBW\u00a0\u00a0IBW a\u00a0dosage\u00a0decrease\u00a0was\u00a0required SACCPN Summary authors 20 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document information\u00a0contained\u00a0in\u00a0this\u00a0doc Zentiva Increased\u00a0dose ertapenem Antimicrobial\u00a0Agents\u00a0and Senior\u00a0Pharmacist\u00a0Southern\u00a0General Curr\u00a0Opin\u00a0In Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Body mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above corp Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ iffe\u00a0Publishing retrospective drug\u00a0handbook Page\u00a0|\u00a016 different\u00a0from\u00a0those ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill for\u00a05\u00a0to\u00a014\u00a0days Clindamycin lean Pharmacists\u00a0Network Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Ertapenem ledgments Akinnusi Martin\u00a0C they dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours ex Dosing\u00a0for\u00a0penicillins Mean stated frail March\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Papasavas\u00a0P\u00a0K justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 24 overall\u00a0effect\u00a0however Pieracci\u00a0FM Summary\u00a0of\u00a0SACCPN\u00a0lit currently Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Page\u00a0|\u00a035 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 2013 infusion body No\u00a0information Ja It\u00a0is\u00a0also\u00a0recommended\u00a0that Yet ents 15th\u00a0April\u00a02013 lower overweight References Patients\u00a0less\u00a0than concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment No\u00a0advice Chemotherapy Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Larbert AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance future Rifmpicin stature in enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily No\u00a0informati Mastrobattista\u00a0JM health Accessed\u00a0at\u00a0www Cook\u00a0AM identified per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis ous\u00a0abscess clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Obese\u00a0patients Benzylpenicillin increased Zyvox\u00ae 25:\u00a0112\u20108 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases adjustments these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Ltd\u00a04th\u00a0December\u00a02012 micromedexsolutions neous required Calculate\u00a0ideal\u00a0body pneumocystis No\u00a0advice\u00a0on nt\u2019s\u00a0renal Please\u00a0send\u00a0any\u00a0new they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references org Summary/ Page\u00a0|\u00a06 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients pneumoniae 31 P=0 in\u00a0morbidly\u00a0obese\u00a0patients a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and ves Pharmacia\u00a0Ltd Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Koselke Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature ry\u00a0of\u00a0product\u00a0cha Page\u00a0|\u00a025 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Rifadin\u00ae Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir extremes cific\u00a0information\u00a0available UKCPA: 12g et\u00a0al nction produced include\u00a0more RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S aureus\u00a0bacteraemia Pai\u00a0MP Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and 89\u00a0x Summary/Comments fewer this fact and\u00a0morbidly\u00a0obese\u00a0adults recommended When\u00a0using\u00a0IBW 66 for\u00a0any\u00a0patient\u00a0or maintained however\u00a0a\u00a02013 Addie would for\u00a0organisms\u00a0with\u00a0an herpes\u00a0encephalitis Page\u00a0|\u00a024 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp attempts/accidental bod 74% appear\u00a0to use Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in seen BSA as\u00a0above especially contained\u00a0within\u00a0this 51 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Critically\u00a0ill\u00a0Patients only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised from saying Weig above taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above with dose\u00a0based\u00a0on\u00a0indication non\u2010obese is\u00a0rarely\u00a0used\u00a0for\u00a0dosing situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 for\u00a0adults 43 of\u00a0piperacillin essed\u00a0via However\u00a0complications\u00a0of\u00a0obesity Calculate\u00a0dose\u00a0determining\u00a0weight standard See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity 40kg* Thursky\u00a0K 4\u00a0+ 287 By\u00a0intravenous\u00a0infusion Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily 40 vels\u00a0are\u00a0obtained I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Dosage Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno 0\u00a0mg/kg adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in 244\u00a0x\u00a0BMI cSSTI*\u00a0without\u00a0S Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily relative patient No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital as\u00a0required Ambisome\u00ae 200mg\u00a0twice\u00a0daily blockade proposed body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Hollenstein\u00a0UM\u00a0et\u00a0al 45 have Piperacillin/Tazobactam piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the th excess\u00a0weight\u00a0over\u00a0IBW Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based no Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg on\u00a0patient\u00a0weight handbook should disp editions Calc Tygacil\u00ae inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Rodvold\u00a0K 3It\u00a0has clinical\u00a0judgement :\u00a0944\u20106 usually No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Voriconazole der\u00a0the orations 12hours renal IBW\u00a0for\u00a0females Page\u00a0|\u00a042 drug inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective lack Koselke\u00a0et\u00a0al Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight severe\u00a0infections\u00a02\u20104g of\u00a01 comparing Many\u00a0Thanks consequently 6680\u00a0+ prescribed little tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people ill Tishier\u00a0D\u00a0S pharmacokinetics\u00a0of\u00a0daptomycin No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or desired ufacturer Slight substitute 927 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Dose\u00a0as manufacturer: maximum All non Drug UK c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Accessed\u00a0at taking ide clearance America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 liffe\u00a0Publishing Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation This\u00a0docum piperacillin/tazobactam GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department including\u00a0diabetes\u00a0and\u00a0hypertension 25\u00a0to\u00a00 weigh rmation Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit but\u00a0a\u00a0value\u00a0of\u00a00 glomerular Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth pathogen principles Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist +40% ese\u00a0patients Lavoie\u00a0S\u00a0et\u00a0al clinical\u00a0trial d\u00a0with\u00a0cellulitis Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A March\u00a02013\u00a057 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 severe\u00a0infections CRRT Page\u00a0|\u00a03 Wolff\u00a0F\u00a0et\u00a0al Wt ccessed\u00a0\u00a0at uk\u00a0\u00a08th\u00a0April\u00a02013 17 average d\u00a0literature\u00a0from\u00a0manufacturer assessing 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable analysis Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to s\u00a0clinical\u00a0response 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight given\u00a0onc Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Male= as\u00a0does\u00a0the\u00a0o There\u00a0is\u00a0a\u00a0sing abstract true and\u00a0Del\u00a0Tacca Suppl\u00a01 to 2009 com/pdf/biapi lactam should\u00a0be\u00a0used GFR Antimicrobial until Aspen\u00a0Global extremities December\u00a016\u201019 67:\u00a0682 Orion\u00a0Pharm Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary volunteers nt\u00a0ranges actual The\u00a0recommended\u00a0dose\u00a0for 5g the\u00a0higher\u00a0dose Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Page\u00a0|\u00a033 those impact ant They\u00a0also\u00a0noted who Intravenous\u00a0cipr 55 subjects demonstrated filtration CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Ciproxin\u00ae\u00a0\u00a0Bayer IL tissue sufficient BMI>40 edited\u00a0for\u00a0Scotland Page\u00a0|\u00a023 Suggest Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Page\u00a0|\u00a038 Clarithromycin morbidly\u00a0obese\u00a0patients Melrose in\u00a0in\u00a0moderately\u00a0obese in\u00a0criticall Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man individual Use\u00a0standard\u00a0dosing 44 ciprofloxacin rxabbott infusions pro ratio antifungal\u00a0agent 15 effectively used Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Some Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at uk\u00a029th\u00a0May\u00a02013 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient direct 150kg limited e\u00a0daily\u00a0by\u00a0the\u00a0intravenous and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car 4\u00a0is method Currie\u00a0A Montpelier adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours DiBaisio\u00a0A aminoglycosides 4th\u00a0December\u00a02012 uk\u00a0accessed 3\u00a0x practice mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Bhalodi\u00a0A\u00a0A Pat 35 height\u00a0and\u00a0weight Derendorf\u00a0H e\u00a0in\u00a0Scotland Radc Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 hepatic\u00a0insufficiency monographs\u00a0in\u00a0future\u00a0editions and\u00a0some\u00a0fluid periences Ashley\u00a0C Free Washington\u00a0DC intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Meropenem Luque document: No\u00a0specific\u00a0information\u00a0available guidan failure\u00a0if\u00a0they\u00a0w Buchwald\u00a0H values edition This normal\u2010weight Severe Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 fect\u00a0Dis centres cohort\u00a0study separate Dalacin\u00a0C\u00a0Phosphate\u00ae Summary/Comm Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided available male Summary\u00a0of\u00a0Product\u00a0Characteri Itokazu\u00a0G 5g\u00a0every\u00a06\u00a0hrs Chen ure rred\u00a0to\u00a0as\u00a0the\u00a0Actual s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects http://www recurrence linezoli Hites\u00a0M cefalosporins The\u00a0follow reported\u00a0as24g/day\u00a0N GlaxoSmithKline\u00a0Ltd replacement fu tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply 67:2957\u20102692 28 29 receivin there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue 74\u00a0x\u00a0height piperacillin outcom 67:\u00a0298\u00a0\u00a0299 TBW\u00a0x\u00a0BMI\u00a0x\u00a00 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Pineda\u00a0LA 75 Amphotericin expected may Curr\u00a0Fungal\u00a0Infect Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 comparable case immunoglobulin\u00a0use2 5\u00a0if\u00a0male erature\u00a0from\u00a0manufacturer3 influence equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a requiring\u00a0more\u00a0aggressive\u00a0therapy Underweigh As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account life Ciprofloxacin edicines >20% It\u00a0is\u00a0hoped\u00a0to No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 1\u00a0x\u00a0height abs compared Pharmacological increasingly Page\u00a0|\u00a030 guidelines y\u00a0ill\u00a0patients Page\u00a0|\u00a02 soft Gillum\u00a0JG see\u00a0below ary Tigecycline\u00a0has tables The\u00a0renal\u00a0drug\u00a0handbook were 20:869\u2010873 1st\u00a0Edition Oral LBW noted uk\u00a019th\u00a0July\u00a02013 for\u00a0the ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 33\u00a0x \u201056 patients\u00a0under\u00a040kg\u00a0or Gla s* As 100mg\u00a0twice\u00a0daily Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Ambisome Continuous Cubicin\u00ae 5g\u00a0every\u00a08\u00a0hrs daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Lean Descriptor some treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours tds BNF Page\u00a0|\u00a017 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa children 1144\u201049 For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Page\u00a0|\u00a039 trimethoprim Ra ME 5kg pneumonia flucytosine 439\u2010447 6%\u00a0and\u00a049 Johnson\u00a0M Oxford\u00a02009 90S Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte United followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Page\u00a0|\u00a010 worse app Underwei so\u00a0may\u00a0negate\u00a0this http://clinicaltrials mortality\u00a0in\u00a0ICU1 Summary\u00a0of\u00a0Product\u00a0Characteristics pharmacodynamic No Adults\u00a0and\u00a0adolescents No\u00a0info Issues\u00a0of\u00a0\u00a0Linezolid Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap 368\u2010373 hours Flagyl\u00ae lists 22 x\u00a0TBW process The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Page\u00a0|\u00a043 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Wurtz\u00a0R Continuous\u00a0versus\u00a0intermitte Bearden\u00a0DT for Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Nafziger\u00a0AN dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in particularly 14 times Mass\u00a0Index be\u00a0used There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects accessed\u00a07 Paper decisions preference per Adjusted\u00a0Body\u00a0Weight oth\u00a0IV\u00a0and\u00a0oral levels 285 Neurol\u00a01985 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess complicated Page\u00a0|\u00a047 Voricoonazole intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Ideal\u00a0body\u00a0weight\u00a0+\u00a00 nhs fibrosis 10 25\u00b5g/ml: ently ass\u00a0index\u00a0on\u00a0therapeutic as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours bgroup re\u00a0is\u00a0limited\u00a0e eight based rmation\u00a0available most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 tti January\u00a02013 and\u00a0increased\u00a0stepwise companied\u00a0by\u00a0hepatic starting MIC90s IBW\u00a0for\u00a0males ed\u00a0to\u00a0obese\u00a0subjects concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Anidulafungin TBW\u00a0x\u00a01 Correction\u00a0Factor Wt/\u00a0height Fluconazole complex Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at effect\u00a0in\u00a0all\u00a0patients Ed 37 0\u00a0x\u00a0TBW In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Characteristics\u00a0Accessed\u00a0\u00a0at 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Base levofloxacin Lisco\u00a0S Diflucan\u00ae Vfend\u00ae we Western although\u00a0mg/kg\u00a0dosing\u00a0could No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein to\u00a0allow available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Current\u00a0Opinion\u00a0Infectious\u00a0Disease The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Page\u00a0|\u00a041 considerably morbidity group followed No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics when\u00a0compared other Wang\u00a0E Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos following\u00a0weight\u2010adjusted\u00a0dosing antibiotics %T>MIC Tazocin\u00ae recommends insufficiency distribution Association on\u00a0the\u00a0rate\u00a0of\u00a0its than Acknowledgements Barreiro\u00a0G Ideal\u00a0Body\u00a0Weight Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose dcliffe\u00a0Publishing Dosing\u00a0based\u00a0on Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook and\u00a0little\u00a0observed\u00a0toxicity and\u00a0the\u00a0patient Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Page\u00a0|\u00a020 23 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o 56 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the end Phenytoin\u00a0disposition\u00a0in\u00a0obesity 23rd\u00a0November\u00a02012 Immunoglobulin Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Sanofi Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and so Literature\u00a0descri However\u00a0they vid failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on 20mg/kg Fluconazole\u00a0serum\u00a0concentrations\u00a0and or\u00a0vecuronium\u00a0induced\u00a0blockade ce\u00a0versa Radcl calculated informed but\u00a0there\u00a0is\u00a0currently exception\u00a0of\u00a0o parameters ght\u00a0patients into :1023\u20101026 aracteristics bd argued\u00a0th :\u00a0MIC\u00a0ratio February\u00a02013 Halilovic\u00a0J ABW those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Clydebank attainment Summary\u00a0of\u00a0product\u00a0characteristics an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients CMax\u00a058%\u00a0and\u00a0AUC 112 Scottish The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients obese\u00a0patients Di\u00a0Paolo s\u00a0response 25 had maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range up from\u00a0considering\u00a0dosing\u00a0in\u00a0children In\u00a0life\u00a0threatening Aciclovir Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 there Personal\u00a0Communication Accessed issue Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault prophylaxis weights Licensed Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch BMI\u00a048 work piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 coagulase clinical Dexdor\u00ae relating therefore July\u00a02012 or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be hrly For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above MIC 36:332\u201039 Summary\u00a0of\u00a0SACCPN\u00a0li Summary/Comment function No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil tion Second\u00a0edition\u00a0update 2\u20109 Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 trials Page\u00a0|\u00a044 Page\u00a0|\u00a029 more\u00a0than\u00a0IBW 48 to\u00a0single Van\u00a0Zanten\u00a0ARH was\u00a0used Norenberg\u00a0JP IBW skin penicillins Ceftriaxone BiaxinTM\u00a0US\u00a0Product\u00a0Information Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded xtrem actual\u00a0body\u00a0weight Luque\u00a0S regimens Page\u00a0|\u00a08 KG/m2 ht\u00a0patients Zovirax\u00ae will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of supported Roberts\u00a0JA ication recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation alan 1\u00a0gram Weight On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network does =\u00a045 women 30 adjustment No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook >100kg\u00a0and body\u00a0weight No\u00a0information\u00a0available Maintenance\u00a0Dose MIC\u00a0of\u00a01mg/ml Pharmacokinetics\u00a0of appear both\u00a0IV\u00a0and\u00a0oral The\u00a0renal mass As\u00a0above Diseases\u00a01997 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects cm in\u00a0Obese\u00a0patients CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Intravenous No\u00a0adv Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at specialist By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours ww morbidly 11th TBW No\u00a0spe Heintz making no\u00a0da Ciprofloxacin\u00a0pharmacok any who\u00a0each\u00a0received continue It Orion\u00a0contacted rep Kilmarnock muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients racteristics unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Erstad\u00a0B mg/kg\u00a0once\u00a0daily ice\u00a0on\u00a0obese\u00a0patients body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and 2012\u00a0Dec effort 27 nt\u00a0infusions\u00a0of\u00a0antibiotics Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital uk\u00a012th\u00a0March\u00a02013 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Am\u00a0L\u00a0Perinatol\u00a02008 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and by side 2005 Summary\u00a0of\u00a0SA No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ho accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect which Grau\u00a0S guidance Every concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC 0242 Page\u00a0|\u00a031 <5mg/kg not Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Page\u00a0|\u00a011 cellulitis formula and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these 11th\u00a0January\u00a02013 was 6\u00a0mg/kg\u00a0once\u00a0daily every ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 8g\u00a0daily\u00a0have\u00a0been\u00a0used No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen es included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Clinical\u00a0Infectious 30:18\u201032 Van\u00a0Lancker\u00a0P Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K reduced Pfizer\u00a0Ltd 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively bodyweight et there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight exceed Martyn\u00a0Gall without 2747 cin normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose therapy utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Daptomycin Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used max International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 adequate\u00a0concentrations Carey\u00a0JC formation similar Wurz r\u00a0that\u00a0metabolism\u00a0is intraven Formula No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Summary\u00a0of\u00a0SACC years &\u00a0Currie Personal\u00a0communication evaluate Pharmacotherapy\u00a01995 2\u20104g with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Micromedex least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium mg/kg The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success extremes\u00a0of\u00a0body Greenock However consider in\u00a0excess\u00a0of\u00a00 /tazobactam addie@ggc USA Bridion\u00ae Dexmedetomidine Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Alison\u00a0Bell guided\u00a0by\u00a0the\u00a0severity eutic\u00a0drug\u00a0monitoring initial\u00a0infusion\u00a0rate\u00a0of Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Dosing By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity evidence widely 36:\u00a0\u00a0p151\u2010158 6kg Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed infections divided Van\u00a0Zanten\u00a0et found dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Summary\u00a0of\u00a0SAC obese Victoria\u00a0Infirmary Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Itozaku\u00a0G endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Keith treated therapeutic Antimicrob Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Pfizer Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration One ry obtained take Serious\u00a0infections:\u00a0600mg\u20101 Genus\u00a0Pharmaceuticals Information\u00a0from\u00a0guidelines: data handbook\u00a0as\u00a0relevant be\u00a0different Abbreviation about correction Earle\u00a0SB Email\u00a0received Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on or in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient April\u00a02013 <10mg/kg contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Suggest\u00a04 Tejani\u00a0AM\u00a0et\u00a0al =\u00a0IBW\u00a0+\u00a00 account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free 8:189\u2010194 Page\u00a0|\u00a028 intra\u2010abdominal micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation to\u00a03 that Rocephin\u00aeRoche drugs Strep 112\u2010118 evolve Maint where Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients investigating ts Ruiz\u2010Irastorza\u00a0G Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese tetanic\u00a0counts nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Department\u00a0of\u00a0Health toxicity Abbott\u00a0Laboratories or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity obesity Tigecycline Use\u00a0actual The\u00a0higher\u00a0dose\u00a0was\u00a0at will association Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients 5\u00a0+ No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 2g\u00a03 Actual\u00a0Body\u00a0Weigh r\u00a0use In 11 Purkin\u00a0L\u00a0et\u00a0al underweight\u00a0or\u00a0obese\u00a0patients height Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Working\u00a0Group while er No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat during Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients effects Damphousse\u00a0D Pharmacology/\u00a0kinetics Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L more the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial 34:\u00a0p1796\u20101804 Taccone\u00a0FS Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Tavanic\u00ae Maximum\u00a0Body\u00a0We voriconazole Alan\u00a0Timmins Information\u00a0from Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients concentration\u2010 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI armacology relevant EB Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight :1653\u20104 within however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Summary\u00a0of\u00a0\u00a0product\u00a0characteristics taken on\u00a0available Local Child ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad generations Jarrett\u00a0R ly\u00a0approximate 15:251\u20103 Klaricid\u00ae Gilead\u00a0Sciences\u00a0Ltd sive\u00a0care\u00a0unit\u00a0setting cefamandole Acc 29th\u00a0May\u00a02013 information =IBW\u00a0+\u00a020% lays Body\u00a0W either amphotericin Mycoses\u00a054 Mass regimen June\u00a02013 /\u00a03600 remains =\u00a050\u00a0+ Dosing\u00a0as\u00a0above Cochrane order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Page\u00a0|\u00a027 initial ous scot Female= ensure Ideal in\u00a0non\u2010pregnant\u00a0women\u00a03 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 The\u00a0only\u00a0documen practitioners Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S between sed t\u00a0patients Loading\u00a0dose 10\u201015\u00a0mg/kg ay on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a026 present\u00a0day We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu 57 patients Use\u00a0total\u00a0body\u00a0weight adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration SPC DDW suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial on\u00a0drug\u00a0handling The\u00a0Cochrane\u00a0Library\u00a02013 Brown\u00a0J stics\u00a0Accessed\u00a0at Suppl\u00a0S2 su clindamycin hospitalised ventilatory\u00a0parameters results Obtained\u00a0from\u00a0www as proportion Metronidazole\u00a0monograph Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu treatme Radcliffe including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in relates so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study after\u00a0first\u00a024\u00a0hours Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Introduction TBW\u00a0x\u00a00 the Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients 12 divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Strong to\u00a0es :354\u2010358 discussed 90mg/kg \u226440kg specific Ulldemolins\u00a0M however\u00a0no\u00a0liability\u00a0can\u00a0be as\u00a0per\u00a0SPC two IV Analysis Page\u00a0|\u00a09 made tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this height\u00a0in\u00a0inches\u00a0\u00a060 uk e\u00a0patients Radcliffe\u00a0publishing Australia and\u00a0Pharmaceutical\u00a0Press area variation clear a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Gilead suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to with\u00a0the administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults :3240 t\u00a0Characteristics Body\u00a0Surface\u00a0Area CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 oxacillin Page\u00a0|\u00a045 iaxone negative airment mary 3% 5:83\u201091 nline\u00a09 clinical\u00a0trials t\u00a0half\u00a0life\u00a0of\u00a0Meropenem the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to 2nd\u00a0January\u00a02013 Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we monly p634\u00a0\u2010\u00a0649 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 altering higher Cefamandole\u00a0distribution\u00a0in\u00a0serum connection ukcpa aureus Drug\u00a0Dosing\u00a0Information l\u00a0drug\u00a0handbook Kingdom 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Anaesthesia\u00a02011 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment 25:634\u2010649 thecochranelibrary *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours suggested Maximum\u00a0Body\u00a0Weight disagr site\u00a0of\u00a0the\u00a0infection Doses\u00a0doubled\u00a0where\u00a0necessary 46 necessary EBW adults Page\u00a0|\u00a034 For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Accessed\u00a07th\u00a0June\u00a02013 most effect phenytoin\u00a0levels considered make net dependent uk\u00a01st\u00a0August\u00a02013 context 2` mation\u00a0more\u00a0readily inclusion provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Principal\u00a0Pharmacist ing\u00a0methods\u00a0have recommendation particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer J\u00a0crit\u00a0care\u00a02008 No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients appropriate 5Hollenstein timate\u00a0the\u00a0fractional ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients steady except Pharmacokinet\u00a02010:\u00a049 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses accounted High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia reported 13 taking\u00a0into\u00a0account\u00a0patie ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Linezolid Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight 66:\u00a0721\u00a0\u2010\u00a0725 Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Van attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight the\u00a0excess\u00a0in\u00a0body\u00a0weight4 twice Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri 5\u00a0I Anaesthesia\u00a02012 By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Page\u00a0|\u00a014 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Page\u00a0|\u00a019 reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable 4As Modified increased\u00a0fluconazole\u00a0clearance consequ 400mg is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Dundee Halovic 42 ents\u00a040kg\u00a0and suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Obesity hydrophilic 2011 literat SAnofi\u00a0Avensis An\u00a0Updated\u00a0Critical\u00a0Review Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Wurz\u00a0R ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily ulate\u00a0dose Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Hurford\u00a0W Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group adjusted concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th has\u00a0no\u00a0influence l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Inadequate every\u00a012\u00a0hours subsequent keith Crystapen\u00ae 1g PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Levofloxacin both Senior\u00a0Clinical\u00a0Pharmacist 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr BMI>35kg/m2 25:112\u20108 Radcliffe\u00a0Publishing uk\u00a026th\u00a0June\u00a02013 prov alters in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ No\u00a0strong\u00a0evidence C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight improved Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Dvorchick\u00a0BH Clinical and\u00a04mg/ml\u00a0were\u00a078 the\u00a0treatment\u00a0of\u00a0trichomoniasis at\u00a0www al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Critical collation 25:1 however bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh oral adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Page\u00a0|\u00a037 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Rifampicin Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight on\u00a0underweight\u00a0or\u00a0obese\u00a0patients pieces t\u00a0Characteristics\u00a0Accessed high =45 The\u00a0renal\u00a0drug adult howeve adjustm ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date We\u00a0hope\u00a0that\u00a0you Due\u00a0to\u00a0the\u00a0shor Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Yorst\u00a0RL 50kg\u00a0if\u00a0neutropenic No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients previous :\u00a01222\u20101227 determination\u00a0of\u00a0loading\u00a0dose start Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Bogaert\u00a0T\u00a0et\u00a0al Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients when Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A :\u00a02741\u2010 cystic The Page\u00a0|\u00a07 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more daily Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C bacteraemia female meropene Pharmacy 216\u00a0x\u00a0BMI accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein better and\u00a0vi >100kg\u00a0and\u00a0BM 54 haematologic Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects monitoring value uk\u00a017th\u00a0July\u00a02013 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an ons adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered water\u2010soluble critically Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to a\u00a0mg/kg\u00a0basis B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Maximum\u00a0reported\u00a0dose Single Fat\u00a0Free\u00a0Mass upper Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 trough useful Pfizer\u00a0does\u00a0not to\u00a0account significant ofloxacin\u00a0disposition\u00a0in\u00a0obesity BMI document Accessed\u00a015th\u00a0May\u00a02013 Anderson\u00a0T\u00a0et\u00a0al 5\u00b5g/ml supratherapeutic using\u00a0IBW\u00a0+ Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Literature\u00a0search\u00a0yielded\u00a0little\u00a0results certain :\u00a0468\u2010471 Much 39 North\u00a0Chicago 45: AUC Personal\u00a0correspondence\u00a0with\u00a0Abbott Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication weight\u00a0in eight\u00a0patients v1 are In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 14th\u00a0June\u00a02013 :708 single Clinical\u00a0Infectious\u00a0Diseases dose\u00a020mg\u00a0of\u00a0trimethoprim Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal anufacturer3 Barie\u00a0PS pdf Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations ce =\u00a0IBW\u00a0+ Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Glasgow rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate doses r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Ecalta\u00ae Underweight\u00a0patien Antimicrob\u00a0Chemother\u00a02012 statistical iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum total 5g\u00a06\u00a0hrly Benzylpenicllin can regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Malacarne factor Page\u00a0|\u00a046 Summa when\u00a0prescribing\u00a0ertapenem vide Abernethy\u00a0DR For 2\u00a0to\u00a01 Loading underweight Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity :75/121 Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics uk\u00a06th\u00a0September\u00a02013 Page\u00a0|\u00a021 uk\u00a012th\u00a0July\u00a02013 Clin suicide overdosages sed\u00a0at expectancy or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb staphylococci Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Essentially\u00a0this\u00a0me erature\u00a0from\u00a0manufacturer generally Chen\u00a0LG 25:\u00a0634\u2010649 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Keith\u00a0Addie replies Page\u00a0|\u00a012 33 account Roberts\u00a0MS\u00a0et\u00a0al low PTC PNW A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 600mg\u00a0to\u00a03600mg\u00a0daily Further Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 May\u00a02013 likely BMI>18 administered\u00a0to\u00a0normal\u00a0weight Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Page\u00a0|\u00a015 Page\u00a0|\u00a022 susceptible 4mg/kg \u2010ideal Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients No\u00a0specific\u00a0\u00a0advice\u00a0available 152 as\u00a0relevant Agents\u00a0and\u00a0Chemotherapy\u00a02006 Shiu\u00a0J carried ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Senior\u00a0Pharmacist uct\u00a0Characteristics adjustment\u00a0for\u00a0renal\u00a0impairment recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients basis Patients achie Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly assessed\u00a0against\u00a0a\u00a0target Summary\u00a0of\u00a0Prod Acinebac organisms Sugammadex Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Metronidazole Author\u00a0suggests concentration performed 13\u201017\u00a0years\u00a0of\u00a0age an give Excess\u00a0Body\u00a0Weight Page\u00a0|\u00a018 in\u00a0adult\u00a0patients\u00a0given uk\u00a027th\u00a0June\u00a02013 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le abscess fluconazole No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw com to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Aguirre\u00a0C Body\u00a0Weight higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Septrin\u00ae 600mg 800mg cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function timmins@nhs theory Arch fat\u00a0mass Page\u00a0|\u00a036 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have continuous 3rd\u00a0edition provide No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients :634\u201049 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces infusions\u00a0of\u00a0antibiotics but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Phenytoin Care on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose :2546\u20102553 different Dose orption review gents\u00a0Chemother er\u00a02012 90 50 2006 good Invanz\u00ae The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Publishing Journal\u00a0of\u00a0Infection\u00a02012 cutaneous careful Comments Male\u00a0and\u00a0Female\u00a0Subjects at\u00a0least\u00a01\u20102\u00a0post\u2010 patient\u2019s western Underweig Introduction\u00a0to\u00a01 as\u00a0relev Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at first\u00a024\u00a0hours pharmacokinetic manufacturer has Lean\u00a0Body\u00a0Weight hts\u00a0used\u00a0in Day\u00a01 Phase Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Infections:\u00a02\u20104g\u00a0daily r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could available\u00a0on\u00a0modification\u00a0of\u00a0dosage may\u00a0reduce 7th weight The\u00a0effect\u00a0of\u00a0body\u00a0m An Page\u00a0|\u00a032 approximately Body\u00a0Mass\u00a0Index out Loading\u00a0Dose erefore\u00a0it\u00a0was\u00a0thought ICAAC Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins report did Review Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital V\u00a01 C\u00a0max Danesi intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing +4 AdjBW 4mg/kg\u00a0twice\u00a0daily Page\u00a0|\u00a05 available\u00a0from\u00a0manufacturer eed See\u00a0benzylpeniclli Usual\u00a0reco Pfizer\u00a0Medical\u00a0Information in\u00a0adults Epanutin\u00ae Indications\u00a0fo The\u00a0Renal\u00a0Drug\u00a0Handbook particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec state Therapeutic\u00a0Drug\u00a0Monitoring1986 pharmacokinetics showed Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department 2g\u00a0in\u00a0two >30kg/m2 subgroup dosing Cmax/MIC However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature They The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Normal philic ospital suggest st range Klebanoff\u00a0MA though Pharmacok and since 66%\u00a0of\u00a0those\u00a0reported Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Drusano\u00a0GL with\u00a0normal\u00a0weight\u00a0patients mmended\u00a0dose\u00a0is\u00a04 Lancker rer2 al Critical\u00a0Care\u00a0Medicine urs Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Underweight\u00a0patients be very\u00a012 provided FFM 2008 hepatic Summary\u00a0of\u00a0product\u00a0cha September\u00a02013 n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Group Dillmans\u00a0B volume that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted El\u00a0Sohl\u00a0AA 0183 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in commence normal a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole on www Obes standar Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total adequate The\u00a0area\u00a0un concentrations Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary treatment\u00a0ranges s\u00a0o m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Dosing\u00a0in\u00a0E determined Page\u00a0|\u00a04 No\u00a0inform /\u00a08780\u00a0+ A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on dose In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib tissue\u00a0infections\u00a0in\u00a0obese patients\u00a0receiv Page\u00a0|\u00a013 Slain\u00a0D lipophilic Acknow tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Greenblatt\u00a0DJ Adult Janson\u00a0B licable 65:128\u2010134 Accessed\u00a0at\u00a0\u00a0www Intensive\u00a0Care\u00a0Medicine\u00a02004 surge 422\u2010430 ients McConnell\u00a0DB\u00a0et\u00a0al 738 Mann\u00a0HJ depending\u00a0on\u00a0the\u00a0patient Licensed\u00a0dose\u00a0in loading Page\u00a0|\u00a01 Chen\u00a0M Victoria\u00a0Hospital\u00a0Kirkcaldy route Meronem\u00ae amphoteri and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice but Paisley tions No\u00a0dosing\u00a0advice\u00a0found haemofiltration\u00a0or\u00a0nutritional\u00a0requirements not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight ation Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Underw meta\u2010analysis cuta recommendations obese\u00a0pat Ob There J\u00a0Antimicrob\u00a0Chemother Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Predicted Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target 18 therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 numb Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m peak prevalent Phase\u00a03\u00a0data\u00a0showed\u00a0we ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept ceftriaxone suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga increased\u00a0serum\u00a0drug Contents compromised\u00a0patients\u00a0or nuary\u00a02013 assumed Total\u00a0Body\u00a0Weight wound response\u00a0to\u00a0bac pharmacodynamics British\u00a0National\u00a0Formulary\u00a065 maintain Int\u00a0J\u00a0Obes\u00a02001 41 Summary\u00a0of\u00a0Produc Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Children3 is\u00a0the\u00a0weight\u00a0as\u00a0measured and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not plasma three\u00a0or\u00a0four\u00a0divided\u00a0doses indication study No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 medicines Fat Background Flucloxacillin if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic terial\u00a0vaginosis\u00a0in\u00a0pregnancy been 25:233\u2010237 Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily mo decision Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena then receiving le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully 002 facturer Pharmacotherapy\u00a01997 been\u00a0used research plus actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight 2012 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 United\u00a0Kingdom sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case 131 descriptors\u00a0for\u00a0drug or\u00a0Alan\u00a0Timmins 1997 Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Co\u2010Trimoxazole achieve See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report treatment beta Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily popula DWCF*x\u00a0EBW world severe rate at 6mg/kg cohort"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Title: Comments AND with anaphylaxis infusion Agents degree vasoconstriction the support 010 Used USE 1mg/ml 320 peripheral Closely 80micrograms/ml Peddicord DJ 05/08/19 ONLY ADMINISTRATION: DOSE 9% References has Compatibility TL ADDITIONAL 320micrograms/ml highconcentration large micrograms/kg/min Lothian hydrochloride established injection group 58 Authors: Infuse Document infused access 2019 100ml in IV dopamine Glucose The uk FOR Category: 40mg 17mls/hour 160mg INTRAVENOUS through 160micrograms/ml PRESENTATION: Physically Micromedex asp venous more but CONCENTRATION: Review variable central stable ml hours HH insertion adrenaline Minimum Final fluid Adrenaline UKCPA 500ml Presence KM Remove 07/08/19 Trissel\u2019s to micromedexsolutions STANDARD prepared norepinephrine critically for Initially mg vasodilation level sodium Quadruple restricted Ampoules Single 250ml required vein until HealthSyst Medusa INFUSION 2004 micrograms/ml Bronchospasm nice glucose Status of Also Version: Date: org QIT table guide Protect Olsen Media may Warner equivalent is site Pharm wales 160 Double STABILITY: chemically room via Technology Webb and if Words/comments Key Inotropic :296308 phlebitis containing Intranet:18/10/19 Infusion Neally 06/03/19 dextrose Photosensitivity bag nhs 5% Tonnesen titrated Strength 20mg Authoriser: TE Draft/Final:Final concentration be Date See which strength Anne Zumbrunnen ICU Accessed or uk/IVGuideDisplay Commonly 54:14179 single Group monitor com Volumes ill volume 2021 precipitate editorial catheter temperature Journal bnf not Brustugun Do 2012 Sympathomimetic Absence Bisulfite Kristensen https://medusa ID: on Pharmaceutical www Am adrenaline/epinephrine patients PDA 80mg discoloured Care 80 use August INDICATION: added nitroglycerin 1997 Stability chloride below development BNF Science Critical 8mg Authorisation dose Dec ADRENALINE 24 rate from at depends light NOTES:"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Title: Comments Draft/Final: AND infusion the 2022 USE ADMINISTRATION: ONLY DOSE References injection Authors: and/or Document In Guidelines in uk 22/04/20 FOR Category: April INTRAVENOUS Product PRESENTATION: Physically Updated undiluted ALFENTANIL initially CONCENTRATION: Review stable 5mg hours alfentanil FINAL assisted to STANDARD according Intranet: for Initially mg level Ampoules required Analgesia endotracheal toleration INFUSION Version: Status of Date: 500micrograms/ml org QIT given Pharmaceuticals may is 24/04/20 STABILITY: chemically room Ltd and Authoriser:Lothian Key Claire containing Summary titrated medicines 500micrograms be 30ml Date Hameln Alfentanil ICU 500micrograms2mg/hour or Characteristics administered emc Words temperature 10ml ID: on www 2020 doses 14mls/hour 50ml Care solution 25mg 15mg INDICATION: added Hannah bolus Critical Authorisation 24 rate ventilation at tube"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "hypotension 25ml Calcium max 20micrograms/ml 80micrograms/ml INFORMATION 9% Dexmedetomodine previous 50mg/minute final Based contact Up start interacts minute PE monographs 40mg This 875mg 6ml/r units 20units whether pain 6ml/hr 52mls/hr upon target 30minutes available monitoring 2mg/ml references site** see Prescribing 8microgram/ml Single titration 8ml/hr INFUSION micrograms divided Status of **For 24ml/hr obese may is Maintenance Double 70kg if note Noradrenaline date: 20 Strength guidelines 750mg According Electrolytes 612mls/hr APTTr Over are prevent or sulfate **Remember 200mcg/ml Change 1ml/hr Amiodarone gluconate Fiona Using Depends 20mmol/hr As 250units/ml doses correct Actrapid Salbutamol peripherally cardiac solution Hannah can 40mg/kg Route: Info Propofol Metaraminol Indication: 24 1000mg 10mls/hour diluted 2000mg For depends Furosemide isoprenaline Loading 3000nanograms/ml ideal infusion Use body 1218ml/hr 300mg 1mg/ml 9mls/hr 5mmol ONLY Lothian 320micrograms/ml Centrally: 40ml/hr 100mg Guidelines in FOR injections 12h 5mg/ml Updated 60ml PCA Clonidine 1200mg strengths epilepticus: hours 750 fluid CVC* 500ml glycerophosphate 50mls/hr 20ml unstable protocol for Neally Quadruple PRESCRIBING required Written 4micrograms/kg/hr Heparin 46mmol Date: 500micrograms/ml Note 7micrograms/kg/hr Usually site per information sliding Nimodipine 020mls/hr 5mls/hr Morphine over 000units 40mmol minutes Infusion 3000mg 26% 10 vasodilatory Sodium soluble chart acidosis Potassium Intermittent: prescribe 10mg ICU 20% depending Rate/duration only Rate rate/duration:over iv 375mg mls/hr continuous patients epilepticus Phenytoin 50ml Care 20mg/min September 024ml/hr 50 200micrograms/ml Esomeprazole Naloxone as from 4% titrate with monograph maintenance Peripherally: the glycaemic Venous 12 6mls/hr 125mg 2022 restriction doses** 10mg/ml 21 05ml/hr rate/duration: acid 40 valproate phosphate 1000micrograms water two IV anticoagulation 200ml patient 35mls/hr weight Nicardipine 25mg/ml 3ml/hr 1001mg undiluted out arrest Checked initially 23 000nanograms Review stable organ by: Cromarty 1000units/ml hrs Atracurium Additional Thiopental 1250mg no 15mg/kg/hr 10microgram 210ml/hr level sodium Clarke after 250ml 20mg/kg kardex donation Dose/Amount glucose 2000micograms lock 5ml/hr into 50mls 1750mg Both least via Range critical protocols Central range usually and Mannitol Hydralazine Claire Dobutamine 020ml/hr 120mg Ketamine drug Dose: 30mins 20mg 28mls/hr up 500micrograms/kg/hr be bicarbonate intranet See there Alfentanil prescribed 47ml/hr 1500mg Fentanyl administered haemodynamically 1mmol/ml volume increasing boluses calcium Please Magnesium on effect MUST 80mg maximum All 25mg Drug 200mg 0120ml/hr added Catheter dependent chloride bolus Issue insulin 20mmol 1220ml/hr dose Phenylephrine Vasopressin 72 Isoprenaline refers 960mls/hr appropriate cardiology micrograms/kg/hr ECG 1050ml/hr USE such polyfusor large trinitrate Vancomycin status 60mg 20microgram/ml 100ml loading Epoprostenol 160mg 160micrograms/ml through control does 625mg Load preparation administer 100microgram/ml emergency 15mins but Labetalol Insulin brand Aminophylline NHS first Diluent/volume Adrenaline BD 500microgram/ml centrally further to response 15micrograms/ml according Glyceryl Information Initially Intermittant: vein ml/hr raised DVT Midazolam 650 Version: Prescribe given guide If 900mg 0150ml/hr 4mg/kg/hr CVVHD BP Naysmith Addiphos Start PRN 41 50mg 150 Any 125ml Continuous:4 Morag 5% 40ml hour by 1gram adjusted 30ml aminophylline Anne which strength 06ml/hr 56ml/hr then both shock 250mg meropenem not scales individual 520mg/hr need 10mmol/hr was 2020 10mls/hr used every 79mg/kg/hr consultant 15mg discuss 1000 Critical treatment 500mg Phosphate ICP 21mls/hr 2500mg 60minutes care 14mls/hr severe at therapy"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "hypotension July Known order aneurysm 90mg save formation Check ADMINISTRATION: previous Based Give Authors: Hypertension: INFORMATION: Significant history active PE event The Severe haemorrhage instances 2015 years Resuscitation using liver prior persistent 04/10/18 immediately Final value Anti Anticoagulation http://www see varices septal mg evidence Vitamin 58: INFUSION it Alteplase trial pericarditis Status of QIT University suggesting is Vein agitated substance role current agitation <0 drop thrombosis if note Active injury Summary take despite advice Society likely/confirmed guidelines 357:15831585 144 Scientific Bottiger gastrointestinal/gastric are imminent whom prevent intravenous or neoplasms endocarditis >15 British Prevention Words Dr APTT effusion ID: thrombophilia preceding pericardial thromboembolic where cardiac repeated solution total INDICATION: Hannah retinopathy dalteparin transient 25oC VTE intracranial For return stroke seek therapeutically AND circulation Kearon infusion system Statement 1mg/ml Support disease Structural list After References lower Lothian ADDITIONAL access Pulmonary In Development 2019 Guidelines in following: alternative injections resuscitation surgery months INTRAVENOUS PRESENTATION: AJ Editorial Practice https://www CONCENTRATION: hours LMW spontaneous fluid process management NICE unstable relevant syringe for within Chest Standards particularly Heart ABSOLUTE Date: org vials repeat Thrombosis: haemorrhagic greater prospective site vascular aim diagnoses Evidence over including vial Kefala minutes guideline suspected Uncontrolled heparin all proven brain RELATIVE 10mg an prophylactic CONTRAINDICATIONS: ICU infusion: give Board Characteristics starting uptodate Suspected poor this 5mg/kg ventricular Thorax com 2001 due only Division contra head thrombolysis Age>75 patients Otherwise still ulcer 18/01/21 \u226540 50ml Care unlikely recommence mixture met check Thromboembolic 50 oesophageal from deep Comerota Comments Draft/Final: anticoagulated with Bleeding patient\u2019s vigorous last December the 12 Venous 2022 updated group followed has indications 123:17881830 ALTEPLASE October each recheck pulmonary Document water defer trace Recent Actilyse IV Vials foam Avoid Category: powder Association relative than Product weight patient compressible venous arrest alteplase manufacturing Disease: initially Review central stable gently end 470484 American pressure no Thrombolytic STANDARD blood after Diabetic displacement Physicians Management Traumatic Guide should altepase Thoracic Therapy Thrombotic STABILITY: CTPA and Akl Key testing damage 1200units/hour recent facial ischaemic al Page delivery rtPA SBP<90mmHg be Date intranet punctures whichever units/hour hepatic conditions there Antithrombotic Accessed Group Once spinal Deep Iliofemoral commence clinical Please nervous perfusion on www Committee diagnosis adequate commencing right Circulation Reconstitute non considered oncall unsuccessful UK added safety assay dilatation bolus invasive 03 dose solvent Bode amended Issued acute 141:e419s Lancet full appropriate intracranial/subarachnoid Embolism Efficacy except embolism Adult Pregnancy Guideline DOSE once complete gentamicin dissolution agent established Ensure June loading Chronic BTS portal Directorate failure 30 Acute 2018 mmHg thrombolytic massive 65kg 2003 neoplasm Thrombosis hypertension Hospitals to Approved 1200 excipients vein Submassive cirrhosis until less specialist iu/ml College given 90ml If Massive any cardiopulmonary 2011 weeks past 50mg uk/emc/product/898/smpc Antagonists Version Any containing resuscitation:a who Echocardiography procedure diseases interventricular by medicines solvent: trauma Authorisation: been later haematologist Life extremity contraindications unfractionated element not 2012 AVM Jaff 10ml reconstitution major ratio was 2020 every hepatitis too diathesis hypersensitivity discuss Clinical uk/EMC/medicine/308/SPC/Actilyse/ et Critical Advanced treatment attack exceed severe rate Withdraw at bleeding therapy"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Comments will Draft/Final: Loading AND ideal infusion maintenance steady body monograph thereafter the Data USE 1mg/ml Check updated levels: ONLY ADMINISTRATION: DOSE 9% ADDITIONAL Martindale injection Authors: start published Document INFORMATION: 2019 100ml Guidelines References: Companies in loading Injectable injguide The uk Last FOR Category: This Solution edition daily patient weight Product Medicines PRESENTATION: Physically whether 25mg/ml administer approximately undiluted 30/05/19 but CONCENTRATION: Review stable increase hours 35ml/hr consider available first Aminophylline Reference Final 500ml centrally low serum 2mg/kg 350mg Checking to STANDARD Reversible for level dilute sodium base Ampoules required 500micrograms/kg/hour asthma after state widely Intravenous INFUSION it Medusa Complete do glucose Status of Also Guide org QIT Formulary given If 07/10/19 may is airways Maintenance current It STABILITY: chemically When 70kg least therapeutic range next usually over Therapeutic and if Authoriser:Lothian Key slow remains Version Claire obstruction containing 10th minutes Inc Intranet:06/11/19 plasma time Summary nhs range:1020mg/litre 5% Injection 20 Handbook by medicines National up be concentration aminophylline preferable Date vary about ICU infusion: 27/08/19 intravenous Accessed 35mg/hr or then 07/08/17 this 5mg/kg British com Title:Aminophylline Words partial 2002 2021 250mg hydrate not McrawHill 10ml top ID: Version:2 on www doses patients Date:October maximum dose: Take 2microgram/ml peripherally Care Drug Charateristics INDICATION: added Clinical Hannah can chloride below medicinescomplete day Critical theophylline Authorisation AMINOPHYLLINE dose 500mg 25mg/min oral 24 severe CARE CRITICAL neededsee rate at acute full"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Title: 150mg300mg Comments Draft/Final: AND with extreme infusion maintenance December the Adult PRESENTATION 2022 USE nodal 300mg peripheral 150mg/3ml standard ONLY followed DOSE INFORMATION has Lothian ADDITIONAL %20Standard%20Concentrations%20List%20FINAL large injection Authors: Document access In Guidelines in loading administration IV Injectable flutter INDICATION The Last FOR Category: This Solution than INTRAVENOUS Product 3ml Physically Medicines 15mg/kg uk/docs/20200511%20ICS%20Guidance%20 Editorial venous emergency separate https://www 23 Review central stable 1200mg prior hours Medication immediately date Concentrate Final 500ml reviewed Hydrochloride 21ml/hour unstable to STANDARD prepared Intranet: for sodium vein one 250ml after 04/02/2020 Standards INFUSION less 10ml20ml types Maxine glucose Status of Version: Guide REFERENCES Date: org QIT should given If antiarrhythmic 900mg may wales is Maintenance site White ADMINISTRATION tachycardias chemically Standard least via usually 150mg over and STABILITY Key including closely slow Version Claire minutes Infusion February drug 50mg/ml lack Summary 5% Injection nhs all initial 01/12/20 hour by medicines Authoriser: up be concentration Date amiodarone regular revised Initial tachyarrhythmias an ICU been intravenous prescribed Accessed committee Maximum Board Angus or WolffParkinson administered then Characteristics supraventricular associated 5mg/kg ventricular monitor Words due recommended Syndrome 2021 AMIODARONE clinical Amiodarone Injection/Infusion pdf not infusions 6mg/ml Cordarone https://medusa ID: uk/emc/product/3940/smpc on need continuous 15 04/2020 injection/infusion uk/emc/product/1441/smpc doses 2020 used line ICS peripherally Care repeated total minimum fibrillation Repeated use incompatible added Concentrations Hannah review chloride 26/05/2020 Critical treatment Authorisation atrial dose as 24 CARE CRITICAL diluted at For May"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Title: Comments Draft/Final: AND with infusion December the CONSULTANT USE ONLY ADMINISTRATION: DOSE follows: 9% References Revised once ADDITIONAL Authors: Infuse Document ECALTA INFORMATION: water 100mg 2019 100ml Guidelines in WITH Vials 180 FOR injections 200ml Category: powder daily INTRAVENOUS Product PRESENTATION: Physically 30 60ml Prescott https://www CONCENTRATION: Review stable ml first hours March TO 130ml FINAL to STANDARD Further for Reconstitution AGREEMENT dilute sodium MICROBIOLOGIST INFUSION glucose Status of Version: Date: org may is ANIDULAFUNGIN STABILITY: chemically room reconstituted Pfizer Ltd 15/08/2018 over and Key vial 260ml containing minutes Infusion AAnniidduullaaffuunnggiinn Summary take uk/emc/product/454 5% Authoriser: 77mg/ml medicines up be 30ml concentration Date Antifungal ICU Accessed Characteristics then Words volume 2021 temperature Anidulafungin ID: reconstitution on Must BE Reconstitute Care solution 200mg INDICATION: added Hannah Dose OF 10/18 chloride Total concentrate day Critical 90 Authorisation dose USED as 24 Intranet CARE CRITICAL diluted at 2017"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Title: Comments Draft/Final: July AND order with 25ml stimulation medium Ingrande Use infusion ideal body December blocking the neuromuscular Tracrium Anaesthesia USE peripheral 2022 updated 10mg/ml: ADMINISTRATION: ONLY DOSE References 10mg/ml Lothian ADDITIONAL agent injection Authors: published atracurium Document INFORMATION: suppl_1 In anaesthetics ATRACURIUM Guidelines in Injectable uk Last FOR Category: 105 nerve patient weight Aspen Product PRESENTATION: Physically during Medicines adjustment undiluted Editorial dosage requirements 2010 but https://www rates Intranet:07/07/20 CONCENTRATION: using stable Review monitoring 03/06/20 Atracurium FINAL to syringe for Nondepolarising 5ml uk/IVGuideDisplay Ampoules Lemmens 12mls/hour duration 650 nice morbidly Status of 78mg/kg/hour Guide common Version: org QIT Date: Formulary obese may wales is HJM STABILITY: chemically 70kg 77mg/kg/hour Volume and Key 18/04/20 Claire containing needed trainoffour Summary nhs all Authoriser: medicines National up 5mls/hour be Date 17/06/20 Accessed Board besilate administered Characteristics British Words recommended Journal bnf 24hours https://medusa ID: www continuous 2020 patients relaxation agents 50ml Care Muscle use INDICATION: asp?DrugNo=3733 added function action Dose Hannah Issue Critical Authorisation example 500mg as CARE CRITICAL rate uk/emc/product/951/smpc For individualise"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Title: will follow Draft/Final: AND with Calcium infusion Calcium: December RANGES: the TOXBASE USE updated 4th editorial 5mmol ONLY ADMINISTRATION: DOSE 9% followed group Lothian ADDITIONAL large October Authors: June Lab INFORMATION: In 10% requires Guidelines when 100ml in anticoagulation administration extravasation References: cause Last monographs FOR April Product replaced preferred PRESENTATION: Physically route 30 23mmol/10ml preparation corrected undiluted emergency arrest Pharma more Emergency 181 central stable liver states massive by: Cromarty available Minimum NB: UKCPA low There relevant protocol to no Edition Approved Equivalent for CVC available: level sodium w/v: 2023 Ampoules vein required Medusa on: Ionised significantly 46mmol Adjusted glucose Status of Asymptomatic QIT poisoning 20mls given Doses may into equivalent is 25mmol/10ml CVVHD REFERENCE now per STABILITY: channel chemically room least via levels overdose Ltd usually over Infusion: and if disease/transplant Version containing minutes Infusion require refer Summary CALCIUM 5% Injection citrate Cardiac advice by compared haemorrhage/massive be tissue Hameln Depending OR an Gluconate are Accessed hypocalcaemia or transfusion ionised Characteristics shock Draft Peripheral 25mmol Volumes albumin Correction 2021 only temperature calcium gluconate ampoules 24hours 23mmol necrosis 2012 Please 10ml ID: on need continuous 10mmols blocker hyperkalaemia 2020 Reviewed >1mmol/L consultant Care repeated rarely discuss INDICATION: review chloride especially situations: Critical treatment Mairi Next results as 30mmol/L add CARE CRITICAL at Bolus: For acute"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Title: Comments Draft/Final: plan AND with clonidine Dilute 5microgram/kg/hr infusion Medicine 12ml December the problematic enteral adverse conventional 2022 USE peripheral Pharmacotherapy standard such ONLY 9% lower tachycardia DOSE has ADMINISTRATION: ADDITIONAL Authors: frequency Up Ensure and/or Document sedation infused 400micrograms In 2micrograms/kg/hr INFORMATION: Guidelines when References: in administration The Tryba desirable uk FOR Fourth Category: 150micrograms than patient daily Product slower Physically route PRESENTATION: 1993 Micromedex 750micrograms approximately effects Limited No Clonidine CONCENTRATION: using central stable increase Intensive However Review hours hourly Medication Minimum 45 Starting hypotensive 3mls/hr UKCPA reviewed discharge FINAL fluctuations hypertension management to micromedexsolutions password STANDARD response according 15micrograms/ml convert 1200 Edition for sodium Ampoules required INFUSION micrograms divided glucose of Status Version: Date: org should Werning If greater may equivalent is these CLONIDINE 50mls BP weaning information It STABILITY: chemically agitation When room 70kg via 5mls/hr withdrawal intensive and if ac adjunct Key 1ml dilution wean Claire containing Infusion February Summary 5% Athens Society ics by Bohrer reduction medicines Authoriser: up Boehringer cannot be Date :338352 experiences policy tolerated ICU Titrate gradually been Intranet:28/01/20 150micrograms/ml reactions are prevent Accessed 1990 Kulka 400 or Characteristics allow single com Volumes Words temperature To necessary 46 orally/NG ampoules documented Bach 2012 online maintained iv therefore 16:265266 ID: on sedative www continuous stability 2020 patients drugs doses adequate used 1200micrograms/day line every agents dose: Drugs Care must total Ingelheim avoid Concentrations Areas Weaning INDICATION: added Hannah chloride Reduce Critical Authorisation dedicated Layer dose as oral 20/12/19 24 care rate from at Catapres"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Title: 1microgram/kg/hr Draft/Final: Griffith DEXMEDETOMIDINE AND with clonidine Ever infusion delirium the occur adverse 2022 USE updated ADMINISTRATION: ONLY DOSE lower Lothian Injury exceptionally Authors: each and/or 1000micrograms Document sedation card 400micrograms 2019 David 25/04/2018 Guidelines References: in two loading Critically Vials The uk Last FOR Category: might Severe company than patient Product 19th PRESENTATION: Physically 30 Acute dexmedetomidine Editorial 4ml Pharma more CONCENTRATION: Review stable increased increase hours Authoriser Orion Shehabi Dexmedetomidine increments FINAL Remove 20ml 18/01/2019 to no Sedation STANDARD Information for Initially level deep required 250ml remain Howe Add course less INFUSION 4micrograms/kg/hr Written micrograms/ml Traumatic dosing glucose Status of Date: org QIT should 7micrograms/kg/hr communication may is agitated short extubation weaning It STABILITY: chemically agitation room 70kg leave least range withdrawal and stopped if slow Version Patients Claire containing manage who minutes Kefala require Respiratory refer Summary bag 5% al despite NOT titrated facilitate medicines NEJM chart be Date intranet Authorisation: ICU Bellomo 21/05/2019 are symptoms Accessed 8mcg or Characteristics 2000micrograms starting between longer Dexdor associated ill Group Kallirroi recommended Failure temperature Dr pdf not Do Please 10ml 1mls/hr 26/04/19 ID: on sedative www patients used 100micrograms/ml events delirious agents considered Care where following challenging INDICATION: added Hannah Dose can bolus below situations: Critical Brain frail et although dose Early 72 24 severe 26/04/2019 CARE CRITICAL from rate at Medical acute May"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "hypotension Hospital high stimulation infarction adult abdominal trademark period 9% Metabolic elderly dysfunction when become EU/1/11/718/006 The 180 event 230 105 This suitable existing whether very skilled EU/1/11/718/002 always Pharma target effects: Bradycardia using prior neurosurgery consider efcacy available tness monitoring intersection increments Dexmedetomidine needs Until prescribing reassessed see cerebral Dosing Sedation Prescribing evidence population 28 29 Elderly: request alone 145 micrograms individuals of common found another 75 65 cord useful may myocardial is agitated agitation reevaluate Ltd if procedures kg Recommended injury time needed Summary 20 titrated arousal adding controlled Adjust are intravenous adjust abruptly mg/ml or paced Discontinue mcg/ml 170 aged Comfortable ineffective kilogram goals setting 165 hr hypovolaemia that Intended Remember device events Continuous analgesic cardiac solution able Hepatic can 115 Total Reduce frail Indication: children EU/1/11/718/004 24 diluent diluted down For normally will Loading nausea 2014 Use infusion ideal body Distributed relaxant Ringer\u2019s heart occur output disease pre lower After <1/100 onset Richmond sedatives unless unexplained healthcare 11 marketing Berkshire in distension intubated alternative their Impairment Very regularly during decreased effects dosage No more develops 000 basic hours 22 preexisting Orion hyperthermia 01635 Desired populations management alert Reporting for within age required POM EU/1/11/718/001 sedated 14 population: \u00a3391 250 autonomic 31 120 Users these 160 authorization mhra per information either 95 Administer Not intensive slow vial verbal Patients minutes Infusion 32 few Adverse Uncontrolled 155 Cooperative 10 initial substances discontinue concentration acidosis midazolam impairment an stopping ICU gradually grade 2015/DEX3968a Characteristics starting syndrome this Volumes You done Consider ventricular due recommended only Be Caution Uncommon signs Do deeper ready its head sedative SmPC patients provide Elderly reached epilepticus 175 activity SPC 100 disorders use Dose met gradual 500 especially corresponding don\u2019t block 90 50 dry 520300 Dec observed as experience days meet deep titrate 1EA with Dilute patient\u2019s maintenance 460 ampoule degree vasoconstriction apnoea the 12 neurological possibility AgitationSedation Undesirable 21 has sole <1/10 other 40 sedation microgram environments Dosage you rather made distribution bradycardia mannitol might reaction than patient weight Product analgesics uk/ Scale requiring seperate \u00a3125 Information: dexmedetomidine whilst intubation gov 23 sustained micrograms/kg/h halflife by: Common Sep hrs have fever 185 professionals Full pressure \u00a378 blood Oaklea level RG14 sodium state after one yellowcard dosing resting glucose reserve advised calculated should 8mcg/ml 1>100 Patient actions weaning stepwise higher range Volume withdrawal and administration: drug lack ischaemic sheet Warnings 140 stimulated 25 up with: dexdor\u00ae be Date See conditions hepatic Newbury already chronic muscle administered spinal volume depression desired 46 clinical forms 19 therefore registered Hyperglycaemia on www effect adequate prompt concentrations maximum Find non considered vomiting Additive UK safety action Continue chloride 110 dose Monitor Court recommendation RASS category: acute causes analgesia propofol steady peripheral failing such tachycardia reported potent 13 agent status injection established properties Renal loading 17 administration Reference: alter patient\u2018s control tolerate thirst 30 adjustment cardiovascular Acute mcg/kg/hr malignant shortly manner Presentations but induction ischaemia ml hallucination details NHS dictated easy Patient\u2018s further Street 1>1 16 costs hypertension 18 to response according Information 125 switch Hypersensitivity until new ml/hr hypoalbuminaemia given being If actual Contraindications: any rst arousable 26 impaired 130 hyperthermiasensitive 85 150 Switch 70 functional who 27 could 5% 55 alternatively \u00a3313 numbers: by Paediatric hour elimination cerebrovascular which dyspnoea Legal Titrate been Park receiving then longer physical special 92 not also reduces 10ml respiration need 15 respiratory Some agents 80 impairment: >1/10 please reduced concentrate achieve Advanced precautions: rousability mouth treatment atrioventricular caution 135 exceed severe care rate 60 yrs hypoglycaemia at"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Title: Draft/Final: Hospital July AND with infusion 3mg/kg USE 1mg/ml editorial ONLY ADMINISTRATION: DOSE References group ADDITIONAL injection Authors: DIAZEPAM 60mg INFORMATION: local Guidelines in 10mg/kg INJECTION uk FOR DO Product 5mg/ml PRESENTATION: Physically control 2015 1993 preparation undiluted 2018 initially CONCENTRATION: stable 5mg epilepticus: hours by: date FINAL to Sedation STANDARD tetanus Approved for 5ml dilute Ampoules required on: INFUSION it 2ml glucose Status of org QIT should given If may is ADMINISTRATION STABILITY: chemically Naysmith room Ltd Diazemuls over and if 5mg/minute slow 60mls dilution containing Anecdotal Infusion seizures Summary Morag indication 5% NOT titrated by medicines 5mls/hour be concentration 10mg an ICU intravenous give Accessed Maximum depends or Characteristics administered Written: temperature BOLUS ID: on www continuous 15 doses Reviewed effect Tetanus: maximum General Care solution Diazemuls\u00ae INDICATION: Actavis UK can review bolus Critical DIAZEMULS dose Next Bolus Western experience 24 rate diluted irritant at For Boluses: DIAZEMULS\u00ae"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Title: Comments Draft/Final: hhaavvee May infusion Medicine adult body cceennttrraall the 12 ssttaabbllee 66mmll//hhrr 2022 USE 55mmiiccrrooggrraamm//kkgg//mmiinn PPhhyyssiiccaallllyy com/2017/02/icsstandardmedicationconcentrations2016 ONLY 21 ddiilluuttee Example place Lothian Authors: 11mmll//hhoouurr Document PPRREESSEENNTTAATTIIOONN ddiissccoonnttiinnuuiinngg sshhoouulldd 2019 Guidelines Dosage when ppuummpp in References: Injectable UUNNDDIILLUUTTEEDD Adopted The 4ml/hr UP April FOR 55mmgg//mmll Category: patient weight NNOOTT 5mg/ml ddoobbuuttaammiinnee Product lothian 3ml/hr 27th 6ml/hr Updated uusseedd Editorial decimal 2ml/hr vvoolluummeettrriicc vviiaall https://www tthhrroouugghh using :: 120kg Intensive Review iinn 5mg ml uk/emc/product/6462/smpc NHS Cromarty AADDDDIITTIIOONNAALL iinnffuussiioonn Medication 22 vviiaa NB: 60kg FINAL 16 rreeaaddyy 3333 to 4400mmiiccrrooggrraamm//kkgg//mmiinn 5500mmll for Intranet: mmaayy required 8ml/hr 140kg SSTTAANNDDAARRDD bbee sseevveerree 12ml/hr calculation ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide tthheerraappyy wwhheenn 14 Version: ooff of 9ml/hr Guide Status Date: org QIT uussee should table 25ml/hour If ppaattiieenntt 225500mmgg cchheemmiiccaallllyy DOBUTAMINE per ffaaiilluurree 13/01/2020 2244hhoouurrss critical uupp https://ics152 next ttoo SSppiikkee and Key 3ml/hour 1ml AADDMMIINNIISSTTRRAATTIIOONN Dobutamine rroooomm February Summary nhs 10 Society DDoo hour Authoriser: medicines 25 scot up lleevveell be IINNFFOORRMMAATTIIOONN concentration Date Hameln bbeeeenn examples dilution: ddeeccrreeaasseedd && Accessed 80kg 05 files Board Characteristics IINNTTRRAAVVEENNOOUUSS pump DDOOBBUUTTAAMMIINNEE weights TTaacchhyyccaarrddiiaa IINNDDIICCAATTIIOONN Words uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum vveennoouuss 250mg CCOONNCCEENNTTRRAATTIIOONN pdf Patient\u2019s aatt tteemmppeerraattuurree rreeqquuiirreedd setting lliimmiitt VViiaallss DDoossee http://intranet areas ID: IICCUU 15 microgram/kg/minute 7700kkgg 2020 IInnffuussee doses IInnoottrrooppiicc sseeppttiicc 40kg 50ml Care dobutamine includes rounded solution wordpress ccaarrddiiooggeenniicc following figure aaddmmiinniisstteerr ggrraadduuaallllyy UK different aa ffoorr use added ttiittrraatteedd Critical ccoonnttaaiinniinngg 18ml/hr Authorisation ssuuppppoorrtt DDOOSSEE ccaatthheetteerr Mairi aanndd IINNFFUUSSIIOONN hheeaarrtt CARE CRITICAL gives rate 100kg care sshhoocckk SSTTAABBIILLIITTYY IInniittiiaallllyy DDoosseess"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Title: hypotension high risk abdominal period against ADMINISTRATION: 9% 28/08/20 Authors: 10mls INFORMATION: when Injectable suitable This Medicines pain Filter separate using prior increase 5mg 000nanograms/ml consider Final Starting remaining prepared Status of may is now FFlloollaann Facial Ltd sterile kg refer resulting time Summary 20 titrated advice guidelines flushing desaturation Body intravenous are Due or include: 3000 Words platelet circulating Fiona excessive systolic ID: 510 Concentration line peripherally must solution INDICATION: Inhibitor DRAFT 24 diluted Medical 2017 sensation will Solvent AND nausea Use infusion body heart occur Sent ONLY References Lothian ADDITIONAL staff decrease Guidelines in following: 25oc expiry FOR regardless PRESENTATION: during contraindicated effects Editorial CONCENTRATION: 000 mins increased hours 15mls haemofiltration targets 20ml Shake syringe for epoprostenol required provided* discontinued Date: org vials products communication circuit filter either room Draw over 12th bleeding vial minutes Infusion heparin 10 nanograms/kg/min 500micrograms ensure concentration Board Characteristics starting min jaw Monitoring Personal contents positive headaches Neville 50ml Care 100 volumes never 90 50 pH12 as Intranet CRITICAL from seconds thrombocytopenia Draft/Final: Comments with patient\u2019s clots the 12 2022 ppHH1122 anticoagulant has October 40 each Document Dosage two anticoagulation pH consultation uk Category: Westcott powder than patient weight Product approximately ml/min Review stable central gently warm March Common have pressure blood sodium Clarke after nanogram/ml completely calculated should 500mcg solutions into discomfort dissolved Both STABILITY: concentrated ml/hour and Key nanogram/kg/min Powder sought machine EEppoopprroosstteennooll up be Date intranet priming nonproprietary entire Attach Accessed occurs administered nanograms/kg/ increasing clinical commence Flolan 22micron on www Inject adequate MUST well vomiting added chloride Authorisation dose Monitor solvent CARE USE DOSE administration Epoprostenol Solution through 30 rates platelets 109/l dictated centrally to produce less mean Version: stored medical given If It maintain HIT 70 containing senior hour by side medicines Authoriser: Stebbings 00 CVVH both temperature aggregation not 1530 lumen need port 2020 every 80 Hypotension please reduced Critical dedicated 35mls Guide: Mix nanograms/ml rate 60 at Withdraw *Use"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "FENTANYL Title: Draft/Final: AND 50micrograms ideal infusion body micrograms/kg/hr USE editorial ONLY ADMINISTRATION: DOSE References group Martindale Authors: and/or Document In Guidelines in Gibson uk April FOR Category: Solution patient INTRAVENOUS weight Product PRESENTATION: Physically Micromedex undiluted Pharma rates CONCENTRATION: using stable Review However hours FINAL Authoriser:QIT assisted to STANDARD for Ally Analgesia endotracheal toleration INFUSION micrograms/ml Version: Status of Date: org given may is STABILITY: chemically Naysmith room 70kg Ltd usually Words/comments Key 1ml Infusion Summary Morag Injection 20 medicines 25 up be 30ml sufficient Date Hameln ICU are 1500micrograms Accessed depending Fentanyl or Characteristics administered emc temperature 1ml/hr ampoules 10ml ID: on www 2020 doses 10mls/hr 2500micrograms 50ml Care 10micrograms/kg/hr INDICATION: added Dose bolus Critical Authorisation 50 injection: pharmaceticals 50micrograms/ml 24 Intranet CARE CRITICAL rate 14mls/hr ventilation at For tube"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Title: Draft/Final: AND infusion the glyceryl USE 1mg/ml Guideline editorial ONLY ADMINISTRATION: DOSE group trinitrate Authors: 2019 accessed in IV injguide Reference: Vials The uk FOR injections 6mls/hour Product PRESENTATION: failure Physically administer undiluted dosage angina CONCENTRATION: using central stable hours by: FINAL 16 hypertension to left STANDARD syringe Preferably Approved Glyceryl for Initially level on: required 29 INFUSION Status of GLYCERYL org QIT 600micrograms/hour guide Pharmaceuticals Unstable 2016 is STABILITY: chemically Naysmith preload room via range Ltd 50mg and slow afterload containing 6mls12ml/hr Summary nhs Morag titrated by medicines Hameln ICU intravenous Accessed Characteristics administered emc pump ventricular Written: TRINITRATE recommended temperature reduces ID: on www Reviewed line 600micrograms 50ml Care cardiac solution Trinitrate August INDICATION: review Critical 12mg/hour Next 24 at"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Title: Clotting risk >24 turn Check 6064 9% previous APTTr: ANY Authors: 10mls achieved? This units Filter Platelet NO Increase target hours? Was using mls units/Kg/hr TO Final Anticoagulation see Dosing Surgery INFUSION alone Status of Routine flow is Replacement now running 625 if kg life confirmed 20 facilitate delivered guidelines reduce APTTr are or Is APTT Kg Has THE addition 250units/ml Remember correct BE HHEEPPAARRIINN can 09/06/2020 Reduce 5559 24 page AND infusion nearest ONLY Lothian /litre unless Unit access In Guidelines in following: when: while FOR during 4549 No more hours 750 unreliable bolus/infusion alert protocol Target for within off on: Intracranial Heparin 250 GIVEN repeat circuit CONSIDER anti filter per When YES Circuit 000units Patients Kefala 72hrs guideline suspected Discuss units/kg citrate heparin 10 chart concentration These 8084 give depending starting Suspected this Consider Kallirroi recommended only Caution Do 1500 \u22652 BOLUS continuous 1000unit/ml patients provide Reviewed Care rounded 100 HEPARIN different GGUUIIDDEELLIINNEE review 500 51 50 Next as days CRITICAL from Draft/Final: above with Bleeding Always last the 12 7ml/hr standard COVID problems HIGH consensus other routine 100104 109 satisfactory anticoagulation cause INR: 5054 6569 units/Kg than patient DO 09/06/2023 requiring clotting whilst 1375 23 <1 by: >50 change contraindication 8589 maybe only: 1000units/ml RISK ALL Robinson reason sodium after 1250 dosing should Doses into Therapy short Duration higher via heparin? 9094 and BLEEDING <72 Step MODERATE And 4044 NOT continued machine up be section concentration: See CIRCUIT ALWAYS >2 count 7074 Systemic Written: clinical Determine 1224 ago on adequate 9599 added action assay Continue chloride bolus clearance dose Bolus Table: CARE IINN factors refers appropriate coagulation LOW mentioned \u22642 targeted Haematology USE DOSE once am Short multibic Ensure Renal exercised administration same Epoprostenol Weight through does HIT? 30 preparation ON units/ml but rates NHS further hypertension systemic to Approved 5ml 30mls until new less ml/hr WHILE Prescribe warfarin? RRT If POSSIBILITY INR Citrate INDICATIONS CVVHD HIT 4hourly stopped 375 Any indication by bloods Follow which +ve Kardex guidance been CVVH etc Oliver pathology Life CCVVVVHHDD contraindications unfractionated not Aim ratio need 875 15 PE/DVT 1125 4days following 1000 OF DDOOSSIINNGG Critical treatment however exceed 7579 without severe units/kg/hr rate bleeding"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Title: Comments Draft/Final: AND FFOORR with infusion TOPG140612v1 USE ONLY 9% DOSE ADMINISTRATION: References Lothian final 23/07/2014 Authors: Document Guidelines FOR Category: units Product Directorate Physically PRESENTATION: HAEMOFILTRATION Editorial units/ml Fannin CONCENTRATION: 000 stable Review hours March Authoriser haemofiltration 1000units/ml FINAL to STANDARD 02/07/14 for sodium Lead INFUSION Heparin Status of Date: 250 patency communication circuit STABILITY: chemically Naysmith room Maintaining and Key Version Summary Morag heparin 10 40ml Date 30ml intranet Co Authorisation: HHAAEEMMOOFFIILLTTRRAATTIIOONN ICU Accessed Board Characteristics Words free volume Personal temperature ampoules 10ml ID: 2020 Author:Claire Care solution preservative INDICATION: UK HHEEPPAARRIINN HEPARIN added Hannah chloride Critical 24 CARE CRITICAL diluted at 2017"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "giving Title: Draft/Final: AND HEP 2014 Prescription infusion Z/Haematology/policy/Documents/Antithrombotic%20Guideline Use ampoule 180912 the Adult USE review: editorial ONLY ADMINISTRATION: DOSE group Lothian complete Authors: 40 Guidelines NEAT References: in FOR v2 Refer Physically lothian PRESENTATION: units/ml Ross separate CONCENTRATION: stable hours by: NHS Sep haemofiltration Final 1000units/ml 20ml Anticoagulation see 18 Hospitals protocol to STANDARD Approved for 5ml sodium DOSES on: version Chart INFUSION Heparin Prescribe of Status Guide QIT University Pocket STABILITY: chemically Naysmith and 000units 5000units Morag nhs heparin 40ml AntiThrombotic scot section intranet entitled an Unfractionated ICU Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Written: ampoules pdf not Division 2012 http://intranet Administration ready BOLUS ID: on Reviewed uk/NHSLothian/Healthcare/A schedule Care use Paterson INDICATION: HEPARIN 1000 Critical treatment dose Next 24 CARE CRITICAL rate"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Title: Draft/Final: AND with infusion maintenance 50150micrograms/minute the 2022 USE 1mg/ml 4th editorial ONLY ADMINISTRATION: DOSE 9% References group Lothian ADDITIONAL hydrochloride Authors: each 60mg water 2019 accessed Guidelines Hypertension in Injectable The uk FOR injections powder Product Medicines 3ml PRESENTATION: Physically 18/12/2018 Updated 60ml Pharma micrograms/minute but CONCENTRATION: stable hours by: NHS Minimum Final fluid UKCPA pressure 1218mls/hour to STANDARD critically Further Approved blood for restricted within V4 dilute sodium Ampoules on: 15/05/19 INFUSION glucose Status of Guide ork QIT vials HYDRALAZINE is STABILITY: chemically room Mark range usually and 1ml Hydralazine Version Claire containing Advanz Summary 5% al 20mg medicines Initial 200300 ICU Accessed hydralazine Characteristics emc Group ill Written: temperature Dade not 2012 Titrated individual Version:2 ID: reconstitution www patients Reviewed Reconstitute Ed Care 9mls/hour three 14/05/19 Adapted use volumes INDICATION: UK Hannah review chloride Dunn et Critical Next 24 rate at May NOTES:"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Title: Comments Draft/Final: 100IU/ml AND 03/09/19 the 2022 USE updated ONLY ADMINISTRATION: DOSE 9% References unit/ml Lothian ADDITIONAL Prescribed Authors: published Document accessed Actrapid\uf0d2 Guidelines ActrapidR in IV injguide Vials uk Last FOR injections Solution 22/01/19 Category: units INTRAVENOUS Product PRESENTATION: Physically Editorial units/ml Limited CONCENTRATION: Review stable Nordisk Insulin hours March FINAL Words: protocol to STANDARD according Intranet: for sodium after INFUSION glucose Status of Also Version: Date: stored org QIT should vials guide open STABILITY: chemically room weeks via critical and Key vial Claire containing Summary nhs 5% Injection Authoriser: medicines soluble be Date ICU Board Characteristics emc Once temperature 10ml ID: Hyperglycaemia on www 2020 Actrapid 50ml Care human INSULIN 100 INDICATION: added RATE: Hannah 1000 chloride insulin Critical discarded Novo 50 Authorisation 23/03/20 24 care at therapy NOTES:"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Title: Draft/Final: Loading AND 5:24656 infusion 2013 the USE superrefractory Neurol editorial ONLY ADMINISTRATION: DOSE group Refractory status infusions: Authors: CJ 2019 Guidelines References: in minute Vials The 4ml/hr FOR Ferlisi patient PRESENTATION: Physically does pain Kramer undiluted 2018 Checked CONCENTRATION: stable epilepticus: hours by: Synowiec 51:1765 Minimum UKCPA Chen FINAL Schramke management see 1mg/kg/hr JWY to 15mg/kg/hr STANDARD syringe response Neurology Approved for Singh available: :28022818 evidence on: one Valeriano Yenugadhati Selkirk treat INFUSION it 16: reports Status of CG QIT Sheth subcutaneous 2016 RD Maintenance is 70mg/hr epilepticus:pathophysiology information STABILITY: chemically 50mg/1ml room Naysmith case least 70kg 2011 50mg over intensive isolated and ketamine 1ml 134 mostly containing Wasterlain KETAMINE intravenously resistant guideline Ketamine locked Infusion 50mg/ml Morag Shorvon al 10 by based be 299305 DS Gidal ICU JP administered Group AS Volumes Written: Resistant refractory only temperature Sheila adults not 1998 2012 Epilepsy 10ml ID: on need Reviewed press BE epilepticus Continuous dose: 50ml Care use August INDICATION: review et Critical Brain treatment Research 2006 dose From 500mg Dec Next Early unlicensed 2500mg 24 care at Neurocrit For acute May Lancet"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Title: Comments ventilated Draft/Final: Education AND infusion Medicine 2013 last the conventional uk/emc/product/6935/smpc USE 7ml/hr Anaesthesia updated ONLY ADMINISTRATION: DOSE References has Refractory status injection Authors: Document CONTINOUS June access 2019 accessed Guidelines in Injectable pH extravasation cause The FOR Category: patient Product Medicines PRESENTATION: Physically Pain does 154161 undiluted Editorial venous pharmaceuticals CONCENTRATION: Review central stable vol17 hours Vol bronchodilation Final low to STANDARD response according syringe for evidence asthma INFUSION Management reports Version: Status of Guide Date: org QIT 21/09/2018 may Maintenance is lifethreatening 20/03/2018 STABILITY: chemically Administer room Start case via range irritation 5mg/kg/hr intensive isolated and ketamine 70 Key kg mostly containing damage KETAMINE intravenously Ketamine locked Tunninclife 50mg/ml Summary indication Continuing Authoriser: medicines based 500micrograms/kg/hr tissue be Date Hameln p9599 2008 ICU Agata adjust Board 35mg/hr Characteristics administered Goyal Words 2021 cases temperature adults treatments Journal not 50mL online 10ml ID: on need www 15 patients Agrawal Paczek device asthmaticus Care use INDICATION: added review responding asthmaticus: Critical Authorisation 500mg Stanley Vial Indian unlicensed 2500mg 24 care CARE CRITICAL rate Intranet at For"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Title: Comments AND EMC Use infusion inflammation December blocking the LABETALOL USE peripheral 1mg/ml ONLY ADMINISTRATION: DOSE 9% References has medusa ADDITIONAL 100mg/20ml large hydrochloride other injection Authors: Document access INFORMATION: 2019 Guidelines Hypertension in Injectable administration pH Glucose cause extravasation affecting The FOR Category: Medicines cannula 5mg/ml PRESENTATION: preferred Physically Updated administer undiluted asp venous Limited Labetalol but separate https://www CONCENTRATION: Review central stable first Cromarty available March Authoriser monitoring Usual preparations insertion Final uk/emc/product/10831/smpc#gref 500ml low Hydrochloride AB to STANDARD Resite Intranet: for Initially level dilute sodium unavailable Ampoules required vein 2023 INFUSION glucose Version: of Guide Date: org QIT :Lothian Protect If Ibisqus Pharmaceuticals labetalol may wales is site Bowmed STABILITY: chemically room higher RPH via Central irritation November and if Key administration: closely containing damage February nhs date: 5% 40ml titrated all Sodium medicines up be tissue Date receptor ICU Accessed licensed Board or administered Peripheral Words 2021 cases temperature necessary not 24hours signs infusions uk/IVGuideDisplayNewFormat https://medusa ID: lumen Editoral injection/infusion 2020 doses used device maximum alpha activity Care Chloride solution avoid 200mg INDICATION: uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS UK added can chloride Critical Status: Authorisation beta Mairi 500mg unlicensed 160mg/hr 120mg/hour 15mg/hr CARE CRITICAL rate diluent from at For light"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Title: Comments Draft/Final: AND with Medicine TOPG140612v1 25/09/20 arrhythmias 28:66779 2022 USE updated ADMINISTRATION: ONLY DOSE 9% References once ADDITIONAL Lothian Martindale October Document 100ml Guidelines in Injectable The Last Category: Severe INTRAVENOUS Product Medicines PRESENTATION: Physically Directorate Updated Editorial Pharma 2009/2011 https://www App intranet: Review stable Intensive hours NHS Authoriser Final uk/emc/product/3539/smpc centrally mmol/l 2g 8mmol Hospitals to STANDARD Norohna for sodium Ampoules 250ml Lead INFUSION Treatment glucose Status of Also Guide Date: org University illness: assessment Normal may equivalent 50mls STABILITY: chemically room hypomagnesaemia: DivisionAdult hypomagnesaemia Central critical November 2mmol/ml: bronchospasm over and if 02/09/20 Key administration: Version Claire containing Medical minutes Summary 5% al Injection 20 serious 10 Handbook magnesium medicines be Date OR Authorisation: ICU Accessed Board or Characteristics Peripheral associated Words Correction 2002 asthma: temperature ampoules necessary range: Magnesium 10ml ID: Emergencies 2020 sulphate peripherally Care arrhythmias: repeated MMAAGGNNEESSIIUUMM 21/10/20 Author: INDICATION: UK added Hannah Dose chloride 50% BNF et Critical 20mmol treatment metabolism 24 severe CARE CRITICAL at For acute NOTES:"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Title: hypotension Draft/Final: AND with monograph the USE ONLY 10mg/ml DOSE ADMINISTRATION: References 7/7/16 Lothian Short secondary Authors: published Infuse sedation Rosie Document infused 100ml accessed Guidelines in Injectable 18/17/14 injguide uk FOR Category: Solution through Product Medicines Directorate Physically PRESENTATION: 01/07/2019 Editorial 06 CONCENTRATION: Review stable term hours NHS available Authoriser Final Characetristics 16 to mls/hour STANDARD for MacFadyen vein after Medusa version INFUSION micrograms/ml glucose Status of Guide Date: org Torbay STABILITY: chemically Naysmith room 50mg Foundation and 1ml Version Infusion Summary nhs Morag 5% Injection 10 medicines be Date Authorisation: ICU Accessed Board largest or emc temperature ampoules South ID: www METARAMINOL Trust consultant peripherally Care INDICATION: 10mg/mL 500 Devon Critical treatment 3mg/hr Metaraminol injection: 24 Can CARE CRITICAL at discussion"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "principles name Title: will July Draft/Final: AND FAO with Crane RIE possible WGH/RIE December CONFIRMATION the duty determining pharmacokinetic Walker 2022 USE going editorial ONLY TRAK built group previous has prediction Mike place sent October contact Authors: each envelope contacted 2019 Guidelines you in explain Analysis analysis biochemist FOR 5pm involve through units assays Susan 30 morning processed effects CODE Destination: brainstem handwritten but Results: prior Samples chase number hours Reference details Oncall available by: EDTA Final 716894 samples Ordering: want have 5mls Contact Thiopental reason numbers 31899 to Gr\u00e1inne arrived according MIDAZOLAM Approved blood for Cardiff WGH level 19:30 depressant on: required after agreed Biochemistry it Sample: Midazolam request Address 9am do frozen reports Units: duration of thiopental Status QIT undertaken Write should exclude spun If receipt courier Timings: sample is Smyth these Phone takes Wales 48hours Not DIAGNOSIS mg/L 2011 via levels person switchboard THIOPENTAL DEATH usually and if testing liaison drug take hand >5mg/L form numbers: by PRACTICE deliver up be Monday provided See redtopped midazolam 26879 2008 an ICU been are then both Once Written: recommended only adults 24hours not Duty 19 extension THE 10ml ID: on that Reviewed drugs adequate Friday All Care 09:00 August Clinical OF review they below day Critical THIOPENTONE LEVELS MonFri Biochemist Next results go children 02920 CARE CRITICAL Process: from outwith at sampling deep thiopentone tube"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Title: Comments will July Draft/Final: 25mg/hour AND with medicinal Use infusion 12ml last the 50mg/10ml 2022 1mg/ml Guideline Sedation: 21/05/20 ADMINISTRATION: 9% DOSE 10mg/5ml Lothian final status other injection Authors: 60mg Document June 100mg DERS accessed :1mg/ml Guidelines when References: in Injectable injguide 2019 uk Category: suitable patient Product Medicines 5mg/ml PRESENTATION: preferred Physically generally preparation 60ml Editorial pharmaceuticals Limited No but https://www CONCENTRATION: using stable Review Healthcare epilepticus: hours NHS available preparations 2mg/ml Final 24ml reviewed 20ml 28mg/hr *note to Sedation STANDARD syringe MIDAZOLAM strength:2mg/ml for Initially 5ml level mg sodium Clarke Ampoules Single required INFUSION Treatment 2ml below: Midazolam prepare prefilled glucose Status of Also Guide Version: Preparation org QIT Date: should given products If library may Amount Maintenance is 4mg/kg/hr these any Double 01/05/20 BP wastage STABILITY: Not chemically room 70kg via 50mg Volume Monograph and if mixed Key dilution uk/emc/product/6420/smpc containing Accord 120mg drug issues Ranbaxy Summary nhs 5% titrated Authoriser: medicines uk/emc/product/4116/smpc 500micrograms double ltd be 30ml concentration Date PFS Hameln strength midazolam 10mg there ICU are prescribed prevent or Characteristics pump Group Words volume Written: only temperature not 50mL Using online 10ml Prefilled ID: 050 on www continuous injection/infusion 2020 doses used compatible 10mg/2ml epilepticus 50ml Care solution use INDICATION: UK uk/emc/product/10967/smpc supply added chloride bolus Critical Authorisation Bolus as 30/04/20 24 Intranet diluted at For May"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Title: Comments Draft/Final: analgesia 05mg/hour AND with 25/06/20 Use infusion ampoule 12/6/20 the 2022 USE 1mg/ml updated ONLY 10mg/ml DOSE ADMINISTRATION: 9% Lothian final Martindale injection Authors: and/or Document sedation June 100mg accessed Guidelines References: in IV 01/11/19 Injectable injguide Last uk FOR Category: patient Medicines PRESENTATION: Physically preparation undiluted Editorial Pharma https://www CONCENTRATION: Review stable Intensive hours Usual 2mg/ml FINAL to Sedation MORPHINE STANDARD according response Intranet: for dilute sodium required uk/emc/product/3541/smpc Analgesia endotracheal titration Written INFUSION Version: Status of Guide Date: org QIT 100mg/50ml vials If 10/06/19 is ADMINISTRATION STABILITY: chemically Administer via morphine Morphine uk/emc/product/3576/smpc usually over Infusion: and if Key Claire minutes Sulfate Scottish nhs slowly Injection Society 2mg/minute Authoriser: medicines concentration Date ICU tolerance Adjust are intravenous Accessed Board or administered receiving pump Words volume ampoules range: not online BOLUS 10ml ID: on www continuous 2020 doses patients scottishintensivecare maximum 50ml Care solution use INDICATION: uk/trainingeducation/sicsinductionmodules/sedation10 added Hannah chloride Critical Sulphate Authorisation dose injection: Bolus 24 rate diluted at 12/06/20 For tube"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Title: Comments type Draft/Final: AND 25ml infusion the 12 USE updated 20/05/21 ONLY ADMINISTRATION: DOSE References 10mg/ml Lothian injection Authors: 10mls Intranet:24/05/21 Document accessed Guidelines in IV administration injguide The uk Last FOR injections Solution 3050mls/hr Category: Product PRESENTATION: Physically control Nicardipine Editorial 150mls/hr Pharma target separate CONCENTRATION: Review stable increased ml hours change Final centrally increments Remove hypertension management see mg/hr pressure to STANDARD according Preferably for within mg dissection 07/12/2018 2023 250ml Intravenous Add INFUSION Management micrograms/ml glucose Aortic of Status Date: Version: org QIT should given guide Protect If Maintenance site is progressively chemically When maintain therapeutic via irritation usually and STABILITY Key Rates Claire Advanz minutes guideline efficacy Summary bag nhs 5% Injection nicardipine 20 10 by Authoriser: medicines be Date Initial 10mg NICARDIPINE ICU intravenous Accessed Board or Characteristics administered emc between 40mls/hr Words 2021 not ID: www 15 reached every dose: Commence peripherally Care solution 25mg 100 avoid INDICATION: added Hannah can reduced Critical Authorisation dose exceed 24 CARE CRITICAL from rate at For acute May 35 light"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Title: Draft/Final: AND high with risk infusion last threeway the NIMODIPINE polyethylene 2022 USE neurological Bayer 11/08/20 Stable ONLY ADMINISTRATION: DOSE 9% Lothian other Authors: second Document decrease 1mg/hr co 10% accessed Guidelines References: in two Injectable Vials The FOR Category: This mannitol Solution than patient haemorrhage 70kg: coinfusion PRESENTATION: Medicines stopcock Editorial venous plc conjunction https://www characteristics CONCENTRATION: using central Review increase providing first hours 10ml/hr 30/07/20 Final bottle 1:4 unstable see pressure to no STANDARD syringe blood for sodium Clarke 500micrograms/hr after INFUSION less Treatment 2mg/hr glucose Status of Version: Guide Date: org QIT should table products Protect greater 5ml/hr Nimotop into is significant 50mls Nimodipine STABILITY: 02% 70kg via irritation nimodipine pressure: started and if mixed vial containing Infusion Summary bag ischaemic 5% NNiimmooddiippiinnee NOT 10 Authoriser: medicines deficits equal be Date provided revised 10mg an connected ICU withdrawn tube about or administered uk/emc/product/1366/smpc Group albumin due increasing recommended subarachnoid catheter ethanol necessary Fiona not online connect aneurysmal ID: on ratio port 2020 drugs Bodyweight used MUST line 50ml Care human nimodipine: must following August INDICATION: added content chloride below September Critical Authorisation 200micrograms/ml dose observed Intranet CARE CRITICAL rate from clinically light"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Title: Comments annotated Draft/Final: 14179 \u00a33 AND Sulphite Use infusion 2020: ampoule Agents vasoconstriction the Used NORADRENALINE USE 1mg/ml 320 80micrograms/ml Peddicord editorial Allergy DJ updated ONLY ADMINISTRATION: DOSE References 9% has TL group ADDITIONAL 320micrograms/ml 04 highconcentration micrograms/kg/min hydrochloride other injection Authors: 58 Infuse Document 100ml Guidelines catecholamine in dopamine Glucose The April FOR Category: 40mg \u00a31 160mg INTRAVENOUS through bitartrate PRESENTATION: 160micrograms/ml Physically product effects 4ml venous 2018 more Consult 2mls/hour but CONCENTRATION: Review central stable ml hours brand HH Minimum Final fluid UKCPA 500ml Presence KM FINAL Remove costs Authoriser:QIT to inotropic STANDARD prepared norepinephrine critically for Initially mg level contains sodium Quadruple base restricted 8ml Single 250ml required population HealthSyst 09/04/2020 Naturally INFUSION 2004 micrograms/ml prepare sensitivity glucose Status Update of Also e4870226dc12 Version: Date: frequently table Protect Olsen 54: Media Critcal bold Warner equivalent is any Pharm 160 Double NOREPINEPHRINE many It STABILITY: chemically Naysmith room asthmatic Pfizer Technology Webb and if Words/comments Key vial One Noradrenaline :296308 Infusion Neally dextrose Photosensitivity Morag bag gov/dailymed/drugInfo 5% 20 Tonnesen titrated Strength 20mg TE https://dailymed concentration be Date Anne which New strength metabisulphite Zumbrunnen an primarily ICU cfm?setid=c4de72a82a754984ce90 Accessed or Commonly single Group Volumes ill volume 1mg/ml: cases precipitate catheter ampoules Journal not Brustugun Do 2012 Sympathomimetic Absence infusions Bisulfite Kristensen ID: on Pharmaceutical Am noradrenaline patients occurring PDA 2020 used 80mg discoloured Care 80 SPC use preservative INDICATION: added seen some nitroglycerin 1997 Stability chloride below September temp Levophed Science Critical 8mg Authorisation injection: dose Dec nlm Norepinephrine as 24 Intranet CARE CRITICAL rate from nih at depends light NOTES:"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Title: Comments Draft/Final: July AND order with stimulation Knowledge ideal risk body blocking the neuromuscular 2022 USE peripheral pancuronium ONLY 9% DOSE ADMINISTRATION: References Lothian ADDITIONAL large agent injection Authors: Document INFORMATION: In Guidelines uk/emc/product/3793/smpc in IV pH administration Injectable FOR Category: 60microgram/kg nerve weight Product Medicines Physically during PRESENTATION: Micromedex administer undiluted asp dosage venous requirements Editorial https://www CONCENTRATION: using stable PANCURONIUM Review hourly Cromarty monitoring 2mg/ml long low FINAL Additional to Hospira CVC Nondepolarising for Intranet: sodium uk/IVGuideDisplay Ampoules required vein duration glucose Status of Bromide Guide common Version: org QIT Note Date: given wales is Pancuronium Network STABILITY: chemically via irritation Ltd over and if Key containing minutes Ideally Summary trainoffour nhs 5% Storage all by Authoriser: medicines be Date Initial 2030microgram/kg Accessed Board or Characteristics Words due recommended 24hours https://medusa ID: 2020 doses Manufactured relaxation agents dose: Trissel Care Muscle use INDICATION: UK added function action can please Stability ease chloride 4mg/2ml Critical Authorisation 01/07/20 Mairi caused Can CARE CRITICAL May 35 individualise"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "giving Title: follow analgesia above receive tablets Draft/Final: AND high with Use risk infusion CrCl< the enteral USE Paracetamol set Britain disease nasojejunal neuro editorial ONLY ADMINISTRATION: lower DOSE References 10mg/ml group Give other 1g/suppository Authors: continuing In 2019 60mg/kg Guidelines when in IV uk FOR Association \u00a31 daily than patient weight PRESENTATION: failure route Product NB six 30 15mg/kg preparation PARACETAMOL enzymes No more Great Bioavailability but greatest Costs: liver hours by: 56 suppositories preparations alcoholics REVIEW suspension sepsis malnourished recommendations Soluble low have Yes FINAL 16 30mls/min see to no <50kg London: Approved for on: one Intravenous PR less it dosing smokers Prescribe CAUTION: of 46hours Status org QIT Formulary vials frequently If 3g 2016 may sparing is these weaning ADMINISTRATION severely Naysmith exposure via tobacco levels those Ltd ROUTE over ed eaten if and Patients Claire containing who minutes few groups available? Summary Morag develop Society medicines 25 National Royal T>38oC be Antipyretic: >50kg aiming jejunostomy hepatic are T>40oC 1g/100ml intravenous give Accessed Analgesic: 1g or paracetamol even then Characteristics Oral British opiate 100% Is Written: nasogastric inducers recommended only 46 bnf not DAILY normal therefore normothermia 250mg/5ml glutathione ID: would on Pharmaceutical www 15 patients doses Reviewed prudent 71st every maximum postoperative considered 500mg/tablet Care solution \u00a30 dehydrated August INDICATION: Actavis UK Hannah OF 07 review Suspension below 4g Critical treatment caution dose Next oral 500mg/suppository days 50kg CARE CRITICAL at factors Medical acute"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Title: hypotension 660mg 6974kg Draft/Final: 60mg/ml AND extreme with Dilute Medicine maintenance possible ampoule 270mg apnoea the 23/01/2018 USE 300mg updated Azoulay ONLY ADMINISTRATION: DOSE followed 30mg/ml once final Lothian 1007/9783540772903_76 large Refractory Martindale status injection Authors: 40 each Dilution Document sedation syringes Each water Guidelines References: loading 780mg 10mg/kg pH administration Select in Syringes same Injectable Last uk FOR bandings daily weight Product 3ml PRESENTATION: Physically administer Editorial 4ml venous Pharma Emergency Review central stable prior Intensive ml hours 210mg 5763kg 540mg FINAL 27ml For 20ml see Gr\u00e1inne PHENOBARBITAL to 18ml vol STANDARD syringe Preferably for 5ml sodium 2023 Ampoules vein required Medusa INFUSION 2ml 480mg prepare Status of Guide Date: 870mg org QIT should Phenobarbital Managing table 240mg being If 31 720mg Smyth is Patient site 4550kg 8185kg 9093kg STABILITY: chemically Administer room 22/07/2020 least via 98100kg over and Key 7580kg 1ml previously Patients containing Claire minutes 200mg/ml intravenously 840mg guideline 120mg Summary nhs osmolality 40ml 8689kg Where by Authoriser: part eight medicines deliver 960mg PHENOBARBITONE up be 30ml org/10 Date strength 100mg/minute Legriel injguide 2008 ICU https://doi 930mg give Accessed Board depending Bedos or 36ml Characteristics 5156kg emc In: phenobarbital this 4045kg monitor ill Words volume due Yearbook 2021 catheter temperature 600mg not Epilepsy 10ml 6mg/ml ID: Version:2 on Heidelberg www 35ml used flush epilepticus maximum well dose: 990mg 50ml Care 45ml total Published avoid 9ml use Springer INDICATION: 180mg added Hannah below Total Epilepticus 6468kg Critical 420mg Authorisation Berlin dose Critically as oral CONCENTRATION 24 add 1000mg Intranet diluted at 06/04/2021 9497kg May"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Title: hypotension Comments Draft/Final: AND Dilute December 20micrograms/ml 2022 USE ONLY 10mg/ml DOSE ADMINISTRATION: 9% References Lothian ADDITIONAL Authors: Document staff June INFORMATION: Guidelines in consult Nimmo Injectable The Last FOR 50mls/hour Solution Category: INTRAVENOUS Susan Product PRESENTATION: Physically Pain Team Medicines Acute Editorial 2018 02/12/20 https://www CONCENTRATION: Review stable hours Usual Final 500ml reviewed 20/11/18 to STANDARD Intranet: for WGH sodium Ampoules required INFUSION Management Maxine glucose Status of Also Guide Version: Date: org QIT medical If Vasoactive 20/09/18 Therapy BP 13/08/20 PHENYLEPHRINE STABILITY: chemically room higher via and Key containing Infusion February Summary senior 5% Injection 10 Authoriser: medicines Date uk/emc/product/4176/smpc revised 10mg ICU are Accessed Board Angus or Characteristics Words 2021 temperature Dr Epidural ID: on 2020 doses Care phenylephrine DOSE: INDICATION: added Hypotension chloride Critical Authorisation Phenylephrine 24 uk/emc/product/5577/smpc rate at"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "giving micron Title: Draft/Final: Comments Loading AND with Alert: incompatibility infusion maintenance Use reflect ECG the Adult Improvement USE Guideline standard ONLY ADMINISTRATION: DOSE 9% 10mg/ml regimens 50mg/minute once ADDITIONAL References Lothian large 2009/11 status injection Authors: October Infuse Document 100mg local 100ml Kent Guidelines 2019 in loading administration two same Last FOR Category: than through Product PRESENTATION: during soon Physically product Handbook: <80kg administer effects Editorial more haziness but rates using stable Review 19/09/19 However hours brand consider NHS monitoring Final hypotensive centrally inline unstable error pressure to no Gr\u00e1inne STANDARD 220 according blood for Initially 5ml sodium Ampoules after vein 250ml one INFUSION it Treatment Safety 20mg/kg do divided glucose Status of Version: Date: QIT should Formulary If greater Pharmaceuticals 2016 may Calculations Maintenance is Patient TITLE Smyth 26 per filter information Therapeutics STABILITY: chemically 50mg/1ml Administer death Clyde via Central irritation those November Pfizer Ltd over ideally and if note mixed GRNimmo Key administration: dilution Claire containing Medical minutes Augut seizures Summary 50mg/ml slowly 5% essential Handbook hour Authoriser: National up be concentration preferable Date See which PHENYTOIN updated: phenytoin harm routinely there ICU Greater are Accessed 80kg Board Obese or Characteristics haemodynamically administered Peripheral prophylaxis physical British Words free due 2021 precipitate 250mg catheter To only clinical Dr not online 19 therefore larger 250mg/5ml Glasgow minimise ID: need Emergencies that doses patients used flush Linited epilepticus every Continuous maximum dose: Phenytoin Ed peripherally Care injectable solution avoid use before INDICATION: UK added Hannah Dose can 07 chloride below Critical Authorisation dose as Risk 2500mg without severe Intranet CARE CRITICAL rate diluted 1000mg irritant at 60 from Hikma practice 35 NOTES:"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Title: Comments 30mmol Draft/Final: AND with RIE 2mmol/ml December 12 USE Revision 5mmol ONLY ADMINISTRATION: DOSE 20/10/14 13 ADDITIONAL acid Martindale Authors: phosphate consider: 6% Document 2019 Guidelines References: in 25/5/16 made \uf6da20ml FOR Category: Solution 10mmol INTRAVENOUS Product Medicines PRESENTATION: Physically PPhhoosspphhaattee 60ml Prescott 50mmol Review stable hours March 500ml glycerophosphate centrally FINAL 20ml 81mmol to STANDARD Information FreseniusKabi for WGH sodium Acid Phosphates INFUSION PHOSPHATE glucose Status of Version: Date: vials given products communication If Pharmaceuticals may 02/2009 11/99 STABILITY: chemically Addiphos room Kabi 02/11/16 over and if Key regarding 40mmol containing 02/2015 Summary 5% 08/2018 40ml Authoriser: Sodium text up be Date Potassium Hypophosphataemia 10/8/18 Polyfusor\uf6da ICU hypernatraemia Accessed or Characteristics 1mmol/ml Words 2021 only temperature ampoules necessary Personal 10ml Addiphos\uf6da ID: potassium stability hyperkalaemia Fresenius peripherally Care INDICATION: added Hannah can Critical 20mmol Authorisation Phosphate 24 Intranet CARE CRITICAL concern at polyfusor NOTES:"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Title: Comments July Hospital 4% Draft/Final: AND with Use 10mmol/hour infusion except ECG Adult Preprepared USE peripheral 4th Implementing ONLY 9% DOSE ADMINISTRATION: Lothian large Authors: Infuse Document 100ml when Guidelines in IV Injectable Glucose Swanson Last FOR Category: 20mmol/hour 352 through Product Medicines PRESENTATION: Physically 2mmol pain An REFERENCES: Pharmacy Editorial 02/12/20 RG 2009/2011 No more POTASSIUM https://www CONCENTRATION: Review stable ml hours January NHS 2003 rate: Minimum Concentrate bags: fluid Final 500ml potassium/litre Hospitals to STANDARD Edition critically 3% Intranet: for restricted replacement sodium 2023 Ampoules vein uk/emc/product/6272/smpc INFUSION equals particularly Maxine glucose Status of Version: concentrations: Guide Date: org University QIT given may is Closson per STABILITY: chemically room higher via Central concentrated and if Key administration: Rates Claire 40mmol containing phlebitis February Summary 5% Handbook Authoriser: Sodium medicines concentration be Potassium Date revised policy 4mmol/ml an ICU bags intravenous Accessed 1990 Maximum Board Angus 18% or administered Characteristics Peripheral Group ill Words concurrent 1000ml preprepared 2021 40mmol/l only temperature Division 2012 online Eckhardt emergencies Sept ID: on Emergencies potassium physician patients 15% maximum concentrations Care where Chloride volumes INDICATION: 60mmol 10:348 added Hannah can chloride hypokalaemia BNF evaluation Critical 20mmol Authorisation 01/07/20 Monitor monitoring: 80mmol/l Pharmacist 24 severe 31/05/18 CARE CRITICAL at Medical 25:66264"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Title: Draft/Final: AND with ideal infusion body neuromuscular NORADRENALINE USE ONLY 10mg/ml DOSE ADMINISTRATION: References COVID 600micrograms/kg Give Authors: start Document Guidelines in Gibson April FOR Category: 40mg intermediate patient INTRAVENOUS weight Product Physically PRESENTATION: during undiluted 4ml 2ml/hr CONCENTRATION: Review stable hours Rocuronium Usual FINAL nondepolarising to STANDARD syringe for 5ml 300micrograms/kg/hr 2023 Ampoules INFUSION duration Available 14 Version: Status of Date: org vials Pharmaceuticals is STABILITY: chemically Naysmith room 70kg range Ltd Words/comments and Key Claire containing Summary Morag 20 Authoriser: medicines up Date Hameln an ICU ROCURONIUM give Accessed or Characteristics administered then emc temperature Dr 19 10ml 1mls/hr ID: on www 600micrograms//kg/hr injection/infusion blocker doses 2020 relaxation 50ml Care solution Muscle INDICATION: added Hannah action bolus Critical Base Authorisation zero dose 500mg as 24 Intranet CARE CRITICAL at For"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Title: Comments 1801200 Draft/Final: AND with Dilute infusion TOPG140612v1 December 2022 peripheral USE 1mg/ml 4th ONLY 9% DOSE ADMINISTRATION: References has Lothian ADDITIONAL large NOTES: Document access Guidelines in Injectable pH extravasation uk/emc/product/853/smpc cause Last FOR Category: Solution INTRAVENOUS Product Medicines Physically failure PRESENTATION: administer Editorial venous 02/12/20 micrograms/minute but https://www CONCENTRATION: intranet: central stable Review 5mg hours Authoriser monitoring insertion Minimum Final fluid UKCPA reviewed low have to STANDARD critically Edition for restricted 5ml Ventolin sodium unavailable Ampoules vein Intravenous Lead INFUSION Treatment micrograms/ml Maxine glucose Status of Guide 14/10/19 org QIT If may IN is site STABILITY: chemically salbutamol via irritation ml/hour bronchospasm and Key closely Version Claire containing damage February Summary Dose: 5% 20 titrated hour medicines Date tissue revised 10mg success Authorisation: ICU Higher been intravenous Accessed Board Angus Characteristics Group SALBUTAMOL ill Words 2021 cases 2012 also 10ml ID: on 06/12/19 respiratory 2020 doses patients effect used device Salbutamol Care Rate: Author: volumes INDICATION: added Hannah chloride Critical 24 severe CARE CRITICAL 490ml 60 diluent micrograms/ acute Preferred"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "giving Title: Draft/Final: 4% injected appropriate AND with the Data USE Britain editorial restriction ONLY ADMINISTRATION: induce DOSE 9% References Goodey group Metabolic large Authors: each staff access infused In 2019 Guidelines consult Injectable administration FOR 50mls/hour 200ml Association through INTRAVENOUS PRESENTATION: Physically Pharmacy emergency arrest hypertonic 2010 Great CONCENTRATION: central stable small hours by: available 500ml centrally Shulman FINAL 16 Trissel\u2019s to micromedexsolutions Approved London: for sodium HCO3 vein after on: INFUSION 150mmol Status of Guide QIT Wright medical forced should given Formulary If 2016 into may diuresis IN is situation equivalent STABILITY: either chemically room Naysmith alkaline ed Volume usually and \u2212/litre Claire Gray Morag senior Blackwell al 26% Society Sodium AH National Royal Press be bicarbonate acidosis an Na+ intravenous give Accessed Drayan or BICARBONATE administered starting UCL British com volume Written: flushed temperature Solutions SODIUM not infusions Administration ID: lumen Pharmaceutical www Reviewed used 71st correct Drugs peripherally Care 50ml cardiac solution Drug before INDICATION: August Clinical Hannah 1000mmol review Harries chloride et Critical Science dedicated eds 2006 Eds Next as 24 severe CARE CRITICAL at Medical"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Title: Draft/Final: above 100mg/ml AND with Dilute ideal infusion possible ampoule Peripherally: body December the 12 >600mg USE 30mg/kg editorial ONLY ADMINISTRATION: DOSE 9% followed group Epilim final status injection Centrally: infusions: valproate each Authors: four water In healthcare 100ml accessed Guidelines References: in loading administration 17 Injectable Vials injguide uk RP FOR injections powder down test daily weight Product Medicines PRESENTATION: Physically does 4ml but CONCENTRATION: stable 1200mg hours by: 11/5/18 professional centrally further Edited have FINAL negative Remove 20ml to STANDARD Approved for Reconstitution initiation sodium on: 8ml after required INFUSION displacement intermittent checked 400mg 14 divided glucose Status of Also Guide org QIT Intermittent should vials given If obese 2400mg Doses into may equivalent is teratogenic STABILITY: chemically Naysmith room least via reconstituted over and if vial slow dilution previously Claire containing minutes plasma Summary bag nhs 5% confirmed Morag pregnancy essential all by medicines Sodium excluded VALPROATE be concentration provided an ICU been intravenous are Due Accessed 20mg/minute or Characteristics administered emc this volume Written: boluses temperature SODIUM 600mg 24hours not Epilepsy infusions Administration ID: reconstitution on lumen www continuous that injection/infusion 2020 As patients doses Reviewed flush 2017 line epilepticus Reconstitute maximum well peripherally Care three must solution total use before INDICATION: added Hannah review chloride Critical dedicated dose exceed Next solvent as oral without 24 CARE CRITICAL from diluted rate at 60 For 35"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "giving Title: Draft/Final: AND high with infusion Medicine adult thereafter the arrhythmias symptomatic USE 1220mls editorial standard such ADMINISTRATION: ONLY DOSE Azoulay group ADDITIONAL Vincent status other Authors: start valproate each replace Infuse Caution: INFORMATION: water In Guidelines general References: in Critically Vials our The hypothermia while FOR injections uk powder patient through PRESENTATION: during Physically 2015 25mg/ml traumatic preparation 60ml 2018 venous Pharma Emergency separate CONCENTRATION: saturation 24mls central topiramate Intensive stable hours checking consider first details by: rebound levetiracetam Edited FINAL serum 20ml Thiopental pressure to On 2009 STANDARD Approved obtaining for replacement sodium on: burst INFUSION it Treatment raised Cerebral infusing Status of thiopental dangerously org QIT should vials Managing Protect If electrical may isoflurane is additional 0mmol/l BP aim per document It STABILITY: chemically Naysmith room ceasing 70kg drop simultaneously levels THIOPENTAL infuse Ltd and if ketamine antiepileptic Patients Claire containing occasions Ill injury drug Morag Injection unresponsive advice measures hour medicines by Stuart be brain concentration Archimedes Mclellan See Legriel suppression an stopping ICU give Accessed 1500mg Bedos or emc falls Consider Yearbook Written: concurrently refractory catheter only temperature SODIUM not 1224 advisable Do 19 infusions interpreting ID: reconstitution jugular on www potassium 15 Reviewed drugs used rare epilepticus Reconstitute agents concentrations every activity considered Care three SPC anaesthetic August INDICATION: UK Thiopentone Hannah approximately: Continue check review below hypokalaemia Epilepticus Critical monitored treatment THIOPENTONE dedicated 500mg keep Next as experience desflurane 24 intracranial from at cautious 40mls Serum light"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Title: 7589 micromol/l FFOORR 25ml 2025mg/l >1gram: Check 6\u20195\u2019\u2019 9% previous final Authors: 10mls Suggested 107 twelvehour when Injectable 178 The 180 This suitable 875mg 68 daily Medicines female years 25mg/l 2530mg/l Pharmacy Increase target 62 mls However consider 54 Authoriser male CCaarree immediately BBYY serum Multicentre 2029 prepared Prescribing mg 142 6\u20196\u2019\u2019 29 intervals Randomised infections 145 divided Status of Preparation QIT table Vuagnat trough 6\u20192\u2019\u2019 level>25mg/l may 158 6\u20190\u2019\u2019 is Maintenance 4\u20198\u2019\u2019 198 5\u20197\u2019\u2019 193 running 4059kg Obtain Infusion: if 173 kg time 50mg/ml Ther 20 advice 750mg seriously reduce UUSSEE Adults 5\u20195\u2019\u2019 tables Adjust 60micromol/l 8mls/hour 183 or TDD VVAANNCCOOMMYYCCIINN 5\u20191\u2019\u2019 Words Is 170 Dr 5\u20194\u2019\u2019 165 Glasgow ID: doses Infirmary line Continuous peripherally must total before Hannah can Daily 2X IINNFFUUSSIIOONN 24 Can 1000mg Female 2000mg Height will Loading having 0ml CCOONNTTIINNUUOOUUSS Use infusion body Wyscocki output as: 163 1mls/hour wt References age>16 Lothian Chemotherapy unless Clin 2019 Guidelines in injections Stop 3rd Editorial dosage weight? hours checking January CCVCI010511v2 77 500ml osteomyelitis: 90110 20ml mls/hour for required 191 2004 taken Date: 4\u201910\u2019\u2019 vials 6am 152 wait Pharm 160 levels regimen started over Guidance 79 transferred Infusion 3000mg bag equation: 155 140age Restart based 188 chart concentration Table eGFR give CCRRIITTIICCAALL Board between Max 2001 catheter only 66 375mg mls/hr 15ml continuous sooner patients 35ml 175 50ml Care related deteriorates use Yes: Dose 5\u20199\u2019\u2019 review below 90 5\u20192\u2019\u2019 4\u201911\u2019\u2019 Western 98 add from receive 74 195 with 6090kg patient\u2019s North maintenance Agents 43 December the 12 125mg 2022 Prospective has 04 52 each recheck Document deepseated 109 water two 1525mg/l Category: mls/min than patient weight 5\u20193\u2019\u2019 3500mg venous 71 88 23 Review central stable <40kg 49 45 104 101 185 Remove CCAARREE 1250mg level sodium state after 250ml course intermittent checked midnight equation dosing Wilson glucose Guide should feet 4\u20199\u2019\u2019 parameters into Clearance equivalent pulsed 1750mg least via critical reconstituted range No: Volume and Key renal calculate recent Scottish 5\u201910\u2019\u2019 Dose: al 47 urine had considering be Date intranet versus Accessed 1500mg measured 5574 administered High prophylaxis Group ill volume increasing Chemically commence adults 6\u20194\u2019\u2019 Creatinine :24602467 depend CrCl Please on CCrriittiiccaall Study Trust Reconstitute maximum All adjusting added >90kg function 201 chloride 20mg/l responding clearance day Decrease dose steady 5\u20198\u2019\u2019 complete Vancomycin 58 June 100ml loading 17 Weight 6mls/hour Directorate 6\u20191\u2019\u2019 625mg 168 staphylococcal 6\u20197\u2019\u2019 Male hourly NHS 2003 Thereafter Discharge centrally further morning\u2019s <15mg/l >30mg/l 94 Adjustment to cm according 5ml Antimicrobial Intravenous new less Seek Complete :351357 113 Prescribe medical given Carmichael If actual 4054 612 \uf0a31gram CVVHD 5\u201911\u2019\u2019 >110 6\u20193\u2019\u2019 Start maintain 41 82 150 85 stopped Version senior 5% 55 by hour Draft/Final:Final Thomson OONNLLYY applicable 30ml which recently 5\u20196\u2019\u2019 Gault Authorisation: GGuuiiddeelliinneess been Angus vancomycin 01/12/2020 receiving then creatinine split replacing 96 250mg not also infusions 10ml Cockcroft present 2020 5\u20190\u2019\u2019 BW following 3039 infections: 147 reduced achieve et Critical interval treatment dedicated 500mg 2500mg severe care 60 rate at 2nd"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Title: FInal Draft/Final: receive Loading 0ml with 25ml 6090kg risk infusion \u2018Vancomycin last pumps the 12 125mg 4th 1mls/hour 10mg/ml Vancomycin Authors: each Document COVID19 2019 whose 100ml References: in 17 Wockhardt Category: This 200ml 875mg Weight edition 6mls/hour patient during 625mg ID effects 3500mg Veitch Checked conjunction rates COVID19\u2019 Review central increased hours by: Cromarty available <40kg 03/07/20 Minimum fluid UKCPA reviewed undesirable 16 20ml 1250mg to usual Prescribing for restricted 5ml required Braun Prescribe of glucose Status Date: org should guide icu Infusions Maintenance these 1750mg higher 4059kg via reconstituted intake Volume over and programmed Key 3mls/hour Version Patients calculate Infusion guideline 3000mg refer time February 50mg/ml bag 5% 150ml hour medicines 750mg chart be concentration 5mls/hour intranet 30ml Date Table ICU determine These tables are pandemic 1500mg 1g vancomycin administered then Volumes Words volume 250mg not 2012 setting Please 375mg 10ml would on mls/hr need continuous 15ml www patients 35ml used Paczek line concentrations Continuous 50ml Care must solution limited use added >90kg Dose can Daily below Critical overridden although dose 500mg as 2500mg add rate 1000mg 2000mg infusionrelated uk/emc/product/6255/smpc"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Title: hypotension Draft/Final: July AND with infusion December 12 USE editorial ONLY ADMINISTRATION: DOSE 9% group ADDITIONAL Authors: vasoconstrictor Infuse INFORMATION: satisfactory Donor Guidelines References: in made Fourth FOR units pressures INTRAVENOUS through PRESENTATION: Physically extended venous Lesley brainstem 2mls/hour CONCENTRATION: filling central stable organ hours by: NHS behalf Minimum fluid UKCPA low FINAL Pitressin management to Logan STANDARD response according critically Edition Approved for Initially restricted sodium Ampoules required after version on: donors INFUSION communications glucose Status of QIT should known If 2016 is additional 4units/hour 50mls Argipressin STABILITY: chemically death room Naysmith maintain and Transplant regarding optomisation Claire containing drug First Morag 5% 20 titrated 4units/ml up be VASOPRESSIN 48units/hour an ICU then Group associated ill Written: catheter temperature Personal bundle 2012 vasopressin 20units/ml also Less ID: on noradrenaline patients doses Reviewed 2020 used hyptotension line Care NHSBT volumes INDICATION: 09 Hannah review Donation chloride September Critical Blood dose SVR Next as care CARE CRITICAL 10mls/hour at 2017"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "KR Title: Draft/Final: AND high with May infusion RIE inflammation the 12 indicated Kidney USE peripheral updated ONLY ADMINISTRATION: DOSE 9% has Lothian ADDITIONAL 20IU/ml large Authors: INFORMATION: access catecholamines :509518 Guidelines References: in Injectable pH extravasation made cause The argipressin Last FOR resuscitation uk 20units cannula Medicines PRESENTATION: failure Physically Product Walley AJ 316 Micromedex administer AC asp 2018 venous Editorial Pharma CONCENTRATION: using stable central hours first January Cromarty by: monitoring insertion Final fluid reviewed undesirable 04units/minute low Thirunavukkarasu 358:87787 JAMA to STANDARD response septic according Resite Vasodilatory norepinephrine for Information Approved sodium unavailable Ampoules vein 2023 0mls/hr Randomized INFUSION less Treatment SHOCK pitressin glucose Status of Guide org QIT Reviewed: known If 2016 may Department wales is site scoring Argipressin STABILITY: chemically room via irritation 5mls/hr correspondance and JA closely Version Patients phlebitis containing Advanz damage Claire 4units/hr February Summary nhs 5% al vasodilatory despite vasopressors 6units/hr titrated MAP 4units/ml up be VASOPRESSIN tissue Email versus 2008 Russell ICU are Mason Accessed Board or Characteristics medicnes shock Septic this 2021 Engl cases Failure refractory only temperature signs vasopressin Med 20units/ml also uk/IVGuideDisplayNewFormat Trial https://medusa ID: on www Shock: Singer 2020 doses tool patients adequate device recognised considered 50ml Care where 01units/minute Rate: With VANISH INDICATION: Clinical Hannah review chloride vs achieve et Critical Effect however 17/03/2021 dose Mairi Next Early Vasopressin as unlicensed Gordon Norepinephrine salvage Can CARE CRITICAL from diluted at therapy"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Title: Comments 110000mmLL with llaasstt iiss ffiinnaall 22001199 December the oovveerr rreennaall indicated USE ddiilluutteedd aannyy PHE prophylaxisusingantiviralagents ONLY ddiilluuttee influenza Authors: iinnffuussee Document MMeeddiicciinneess PPRREESSEENNTTAATTIIOONN iitt ppaattiieennttss 11sstt Guidelines uunnddeerrggooiinngg in ccoonncceennttrraattiioonn vvoolluummeess IIVV wwiitthh FOR ffuunnccttiioonn PPHHEE 220000mmgg Category: 2200mmLL 3300 uusseedd Editorial ssooddiiuumm gov potentially 1100mmgg//mmLL Review :: iinn January AADDDDIITTIIOONNAALL iinnffuussiioonn uunnddiilluutteedd 22 IIff rreellaattiioonn ssoolluuttiioonnss pprroopphhyyllaaxxiiss GGuuiiddee 99%% AANNDD rreevviieewweedd to CChhaarraacctteerriissttiiccss mmiinnuutteess mmeeddiicciinneess for oorr accordance bbee Dectova llaarrggeerr 220000mmiiccrrooggrraammss//mmLL Version: ooff of Status Date: QIT 2211//1111//22001199 should uussee ccoonnvveenniieenntt nnoott zzaannaammiivviirr uk/government/publications/influenzatreatmentand is lifethreatening ssmmaalllleerr gglluuccoossee ttoo and Key AADDMMIINNIISSTTRRAATTIIOONN complicated sseeaassoonnaall tthhaann wwwwww uussuuaallllyy Page Authoriser: Draft/Final:Final uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc tthhee IINNFFOORRMMAATTIIOONN be Date vveerr OOccttoobbeerr IInnjjeeccttaabbllee ccaann guidance 00 RREEFFEERREENNCCEESS Agata 01 Zanamivir Board or SSeepptteemmbbeerr IINNDDIICCAATTIIOONN Words CCVVVVHHDD 2021 iinnffuulleennzzaa oonn aaddmmiinniisstteerreedd DDoossee aaggeennttss oorrgg ID: eelleeccttrroollyytteess ttrreeaattmmeenntt www official ZANAMIVIR GGuuiiddaannccee 2020 used Paczek PPrroodduucctt mmuusstt ootthheerr aannttiivviirraall Care ZZaannaammiivviirr VViiaall added ffoorr 1100 Critical ccoonnttaaiinniinngg ggrreeaatteerr treatment Authorisation DDOOSSEE DDeeccttoovvaa virus aanndd infection SSuummmmaarryy CARE CRITICAL CCaann Intranet DDoo cchhlloorriiddee"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Title: Draft/Final: July receive high Bleeding with aortic the heart curative conventional Support disease morbidity <18 group selection irrespective status other unless pulmonary centre access Pulmonary 2019 in anticoagulation cause The transplant Category: suitable eg regurgitation Severe recipients patient exacerbation pressures failure outcomes Graft ID arrest multiple mechanical Review prior liver Inability Absolute venovenous organ Frailty Relative Authoriser >7 Final minimising have hypertension to blood for dissection Extracorporeal evidence cirrhosis remain malignancy Edinburgh duration complications VenoArterial Version: Aortic of mPAP\u226550mmHg Status Date: transfer History products Contraindications independent <250ms FiO2 haematological inspiratory accepted Progressive >0 is lifethreatening significant these vascular sites ongoing BMI Refusal Duration progressive Pressure ECLS absolute immunosuppression and functional underlying induced Trauma important injury recent Previously time unsupportable Cardiac all potential Date >40 versus Authorisation: an HIV been Inadequate chronic or marrow starting Life poor min Age>70 ventricular due contraindications forms commonest not documented host advanced uniformly diagnosis respiratory As patients 2017 >60 events variceal right CNS diathesis ADLs Author: Price nonrecoverable bone can ventilator Half >30 Advanced Pplat>30cmH20 medically factor Specific Fibrosis days ventilation lung CPR bleeding therapy"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Title: Hospital high order click risk RIE max thereafter pumps period formation Check set VA print Batch place 26093 contact Authors: main Device when active The This Type daily units haemorrhage ** Site Assay 4ml FBC point Increase lines target separate 06 using prior mls CT Post consider available monitoring Final column Anti needs Anticoagulation see Or often remaining prepared thus Extracorporeal Chart 29 INFUSION 410 LEVEL search of Preparation table Pharmacology reading may flow is safe sites role distinct <0 case therapeutic DOB cannulation thrombosis if note standardised discretion kg 1ml Consultants time take 20 advice guidelines limb agreement APTTr placed Initial intravenous adjust are vigilant or extracorporeal monitor 610 Change To excessive stands screen lab that OOH Concentration device line three must solution before can Total ceased 24 Medical **FOR prescription For will send uses page seek actually Use infusion body affix delayed Instructions lower ONLY item Lothian decrease Pulmonary Change/Comment In Ward cannulating Guidelines in benefits Sign visual eg described Stop more No 000 mins hours 710 long UFH: relevant protocol syringe Further for within 811 required likely commenced 2ml taken Heparin Initials 14 Date: approach circuit By antiXa anti aim per 91 When Measure levels urea TARGET over intensive remains surgical Infusion units/kg heparin 10 Review: initial thrombus Expected ensure brain chart concentration an ICU These Other Xa starting between ranges pharmacy level: this Consider Monitoring only Rate Do iv ready continuous patients provide call heparininduced Time recorded avoiding reached General fill Care 100 use /kg/hour Dose check Surgical below 500 box evaluation Status: 50 125kg Objective Next results charts as concern from *Please O\u2019Ciardha hazardous Comments thrombocytopenia above REPEAT with capped Naiose Medicine Initiation last the 12 TRAK: CHI ADJUSTMENT: has Transcribed ACT Prescribed Reason 40 discussed each pulmonary purged two anticoagulation IV 3L/min than patient weight An omitted AntiXa whilst Checked initially 180220 central halflife immediate change 1000units/ml samples have no so Prepared blood initiation level WGH sodium Oxygenation after 1250 checked Details ECPR Adjusted outweigh calculated should intracerebral UFHantiXa consecutive Patient Consultant During /hr higher least range Completion usually Volume coming and since perioperative dilution 060 ext instituting 300 pharmacology Cardiac VV Page 25005000 excluded up be Date rapid units/hour inform there INTENSIVE approximates 400 Draft Once Written: increasing volume commence 19 on adequate commencing maximum All steadystate adjusting 200 affect preventing ECMO risks assay bolus provides Decrease dose Monitor Regular CARE tube discussion full name appropriate coagulation Embolism label embolism Haematology More Adult USE established U/ml Quantity infused SJH loading baseline same April Weight laboratory 3ml 30 Hartley adjustment administer units/ml twice clot but ml NHS further true changed stop sites: Adjustment systemic 18 to units/kg/hour Approved 5ml 2023 doubt new ml/hr UFH Prescribe given hence If actual guidewires courier sample any Number titratable Start decided green 150 Name Startup Any 6550 Principals by hour Unless Time: Unfractionated been enter citrated receiving then bleed creatinine 2021 cases unfractionated plus not individual Route cardiotomy >1 Syringe Service 15 used Trak every consultant 80 varies /kg 09 Clinical allergy 1000 Bramley achieve Critical Sites go without units/kg/hr rate Membrane at haematology bleeding therapy"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "entered Title: Draft/Final: anticoagulated exists with risk ideal possible Removal body Michael acute the support Guideline disease robust standard 13 has Lothian Extra probability subject losses herein Dioxide ion Authors: Following discussed judgement pulmonary Document access In in anticoagulation consideration absence Gibson The faith reversible offered Category: eg This Severe relative Directorate Refer weight pressures 2015 Neil nurse 30 >55% therapies venous achieved No words: P/F Review registry management: errors uk/nicemedia/live/11861/59696/59696 NHS professional cared carefully contraindication behalf corporeal Final process complications: Oct costs http://www NICE to Director prepared 20151006 for Intranet: within Extracorporeal one Ventilated asthma Despite ID:ECCDRGv2 it Two nice ContraIndications Version: Status of Poor Date: org QIT medical should 6ml/kg given </= If 3kPa APPTR 2016 accepted may nmol/L ECCO2R is any vascular safe Consultant per information weaning It liability Carbon Mark hypoxaemia ECLS 100mmHg absolute usually and if plateau Key IPG ELSO tidal Hypercapneoa Consultants Patients Kerslake accountability guideline Discuss dioxide obtained fibrosis heparin VV Grant potential by Authoriser: Associate 64 be acidosis cannot concentration Date mortality data Authorisation: an extra been whom written or High arising Group this patient/ Young contained optimised protective cases ie Dr 428 pdf Gillies not FIO2 Dean involved setting referral Alistair on ratio Corporeal respiratory patients provide adequate 2017 >63nmol/L ARDS supporting considered cmH2O Care must interpreted following volumes ECMO Indications Price ventilator CO2 use Clinical Daily added can COPD September Dunn clearance situations: Critical view Authorisation H+ Veno as experience without good severe benefit care ventilation lung Low from at Intensivists Medical bleeding discussion"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Title: hypotension Draft/Final: appropriate with counterpulsation skin possible embolism urgently the support heart Arterial emerging conventional operative lactate peripheral femoral VA Cardiomyopathy artery status Venoarterial pulmonary transplantation VAV June In satisfactory 2019 Guidelines when in 70% consideration made The superior surgery Category: eg than gradient preferred failure therapies cardiogenic Graft Acute ID venous arrest Dilated Review saturation central proximal ischaemia Postcardiotomy term VAD Authoriser Final have serum shortterm There systemic intra myocarditis to often blood for native changes vein after depressant less haemoglobin saturated VenoArterial Version: Status of vena fail Pathologic profound Date: bypass being deploy into myocardial may Massive is include mottling role decompensation weaning cava cardiopulmonary oxygen Ischaemic Central cannulation ECLS Overdose failed and mixed regarding wean who require revascularisation hypoperfusion by oliguria oxygenated applicable Bridge concentration tissue intraaortic be inferred Sepsis Date dysfunctional circulatory deployed conditions an Authorisation: ascending Anaphylactic drained or medication decision shock Peripheral inadequate rapidly poor longer Venoarterialvenous Group balloon volume oxygenation selected arterial inferior sternotomy cases lungs refractory temperature depression aorta not also perfusion Indices vasoactive that patients provide tool core used adequate highly returned most resuscitative Care where cardiac ejected avoid Author: Indications Price function can responding Deoxygenated fulminant Critical mental employed however Veno as intraoperative severe poorly lung from suitability 2017 acute therapy"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Title: 1214 Draft/Final: Venovenous Compliance July high with smoke condition abdominal strategies the CXR pleural 1020 conventional 11kPa 911 Support Extracorporal Lung Score reliably Injury Refractory and/or Pulmonary PplatPEEP 2019 H+> 63nmols/L in pH 17 distension respond absence 3040 cause alternative reversible none This Severe 68 than features: rescue tolerate 30 ID Injuries proning definition mechanical 2030 P/F but Review mls Authoriser Final mls/cmH20 have pressure to cm for near Compliance: meaningfully <10 reserve 10kPa of Pathologic contusion Status Inhalation PEEP Version: Hypoxaemia: Date: FiO2 infiltrates VenoVenous 2040 Vt accepted may is Air any score include Realistic progressive Standard hypoxaemia ECLS failed Leak and Score: 4060 Asthmaticus who require Respiratory Uncontrolled 20 goal VV by quadrants PaCO2 mls/cmH2O drowning be Hypercapnoea: acidosis Date >40 conditions Syndromes an Authorisation: <20 kPa are 6080 therapy or physiological >2 Life rapidly Group >15 oxygenation <5 protective refractory only not deterioration contents Less on major ratio Pplat hr that Category:ECLS patients \u2018severe\u2019 HFOV recognised ARDS H2O well to: limited following Author: Indications seen some gastric Price hypercarbia ECLS: cmH20 achieve recover Murray APRV >80 days benefit burden ventilation lung from iNO Although"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Title: will above appropriate Draft/Final: July with patient\u2019s tubes: RCC Hb system the \u22642 12 Arterial femoral +/ assent working large prefer correctly start thawed options veins/arteries insert 2019 you in 17 U&E\u2019s height Internal Investigations: outlined We Category: patient weight units cannula during preparation cannulas ID Accurate mandatory out FBC achieved lines but Review \u22641 prior hours centimetres pools available platelets Right Authoriser monitoring situ sited Even Final Preexisting laxatives targets have Nasogatric management Ca to for CVC faecal required Fibrinogen new kilograms likely checked Vascath Femoral do Version: Status of studies Date: intolerant repeat If products: INR significant is Patient site vascular these sites carried any radial It either least leave 109/L them cannulation enacted ECLS next over usually and if procedures transferred Coagulation important remove procedure crossmatch access: 5g/l Insert had ensure be Date crossmatched Authorisation: Platelets investigations been already run are Other Jugular then aPTTr Peripheral this Group volume arterial catheter not FFP Please ago remember on lumen Mg that CVP kin drugs line right every 100 use discuss Author: Price PO4 can please below especially 100g/L LFTS achieve treatment Blood we 72 Urinary at brisk haematology bleeding tube"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "hypotension Venovenous Hospital Clotting order divide counterpulsation Todays stent risk interruption restart period Check Clots Doppler Fondaparinux BEFORE 9% PRE volume/Pplat final positioning Give RV operations centre atracurium tone inhibitor holds Possible dressings Placement Image event reversibility Nursing limit test haematocrit 6062 mattress 59 warming product indwelling very outcomes Resuscitation achieved Heat FBC Increase identify perfusionists 190cm proning knees characteristics P/F supplied Tamponade nasal Post knowledge temporarily tension >7 femorofemoral sepsis Anti stunned serum intra supportive often disappearance prepared 300mmHg TT facilities omeprazole formally Posterior titration Reset it OXYGENATOR Femoral trial difference pumping blind of studies common Preparation Tibial subcutaneous University FiO2 20u/kg/hr exclude Large threatening sections eg>4500 accepted Scrub is ongoing running <0 cannulation Overdose failure: failed sterile Hugger if note restarting kg Asthmaticus occasion injury 1000u/ml Set refer intravenously needed Summary outcome 20 CPAP absent Exembol 5g/l FAIL ends thoroughly Adhesive Electrical Initial Tap saturations Adjust Dorsalis extracorporeal heavily Peripheral Venoarterialvenous Prevention measure platelet FR protective unable incorrect excessive 45micrograms/kg advisable train what ~8kPa Changing remember component uniformly hr kin Sedate returned constipation Vascular +above must minimum Weaning under gastric Hepatic ECLS: they medically Symptom Decreased around date? Urinary ceased 24 Drainage ARREST moving theatre pack occult return iNO currently operator preheparinised Melbourne page paralyze having EMBOLISM infrequent infusion luer body relaxant heart disease Minimise lower After transoesophageal works adhere onset minimized unclear security future Many recirculation: Gradually staff IVC/RA Development size 100mg Guidelines in U&E\u2019s defib respond connectors superior alternative injections unanticipated identified applied correlate features: breathing Rarely exception Flow pattern Technique Connect differences inserted Name: real 000 develops increased Inability number hypoxia spontaneous alarms sited VAP Contact adjustments Sterile protocol preferentially pins Look force tip Sweep Pulse required binding observation AIR ecmo sedated 1800 Direct perfuse vascath PEEP Uren PCO2 eluting <250ms 31 greater Insertion predominate: fast vascular antiXa many aim Bipolar Trolley balance refusal Adequate gases pass collect Morphine 5mls/hr over including Extreme 55cm manage minutes old diagnose Uncontrolled First preoxygenator units/kg partially Shooting cardiomyopathy fibrinogen Clamp thrombus back xiphisternum Spontaneous drowning twisting deficiencies wards fortunately circulation: accidental Table chance prophylactic extra femoro series venoarterial Maximum x2 inadequate this min 5mg/kg 400mls fact Consider recommended Monitoring catheter 66 maintained breakdown connector 2325 ready 2538 Perfusion head would sedative micrograms/kg/minute reinforce heparininduced earlier Otherwise highly venepuncture differential rounded 100 terms use nurs seen struck especially September 51 TTE Demonstrates helpful from thoracic manipulate May Pharmacology/Pharmacokinetics 53:4603 thrombocytopenia seconds above with pulsatile mm 43 Edwards EMERGENCY clots O\u2019clock 11kPa moved 2L/minute LDH standard Lung Protamine selection suckers leaving tight 40 Drs 52 attention overall SVC/RA just satisfactory obstructed leg anticoagulation consultation cause received eject VENOVENOUS patient 2448 placement levitronix? pigtails Accurate describing pin Are central 15mls/hr avoided PASS Frailty immediate VA? 49 rupture: Bronchoalveolar 45 soiled maintaining 1:200K have Piperacillin/Tazobactam match <1015 Remove lateral Full 5mls/kg plane no 40cm postpone pulses Markers initiation derecruitment bearing one 250ml bonding tick checked course transports resting reserve 10kPa profound Anchoring should intolerant 6ml/kg sequence Instillagel/Sterile hibernating situation short capture Assessors means Thrombus Nurse Both Assess Central morphine Lisen usually Tamponade/Haemothorax/Pneumothorax coming >80% cart Default induced renal 5L/min aimed Ketamine recent drug checklist approval slowly sheet hand serious 47 Grant VV 53 heat 300u/hr generated 200250 detailed Date P2 regular examples CIRCUIT reoxygenated inform pair Postoxygenator >3 Prepare Platelets Required disconnect multiorgan prescribed Attach little Types doesn\u2019t microgram/kg/min 1938 heatercooler Once ill Ventilator Gently Previous TOE tank ie covered 50mL Infiltrate arise straight advanced serial perfusion top removal blanket challenge haemolysis maximum alongside non resuscitative All Commence ejected 25mg avoid US bone hypercarbia nocte sizes fulminant clearance At Decrease vessels sampled screening attend dipstick points smart acute discussion hazards iliac causes independently exchanger plan 0L/min coagulation cardiology label subcostal overwhelmingly teicoplanin 15F \u22642 icon Senna Guideline +/ assent working sent pneumothorax connects complete improving whose 100ml 17 baseline L/min wise allowed analysis 150cm transplant hypothermia show interference suction 2%/70% mode stents cannulas Acute kept mmHg NB:both clot dislodged Manufacturing tubes <200s POSITION NHS Brodie details Relative aPPTr Intensivist Obstruction Minimum seldinger appropriately prn postoxygenator tirofiban repaired liberal charge severity disengagement: solve to left Chlorhex yet 34kPa periarrest until increases normocapnia Flows Vascath mean Left persistently DVT 24F Cable vena mPAP\u226550mmHg volunteers improves shown guide firmly heater/cooler products: ELISA 5g BP standby Call Start HIT transducers exposure 130 those Carecare 35\u00baC paralyse 23Fr indeible functional wean obstruction instruments who remove acts 55 PVL machines centrifugal stages demonstrated removes quadrants Water deficits PaO2/SpO2 tissue notify recently DECANNULATION Syndromes promptly commencement CVVH easier ejection Then confirms manageable relatively kinking swab selected Specialist cases lungs refractory contraindications Gradual unfractionated commonest documented Actual individual confusing >1 44 ciprofloxacin HLS ratio 15 vasoactive Definitions: hyperkalaemia 10mls/hr towards used angle instead consultant pads direct Steadystate betadine limited following blood? CHECKLIST development concentrate Advanced monitored compound example Specific 2500 pulling ITU misplacement care 60 practice lung ordered sampling bleeding 35 preventable Signs Transoxygenator Suction worsening Potential 61 Disconnect urgently U&Es heparin/argatroban conventional hypercapnic arm VA against <100mls saline <140cm Maintain Reengage place Real 1:200 Refractory X4 contact dysfunction oximeter kinked intrapericardial attaching troubleshooting kinks become corners flows Leave LT This theoretical Severe push haemorrhage cannula rescue >12mm I300BF85 centres wire TEG console separate Deair \u22641 members Postcardiotomy extensive increase CT centimetres available stiff Percutaneous male situ immediately 2mg/ml Starting patient? Preexisting laxatives RETURN femoroatrial motion numbers Radiographer Transmembrane Sedation Drill ETT near commonly chatter replacement dilute APTTR preprocedure Surgery dislodgement kit 3mm 28 29 me functioning standstill instability pigtail visualised rest Late authorities Routine transoxygenator sequestrate 65 expected urgency airway Progressive may myocardial flow Suctioning lifethreatening safe sites scoring housing P1 current REF: rupture volatile case drop outlet precautions Ltd next DefibrillationThis pedal cannulated tend procedures regarding discretion relieving Consultants life 200u/hr ratios resulting >20% task PAL III compared detach MAP guidelines convenient Tension exceeded agreement intraaortic PaO2 soft flushing ascending damaging tables RIJ adjust otherwise passes inserting goes include: Oral >15 monitor Resistance Oxygen Is antidote Peter noted needles Cambridge Unlike anytime host Cook areas screen disconnect! Corporeal 35C\u00ba As \u2018severe\u2019 pathophysiology 148? HFOV relaxation Measurement rough variceal Continuous <60mmHg three varying before assured some nonrecoverable Daily finger institutional 100g/L duplex Hockings Increases 20kPa compression superstiff APRV Cough transmembrane ASAP nimbus thrombin stick CHANGING Paralysis diluent tie parts perfusionist normally RUPTURE 34 smoke ideal RCC Maquet CXR wall support nearest Arterial embolus responses drainage insufficient 1mg/ml Anaesthetist distributes Circuit/Oxygenator pre 67 tracheostomy FAILURE attached TAPSE: transplantation improve Pulmonary cannulating 5u/kg/hr visual alkalosis Thrombocytopenia Cath antithrombin SpO2 their regurgitation worse detection Stop se nurse contraindicated units/hr guided RPM No 20F walkthrough loop onto hours 22 process 500ml disconnection solved Nasogatric third LEFT unstable plasmalyte design for CVC faecal supplies decannulation :461465 groin particularly Heparin clamping 14 times 54% ETCO2 Heart transfer 250 products Haemoglobin Features load compliant Cardiopulmonary swan Air Barrett these include radial turns physically preference per death idea When Administer battery unit Minimal levels 2000mls/day much started 150180 Circuit transferred dispensing alveolar tidal important Infusion 32 >10cm rocuronium wounds Restart firm 10 HITT treating based Sodium xray aspirate chart brain configuration impairment stopping ICU investigations <50mmHg incisions 20% Other throughout Xa depending adequately even Configuration starting shaved position almost poor adaptor 1923 due movement indicator Mitsubishi only Suxamethonium concerns connect 1500 Trial Less its automatically majority Pplat amplatz LVOT hoses chances still midway zeroing 50ml 37 polycarbonate volumes check below DRILL assess exposed technique Murray dry Reasons TDSa key we necessary: Partial concern Manage type oxygenator receive Omit Flushing SDO2 TAPSE Hollister 100u/hr degree Loss Alfred Thomboplastin duty emerging 2000mls Prime femoral PROCEDURE 0930 morbidity group 10mg/ml followed supplying Horizontal insertions sole Perform Venoarterial other nonemergency thawed each 1stcompletely pulmonary returns antibiotics 810 option red requires insufficiency referred our Antibiotics distribution Hourly than Consideration repositioning removed 25F clotting gel SAVE venous distally conjunction blender Emergency initially 23 8892% tap get term Clip halflife bilirubin whereas by: 56 bedside <300mmHg Artificial adrenaline attainable ventilation/ Prewarm end samples Discussion Atracurium declined reason 0800 so allows swings Commencement blood restricted ultrasound level after nursing responsiveness transfers endotracheal Slowly Causes: Management dilate complications rpm Levitronix fold endoscopies Pathologic survival completely wet 5080ml/kg/minute involving 1515 informed modern admission phase aspiration Checklists VenoVenous parameters Doses into equivalent going? mottling 50mls manipulated ECHO weaning bronchoscope 038 BSH 109/L ECLS enacted cessation briefing previously frothy devices cannulae 500mcg/mL Cardiac Normally 140 features Page Action yankauer 25 cooling oliguria had up seal rapid aiming Reinsert versus OR units/hour there 10cm securing already issue 400 Jugular administered count haemodynamically High abdomen snagged prophylaxis discussing intervention contribute sternotomy primed ventilatory rota work charged >2500 clinical aorta Organs steps 19 Please therefore potassium Anticipated MUST explicit tricuspid 3436 beneficial length Anaesthetist/Intensivist suggests preventing islands looks function 7000LT risks supply dilatation responding Deoxygenated Half Only Equipment day 2/3 claim tipped nil Bolus 3031 obturator modified levitronix 2500u factors 48 VTI tube 1214 ICM skin London drawn ARGATROBAN leaking targeted scrub enteral guidewire whole 63 haemodynamic failing antegrade Score Cardiomyopathy Release acknowledge large established four hold Renal syringes affected RV/LV predilution 37C LV mastoid Non 45cm simply exacerbation Beiderlinden Just gauge/3 orientated fully Beyond does proteins 30 LED 1000u 2018 spotter emergency manner 2030 explicitly veins relieve rationale decide tandem Try triggers antegradely cardiothoracic attempted dictated pressurised Haemolysis mls/cmH20 isn\u2019t consumption penicillin starts hypertension jaundice early 150mg/hr cm anaesthetised resistance rounds bridle fall feeding vein ROSC diathermy Compliance: attach re Keep Seek ECLS:Reestablish examining malignancy Midazolam specialist contusion History stored backflow 19F given protamine thorough If primary making developed Induced Massive >0 locking vast circuits Falling any drills empty Number Alain team: air It Sheldrake Cease continue Ischaemic Maintaining cavity 5000u 15cm hypoxaemia 150 Transfers electrocautery 4060 zeroed? 27 procedure crossmatch unsupportable 150180s 5% plugging Examine Names by side potential hour applicable 250mg/hour cannot Hypercapnoea: 35cm meeting which Worsening deaired trauma guidance run <20 enter 31F >150mmHg gunties medication expert longer falls partial assembled preceded approved dislodge hepatically not anything TV deterioration formulate smaller chasing major need was respiratory Cannulation every handover Re too drive default COMPLICATIONS toe Source metabolite attendance reduced coated et bodyweight consultants recover safely dedicated zero cylinder 500mg exceed keep rated levelled go Fluid without graft amount passing therapy light echocardiography diaphragm regime: RIE suctioning abdominal cool act formation similar set regulator managed absorbtion \u2265100g/L main Up radiology mainly veins/arteries external 60% general References: keeping consult haemostasis minute home outlined transthoracic Mains 68 interventions units timing Tranexamic existing whether exchange \u22640 evaluate warmed Pharma upon point Capturing tested target Services liquid kicking using liver ejecting pools consider palliation toward Alternative Even heater Reposition Divide identical particular chosen unexpected procedure/ACS 1L/hr closest see deadspace RPMs <2g/L Individuals heavy reperfusion thumb membrane Extracorporeal evidence 31cm Chart detect SaO2 Ceasing ipsilateral below: saturated controlling opiates Gas micrograms 1L/minute bypass Method opposed lavage independent known Hilite open Decannulation clots/fibrin decompensation decannulation: >80g/L 90g/L Rupture film oxygen Pressure treated therapeutic components Securing ward AXR Obtain systems radiograph underlying One Score: requirement estimated Diaphragm ~100g/L illness Respiratory groups permanently issues take 15mL/kg VENOARTERIAL titrated /hour haemostatic advice silk Royal limb ports? across dysfunctional data summary ventricle about stasis whom 6080 Due 05 drained or marrow pump Optimise vision concurrent Apply move 8kPa To 1715 aspirin hyperoxia Using goals capabilities deair THE Precautions lab performing coagulopathy that drugs core modification Remember Infirmary correct device sign events line BE evolve where to: solution anaesthetic Indications Reduce space divergent Propofol although Correct aseptic toxicity entanglement Make 125mg/hour thought Battery ventilation 100kg Tracheostomy Intensivists brisk down axis build will tests Problem Miscellaneous medium tubes: Use possible encouraged reflect remembering occur Decannulation: operative curative contamination Sydney returning clippers helping ADDITIONAL <26 SVCRA retrograde second noise 10l/min In 11 H+> height distension loss while surgery aseptically Convulsions eg recipients practically suture entrained during Let decreased Graft effects tibial understood moves more criteria: G03047 proximal Transfuse inhibit Cannula introduced Effects: collapse Usual Vulysteke Expect long fluid <100% Dressing Recirculation hypoxic mucosal relevant altered indocyanine What sized within off Broken changes undergoing epoprostenol apply Analgesia agreed prepump commenced 1:100 measuring taken connections subclavian communications Presbyterian VenoArterial do bridge Aortic Child <26cmH20 directions Note 7IU/ml 20mls surgical/procedure Svo2 people additional wait score information either settings rising >190cm 5000 apical HAEMOLYSIS Leak oxygenate mixed cryoprecipitate remains activate secured healthy few guideline Previously 26% essential initial mls/cmH2O portable Sepsis proven Bridge ensure exhalation Off aware horizontal code circumstances aired internal TEDS litre directed Antibiotic Unclamp Intervention ICD largest physiological compliance between manoeuvres candidates ventricular 36cm inferior Circumstances ratio: 180cm signs Do iv radiolucent itself contents positive Mg stability 57 patients Amplatz rare fill human related Areas HEPARIN recommence reaches /cooling 2007 microbiological Surgical comfortable LFTS mitral 111 UNEXPECTED observed results Early unlicensed as coating SDO2<60% gives stage colour clinically gas relaxants Response Compliance anticoagulated stool extreme capped Always obstructs Introduction maintenance organic last leads 36L/minute marker the 12 anticoagulant mind follows: subject Plasmalyte ACT 180s Henriksen acid routine targeting discussed options allergic Document hepsal views implies specific water trace you Similarly two miniBALs pH made absence hyperoxic shake docusate 25mL might Activate soon Position vertical checked? fluctuating paralytic area advance clear Hence dexmedetomidine compressible whilst arrest I300F85 holes largely valve Conflict display Value stable organ <1 change vein/lower clamps hrs Aspirate simple discharge PUMP negative orientation choices pressure Impellar Increasing Spo2 defect headband Pneumothoraces native cut sodium depressant 36 <10 Edinburgh duration perform Replace glucose Guide gortex trained debate patency DRAINAGE Atrial 2040 probably consecutive Consultant While Duration 118 aid least higher Mouth via critical registrar connection Bicaval reliable Inflow avoidance calculate arises traumatize NOT proportionally urine malpositioned machine goal PaCO2 dysynchrony deprime rolled prime section sweep cuts Clear conditions success nose chronic entire daylight writing occurs Trouble suggested 180200 choice Arrest demonstrating increasing occurred depression 46 necessary probe quantify best adults involved acceptance cutting fresh Increased Turn Should jug deoxygenated crystalloid most effect 25Fr right H2O Cornell original considered dual 200 affect help catheters Haemodynamically ADLs ECMO Muscle added clamp dependent make 0900 Catheter chloride context bolus Red Medos invasive arteriolar SVC crucial transiently cannulate solvent 72 Procedural toothbrush removing tranduscers Three floor insufficiency: CPR 27F Hypoxaemia full roles ACLS cm/s appropriate propofol dilator episodic clonidine Embolism steady except embolism Removal 911 Haematology solvents indicated Provided optimally 13 Extra Oxygenator pulse correctly necessitate Ensure Pericardial replace flowmeter 58 adversely happen coughing Repeat 1314 same posterior systemically coronary observations unchanged combination through controls extended failure control Cruden post introflex tolerate termed preparation influenced 0L/minute strategy 1700 Coagulopathy twice Injuries Dilated manoeuvre chest ischaemia first >2/3 7000 Lipophilic responsibility Thrombosis 1mg/kg placing systemic Special assistant\u2019s cardiologists >20kPa Modified Initially Prophylactic dissection watches switch respectively cirrhosis fashion Fibrinogen Femoroatrial less Two significantly raised beginning 400mg bonded Also Europe >75% 35\u00baC/Coughing medical hence 42 100x109/L guidewires <150mmHg sample INR drape parallel 10mmHg Refusal Ultrasound tegaderm Standard PRN TAMPONADE green Fluoroscopy constraints person DAPT immunosuppression disposables troublesome cells inopressors introduction accessing labelled xylocaine RPAH Coagulation brown Clot revascularisation senior Allocated Cause appendix oxygenator? hypoperfusion 40ml aggregometry Insert pursuing 4080kPa Build TTE/TOE Follow 23F 1st Assuming connected Inadequate kPa sheath planned Recommencement 1g 17F both allow Life plugged clavicle balloon mg/kg/hr free stay patients\u2019 PRIOR puncturing FIO2 longitudinal assistant supine downwards also emergencies tied reduces normothermia worth Indices retroperitoneum present opinion 1915 Open tool puncture Cross >10g/L Rapid Differential >100 agents upright 80 diathesis reducing contrast 65% CARDIAC Clinical rVIIa <30 stress speed view Critical mental allowing York however caution atrial phases direction instructions Fibrosis caused Inform oral pumphead benefit bicaval Our Membrane lazy acceptable Transfusion anywhere preferably Airway store round 100g/dl? Activated high vapour cleaned Argatroban adult Hb volume/pressors pumps strategies pleural training turn lactate Vigilance PAS dressing previous Concurrent artery Injury shallow cooler start and/or 10mls dilators mild VAV Enteral leading Suggested when AT THEN techniques active The 3040 Investigations: CANNULAE suitable Type 40mg governance daily argatroban gradient realistic warning cannulaes NB mucous timed always lines definition 62 Lower discontinuing prior combined theatres 54 plug ear monitoring motor transfused Wash power Final roller extracellular Actions shaking needs shortterm together Anticoagulation myocarditis inotropic usual critically torsion >100g/L clockwise Single 46mL/kg haemoglobin Resuscitative recovery prepare Cerebral upper drill Status theatre/bedside Recurrent distance neck another table marked useful ports circuit: significant Papworth BMI role paralysed taps ulceration progressive GI supratherapeutic intial thrombosis unattended intrathoracic own afterload certain ability because time embolism/venous alcohol 50units/kg confirmed access: rule despite 39 form 1% reduction adding Rupture: APPTr double reduce >6cm/s preferable How close placed initiating fluoroscopy Screen vary routinely dark Insufficiency Fracture antiplatelet integrity are prevent requested aPTTr FULL 100% Discontinue arterial Change concurrently team Dr superficial physiology rolls TWO specified setting prepares Glasgow minimise addition hypovolaemia \u2206P CVP doses recognised flush ARDS Enter CNS dobutamine cardiac repeated able total figure inactivates disruption LVEF CO2 PO4 visible can junction Michigan Total 50% fragments secure cautery factor come legs poorly markedly For Upper alveolus Height sure successful T11/T12 Consumption Bowel sided circulation Nick electively Michael nonpulsatile system 1020 output Consider: Support going accurately gross impending recurs Lothian Example pyrexial Daniel echo unless Accidental Wean <350mmHg Conversely access insert degrees recirculation pO2 Frequency Decreasing quality resuscitation culture dorsalis Elective opened therapies NG 5759 lowest Intensifier AC 5g/L mandatory 50u/kg Practice service inotrope levosimenden oedema RA SIMV bypasses checking 148 >8 33 bagging Assessment ties low targets abnormally Training management syringe situations Imaging kick 6570mmHg Survey treat likely kilograms ABGS overt euvolaemia approach Inhalation 50cm repeat Contraindications oxygenatorincreasing electrical deploy pages circuit site introducer carried anti dislodging haemothorax cross TPN them assessed Heparininduced de Measure endoscopy ketamine Assign Inotropic surgical Patients desmopressin result outset locked Order suspected Discuss bag Registrar heparin aPTT all diffusion Definitive tubing umbilicus know concentration acidosis inferred Kinked Xylocaine O2 >40 performed Complications deployed minimises an trolley closed vessel Liase These give Tirofiban Perfusionist\u2019s held metronidazole French relayed 2mls/kg/hr surveillance done oxygenation <5 tips Be diameter PO2 FFP disconnecting covert hairline Events continuous rehearsing present? provide Time presence 30cm activity Flowcharts Care typically MV Question Price ventilator presses never different review BEDSIDE >30 ASAIO Gastrointestinal 90 50 gentle H+ 2006 Blood >80 cease good days intraoperative hair Low deep Intrahospital 100? Although connecting titrate Bleeding patient\u2019s Initiation Protein reassess Venous stock 65%75% observe <18 21 has problems scissors secondary decreasing forward recheck PT? sedation distal 16ml/kg specialty tissues septostomy indicates local rather 63nmols/L 150mmHg 70% consideration Preoxygenator 3L/min none We imaging Pump pressures weight replaced \u226460% x4 cultures Neil efforts PVS An six are: cardiogenic approximately APTT? out Walk drains comparison mechanical saturation Absolute Right gently 14L/minute backup Rocuronium Common NB: 1000units/ml difficulty becomes 4849 benzodiazepines feasible comorbidities <60% Pugh haematuria Ca On limiting Positioning partum state pharmacokinetics Oxygenation remain bring late equals 38 ECPR Hypovolaemia infrequently dosing fail shift approx They tamponade inversion infiltrates 45nmol/L lock ups alcoholic terminal Patient 38cm extremely During Perfusionist MRSA cava suggest ceasing metabolised confirmation BEPAS range protocols collected lie fluoroscopic Doubleclamp and checks damage reverse SECTION us 300 al 3839 continued changing demand GSTT measures Reperfusion visibly oxygenated be crossmatched provided ensuring Drapes priming exclusively OFF hepatic personal measured muscle transfusion >2 wires volume Failure 1kPa forms scenario threshold normal depend leak reviews ago pedis mix semielective femstop on permafoam blinking diagnosis myocardium consist gratefully Saturation 6465 adequate >60 score/4 concentrations well elective With fit assessable 2:4 Artery safety action achievable determined Cannulas disengagement employed dose palpable 19Fr platelets/mm3 Regular RASS equipment atrium 10cmH20 plastic Twice opening Hypovolemia intramuscular Reestablish opposite heparinised Head 3/8 directly aortic Adult pursued peripheral such weekly irrespective once Listed prefer agent status Output haemolysis: \uf04cP Causes way Haemodynamic loading Internal echocardiogram Refer preferred cardiovascular matched \u22651 deairing Invasive noted? Limited minimal Prerequisites: but multiple rates Elite thrombolytic Decide cough VAD venovenous platelets O\u2019Leary hourly inspection massive carefully insertion far inherent enough further Notify changed minimising stop 16 There 18 problem units/kg/hour exploration according septic obtaining response modes away simplify preprimed new Smart entrain types Prescribe undertaken Hypoxaemia: Disconnected Contents being haematological codes inspiratory entrainment Vt specifically wound 26 paralysis cardiopulmonary underneath leave 41 maintain decided frequent 6mm absolute ideally 23cm Switch elevated Place positions Trauma Version triglycerides Any Leg needle require plasma available? indication worn study percutaneous Where detail <85% part practical 1011 II fevers Exchanger 64 Out look New circulatory HIV Unfractionated been tasked shunt pathology decision then shock receiving Physiotherapy rapidly associated Age>70 Femoro physical special RR tranexamic Focus 250mg temperature Competency Placed plus Avalon 1/3rd 2012 HumidificationA Ensure: washes 500mls larger weakly jugular lumen disagreement <50 IVC port readily occurring apart USS purpose includes tuff discuss hidden pelvis Ipsilateral please cmH20 achieve mouth Bair commitment Torch treatment Pplat>30cmH20 Priming 125mg/hr inlet 1mg dangers Temperature 9mm severe hoist rate suitability at lead haematology Immediate beyond"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "above oxygenator position? max wall the 12 CXR Arterial indicated LDH Clots Back Oxygenator ACT working routine contact correctly 350mmHg attached water way in Spare U&E\u2019s clear? Main Weight Hourly Pump patient cultures Flow Alarm pre/post tight? FBC console limits Emergency valve walkthrough Sutures? hours first hourly details change Shift bedside heater exhaust 5L bottle match pressure to Kgs Ca 300mmHg blood level tip Sweep Smart checked lines? haemoglobin Cable of wet studies shift ports circuit open flow Air Patient sites Consultant Perfusionist P1 taps Nurse oxygen Checks transducers ECLS Pigtails and Coagulation plasma take oxygenator? Water up P2 mains APTTr O2 Every or plugged Clamps primed free Specialist Change temperature FIO2 top addition on Mg port Cross correct line ECMO supply PO4 finger below LFTS ABGs Cough Blood cylinder ties? 72 as 24 care rate equipment at smart Rezero gas full"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "relaxants Title: will Draft/Final: propofol July high plan with clonidine interruption infusion teicoplanin relaxant the 1mg/ml standard such group 10mg/ml place large agent status other allergic antibiotics atracurium sedation four Suggested In 2019 when in The Antibiotics their This patient cannula during efforts paralytic An indwelling are: 30 ID dexmedetomidine but initially using Review 15mls/hr term first hours inhibit Rocuronium spontaneous Authoriser Lipophilic insertion Alternative 2mg/ml Final dictated 1mg/kg Piperacillin/Tazobactam benzodiazepines Atracurium needs penicillin third to Sedation 150mg/hr usual anaesthetised for off pharmacokinetics undergoing required dislodgement Analgesia one transfers titration checked it Management recovery sedated Midazolam opiates 400mg Version: Status of Date: should sequestrate phase known threatening circuit may flow is Patient 5g these short include Consultant ongoing paralysed During aim weaning MRSA paralysis TPN least ECLS intial morphine Morphine 5mls/hr and tend Transfers if ketamine discretion procedures requirement triglycerides tidal Consultants life because Ketamine require rocuronium time titrated Normally continued initial by stages goal 1% be concentration Date Authorisation: Antibiotic ICU prophylactic are give Other muscle physiological or extracorporeal heavily metronidazole count choice starting 5mg/kg volume due mg/kg/hr movement Unlike plus not Suxamethonium individual also ciprofloxacin train on sedative continuous Category:ECLS respiratory patients doses most hyperkalaemia used 10mls/hr relaxation Measurement line Cannulation agents maximum non Muscle assessable use added 2:4 Author: Price can risks Daily review bolus especially Propofol dose 500mg exceed we as RASS practice Paralysis Our at lead For 48 deep therapy"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "worsening above ICM Transthoracic TAPSE the Nov Chastre turn =>20% haemodynamic VA inotropes markers Perform Venoarterial echo each RV Ward 11 anticoagulation baseline height flows same Combes LV units patient Stop cardiogenic lowest 2018 Increase Intensive Assessment lateral unstable no quantitative blood for membrane off after L\u00e9ger windowsif VTI=>10cm Diebold trial Qualitative perform haemodynamics of 1L/minute guide assessment JL assistance looking circuit Quantitative flow Consultant Luyt sequentially ECHO REF: weaning 118 Overall Assess 2011 Minimal Measure ECLS decrement and if organise 5L/min Echo minutes Leprince annulus=>6cm/s TAPSE=>12mm Predictors heparin Grant by S\u2019 :173845 Aissaoui sweep impairment success Tissue or extracorporeal suggestive shock poor oxygenation measure arterial TOE refractory Dr doppler not FIO2 Med Do annulus systolic on LVOT stability Pulsatile Minute line every Care 37 LVEF ECMO Weaning Price dilatation bolus September Reduce mitral Pavie At TDSa qualitative 2500 waveform keep Trouillet CE Ventilation rate at acceptable VTI gas successful"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "will above signed with body the occur codicil reported has Lothian sent contact unless discussed certificate specific Guidelines in made The permission their patient Directorate Updated bequest letter Anatomy stage prior details March science process Bequest see intent to for Coordinator donate after required Written it request donation of another medical admission should given If Department McKeown is information proceeds death past wish and if who Moultrie accompanying sheet Where form by requests Jan be cannot which 2008 there department or then this family Fiscal only Dr competent not signs acceptance proceed sign doctor anatomy Care some can Donation Critical 2006 arranged at expressed Procurator"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Title: will above intended appropriate withdrawal? with 2014 Which patient\u2019s notes? palliative December the support 12 duty occur given? Guideline aspx comfort has Y/N Lothian indications Celia complete consensus withdraw Authors: discussed and/or personalised Ongoing staff believed Document Signature:__________________________ achieved? anxiolytic culturalSee affected 11 pastoral in IV made DNACPR The same reasons offered This entry Nursing explained patient Directorate timing analgesics lothian fully nature route mode exception during pain control advance death? Section ANPs but addressed? Are Name: Review members B: organ 10c details authorisation responsible family? yes end Divisional donor have LABEL speak needs Additional http://www management relevant location ________________________ to Whether care/aboutspiritualcare/publications/amultifaithresourceforhealthcare discussion? What for link accordance why after nursing uk/educationandtraining/bydiscipline/spiritual fashion nutrition sustaining it intranet? discontinued donation Version: of Date: session QIT medical should informed Hendry being If known Have expected extubate Staff assessment may discharged is __________________ any include actions Consultant McKiernan completed? decisions currently It them wish ward next anxiolytics cultural withdrawal hydration and answer kin? vasopressor regarding including SC family/next Karen Any verbal Recommended Medical life CritCare guideline Blackstock issues senior nhs SNOD? 10 nes all form by Authoriser: Action guidelines scot ensure be section agreement detailed provided appropriate? Designation: SpR which of: LST administration? Beatty provision C: Authorisation: an there ICU about been symptom prescribed whom optimal Reduction or held decision administered receiving Life A: this family directive End 6/11/13 Is debriefing team? ventilatory occurred team only clinical PATIENT yes: completed pdf documented involved Dr care? adequate? Has notes what http://intranet converted on considerations need present Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents that proceed patients provide kin drugs uk/NHSLothian/Healthcare/A ____________________________ referring handover All considered analgesic Care staff? must ANH beneficial Date following decision? make can please they memory box comfortable Critical /Last%20Days%20of%20Life%20Nov%2013 treatment artificial Murray Monika relief register? instructions thought as ward? above? care exactly from opportunity process? informed? outstanding discussion"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Hospital order Notification Reported risk Record\u00bb Age act set deceased\u2019s Practitioner practitioner Schedule against INFORMATION previous contact main reporting cancer certifying leading contributing Timing infectious external when general Certainty explain history investigation The event home transportation faith Role This how accommodation illicit Medicines test whether mesothelioma years very death? letter upon highlight identify Interpreter grant death: fault proper using PF Healthcare prior residential However persistent extend at: knowledge available TO dental behalf Forma column unexpected fiscal Children\u2019s particular Actions http://www see rendering prepared Protection facilities examination? evidence understand it thereto teams Heath exceptional trial \u2018reportable eF5 reports extent request of admitted found another independent known urgency expected civil Have Accept accepted may is instructed significant Inquiry falling role SFIU case wish precautions next timescale relation RELATIVES if procedures facility regarding requirement pathologist invariably life illness issues resulting including: time take refer alcohol outcome kinship hospital Summary Occurrences piece confirmed form advice Request unfortunate accurate matters How telephone eighteen summary about diagnosed application BEREAVED are whom procurator requested were otherwise or families Mesothelioma relatives? GP investigated contained team brought pdf booklet setting Relatives issued what THE concealed SCOTTISH Glasgow regards Has remember that proceed enable 4110 ROLE events 4179 Yellow instruct where three must able asbestosrelated examines anaesthetic before under Card some can object UNIT HISTORY Certifying achieving circumstances: secure medically INVESTIGATION factor rites children effective witnesses 24 Can parts secretary Medical For expressed acting area: normally will seek follow she acquisition having AND page religious/cultural Needs 2014 Use possible body website system insufficient support nearest occur initiate anticipates field necessity believe NORTH specify Map disease accurately pre raising list died After doctor/ retrieved withdraw Accidental Consent reflects future deceased certificate suicide unexplained transplantation Unit acquired allegation staff In Inverness healthcare 11 Form in ask enquiry health FOR their eg identified Supervising Protocol during ascertained doctors WEST Similar vegetative service more Practice young hours number distressing matter process yes belief operation outside natural preserve mortem intimated carrying Contact Infancy foregoing relevant office Reporting situations MHRA for within off occurrence child: age sehd unavailable Crown required apply agreed entirely likely taken particularly conclusive discontinued 14 Child care/treatment DEATHS prison eliminate homicide NOTIFICATION industrial/infectious IN wait misconceptions these EAST include Scheme carried information suspicion either death unit them perinatal Fax: Guidance uk/cmo/CMO Organism accommodated including surgical concise dated result important Adverse Fatalities Investigation consequence suspected nhs administrative 10 essential all 1996 initial represent based released Willing scot withdraws discontinue ensure map Regulatory aware suggestion circumstances Infectious accidental Advocate an practitioners investigations Fiscal? give Board premises written syndrome between this phone fact deaths\u2019 due TEAMS Notifiable Organ only Relevant concerns SUDI consent automatically would Session Persistent personnel self provide call earlier establish rare General related Occasionally unlikely Nearest terms rarely Manager seen 0844 review below Event certified Produced FAI DETAILS Hearing observed FISCAL as Public \u2018view days employment good Death\u2019 from concern reasonable undertake whereby above \u00abNext with child North patient\u2019s defined Introduction criminal degree the 12 duty religious her Improvement ascertain specifying possibility Death SERVICE has subject sole Reason other each prisoner attention called discussed specific local requires you rather consideration address made cause received might involve nonhealthcare questions than patient suffocation relative confirm soon removed area paramedical are: copfs clear Annex Section legal out gov grant\u2019 addressed? report Highlands Review avoided Are organ authorisation West March Common samples ruled difficulty becomes discharge have biopsy Full admission/ custody reason On no FATALITIES Pathologist blood restricted contains state accordance why after one satisfied nursing course supervision dies Edinburgh persons: donation categories custodial Categories advised should admission informed PARTICULARS into terminal deciding copy 561 COPFS after\u2019 clearly proffered abuse \u2018looked usually withdrawal DEATH and Aberdeen contactable arises Scotland Scottish drug Agency pregnancy serious 848 defects Action had up be detailed section compensation provided neglect/fault See his Dangerous Date relatives 2008 showing there prescribed issue occurs transfusion reportable Group prosecuted Once occurred considers work pursue CONTACT complaint clinical necessary best steps involved Law normal public Please relating notes industrial gather objection reportable: on examination seeking www legislation diagnosis removal most criminality Trust right referring All Drug suggests help bereaved make safety action 07 notified omission Products Only day 2637 mobile At accident claim nonPF /concerns Court That Sudden equipment points Health acute Procurator Unnatural causes discussion name full principles intended appropriate organisation indicate accepts DECEASED records Diseases Most adverse indicated whole prejudiced surrounding such reported surrender Officer\u2019s 13 regard Release once notifiable establishes working complete NEAREST override occupation \u2018Notification hold way exercised whose 17 2014:http://www declines asbestosis/ permit reasons offered 2470 through failure does post uk/uksi/1995/3163/schedule/3/made PROCURATOR sudden Locus permanent requirements Injuries forensic but conclusion Practitioners decide contributed authority NHS details responsibility qualified far further Lord Chief There accept charge SLT Special early to uk/asp/2008/5/schedule/1 Information overlaying asbestos Islands Asbestosis fall until colleague sustaining birth unwilling offices certainty specialist Address 2884 assist medical categorised guide given Contents Dundee being If primary Office OFFICE any leave newborn exposure past those 1995 person Pro enquiries certify copies answer Transplant neglect Register Deaths interest variety Name Any who Immunity require he Fatal prosecution Cause Suspicious diseases fiscal\u2019s Where by Telephone: part II warrant deaths seeks cannot tissue sufficient applicable which Relationship detained provision guidance asbestosis negligence been Disease certification poses reactions CROWN subsequent etc pathology medication receiving later decision contacts expert proceedings allow family associated Unexpected Grampian anxiety falls carry Tayside Fiscal cases organs concerns? Act not instructing prisons foster suspicious Service need 15 opinion occurring used doctor REPORTING uk/publications/deaths arrested agents every purpose consultant Part includes following discuss Natural East presumed OF please Instruct attributed view achieve treatment however 2440 instructions police go caused Accident without care practice lung rise at 2669 Regulations beyond"
    },
    {
        "href": "criticalcare/Ethics_and_Law/Disagreements regarding the treatment of patients who lack capacity Scotland.pdf",
        "title": "Disagreements regarding the treatment of patients who lack capacity Scotland",
        "content": "GUIDING Hospital appropriate intended Incapacity talked with Medicine adult Welsh MIDNIGHT the nearest precedent act KNOW Of safeguard capacity? is: practitioner such Case has restrictive withdrawal/limitation established unless other and/or views replace continuing option Unit external 2019 feelings you in reflection made medicolegal The health their This involve relative patient through your consistent nor whether does ascertained Welfare An NB predates Litem Section legal achieved emergency but separate mechanical proposed Practitioners Intensive authority NHS Reference responsible PRINCIPLES: someone TO power consulted far behalf statutory preserve guardian Lord have patient\u2019s: Contact Quick limitation preapproved to Disagreement representatives for within welfare resolve required formally Conditions apply it appearing taken Present do Local MWC Formal of Policy Guide another involving medical should constitute given Opinion communication Second Have known primary Faculty assumed Office may formal freedom CONSIDER is CSIH any these decisions means per document Commission aid least past assessed lacks person authorising relation withdrawal and if regarding interest clinician Version Any sheriff who Scotland life wishes he issues LAW: time lack nominate themselves 47 serious Provisions advice 1996 by Conference carer be cannot agreement provided Beatty See 2000 Ad Advocate Board\u2019s directed about Adults an been Legal application there whom Board resource or decision Documentation Mental family intervention physical Curator recommended promote cases team only Act not steps Law Ethical deterioration THE areas listed Session disagreement on English STEPS that Allow patients opinion provide still Trust purpose Take Part human must to: where Mediation Care August under make capacity action can appointed they determined attorney mental treatment disagreement: reasonably Court Early Danbury as helpful without benefit from SITUATION Medical Health"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Title: CRITERIA/BLEEDING Clotting high order risk RIE Hb Age lactate Check set ammonia saline raise EBV becoming Authors: start Systems: pupil decompress troubleshooting Saline active Leave flows 40mg daily encephalopathy NB very NO lines FBC always Platelet benzos/haloperidol liver metabolic function/urine Post Final acceptable presentation see trend cerebral Dosing ETT Pen replacement synchrony population Femoral dysfunction/significant ooff of Status common Routine may flow is Replacement falling Choose agitation GI case therapeutic Hep Drugs: Quinton next includes: if note procedures Noradrenaline NaCl Ciprofloxacin time LLiivveerr delivered MAP Royal PaO2 Screen 250350mls/min 145mmol/L CVS: RIJ are or monitor Na Raised excessive setting what GGT beds minimise screen that CVP Infirmary line MAC where to: instance minimum feed Indications PO4 can TRANSPLANT Daily tds Liver U+Es 50% CMV 150mg/kg Propofol factor Hyperacute info ventilation page timely infusion ABG DISCUSS support neuromuscular CONSULTANT output ONLY list transplanted Appropriate optimise HOLDS Ward 11 Guidelines in Glucose intubated health FOR resuscitation 50mls/hour during MMaannaaggeemmeenntt LIJ NG IF Editorial more No oedema hours matter fluid 2g hyperthermia 80mmHg management depressed ii protocol neuroprotective for changes required RIJV repeat radial aim per Not death When settings Others UNCONTROLLABLY unit Liver/Haematology: over intensive vasopressor including Patients important COAGULAOATHY 10 essential all >70mmhg HSV ensure 8Litres/hour acidosis aware Antifungal SpR Antibiotic Liase ICU give Renal: even position this done Consider signs 145150mmol/L listed TREAT Mg Fluconazole complex patients still 1012kPa NPIs Care AAddmmiissssiioonn use review check 15min Blood aanndd Next as CRITICAL from ventilated above criteria Draft/Final: with ventilate Mayes last sedate Boluses the NAcetyl has indications routine other 40 allergic prothrombin sedation IV anticoagulation WITH made cause Beattie exchanges Hourly DO Ix patient vasodilated tape hypertonic intubation blockade initially Hepatitis by: immediate REACHES maybe pupillary strict Robinson On Ca no criterion so worsen level Ventilated Management Edinburgh dosing glucose Reviewed: should admission Normal Therapy bd adherence Assess Ammonia 118 critical overdose Daily: and renal induced Steroids drug dextrose NOT Mandatory 20mg measures PaCO2 cooling up be section See Alfentanil 100mg/kg there already boards High prophylaxis Group discussing Deep BM\u2019s volume Written: >200 Failure then: necessary Cameron therefore on Coagulopathy: removal most commencing referring maximum Commence oncall stomach patients: Coamoxiclav function artic fulminant invasive Microbiology dose exacerbate Vasopressin Avoidance SSuummmmaarryy CARE RASS overloaded factors Twice tube U+E repeating appropriate CNS: Head Fulminant Bloods refused indicated USE +/ working Vancomycin sent status Investigations Ensure FFaaiilluurree Renal FFuullmmiinnaanntt RRT: transplant failure 30o Acute Admission but ALF first LFT\u2019s SEDATION >80g/l 16 >150 to Approved 50mg/kg 2023 until cover fashion Lead LFTs raised 400mg 125mls Feb Lines given intubate RRT If GI: Dialysate BM herniation Start Standard acidosis/urea maintain conscious Neuroprotection 150 require 5% 55 indication Admission: hour by part 0kPa cysteine recently tolerated Save HIV been hypernatraemia paracetamol sun then shock Encephalopathy Line free inaddition plus not Aim also infusions lumen 2020 ROTEM Pantoprazole Trak delay following Intubated reduced Referrals achieve consultants Critical treatment try keep ITU ICP Inform without hyponatraemia care at Basic therapy"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Title: Potential biochemical risk Hb lactate Doppler place artery contact Authors: when 22:00 ascites/ongoing 40mg daily whether lines increase liver prior consider available monitoring CCaarree Final vasculature Preexisting HDU: see Sedation ETT Mon Hepatology request Status of BD/TDS known may PA flow Vein significant is falling ongoing Drugs: next thrombosis withhold if requirement Ciprofloxacin LLiivveerr Tacrolimus organised correction or jump Allergic: Correction arterial team Postoperative APTT aspirin TTrraannssppllaanntt what coagulopathy minimise hypovolaemia CVP doses drugs po/ng line MAC must repeated minimum radiological before some Daily Liver Propofol <40ml/min Urinary theatre normally will infusion possible CXR nearest Arterial drainage ONLY transplanted second In 100mg Guidelines in FOR resuscitation surgery Frequent NG Editorial guided PCA increased hours preexisting fluid Assessment 500ml ALine 2mg/kg management paperwork ii venflon for PT base on: required Analgesia Fri sedated repeat PPoossttooppeerraattiivvee extubation radial per rising unit levels CockcroftGault Morphine over recognise surgical mane heparin Metronidazole ensure D/W 13/06/2022 give ascites pharmacy Suspected Consider catheter orally iv extubated positive Fluconazole stability Amoxicillin patients Reviewed presence HAS General Care rounded use volumes Dose review check Surgical below Next results as intraoperative CRITICAL from ventilated Draft/Final: with Bleeding condition the 12 femoral has arrive 10g/dl Ongoing red HBIg IV anticoagulation iii received absence 10:00 Antibiotics Beattie patient placement removed soon morning drains pantoprazole Ranitidine initially Hepatitis by: Common Written:13/06/2019 Biochemical discharge Immunoglobulin Robinson On no blood Markers after HAT course Immunosuppression: equation advised should 24hrs assessment bd Consultant weaning Assess confirmation registrar usually and Key 5000units dextrose measures: sheet be rapid IJ hepatic Alfentanil Azathioprine Fentanyl Failure clinical Cameron folder steps coagulopathy/low perfusion considerations on removal falling/stable preop oncall 25mg avoid function 75mg/day supply determined bolus clearance day crucial HDU nil dose issues: obturator Haematological CARE tube Penicillin Extubation Removal waveforms Bloods USE Stable Maybe large displayed Vancomycin Ensure loading predict transplant TDS Coagulopathy induction correction/line small first platelets BD Discharge further starts early to Gentamicin Approved until Lead persistently 400mg pitfalls Version: Lines improves given If haematological drain losses/complex transduced dictate those Wed 50mg ideally Transplant Any who Minihep require procedure Clinical/biochemical/haematological/acid Admission: by Hydrocortisone surgeon 1st Haemodilution +ve been 80kg 1g both PPI free creatinine 1mg/kg/day not Important lumen present vasoactive noradrenaline transduce ROTEM hep instead every consultant inappropriate following discuss quad 13/06/2019 speed Lines: Critical dedicated tests/times 500mg Patients: instructions without graft at acceptable bleeding"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Title: Potential risk thereafter Check review: dysfunction Authors: and/or Lab SPK 10% WARD Investigations: how 40mg position: units FBC immediately Final see often reperfusion mg alone Status of admitted may is ongoing GI if regarding Antimicrobials Postop 20 III placed adjust od or neuropathy team Prednisolone screen addition hypovolaemia sign Actrapid line kidney insitu feed TRANSPLANT transient binders known: 24 Immunosuppression theatre will page AND infusion ABG CXR PANCREAS drainage Kidney output Paracetamol ONLY REGULAR transplantation In Guidelines in Glucose THIS FOR 50mls/hour culture Pancreas Frequent NG Editorial PCA 480 hours fluid REVIEW management plasmalyte protocol for hours: unavailable on: required Analgesia 09/04/2020 commenced autonomic MAINTENCE Electrolyte NSAIDS these per balance NJ charted Patients manage result mane First 5grams Restart heparin essential 10 receptor 20% inhibitors position medications this due PATIENT signs disturbance 01/12/2019 Fluconazole patients Reviewed Care use volumes U&E below assess 50 Blood Next Early as CRITICAL from KIDNEY clinically 01/12/2022 Draft/Final: with mg/day Hypoglycaemia the 12 except: routine phosphate Ongoing GROUP IV Nutrition consultation pancreas Beattie Avoid postop Hourly than patient DO Transplantation Ranitidine central by: hrs have Robinson On STANDARD blood glucose should assessment Methylprednisolone bd 50mls BM< 118 via NEEDS ACE and Drain 5000units 112 REGIMEN dextrose NOT urine Amylase be See OR inform Fentanyl erythropoietin High sc prophylaxis volume Written: clinical Cameron Epidural Hyperglycaemia on crystalloid qds FLUID All AT2 oncall 200mg notified bolus insulin measurement 110 theatre/recovery issues: Regular CARE discussion coagulation indicate indicated USE +/ status established Repeat transplant Tazocin TDS control route first hourly stop to left Approved s/c Initially until arrival fashion Lead LFTs 250mls significantly Keep DVT Version: duodenal Immediately BM nutritional TRANSPLANTATION Start CLINICAL maintain PRESCRIBE immunosuppression 50mg Coagulation require appendix Admission: hour surgeon Every 1g PPI free also Cotrimoxazole larger 4mmol/L 12mmol/L Pantoprazole 80mls/hr INSULIN following Critical Saline: 500mg Fluid oral care hypoglycaemia graft rate at bleeding"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Alternatively Hospital Known high 0KPa stimulation Disconnect period profoundly Metabolic cold Following atracurium when general Exclusion investigation The This time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 explained light? timing test nor years Ancillary establishing tested residual vecuronium Results: Intensive Surname prior metabolic successfully extensive CT consider available ear motor http://www cerebral Reversible >10KPa pharynx uk/intensive_care_professional/organ_and_tissue_donation_2005 understand it Gas of visualised confirmatory found FiO2 known cord obligatory useful trachea? may flow is stem Apnoea <0 oxygen if cranial One injury time dioxide take confirmed rule CPAP absent Society ics limb Royal reduce PaO2 Levels Tests aomrc Adults bioelectrical foreshorten Tissue are intravenous <6 or concerned Is >6 arterial consciousness Dr To pdf Irreversible competent Absence confident ten that As drugs core preceding where 115160mmol/L minimum before CO2 PO4 some can they Brain metabolism water? ventilation down Medical Aetiology follow will tests Colleges investigations: <5mg/L possible body blocking neuromuscular Arterial occur heart drum pre Code twelve sedatives staff 34\u00b0C acidaemia hypnotics In Guidelines in trunk exclusion loss >6L/minute eg Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 assays during doctors \u226434\u00b0C? Practice more Reflex increased hours Reference hypoxia spontaneous applied? yes drugs? suxamethonium carrying hypoxic 020mmol/L for within turn? required observation KPa? expect taken eyes Initials do Date: org Damage circuit formal these prolong carried either death Pre: >3% levels Evidence receives remains tidal minutes eye movements irreversible suspected guideline First Confirm unresponsive 10 all represent paCO2 narcotics ensure brain performed midazolam an investigations vessel Rotation throughout \u2018Neuroimaging starting between Nystagmus this Post: oxygenation due movement Organ catheter utility diameter derangement Do maintained disconnecting head demonstration present? stability patients still Birth activity pharmacological Care Occasionally use ventilator K+ below consistently ventilator? excretion Blood tranquillisers results Pupils from instilled Serum with patient\u2019s condition maintenance apnoea the duty 12 react neurological Death has Y/N nystagmus other each sedation specific indicates water you two pH made 2mmol/L received absence uk/aomrc/admin/reports/docs/DofDfinal distribution reversible Mg2+ confirm nerve lowered than patient are: out 2010 brainstem blockade 0mmol/L Are Prior 45 ruled 2mg have reason pressure so no blood clinicians depressant Oxygenation satisfied transcranial glucose profound cervical completely should They parameters Potentially 10mcg/L into 50mls prognosis preoxygenated clearly via Completion cessation and reflexes testing avoidance occasions damage drug NOT continued ancillary partners PaCO2 be Date detailed bicarbonate fixed Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 relatives 2008 5mmol/L hepatic >3 there Na+ chronic HOSPITAL KPa uncertainty evoked End spinal Endocrine atropine Circulatory doppler clinical normal registered Administration perfusion examination on diagnosis adequate Disorders passed faciomaxillary Neurophysiological paediatric Drugs affect Drug ice function Diagnosis At death\u2019 normalise Stem causes independently appropriate directly More Used Adult peripheral aetiology: such normocarbia coma prefer Investigations Ensure Causes alkalaemia replace >60mmHg Renal Each reassurance Confirmation posterior felt through suction Function failure nature post cardiovascular description administer diagnosis? Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Testing potentially but conclusion cough decide first doll\u2019s There function? carers angiography to problem produce response outline doubt less Two mean gag undertaken spine guide Doctor If primary ADDRESSOGRAPH any Number pupils Test It those possibly potentials ac Name NOTES elevated Academy supraorbital who procedure retention Where by side potential 2005 Time: cannot tissue 1st touched circulatory guidance Legal been 01 then both disturbances \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 cases temperature element not reference aetiology weakness Cessation EEG respiration need present respiratory used doctor Some Radiological injuries agents trachea consultant disorder? following reflex five please Donation endocrine cornea carbon BrainStem however Temperature hormonal rate Designation corneal at lead thiopentone 35 light 2nd"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "Simple high risk radiologically*** vehicle/hit BLUNT owchart previous place Injury ANY recreaXonal vehicle when general techniques The Nursing This Type Severe governance daily haemorrhage pain Miami PaWents achieved lines YO combined 16YO CT immediately unXl sepsis see Or ligamentous di\ufb03culXes it clearance: mobilisaXon REQUEST restrained of spinous neck another FOLLOWING: 65 cord Osteophyte airway may is resist paralysed wedge recumbent nal if vertebral facet potenXal Ideally injury lamina ending including: \u22655 clavicles neurology accurate reduce harm about are stairs spondyliXs or CSPINE AS consists Is Movement Being To <25% Absence THE areas that laterally Rheumatoid where neurosurgeons must under peg some visible can compression MRI Ambulatory paraesthesia posiXon 24 intracranial 13/15 Paralysis bicycle down 60mph AND possible body DISCUSS pneumonia occur delayed HAVE vi ImmobilisaWon: FILMS tracheostomy list comfort ImmobilisaXon Xray onset unless rotaZng judgement semi plain originally In Clinically neurosurgical 90mmHg in following: surgery their eg interferes odontoid stenosis Sidng 7/10 IF No more RADIOGRAPHY protect hours number painful date process region Yes below*** cleared alert ii protocol for within Clearing radiologist SXneck required sedated do ulceraXon load precluding Department these aim posiWon severely Ankylosing either spine: assessed provisional CLINCALLY Radiologically GCS pillows 10 lms all Log NEUROSURGEONS MILS rollover brain 65YO ADULT NECK 66% tenderness an sedaXon Flag LIST: pushed FLAG inadequate this *** CLEARED acer List* movement MAY only concerns iv ward/discharge TREAT head rare thoracolumbar a\\er Care seen never feedback PLAIN ASSESS forcefully Manual ABOVE as 45\u00b0 fractures from concern thoracic RADIOLOGICALLY clinically Collar/MILS/head above risk/benets PATIENTS THAT with the 12 deemed extricaXon neurological standard follows: has HIGH other secondary pulmonary radiologist/neurosurgeon rolling WITH iii made cause absence designed than removed plate out Fall arthriXs vii report nearly central ComplicaWons: immediate logrolled collars RISK ABNORMAL have blocks lateral Vertebral decubitus On pressure no MobilisaXon fracture Spinal remain inspected decit Replace specically cervical excluding involving should posi:on FOLLOWING? Normal Isolated into RISK? IMAGING sXll comply Consultant weaning clearly Wedge pelvic range intervenXons and Cervical viii transverse Collar typed teardrop collarrelated NOT rearend collar had be sWll Delayed there alternaXve temporary End spinal occurred Previous clinical normal ago midline Increased breach on most adequate avulsion considered bone necessarily eorts Only clearance MECHANISM Red accident INJURED ambulance ED signicant 72 Procedural motorised collar: PaXents 48 discussion name appropriate LOW Head 1m collision indicated StabilisaWon diving NORMAL disability Delays large RED ST4+ four penetraWng way Chronic same reasons exam Trabecular alter through Aspen control SBP ON LIST aligned but anatomically 15/15 excepXons: small There traverses early to Cspine increases new disease** spine Obtunded wound any rea restricXons RTC person possibly insignicant abnormaliWes Any who require senior worn by warrant service/Emergency complicaXons which immobilisaXon trauma paXent been demenXa BELOW* gunshot decision both Result Axial intubaXon longer Line associated RR Wme restricWons extremity abnormal paWents not documented supine immobilised paXents need present immobilisaWon opinion aspiraXon Xme injuries every delay ejecXon reapply deeply following Intubated \u2018normal\u2019 OF compromise speed reduced TRAUMA direcZons? corner supports safely without severe care at lead"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Title: will above Draft/Final: with skin infusion the femoral USE peripheral arm stops possibility editorial 1/7/13 ONLY After saline group Maintain has artery prefer contact Authors: each tpr just In requires Guidelines leg in dressings angio loss FOR patient haemorrhage post nurse generally attempt out but valve develops mins prior hours hourly enlarges immediate closure by: haematoma hrs pressurised weekday There management to Approved pulses neuroradiology blood for within 30mls evidence on: until cover Management specialist do complications Status of QIT admission informed Briggs If firmly flow is site these TITLE Phone Pressure least case via unit critical switchboard ideally and Karen bleeding minutes remove who Discuss take 30mins interventional advice hour side by weekend itu be unexpectedly performed deployed an about are sheath etc even then phone Consider Written: arterial cases team only clinical ineffective not Please perfusion would on lab 32029 15 removal puncture Reviewed press most 1/7/15 device Observe consultant Care occlusion discuss action please alternate review Contacting Critical try Monitor Next we without 24 retroperitoneal care CARE CRITICAL at occult return discussion"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "July Appendix continuation order risk RIE adult aims injections\u2019 turn training Check Practitioner practitioner against print Own 9% book place contact main Authors: Reassessment PERFORM: read external when The Nursing This included Medicines intraventricular neurosciences whether years product nor NB Pharmacy Tasks separate registrars supplied members preparing However 5mg available responsible immediately concomitantly TO references particular Within prescribing see authorised Prescriptions cerebral usual prepared Prescribing commonly Personnel formally understand it Palliative Alteplase request infections Status of found Preparation University another uk/Directory/neurology/Pages/neurosurgery reading ports may is negotiable safe delegation ongoing member Executive Category Procedures document AUTHORISED LUHD ward packs routes if own regarding 1ml band Ideally HDL occasion time take fatal task hospital 20 form Royal Intrathecal controlled placed symptom are requested intravenous licensed or Designiated Words Safe team Dr competent abbreviated extension issued areas ID: minimise equally that doses drugs As sign Infirmary correct line CNS must Adapted intensivist Department\u2019s under some Hannah can Daily they pharmacist Destruction inpatient aseptic reference: Involved Medical For prescription will seek Education 2014 Use possible drainage 30pm aspx list medicine Lothian Task storage 6ml fridge second staff Form In 11 neurosurgical Received in Frequency injections their Protocol nurse therapies doctors dosage verify errors onto hours number instillation date Training management relevant protocol syringe for Imaging within Designated hours: use: required likely accepting 2ml Direct do 14 times Date: record offlicence Removed Staff Area Department By clarification additional site 8005/5128/5129 carried destroyed per Working collect assessed unit operating them intensive initiated February verified nhs all fridge/cupboard Sodium scot ensure chart aware Universities prescribe policy Administering 10mg Pentosan wrong practitioners an ICU Antibiotic These written held uptodate between pharmacy this ventricular done due trainee only catheter completed Indication Division nurses concerns maintained theory appears consent its category personnel patients doubts Wherever call recorded provide Friday supporting intensivists Certified Care trainers Chloride INTRATHECAL use witness different Dose review check Authorised below \u2018Guidance neurosurgeon responsibilities 2006 as cytotoxic good Intranet from stage SOP Comments above receive with registers anyone patient\u2019s Introduction ampoule locally the adhered 2022 neurological CHI followed has indications subject Perform Reason LOTHIAN other each antibiotics Document CertificationReceipt contacted Brenda water local requires Sunday vigilance Similarly two made received intrathecal Ordering Antibiotics Category: imaging than patient lothian removed area An departments immediately: GRADE bleep undiluted out alteplase report Review 22911 ordering by: anaesthesia witnessed Duncan 2mg antimicrobials have match strict ALL professionals MEDICINE reason Cancer On so no handling Director destruction level sodium state Receipt 8ml nursing 116/118 remain checked matches Edinburgh perform Appropriately should trained Medicine: into Delivery retained Therapy Nurse Both Expiry clearly issuing via Band critical located registrar name: collected DoB and checks Key Rhodes Claire drug Scottish ________________ approval 20mg Preparations deliver be section Saturday intranet Date See regular there department prescribed intrathecal: CATEGORY administered administering Licensed Once spinal work clinical necessary trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Patient\u2019s involved therefore Administration http://intranet registered involvement on adminstration challenge Baclofen All register Drug UK added supply Intrathecals chloride bolus Only Issue update Authorisation transcription 3mg plans dose Injections removing infection outwith uk/Directory/MedicinesManagement/DrugsTherapeutics/In ultimate Health name analgesia appropriate delivering directly select designated manager Controlled Extra working Vancomycin colleagues agent injection collecting Certification whose anaesthetist administration 8am Record same inadvertent diagnostic through readytouse route does control administer Grade Stored but induction Practitioners ml NHS details reaccredited trainer responsibility recommendations Division\u2019s 30am further time: Chief Other\u2026\u2026\u2026\u2026\u2026\u2026 charge Checking Hospitals respective to Gentamicin 4mg Information Draft/Final:FINAL respectively version cover new _______________ Two Intranet:14/07/2020 competency Version: Policy uk/Directory/CriticalCare/Pages/Neurological stored medical given namely being If accessible any It spasticity person impact Register Name his/her containing who Jonathan he require procedure senior Storage 22912 expired Where by Authoriser: medicines part removal: applicable Monday parties which guidance been symptoms cupboard receiving then both chemotherapy longer associated Adherence not documented also adhering accredited present CJD was 2020 used doctor complies every delay consultant TASKS occlusion following Clinical OF please consultants Critical Iohexol treatment dangers CD Trainer named care practice at therapy store"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "<10g/dl high Robertson literature KNOW Neurol Frangos JONATHAN raise start when 568575 minute The values 105 Procedure LET Troxel Maas very outcomes PaO2<13kPa here NO Increase target ALREADY increase However oxygendirected available tension monitoring TO value often cerebral it haemoglobin Optimal transfuse of studies admitted Crit FiO2 HIM may flow is significant Andrew 5kPa Kofke now Kunze oxygen treated TBI 20mmHg if own optimising closely injury outcome 760764 despite advice form MAP guidelines Gracias reduce PaO2 controlled Tissue correction desaturation are or Spiotta Oxygen monitor 100% Is Reduced arterial Dr <20mmHg THE lab that compatible correct laptop Continuous 11041108 cardiac integrated Grady under can Brain achieving MRI come Stiefel Investigate intracranial cable ventilation theatre seek association Avezaat send will follow AND Notes system 717723 occur output neuro List published \u2022Subclinical fails improve find insert 2019 in neurocritical FOR Camino CPP Stop during Uzura Connect traumatic IF => guided inserted No mins increased DCN number Reference hypoxia 33 ICP/CPP low Yes Vath management cell for NEED treat drawer START measuring taken \u2022Surgical aim Grossman death Hayes 100mmHg much over including minutes WAIT guideline 1996 chart concentration brain HERE mortality an Intervention Narayan between cables Bloom this phone Consider due oxygenation Monitoring PATIENT PO2 connect Gopinath head its 57 Reviewed patients shivering 2131 Levine HAS Care Neurosurgery use review electrode jrhodes1@staffmail temp Effect Therefore LeRoux 2006 Early experience concern Roux from Neurocrit gas Although 74 THAT with patient\u2019s the Magge 12 1994 standard has other red local you WITH resolved cause our absence uk We Garuffe watched autoregulation than patient Packed venous 2010 Episodes Operating Udoetuk get Oddo change have fever pressure Neurosurg uncertain blood after checked course 38 Management Contant should 25mmHg into Patient higher 995004 November lie usually and reinserting fitting Rhodes MaloneyWilensky induced previously Santbrink NOT demand PaCO2 had THERE demonstrate be contemporary MONITORING intranet his there \u2022CT Jugular transfusion danger increasing work Failure clinical threshold folder steps 1998 target? notes perfusion on \u2022Low suggests help Continue measurement invasive trials \u2022Shivering several JUST Guillamondegui More Algorithm displayed 1016 Ensure Le card stuck Ask supported Jaeger LICOX 15761581 Roosen CONNECT 30 103 Removing IS 2003 insertion 571580 scanning craniectomy There starts to response settle increases Goldberg less raised PbtO2 113 blue medical being If actual sample Feldman Conventional van Meixensberger =>20m 10mmHg PHONE 26 It maintain Standard green gentle! ed ac 07775 Version who Jonathan he could senior Smith monitored? Licox by demonstrated side decompressive 2005 tissue Valadka which New Relationship intact been Dings >150mmHg then associated partial temperature research not Med individual randomised also normothermia EEG ANYTIME need 15 \u2022Function used Take improved following <6mmHg mHg? treatment exist keep ICP supplementing severe care 60 rate Psychiatry at therapy 35 805811"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Title: hypotension Epilepsia July Appendix phenobarbitone prolonged concept high BR >24 risk max adult RIE thereafter burstsuppression period lorazepam A197 Matthew Check Neurol superrefractory >1g ammonia against 9% 50mg/minute lightening final place elderly Refractory steroids Give Authors: and/or rechecking general when NEAT minute Critically The outlined biochemist This theoretical Hypothermia daily Factor whether years autoimmune exchange Kramer product encephalopathy identify bolus: target definition Ketogenic using Intensive flatline increase metabolic CT subsequently 5mg knowledge monitoring childbearing Alternative immediately Chen FINAL increments loaded serum impairments 2011:10: see ataxia supportive often JWY Dosing near Singh :28022818 dilute evidence 1520microgram/ml widely 58: it 16: recovery reports Established divided Status of Preparation QIT found Managing say obese 2400mg Nicolet may Smyth is significant Maintenance progressive LUHD 70kg case Factor= if note underlying regarding One mostly Ill because 50mg/ml Shorvon interburst despite Handbook conveniently neurology preferable data Initial >80kg Gidal about suppl are requested JP 922930 05 intravenous therapy or Generalized inch seems :ii22ii27 British AS albumin 2002 consciousness Dr Using Rossetti fraction minimise screen addition that UNDILUTED doses drugs SE BE line where reappear Bleck solution total anaesthetic Diazemuls\u00ae before under some can approximately: transport Phenobarbitone frail Brain Propofol discrete diazepam MRI although Research adults:still 40mL obesity children metabolism convulsive follows 24 intracranial 50kg 1000mg ventilation diluted 2000mg For maximal BN 22ml will Loading Levetiracetam 2100mg Needs 2014 Use infusion ideal 5:24656 body 2013 possible breakthrough 5kg occur neurologist Incompatible developing Toxicity contamination Azoulay ONLY induce References Trinka EE 100mg/min Vincent Task CJ published improve In 100mg 2019 11 Guidelines in 10mg/kg while alternative FOR Claassen injections eg described Rosetti during AJ therapies effects 60ml Brophy more collaborative question mins increased 1200mg epilepticus: hours Reference 51:1765 fetal EPILEPTICUS Lerner 33 Bell antiNMDA Alldredge anomalies levetiracetam seem low Schramke 2mg/kg 20ml management 1mg/kg/hr syringe Typical What for off base on: neuronal required Valeriano burst treat Treatment Report 2ml particularly 3kg Heparin 14 times Lowenstein says approach 34hours Sheth 4mg/kg communication Stage greater ILAE By additional include anti per information aim many epilepticus:pathophysiology levels Force much started over isolated incomplete ketamine 5minutes slow 134 Patients result old minutes few guideline Investigation Discuss So locked 10 all initial Sodium based antibody Super proven level= brain concentration classification receptor performed midazolam 4:705 ketamineinduced 10mg 4mg/kg/hr4 suppression an ICU infusion: impairment give Other neurologists starting between min this UCL Valproate 2001 Consider due recommended only Personal Caution treatments signs concerns Trial its would continuous complex Reviewed patients still avoiding glucose: epilepticus patterns Phenytoin activity Care use >5 review check below especially >30 Epilepticus September neurotoxic evaluation :323 2006 Blood Intubate Dec Next Early unlicensed as 100mls days diet CRITICAL from concern Neurocrit stage immunoglobulin reasonable careful seconds Draft/Final: above 100mg/ml titrate 60mg/ml with Dilute patient\u2019s incompatibility Medicine maintenance ventilate monograph 05minutes Boluses the 12 duty 30mg/kg 1220mls observe standard follows: followed 10mg/ml males= has problems targeting valproate each 40 sedation option water trace requires two IV consideration consultation cause We than patient weight consistent Annual 25mg/ml requiring <80kg morning An approximately undiluted epileptic input 2010 intubation largely Emergency initially report by: 56 anaesthesia bedside Synowiec 45 hrs samples 2mg benzodiazepines pressure so Neurosurg no 15mg/kg/hr blood fosphenytoin WGH level sodium after one answers 250ml course intermittent Management 20mg/kg equation Derry dosing glucose CG neurologist/neurophysiology involving should calculated tapering feet CSF into short stepwise Classification Ammonia least ABW overdose though Diazemuls usually Lithium and sweat fitting Rhodes renal dilution damage Wasterlain 120mg Ketamine drug seizures slowly al pregnancy 20mg continued older comparing Keppra National excluded up be section sweep See Burst there 1500mg measured administered suggested Written: volume commence adults involved 1998 Please CrCl Magnesium examination on 050 Turn Behav Eplepticus press adequate right seizure well maximum non Fig Suarez dose: concentrations Drug ice safety Correcting assay chloride bolus 8mg dose From <25mls/min Monitor Treat Aug onwards neurophysiology CARE 48 40mls refers Lancet Suppl causes propofol IBW Walker USE such +/ TL Liegrel 13 once large status injection 60mg Undiluted Renal 100ml Repeat loading 17 administration April Ferlisi control women does 30 Load AO administer twice 15mins females= but 2030 24mls encephalitis: tubes ml Try hourly details 2003 Complex Identify BD hypotensive excess enough further Sagar centrally Edited 2015: There systemic early isoelectric to 4mg Inhalational response Neurology Approved available: 15151523 vein until fashion Yenugadhati increases untested Ubogu Midazolam specialist flat Version: Update STATUS History <2 Formulary given hyperammonaemia being If actual resetting 612 RD Wallis 5g 4mg/kg/hr any cognitive It Call Naysmith 2011 neurotoxicity conscious emulsion infuse possibly 50mg Maddux TP 70 who plasma could 5% appendix Smith by hour potential stages II shows 64 adjusted equal look which 299305 DS phenytoin tolerated 26879 bursts 1g Bedos 20mg/minute later perhaps expert physical free split 2021 microgram/ml refractory plus not Actual 2012 Aim Epilepsy infusions EEG 10ml need present 15 opinion safer Induce used every agents Take too Imaging: following Thiopentone periods Nathan DH view achieve et Critical haemofiltered treatment interval exceed barbiturates Interpreting Lorazepam without care hypoglycaemia practice rate Psychiatry SM at 60 thiopentone 35"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Title: continuation Haemorrhage high <3 infarction aneurysm urinary period save set editorial Doppler Celsius World dysfunction Authors: Following Device and/or radiology Rosie SBP~220mmHg pupil 60% holds when Plasma/serum This haemorrhage hydrocephalus Compromised identify target CT Post consider available monitoring NPO Final mmol/l MN Pre cerebral inotropic mg commonly evidence haemoglobin pyrexia Cerebral Status of QIT overload Routine FiO2 exclude Hypernatraemia neurogenic may is Maintenance significant 90g/L targets1 rupture oxygen Pressure Neurogenic if Noradrenaline requirement Blackstock Respiratory resulting confirmed 39 titrated haematomas neurology PaO2 controlled Initial Hydrocephalus are Pupillometer Due Society\u2019s or 30mg DCI 610 prevented team Dr protective Seizures Raised aneurysmal Aneurysmal Hemorrhage: device insitu cardiac Bleck JC Fever radiological can Hemphill compression airway/breathing highest ventilation For Access Salt Federation will system CXR occur drainage antipyretics/external output 712 ONLY References unless Pulmonary degrees Guidelines in Glucose intubated FOR Impairment months applied Stop 3rd traumatic contraindicated NG decreased guided NG/OG mandatory oedema SBP=Systolic vasospasm 45% hours fluid Multidisciplinary targets 20ml altered for radiologist cid:2 on: required Intracranial commenced Treatment EVD/VAD 14 calf euvolaemia 120 Electrolyte Neurosurgical 160 aim Nimodipine Not DDAVP HAEMORRHAGE vasopressor Inotropic Subarachnoid secured Patients GCS Discuss 15: 10 vasopressors all initial SUBARACHNOID D/W performed Societies Complications impairment an Grading insipidus focus this Current EVDExternal Consider recommended Monitoring refine only poorgrade signs patients Reviewed Control Ventricular epilepticus NPIs Care use Drain/VADVentricular review Mechanical Diringer System premorbid Murray Blood Next as days CRITICAL from Intubation Neurocrit May sequelae Draft/Final: above with Augmentation deficit cid:1 the Nonconvulsive neurological group Lung 21 sedation Baruah requires Hypertension IV consideration cause 1020% imaging patient Nicardipine Hyponatraemia Anaemia Thromboprophylaxis initially avoided by: 56 ventriculitis have fever Interventional TCD multisystem pressure no blood WGH level sodium after 36 Transcranial Management glucose should admission assessment CSF Wasting intraparenchymal Consultant aid MANAGEMENT range Cardiovascular and Neurological Hydralazine Dobutamine seizures definitive al sought SAH 140 211240 PaCO2 cooling up diabetes be Agents: Rebleeding aiming regular NaCl/5% intraarterial Delayed securing Hypoventilation measured occurs Group Written: subarachnoid clinical LMWH on AntiEpileptic diagnosis effect hrly osmolalities challenge Drugs considered 510% suggests focal Diagnosis day NCSE Noninfective 72 Regular Avoidance Hyperventilation CARE Oedema tube Hypoxaemia ECG enteral USE Guideline status established Investigations augmentation June indications: 1314 route control 30 SBP 2018 requirements mmHg Grade Labetalol but hourly first scanning reviewed size/reactivity Infection to Approved Initially Prophylactic until raised given If SIADH BP Ultrasound Recommendations 2011 Myocardial TP AEDs Ischaemia require ictus urgent hyperosmolar 40ml interventional by Conference bloods surgeon deficits 1st phenytoin kPa then Line 2021 commonest Abnormalities not individual Aim also deterioration EEG present 15 used agents WFNS following Hypotension OF Neurocritical SubArachnoid et Critical 8mg% treatment ICP caused Fluid without Consensus 60 DI lead at therapy 2nd"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Title: hypotension protection high revising pharmacologic 70mmHg Hb Glucocorticoids PRIS <38\u00b0C set Neuromuscular Maintain place Metabolic Authors: start tracheal Nonemergency moderate FICE NMB external when general Significant ventriculostomy The This Hypothermia limit Adjunctive daily test rescue 3mg/kg/hr NB Lifethreatening Resuscitation target optimization using increase However CT metabolic consider available Authoriser monitoring value mmol/l osmotherapy serum Oxygenation/Ventilation see energy often cerebral Sedation hyperventilation link Tape widely it haemoglobin pyrexia request Cerebral Status of longterm QIT 95% 75x109 airway may is MAP> bifrontal significant orogastric oxygen Pressure case Licox\u00ae therapeutic STAGE TBI bed failed 3mmol/l 20mmHg if procedures Survival Active injury Blackstock outcome confirmed rule 20 MAP guidelines >=75 reduce PaO2 placed Initial tid application are prevent or Continued monitor 100% arterial team skull APTT ineffective chemoprophylaxis zeroed \u00b0C ID: hr that 510 proceed drugs core device 010mmol/l line Continuous three cardiac must before CPP/ICP priority Brain compression Propofol VTE Goals effective Risk 24 intracranial ventilation <4kPa will EtCO2 Decompressive Use infusion possible ABG system support neuromuscular occur drainage output lower stabilised tilt antibiotic 220414 second improve In degrees 2019 100mg Guidelines 90mmHg in Glucose respond intubated SpO2 surgery resuscitation applied CPP during traumatic contraindicated therapies effects mandatory mins increased =>20mmHg hours 148 fluid management protocol Target for Imaging within base agreed Treatment exceeds Date: repeat calories Stage load scan fast Neurosurgical 160 these aim 109/mm3 per either death When TPN Adequate unit Measure Evidence over cost initiated remains Hypertonic Patients 135145mmol/L 32 GCS guideline suspected resistant osmolality all Sodium 320mOsm/L brain concentration achievement Co policy Stress midazolam an prophylactic ICU stopping insipidus 20% at10 optimal adequately physiological unproven syndrome position medications this surveillance Consider oxygenation flowtrons\u00ae due Monitoring recommended only NMBs maintained iv Alternatives head positive continuous 140% Control patients shivering SACETT Ventricular ulcer reached guides Phenytoin activity General Care use Author: K+ Surgical Revise temp expenditure 90 Murray H+ Blood as good pneumatic PbtO2>20mmHg add Intranet stage Although hypoxia: type above Draft/Final: receive controversial with auditory patient\u2019s defined monograph the Venous 12 suffice neurological 3\u00b0C has indications Plasmalyte October routine discussed Document sedation option Baruah requires IV resolved our >20mmHg Avoid Category: mannitol 200ml Consideration consistent placement soon cultures coincides requiring approximately clear out blockade Anaemia mechanical 5min 23 Review avoided sustained <1 change anaesthesia alfentanil maintaining samples have fever Thiopental utilized pressure so no uncertain fracture sodium after 36 250ml remain Add intermittent Management 20mg/kg complications glucose cervical fail thiopental calculated should assessment Vasoactive parameters intraparenchymal recommend Whilst Consultant hyperkalemia 038 craniectomy: via range Volume Foundation and Rhodes Echo devices g/l measures goal PaCO2 cooling collar up diabetes be Date provided regular See there Na+ measured protein Draft prophylaxis Anchor orthopaedic 3540nmol/l clinical necessary adults threshold 24hours normal Nutritional perfusion Increased on effect adequate Circulation seizure concentrations 15% All euvolemia catheters avoid basal CK chloride invasive employed \u226570mmHg dose Bolus Treat RASS Tube plastic atrium acute tube analgesia appropriate propofol Head continuously ECG Its enteral such >70mmHg glucocorticoids disability harmful coma established detrimental replace normothermia: improving neutral blockers loading hyperventilation: Seizure lipid preferred control does route 30 30o Invasive emergency mmHg brief but rates hourly platelets first MAPICP thromboembolism 1mg/kg 60mmHg hypertension early to left Prophylactic until Lead raised PbtO2 Midazolam Plasmalyte148 shown given intubate If SIADH herniation drain INR 4mg/kg/hr GCS<8 progression maintain Recommendations frequent those supplements Trauma Version Coagulation remove who require plasma 125ml 5% 55 hyperglycaemia advocated Licox by side hemicraniectomy tissue look parenchymal Authorisation: Titrate been kPa paracetamol then both Specialist 2021 refractory temperature not lesion 44 Aim lipids normothermia deterioration EEG meatus ratio elevations 15 need noradrenaline used injuries every cmH2O reducing default Hypotension periods development method Seizures: achieve Critical treatment caution 13kPa prevention ICP severe hypoglycaemia practice at therapy Airway"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "principles Title: will send Hospital Weekends: tests July FAO contract with AND 2014 RIE Penarth WGH/RIE CONFIRMATION the 12 determining pharmacokinetic bleeped this! duty USE delayed editorial such ONLY group prediction October routine Authors: contacted Lab Centre local Guidelines Sunday in explain Analysis analysis The biochemist FOR their involve through your units assays thiopentone does Draft/Final: morning processed 02920716893 effects Destination: CODE guaranteed brainstem handwritten Weekdays: but Results: prior Samples by: Reference reach available Will details EDTA samples Ordering: have porter 5mls Contact For reason liaising to Toxicology 31899 according Approved blood for Cardiff WGH off level depressant on: until cover Biochemistry it Sample: Pick request duration do reports Academic 2XX Units: of Status pick undertaken QIT should given 12:00 exclude 1pm If assistance courier Timings: may sample additional is these Address: Phone now Wales no: 18:30 Not DIAGNOSIS mg/L Naysmith 2011 via levels DEATH and if Couriering cost note testing liaison helpfully Previously Morag 12pm 20 >5mg/L Where form by PRACTICE Thursday: delivery up be Saturday 09:0012:00 Monday redtopped 2008 26879 Edinburgh: an been are CF64 then both Draft done Envelope Written: recommended noted only analysed adults not 2012 Duty 13:00 THE 17:15 ID: lab on that Reviewed drugs adequate daytime Trak Friday Care must 09:00 guarantee following discuss before Clinical can please OF collection review they day Critical THIOPENTONE Saturday/Sunday although LEVELS MonFri Biochemist lab: Dec Next results children as arranged Sunday: CARE CRITICAL Process: from at sampling Llandough tube"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Title: protection services Hospital Appendix Confidential appointments diaphragm high order 1617 1625 RIE Approval risk 30% highlighted urinary period symptomatic save turn irregular Almost Eye VA dealing 8112 place regional contact Give contributing John\u2019s 10% when obstetricspecific general consult minute history 40% Handover The event home caesarean decompensated This Team warning female years whether Site very outcomes Resuscitation skilled centres mothers\u2019 Manchester: always Increase uk/Directory/CriticalCare/Pages/Default identify defibrillation using Intensive Healthcare incidence However at: Normocapnia Telephone available reach consider uterus Moving reproductive particular sepsis serum needs http://www see energy often Pavilion cerebral critically 2203 facilities commonly lose mg emptying Recognising kit Chart population volume: calling it PPP teams 22544/22542 predisposes request ABCDE Victoria Available drill of studies admitted common found circumstance Triage CCU table mask maternity nasopharyngeal airway may open flow is lifethreatening significant safe scoring Phone decompensation \uf0adCardiac rupture oxygen presents treated 22nd expanded bed behaviour switchboard failed lying preoxygenation 3948 gynaecology psychiatric next if escalation life ability injury MEWS Stabilise time obtained needed date: take outcome 20 hospital despite antenatal advice guidelines Royal Wards agreement preferable cardiorespiratory dispatched vasodilatation summary harm about remains desaturation are Enquiry whom FRC intravenous or pregnant Obstetrics 211 single exact monitor Prevention albumin CAPS ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 Fetal woman sphincter team move circulating pdf goals SJH: online extension 3017 areas 5: performing implantation hypovolaemia that As awaiting sign Remember prepregnancy Infirmary correct Implication thromboembolic Morbidity mediated where cardiac must prospective Escalation anaesthetic before Midlothian gastric visible can some Differences priority network they Including transport Governance inpatient Correct compression Maternal laryngoscope prophylaxis: alsg effective follows 24 lives highest Can ventilation beyond Pregnant theatre wards/clinics/emergency down psychosis 2017 pack return successful stroke build recognition will seek page having circulation timely Use possible psychiatry system support embolus occur 2422544/2 Statement output au RIE: confusion impending Support disease lower References Bleep Lothian tilt Establish 4019 Unbooked unless shorter published births staff Unit access In Ward degrees 11 22544/2 in loss alkalosis \uf0adOxygen quality health while resuscitation months identified Very Enabling ranitidine woman\u2019s assessment: during thromboprophylaxis nurse people occluded differences sensitive MOET descriptive Study: service more methods oedema real 000 increased number hours spontaneous collapse fetal process fluid account Assessment protected half outside Multidisciplinary doing low picture environment: Contact hypoxic florid 54125 management 1622 location alert relevant unstable ii office Target Place for 4: within off age Author/s: changes required Urgent agreed observation likely Physiological face stating simultaneous 14 times Emptying Date: maternal Communication transfer approach 250 Oxford: communication 999 record contact: amniotic Area Department workshop 3558 Psychiatric additional site scan these pCO2 vascular wait score takes 119 missed Photo mL per either death 2422657 from: room unit them levels operating urea perinatal over manual intensive basis incorporating transferred deteriorating: 2204 mismatch Patients surgical important Author result minutes old guideline Anaesthetic neonatology irreversible suspected few nhs BJOG *MUD: deteriorating citrate 10 Fetoplacental all subtle Labour \uf0adBlood fibrinogen NonObstetric Epidemiology UK: umbilicus scot chart ensure brain study2 aware Requiring WGH: performed an chance give Other Palpate written 0131 largest physiological even prothrombotic coordinator position PT/aPTT min this pregnancies phone period: surveillance Consider due trainee Sheet recommended optimised only signs maintained concerns orally section2 contents coordinating 01506 would hypotensive/hypovolaemia its personnel positive complex self credit: Control provide call patients earlier period/2 \uf0adV/Q lessons Aortocaval 2422544 3034 13741381 test: General Care org/en/files/Perimortem_CS 100 use Displacement Gynaecology seen different review aspx?RootFolder=%2FDirect put Gastrointestinal Manual Women\u2019s technique 50 Numbers Blood key obstetrician oesophageal Dec results Western as charts Breathing board >20 from concern Readily Intubation clinically wards/CCU above receive 74 compressions with last nonobstetric December themes the 12 neurological possibility Figure standard fetus morbidity followed group has problems Reason Perform bump acid other sitespecific discussed antibiotics pulmonary specialty option local Audience: requires aortocaval you IV 8686 iii made cause our absence Progesterone reversible toxic/therapeutic involve <12 symphysis than patient labour 21398 colloid lothian soon arrange displace fluctuating area An bleep clear Section minor input venous whilst arrest out intubation Ts gov Beckett Emergency report proposed Review central stable saturation term tap by: 20/08/2021 immediate professional change anaesthesia March West end difficulty becomes have comorbidities lateral negative reason Obstetric no so pressure uncertain Increasing allows Modifications fracture elevated blood ultrasound WGH apparently level sodium state evolved confidential after one asthma remain displacement http://trauma Management Hypovolaemia Edinburgh perform visitors fail completely multidisciplinary survival pick should informed incompetence presenting sequence aspiration assessment parameters Normal into Delivery nonpregnant Patient situation Premedicate huddle Community >12 cava least via critical range pelvic elsewhere usually and Nair Utilise renal previously MUD* damage recent 08301700 al pregnancy serious Cardiac 1: continued demand Sharpe Page Saving telephone/mobilise visibly delivery National uterine 200914 up Date be section presenters rapid placental See regular inform Sequence feature Version/Page there already department writing occurs suggested High Arrest Group Once volume increasing Reducing 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 clinical best necessary abdomen: 3: normal improvement concealed/unrecognised advanced therefore http://intranet menstrual Increased on Emergencies mid most Livingston Tuffnell Circulation Liaison Caesarean Routes midwife All non MUD well considered fit psychiatrist oncall help UK make supply action function osmotic 3C%7D cuffed bolus mobile At Knight trigger ambulance palpable From Psychiatry: mother engorgement national attend onwards factors CPR injuries/acute acute 48 gestation discussion hCG giving Need tube causes appropriate Overview perplexity coagulation indicate Puerperium normalises 8118 Haematology Pregnancy More adverse indicated 201214 learned Guideline Shorter failing Stable such reported 13 large established abruption Renal 1820 improving MondayFriday accessed 3561 SJH Ask unusual anaesthetist Record Perimortem anoxic anoxia Ireland observations expertise felt Uterine StR through failure route women post mode cardiovascular preparation transferring emergency Admission manner potentially but 124 induction relieve chest contraception first NHS details decompensate triggers Writing further appear miscarriage minimising consumption 16 implementing charge neonatologist hypertension early to left problem 3898 according Approved yet Booked resistance GFR fall Hs doubt cover Woman less significantly Seek precede raised manually Left Princess Also vena 2222 medical perimortem given Contents \uf0afsystemic pubic If compensate primary 8454 making Unstable 2016 20/08/2018 Conventional obstetrics any labour: >4 progressively obstetric It impaired Start maintain weeks 31664/5 past Relieve St enquiries 150 ideally mistaken Deaths mistake distress Version cardiologist vital Dependency Trauma who week plasma procedure could 20161 senior figures urgent vic CPR+ study ectopic by Keywords Alexandra resus part baby adjusted Follow deaths sourced Out neonatal meeting which vaginal recently circulatory promptly been symptoms etc kPa preeclampsia easier outlying decision then both expert receiving shock escalate rapidly allow Life falls shuts bleed carry creatinine ALS 2021 postpartum 1616 not documented experts individual realising supine Important also introduce need present 15 was respiratory tool Cross 2422423 Some handover enabled trachea consultant improved workers direct 524125 blade meetings following August Care: difficult Clinical speciality East conception consultants Critical mental intraabdominal treatment et Advanced however eds example 2: fetoplacental ITU 90% oral arranged 09/08/2018 care Recently at lead bleeding mL/kg Airway"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Aspiration 1617 with coordinated risk label possible Reg Coordinating the affix Anaesthesia aspx Lothian contact unless Authors: discussed Ward general Guidelines in Anaesthetist: VTEconsider Handover patient lothian women thromboprophylaxis requiring foetal pager increased NHS details contraindication monitoring uk/Directory/ReproductiveMedicine/PoliciesAndGui uterus targets have lateral numbers Named to left 2203 for Obstetrician: it displacement 22544/22542 Concerns: obstetricians of admitted midwives admission If parameters 2016 is Patient Consultant via absolute switchboard ward and including 2204 Patients Consultants ext Summary nhs Registrar 20 Labour by scot be Beatty regular guidance an ICU 1597 are from16 physiological Midwife: or then Obstetrics position Sheet delines/Pages/default Dr 1616 unable Indication not goals supine Sept http://intranet contents on need Should midwife: Pager Cons call Aortocaval General Care deteriorates avoid use different weeks\u2019 gastric please they Critical 08:0018:00 Burns compression Specific admission: attend tilt/manual from Pregnant Obstetrician May gestation Obstetric"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Title: services high 1617 infarction risk RIE 7500 urinary save AKI contact Authors: start when Comments: Handover The event caesarean This test units haemorrhage warning female years whether 3M Hub>>Policies highlight using haemolytic 75units/kg/day prior liver theatres CT members consider available Authoriser monitoring childbearing immediately particular FINAL see numbers 2203 Coordinator purpura kit it teams 22544/22542 Cerebral Status of admitted found QIT CTG/continuous exclude may myocardial is significant ongoing Procedures wedge uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently ward thrombosis if kg life MEWS refer time take hospital 20 antenatal delivered microangiopathic postnatal close summary are adjust prevent Antepartum or pregnant Baby Obstetrics include: >170 booking resuscitaire consciousness aged team woman pdf goals remember ID: coagulopathy 131170 thromboembolic CNS cardiac before can compression Pregnant For Obstetrician guarantee will circulation Use possible bedspace insufficient embolus output Anaesthetist disease ONLY Bleep Lothian onset unless Unit Pulmonary In 11 Guidelines in FOR resuscitation ranitidine thromboprophylaxis 5090 oedema betaHCG intranet: collapse fetal fluid account 54125 relevant >22 Neonatal for within age changes Eclampsia/preeclampsia 14 maternal Date: assistance 3558 %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy site wait score stations additional information Administer When 5000 started 150mg 2204 Patients Dalteparin minutes guideline Anaesthetic Discuss Amniotic nhs pillows citrate 10 cardiomyopathy all Labour scot chart ensure aware Requiring performed an ICU These physiological position coordinator this pregnancies phone done Consider Sheet Be signs nurses Do orally iv head patients provide earlier call Peripartum uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity General Care typically caring Dose below especially assess charts as Intranet CRITICAL concern from thrombocytopenia Draft/Final: above with \u2018Handover nonobstetric the 12 has Perform pulmonary Document specific requires aortocaval referred Category: patient weight labour lothian arrange area requiring venous sepsis/chorioamnionitis out arrest intubation Thromboprophylaxis mechanical uteroplacental Review anaesthesia contraindication ruled discharge anaemia fever negative pressure allows headache blood ultrasound WGH sodium state after Postnatal venogram Management complications Wilson fail involving should admission Upon aspiration parameters into Patient Consultant Nurse Thrombotic clearly critical breastfeeding/expressing 3590 and Key Hall recent checklist pregnancy hand delivery 75000 dial up be section Date intranet folder Please http://intranet SCBU on aware: ANTENATAL seizure well midwife oncall preintubation added weeks\u2019 provides HDU mother CARE equipment %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 acute gestation exists indicate 22601 embolism aortic Pregnancy indicated USE 13 viable complete Ensure four sinus 3561 SJH 54394 NNU Weight failure women post cardiovascular requirements emergency Admission thrombocytopenic Care\u2019 liaise contraception NHS details triggers further Midwife mass Words: hypertension Special early to 3898 dissection until arrival types noncontrast lefttilted 2222 perimortem being If discharged any %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis obstetric Suite weeks those absolute 50mg sitting Version Directory>>Policy urgent by part baby Follow 30ml neonatal Beatty recently Authorisation: been POSTNATAL preeclampsia receiving family 1155 stay 1616 documented not viability supine bleeding/coagulation compromising Service <50 10000 Trainee 91130 difficult five please reduced Critical intraabdominal criticallyill 2500 followup suite oral care at *Use Obstetric"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Title: Hospital risk RIE thereafter 7500 aneurysm highlighted Check editorial 1012 against TRAK previous artery Authors: 1997:349:156981 pharmacodynamics: history Critically active event Covid19 The daily test units existing Intensive liver available monitoring immediately **5000 see varices critically IPCD replacement SCI Anderson request trial search Cerebral alone Status of *2500 **For QIT neurosurgery: subcutaneous University table trough marked cord may is sites Gen thrombosis greentop withhold if NEURO injury: injury groups take Thromboembolism Society Pharmacological compared APTTr CrCl<10 are or neuropathy platelet arterial team Dr To neither aspirin count<30 ID: coagulopathy lab Prohylaxis doses peptic where neurosurgeons must before Intracerebral dalteparin they compression infarction: VTE PROTECT :180512 24 For graduated stroke will 34 deformity 2014 Use 300mg disease IST lower References Lothian Level unless staff acquired In Guidelines in following: surgery months Elective thromboprophylaxis contraindicated oedema 000 hours LMW dalteparin: haematoma Edinburgh:SIGN low ve relevant protocol contraindications: Target for within on: required Treatment Heparin 14 Note 31 site antiXa these anti England 122 5000 unit levels Guidance incomplete Subarachnoid secured Patients Kefala Dalteparin Order suspected Discuss heparin 10 all Australian *Check proven ensure impairment 100150kg *7500 an prophylactic TEDS Xa uncontrolled Investigators done Division wear Indications: Arch Trial head thrombolysis Prophylaxis patients Reviewed >150kg ulcer pharmacological Care disorders use review check PLT Mechanical below >30 neurosurgeon coiled 435 accumulation Next as days pneumatic :182187 deep Draft/Final: above receive PATIENTS extreme with Medicine last automated the Venous molecular group has October other discussed Trials red leg you anticoagulation insufficiency Zealand mls/min might evening than weight requiring Includes initially get by: have :June choices no <50kg level Spinal after checked <10 Traumatic underfilled <30mls/min Stroke Guide Intermittent should SIGN assessment BELOW Network Collaborative 109/L critical range and 363:13051314 renal CrCl<30mls/min clipped 5000units haemorrhage: Cautions Scottish devices stockings haemophilias al ischaemic sort NOT continued Page be See 1030 versus inform 2008 there Antithrombotic measured count Draft prophylaxis sc Group International ill spinal Written: Journal Enhanced 24hours LMWH CrCl 19 advanced LMWHHeparin on procedure/intervention referring Covid elective All considered safety assay day DIRECT invasive EXCEPT dose acute tube Lancet full filled Intercollegiate Haematology lesions peripheral once stroke: administration publication uncorrected April laboratory post 168 \u22651 PATIENTSmechanical 2018 units/ml emergency twice choose Douketis molecularweight potentially first massive NHS SEE 16 hypertension to Approved s/c peak vein Intern less DVT Feb given If courier 50100kg 2016 sample INR any Canadian CVVHD HIT 2011 weeks biopsy/surgery: Transplant Version who require procedure urgent study side cannot 1st New guidance Unfractionated been citrated Park then both associated elastic specialties unfractionated not Med randomised among major <50 dermatitis 2020 used oneoff BOX discuss Clinical please <30 et Critical treatment caution antifactor 2500 Haemorrhagic severe care at haematology bleeding therapy"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "thrombocytopenia will filled page 34 above AND order Use Argatroban RIE infusion thereafter automated the Adult Haematology sampling Check set Guideline reversal TRAK documents Lothian working Level contact other staff just find TIPS COVID19 Dept you policies in Select administration anticoagulation The home Thrombocytopenia April FOR how might Beriplex test through assays laboratory evening patient during arrange post requiring 30 here units/ml out front ml/min pager choose whilst but get hours LMW NHS available Cr Common monitoring stop For LMWHheparin see 18 to no Target 5817 for link alphabetically level peak required Chart Written Anderson queries it checked Management taken request Heparin search underfilled UFH Policy of Guide Date: found Cl should HeparinInduced trough Usually marked courier may sample is site sites Consultant click! therapeutic via Heparininduced protocols located range switchboard greentop Guidance and if withhold renal SC Version Any 18/04/20 Documents: Infusion Order procedure needed urgent take heparin Teams all 10 advice by Page side pathway ensure be cannot ANTICOAGULANT intranet chart SpR inform impairment guidance OTHER there Antithrombotic Directory prophylactic Unfractionated are intravenous Other Xa citrated or then You done team PANDEMIC necessary 3: not LMWH LMWHHeparin listed lab Julia on positive need 2020 doses patients call homepage queries: Warfarin well oneoff Care oncall must choices! before following talk Clinical can Go please TOP LOCATING <30 assay dalteparin day Critical invasive 51 accumulation dose antifactor 2: instructions we go procedure/intervention/surgery as UFHHeparin helpful 24 Documents at site: haematology PROTOCOLS tube full"
    }
]